Trait_category,Trait,Protein,Protein_definition,sample_size,Estimated_effect,se,lowerCI,upperCI,Pvalue
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MFGE8,Lactadherin,42120,-0.134347362861441,0.0043602694685426,-0.142893491019785,-0.125801234703098,3.13328115598231e-201
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GCG,Pro-glucagon,41861,-0.342104035634133,0.012721546116559,-0.367038266022589,-0.317169805245678,5.88424007008756e-155
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGFBP1,Insulin-like growth factor-binding protein 1,42273,0.325423637118728,0.0121677072603772,0.301574930888388,0.349272343349067,1.82573399400121e-153
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AGRP,Agouti-related protein,42256,-0.134752092973381,0.00515016440770063,-0.144846415212474,-0.124657770734287,4.00897900951256e-147
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LDLR,Low-density lipoprotein receptor,42151,-0.126905855803341,0.00514787536170345,-0.136995691512279,-0.116816020094402,3.587422691846e-131
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NPY,Pro-neuropeptide Y,42223,-0.159030569237378,0.00645178746049545,-0.171676072659949,-0.146385065814807,3.71112432555251e-131
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TMPRSS15,Enteropeptidase,42094,-0.223460405202295,0.00923489403329228,-0.241560797507548,-0.205360012897042,1.5320726121267e-126
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C9,Complement component C9,40102,0.125868955942929,0.00539467463078544,0.115295393666589,0.136442518219268,1.53845401758253e-117
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGSF9,Protein turtle homolog A,40080,-0.195112177428236,0.00839621474840032,-0.2115687583351,-0.178655596521371,1.25744179363937e-116
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CES1,Liver carboxylesterase 1,42170,-0.187590860511047,0.00827553559755225,-0.203810910282249,-0.171370810739844,1.33953022021148e-111
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRAP1,Proline-rich acidic protein 1,40097,-0.0948369594976777,0.00418213393882009,-0.103033942017765,-0.0866399769775904,2.78415082405091e-111
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LPL,Lipoprotein lipase,42144,0.103424327022827,0.00473906324838211,0.0941357630559978,0.112712890989656,1.00920133937716e-103
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCN1,CCN family member 1,42076,-0.159329141426636,0.00738499565427653,-0.173803732909018,-0.144854549944254,1.91824076295789e-101
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,42197,0.0808637258910267,0.00381881872975704,0.0733788411807029,0.0883486106013504,7.21802534879695e-98
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APOF,Apolipoprotein F,40102,0.0501916296117422,0.00242128884262303,0.0454459034802011,0.0549373557432834,1.18766159908149e-93
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PON3,Serum paraoxonase/lactonase 3,42184,0.0579167425749908,0.0028112506517089,0.0524066912976414,0.0634267938523402,8.00221795305491e-93
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CPM,Carboxypeptidase M,42158,-0.067214753263367,0.00344834575941811,-0.0739735109518265,-0.0604559955749075,2.00223774683155e-83
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FURIN,Furin,42186,-0.0647134605459316,0.00332670448722071,-0.0712338013408842,-0.058193119750979,4.18424441221573e-83
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGFBP2,Insulin-like growth factor-binding protein 2,42274,0.122638213050939,0.00636421627454685,0.110164349152828,0.135112076949051,1.29334569684114e-81
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADIPOQ,Adiponectin,40113,0.133866067442711,0.00702592533342113,0.120095253789206,0.147636881096216,1.20377731245041e-79
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GH1,Somatotropin,42122,0.328386210344564,0.0175652375621432,0.293958344722763,0.362814075966364,5.58538541320993e-77
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GUSB,Beta-glucuronidase,42217,-0.115624424665069,0.00622534828501772,-0.127826107303704,-0.103422742026434,5.0669530850906e-76
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PYY,Peptide YY,39706,-0.193709660986197,0.0104802760014844,-0.214251001949106,-0.173168320023288,4.33106566222585e-75
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADH4,All-trans-retinol dehydrogenase [NAD(+)] ADH4,41876,-0.153244361918104,0.008315457769268,-0.169542659145869,-0.136946064690338,7.29415585379045e-75
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,INHBC,Inhibin beta C chain,42120,-0.0770870593614879,0.00418445988851829,-0.0852886007429838,-0.0688855179799921,7.88345040773615e-75
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GHR,Growth hormone receptor,39863,-0.0525991727775399,0.00287929766579275,-0.0582425962024937,-0.0469557493525861,1.94589019456295e-73
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MXRA8,Matrix remodeling-associated protein 8,39863,0.0566450375917216,0.00318057035765133,0.050411119690725,0.0628789554927182,6.08467195511717e-70
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NRP1,Neuropilin-1,42211,0.0504913536124841,0.00284270037962363,0.0449196608684217,0.0560630463565464,9.28202111776162e-70
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLC39A5,Zinc transporter ZIP5,42103,-0.0972984150564414,0.00552785136631823,-0.108133003734425,-0.0864638263784577,1.51297499593145e-68
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SKAP1,Src kinase-associated phosphoprotein 1,41985,-0.131723329084197,0.00752060734357831,-0.14646371947761,-0.116982938690783,6.81194983165023e-68
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GIP,Gastric inhibitory polypeptide,39804,-0.105051496450631,0.00599232228806426,-0.116796448135237,-0.0933065447660252,7.48092571891477e-68
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DSG2,Desmoglein-2,42120,0.0482383850598764,0.00278405542872856,0.0427816364195684,0.0536951337001844,1.66656734598817e-66
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SHBG,Sex hormone-binding globulin,40102,0.0877176359333232,0.00516007225624537,0.0776038943110822,0.0978313775555641,5.52174457497139e-64
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACY1,Aminoacylase-1,42144,-0.105830566185308,0.00623472098728643,-0.118050619320389,-0.0936105130502265,6.23316009956353e-64
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNAJB1,DnaJ homolog subfamily B member 1,42094,-0.149177846972347,0.00884460452815088,-0.166513271847523,-0.131842422097172,3.7614958087188e-63
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AGR3,Anterior gradient protein 3,41841,-0.102422629425405,0.00616617138618738,-0.114508325342332,-0.0903369335084779,2.61026764091111e-61
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APOA2,Apolipoprotein A-II,40102,0.0832310357103114,0.00503113428924625,0.0733700125033887,0.093092058917234,9.82028794054749e-61
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CREG1,Protein CREG1,41961,-0.0651445316165668,0.00395334483601473,-0.0728930874951557,-0.0573959757379779,2.20347908932531e-60
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTH,Parathyroid hormone,39768,-0.138466158181979,0.00839379317037671,-0.154917992795917,-0.122014323568041,2.21078534245693e-60
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPY,Pancreatic prohormone,42110,-0.174348218801805,0.0106452631574675,-0.195212934590442,-0.153483503013169,1.09578383591998e-59
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LPA,Apolipoprotein(a),39902,0.303622256611179,0.0186750303039678,0.267019197215402,0.340225316006956,9.84554646053065e-59
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CKB,Creatine kinase B-type,40097,0.100233873896083,0.00617267694366041,0.0881354270865085,0.112332320705657,1.31325334631285e-58
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DEFB4A_DEFB4B,Beta-defensin 4A,41987,-0.247835498018289,0.0154055967694118,-0.278030467686336,-0.217640528350242,1.14970872601937e-57
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ALDH1A1,Retinal dehydrogenase 1,42120,-0.0884879989152317,0.00550451003296032,-0.099276838579834,-0.0776991592506295,1.36807160330893e-57
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANGPTL7,Angiopoietin-related protein 7,42223,-0.0597600043900801,0.00374354313674888,-0.0670973489381079,-0.0524226598420522,7.92971436076022e-57
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UPB1,Beta-ureidopropionase,40080,-0.145775449289987,0.00916400625022206,-0.163736901540423,-0.127813997039552,2.42365798238512e-56
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,INPP5D,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1",39804,-0.0920804036574994,0.00583526564530305,-0.103517524322293,-0.0806432829927054,1.8217966705627e-55
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGF21,Fibroblast growth factor 21,42193,-0.189701257255175,0.0120474322990203,-0.213314224561255,-0.166088289949096,2.36632317021525e-55
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,YOD1,Ubiquitin thioesterase OTU1,39706,-0.101442390083198,0.0064902227308672,-0.114163226635698,-0.0887215535306986,1.86045141368955e-54
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,41876,-0.0882069030761322,0.00567698002853507,-0.099333783932061,-0.0770800222202035,6.05683073023481e-54
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGSF3,Immunoglobulin superfamily member 3,42094,-0.0578878505612983,0.00373366271676074,-0.0652058294861494,-0.0505698716364473,9.89621672415315e-54
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SSC4D,Scavenger receptor cysteine-rich domain-containing group B protein,42122,-0.181310321480709,0.0117180310854921,-0.204277662408273,-0.158342980553144,1.59810545109989e-53
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VPS37A,Vacuolar protein sorting-associated protein 37A,42094,-0.126070443415165,0.00816533035749787,-0.142074490915861,-0.11006639591447,2.65024659121666e-53
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SIT1,Signaling threshold-regulating transmembrane adapter 1,41887,-0.0875767908682095,0.00569800596976548,-0.0987448825689498,-0.0764086991674691,7.80878247518923e-53
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GSTA3,Glutathione S-transferase A3,41861,-0.118620870949112,0.00786855650859765,-0.134043241705964,-0.103198500192261,6.5043446231835e-51
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENO3,Beta-enolase,39804,-0.0899629865745218,0.00602126315461983,-0.101764662357577,-0.0781613107914669,5.74473572608735e-50
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FTCD,Formimidoyltransferase-cyclodeaminase,40035,-0.130501973558573,0.00875528965433374,-0.147662341281067,-0.113341605836079,9.42546346218106e-50
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HHEX,Hematopoietically-expressed homeobox protein HHEX,40054,-0.114070149657376,0.00770066996158972,-0.129163462782092,-0.0989768365326606,3.63926040287329e-49
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLEC4A,C-type lectin domain family 4 member A,42103,0.0534180742816544,0.00362101633145543,0.0463208822720018,0.0605152662913071,7.43464722392902e-49
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SMOC1,SPARC-related modular calcium-binding protein 1,42223,-0.0492607312594579,0.00335900173191379,-0.0558443746540089,-0.0426770878649068,2.60889993776055e-48
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MEP1A,Meprin A subunit alpha,40021,-0.108749915644353,0.00743105041574581,-0.123314774459215,-0.0941850568294913,4.85845569540235e-48
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GPR37,Prosaposin receptor GPR37,41876,-0.102559491172417,0.00702439203543067,-0.116327299561861,-0.0887916827829724,6.81975899090783e-48
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SMAD1,Mothers against decapentaplegic homolog 1,41861,-0.122116348326065,0.0083830093396905,-0.138547046631858,-0.105685650020272,1.10396688033792e-47
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSRC1,Proline/serine-rich coiled-coil protein 1,41861,-0.0881604829884337,0.00608172986537981,-0.100080673524578,-0.0762402924522892,3.06773038534157e-47
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLTP,Phospholipid transfer protein,42255,0.053263525815102,0.00369724278057076,0.0460169299651833,0.0605101216650207,1.07669734760339e-46
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL17RB,Interleukin-17 receptor B,41931,0.0793333248746961,0.0055199457443942,0.0685142312156835,0.0901524185337088,1.78720053750492e-46
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTS,6-pyruvoyl tetrahydrobiopterin synthase,41772,-0.0813356348771441,0.00568548057783702,-0.0924791768097047,-0.0701920929445836,4.62083340730208e-46
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRCP,Lysosomal Pro-X carboxypeptidase,42239,-0.0461688458747695,0.00322966025812606,-0.0524989799806965,-0.0398387117688424,5.21160542504927e-46
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD2AP,CD2-associated protein,42144,-0.0924645834667604,0.00656195955689109,-0.105326024198267,-0.0796031427352539,9.23363970395952e-45
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GSTA1,Glutathione S-transferase A1,42121,-0.119107728707964,0.00848243654268931,-0.135733304331635,-0.102482153084293,1.8371793762757e-44
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRIP2,Cysteine-rich protein 2,42004,-0.0527066389572785,0.00376480356532869,-0.0600856539453227,-0.0453276239692343,3.30635187072107e-44
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ISM1,Isthmin-1,42103,-0.0551310841923586,0.0039620001540674,-0.0628966044943307,-0.0473655638903865,1.06239034548434e-43
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTSD,Cathepsin D,41291,-0.0603764275615738,0.0043566766091281,-0.0689155137154649,-0.0518373414076828,2.42616621158705e-43
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CC2D1A,Coiled-coil and C2 domain-containing protein 1A,42004,-0.10352253567158,0.00750603658595882,-0.11823436738006,-0.088810703963101,5.77975720277738e-43
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRSS8,Prostasin,42078,-0.0596056920886051,0.00433045853894056,-0.0680933908249286,-0.0511179933522816,8.39154814601138e-43
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AFM,Afamin,40113,-0.0281158919674205,0.00205062853493252,-0.0321351238958882,-0.0240966600389528,1.9618712572462e-42
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NOS3,"Nitric oxide synthase, endothelial",41829,-0.0767689666786458,0.00562179054468732,-0.0877876761462329,-0.0657502572110587,3.72166494282666e-42
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ERBB2,Receptor tyrosine-protein kinase erbB-2,42186,-0.0332300239762498,0.00243489860081393,-0.0380024252338451,-0.0284576227186545,4.08180494865794e-42
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SELPLG,P-selectin glycoprotein ligand 1,42103,-0.0385429372773839,0.00282568574621001,-0.0440812813399555,-0.0330045932148122,4.51767797428668e-42
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HS6ST1,Heparan-sulfate 6-O-sulfotransferase 1,42223,-0.0483385554084443,0.00355661881771995,-0.0553095282911754,-0.0413675825257132,8.70500392348438e-42
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CNTN3,Contactin-3,42120,-0.0434418535663861,0.00320503785143402,-0.0497237277551968,-0.0371599793775755,1.4378124271989e-41
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RET,Proto-oncogene tyrosine-protein kinase receptor Ret,42094,-0.0554786519640229,0.0040978599430811,-0.0635104574524619,-0.047446846475584,1.77985640243659e-41
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EZR,Ezrin,42213,-0.0331581727227357,0.00246193724055461,-0.0379835697142227,-0.0283327757312487,4.52430732494263e-41
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SSC5D,Soluble scavenger receptor cysteine-rich domain-containing protein SSC5D,42197,-0.058456980819805,0.00434934285158792,-0.0669816928089174,-0.0499322688306927,6.57057338482465e-41
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD300LG,CMRF35-like molecule 9,42120,0.0530386686689354,0.00395605786031324,0.0452847952627215,0.0607925420751494,1.02966476350353e-40
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RBKS,Ribokinase,41830,-0.0685046762957105,0.00511463273102579,-0.078529356448521,-0.0584799961428999,1.24279685779516e-40
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IDUA,Alpha-L-iduronidase,42223,-0.0638001731620784,0.00477219558620604,-0.0731536765110422,-0.0544466698131146,1.69274389944432e-40
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OXT,Oxytocin-neurophysin 1,42213,-0.190427338549284,0.0142513776040362,-0.218360038653195,-0.162494638445373,1.86104654426588e-40
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CXCL6,C-X-C motif chemokine 6,42256,-0.105037292416409,0.007866295603481,-0.120455231799232,-0.0896193530335862,2.09818254236293e-40
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MET,Hepatocyte growth factor receptor,42161,0.02736207353378,0.0020498401459253,0.0233443868477665,0.0313797602197936,2.23495009702406e-40
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADAMTS15,A disintegrin and metalloproteinase with thrombospondin motifs 15,42094,-0.0600397351783869,0.00450063866975633,-0.0688609869711093,-0.0512184833856645,2.49652519829134e-40
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSME1,Proteasome activator complex subunit 1,41989,-0.050822539401278,0.00382202998259532,-0.0583137181671648,-0.0433313606353912,4.42828728052144e-40
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LSP1,Lymphocyte-specific protein 1,42103,-0.0543359037900178,0.00409218313400559,-0.0623565827326687,-0.0463152248473668,5.67979697489892e-40
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,THOP1,Thimet oligopeptidase,42081,-0.0422158565732251,0.00318005379351728,-0.048448762008519,-0.0359829511379312,5.89705872957602e-40
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GLA,Alpha-galactosidase A,39847,-0.0507592947454639,0.00383724767192129,-0.0582803001824296,-0.0432382893084981,1.24026165261363e-39
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL27,C-C motif chemokine 27,42144,-0.0794776783242332,0.00606659390271896,-0.0913682023735623,-0.067587154274904,5.75711893148453e-39
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSMG3,Proteasome assembly chaperone 3,42103,-0.0690379709694885,0.00527138328967309,-0.0793698822172478,-0.0587060597217293,6.08536528163323e-39
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRG1,Leucine-rich alpha-2-glycoprotein,40113,0.035849939911384,0.0027395599770416,0.0304804023563825,0.0412194774663856,7.75223276714598e-39
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINF1,Pigment epithelium-derived factor,39933,-0.035613301170808,0.00274306356847539,-0.0409897057650198,-0.0302368965765963,2.9613688958055e-38
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RIDA,2-iminobutanoate/2-iminopropanoate deaminase,39863,-0.0659242378369119,0.00510368787486936,-0.0759274660716558,-0.0559210096021679,6.93881916589778e-38
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SELE,E-selectin,42296,-0.0670034655659692,0.00521898347163798,-0.0772326731703796,-0.0567742579615588,1.68088082453774e-37
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STC1,Stanniocalcin-1,42213,-0.0597190290974323,0.00467450328934316,-0.0688810555445449,-0.0505570026503197,3.75594128422006e-37
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLA2G7,Platelet-activating factor acetylhydrolase,42120,-0.043661869418481,0.00342090069916243,-0.0503668347888394,-0.0369569040481227,4.40156332857713e-37
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RBP5,Retinol-binding protein 5,42094,-0.073452076318743,0.00576930309808937,-0.0847599103909982,-0.0621442422464879,6.58573415460029e-37
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD4,T-cell surface glycoprotein CD4,42081,-0.0398073772474114,0.00313437886515863,-0.0459507598231223,-0.0336639946717005,9.78410658728825e-37
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SORD,Sorbitol dehydrogenase,42162,-0.0875956984544776,0.00689908587358358,-0.101117906766701,-0.0740734901422538,1.01981839377911e-36
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FUT3_FUT5,3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3_4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT5,42213,0.0614672655950287,0.00486681186856765,0.0519283143326362,0.0710062168574213,2.36028033305009e-36
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTSZ,Cathepsin Z,42159,-0.0420538397396911,0.0033333945935047,-0.0485872931429603,-0.0355203863364218,2.81793063872856e-36
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EPHA1,Ephrin type-A receptor 1,42167,-0.0425649454858893,0.00339936922746034,-0.0492277091717115,-0.035902181800067,9.17454006474263e-36
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDKN1A,Cyclin-dependent kinase inhibitor 1,42094,-0.134457074158258,0.0107695904354738,-0.155565471411787,-0.11334867690473,1.44887550073706e-35
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PCBD1,Pterin-4-alpha-carbinolamine dehydratase,39858,-0.0594714594018529,0.0047886815902576,-0.0688572753187578,-0.050085643484948,3.59906599972014e-35
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACE2,Angiotensin-converting enzyme 2,41876,-0.0686148086482473,0.00555830788356926,-0.079509092100043,-0.0577205251964515,8.25776935715835e-35
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGFR2,Fibroblast growth factor receptor 2,42186,-0.0283880033494568,0.00231280408436745,-0.032921099354817,-0.0238549073440966,1.93143403470918e-34
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYH9,Myosin-9,40097,-0.14424380935347,0.011761226575881,-0.167295813442197,-0.121191805264743,2.3692801895197e-34
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADH1B,All-trans-retinol dehydrogenase,39863,-0.0938065956999691,0.00765166080575272,-0.108803850879244,-0.0788093405206938,2.53769990888898e-34
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GLB1,Beta-galactosidase,42004,-0.0521785095359626,0.00427425265582216,-0.060556044741374,-0.0438009743305512,4.37603219355182e-34
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAD1L1,Mitotic spindle assembly checkpoint protein MAD1,41954,-0.0608962772327755,0.00498998465445336,-0.0706766471555041,-0.0511159073100469,4.59791877703908e-34
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TCTN3,Tectonic-3,40080,-0.0375831170439501,0.0030833031731987,-0.0436263912634195,-0.0315398428244806,5.90215652314424e-34
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LAMP2,Lysosome-associated membrane glycoprotein 2,41757,-0.0249100473264623,0.00204974496815152,-0.0289275474640393,-0.0208925471888853,8.58205858830333e-34
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KRT18,"Keratin, type I cytoskeletal 18",42094,-0.101111655452554,0.00834193377635978,-0.117461845654219,-0.0847614652508887,1.24696033751241e-33
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NFASC,Neurofascin,42256,-0.0363197239587848,0.00300594575250948,-0.0422113776337033,-0.0304280702838662,1.96699960154904e-33
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VMO1,Vitelline membrane outer layer protein 1 homolog,42094,-0.0869516209748422,0.0071974149732493,-0.101058554322411,-0.0728446876272736,2.01735694599964e-33
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VWA1,von Willebrand factor A domain-containing protein 1,42193,-0.0512638898803022,0.00424524306739566,-0.0595845662923977,-0.0429432134682067,2.14450174272568e-33
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MASP1,Mannan-binding lectin serine protease 1,41985,-0.0291953169030075,0.00241832137009436,-0.0339352267883924,-0.0244554070176226,2.23947666278335e-33
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HJV,Hemojuvelin,40054,-0.054728378214478,0.00454634294822704,-0.063639210393003,-0.045817546035953,3.65107949720959e-33
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KHK,Ketohexokinase,39804,-0.0771619402218171,0.00643197209937984,-0.0897686055366016,-0.0645552749070327,6.04346340440537e-33
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTSO,Cathepsin O,42256,-0.0379606128743926,0.00317279634002557,-0.0441792937008427,-0.0317419320479425,8.10130887696739e-33
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CES3,Carboxylesterase 3,42094,-0.086898513179945,0.00728125686460733,-0.101169776634575,-0.0726272497253147,1.16141009416725e-32
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADAMTSL2,ADAMTS-like protein 2,40097,-0.0417367520847006,0.00352504165872367,-0.048645833735799,-0.0348276704336022,3.81112179163085e-32
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATG4A,Cysteine protease ATG4A,41861,-0.0717060771675153,0.00607523570607837,-0.0836135391514289,-0.0597986151836017,5.53826641253175e-32
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SORT1,Sortilin,42122,-0.0449904605250167,0.00381379631089009,-0.0524655012943613,-0.0375154197556722,5.91436598398259e-32
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLAT,Tissue-type plasminogen activator,42262,-0.0611338111487196,0.0051928258908835,-0.0713117498948513,-0.050955872402588,7.81048794803088e-32
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RARRES2,Retinoic acid receptor responder protein 2,42211,-0.056896876524959,0.00484556299815522,-0.0663941800013432,-0.0473995730485748,1.12061822898844e-31
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL1RN,Interleukin-1 receptor antagonist protein,42095,-0.065461978550014,0.0055965633921252,-0.0764312427985794,-0.0544927143014486,1.90699640894007e-31
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DTYMK,Thymidylate kinase,40080,-0.0813437809453839,0.00696848399028547,-0.0950020095663434,-0.0676855523244244,2.68677142165121e-31
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BPIFB1,BPI fold-containing family B member 1,42083,0.0750439382745655,0.00645619758164754,0.0623897910145363,0.0876980855345947,4.46996860031421e-31
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHMP6,Charged multivesicular body protein 6,40080,-0.0668704515351987,0.00575323993425723,-0.0781468018063429,-0.0555941012640545,4.79593468106322e-31
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RTN4R,Reticulon-4 receptor,42223,-0.0412592648441716,0.00355661318190492,-0.0482302266807053,-0.034288303007638,5.80032981781602e-31
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SRP14,Signal recognition particle 14 kDa protein,42094,-0.0708091082965968,0.00611834436851627,-0.0828010632588887,-0.0588171533343049,7.99432360243039e-31
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MTSS1,Protein MTSS 1,40021,-0.132395185520298,0.0114579911768402,-0.154852848226905,-0.109937522813691,1.05608992196965e-30
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANKRD54,Ankyrin repeat domain-containing protein 54,41861,-0.0689759545386676,0.00597920373948554,-0.0806951938680593,-0.057256715209276,1.23595239190866e-30
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,F7,Coagulation factor VII,42179,-0.0369083577418281,0.00320147127774944,-0.043183241446217,-0.0306334740374392,1.33448875284689e-30
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SNCA,Alpha-synuclein,39863,-0.136663325367201,0.0118515858686882,-0.15989243366983,-0.113434217064572,1.39345434186784e-30
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,41861,-0.0766158805460123,0.00666343929446091,-0.0896762215631557,-0.063555539528869,1.91265742004219e-30
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EIF4EBP1,Eukaryotic translation initiation factor 4E-binding protein 1,42144,-0.0748302401801739,0.00652697610400427,-0.0876231133440223,-0.0620373670163255,2.77576636917606e-30
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD6,T-cell differentiation antigen CD6,42248,-0.0622980538101154,0.00544051129627069,-0.072961455950806,-0.0516346516694249,3.24844891337437e-30
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL16,Pro-interleukin-16,42256,-0.0486066720099478,0.00426525279657999,-0.0569665674912446,-0.040246776528651,6.0650352069774e-30
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NPPC,C-type natriuretic peptide,42103,-0.0590441344771293,0.00519012401218083,-0.0692167775410037,-0.0488714914132549,7.61666748870508e-30
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ERP44,Endoplasmic reticulum resident protein 44,42076,-0.0299746463251694,0.00263832000269383,-0.0351457535304493,-0.0248035391198895,9.03378329519791e-30
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NOTCH3,Neurogenic locus notch homolog protein 3,42296,0.039956788508448,0.00352245527653637,0.0330527761664367,0.0468608008504593,1.09937540790207e-29
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SNAPIN,SNARE-associated protein Snapin,40054,-0.067026189153566,0.00590979953297119,-0.0786093962381895,-0.0554429820689425,1.19920424063622e-29
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL16,C-C motif chemokine 16,42296,-0.0609355019883644,0.00537617816767226,-0.071472811197002,-0.0503981927797268,1.21853419598826e-29
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FEN1,Flap endonuclease 1,41861,-0.0742673224698896,0.00657767484381353,-0.0871595651637641,-0.0613750797760151,2.01339090193396e-29
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APOA1,Apolipoprotein A-I,40113,0.0320386447759271,0.00283734078734211,0.0264774568327366,0.0375998327191176,2.09662491764629e-29
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL32,Interleukin-32,42103,0.0517233041333808,0.00458431446003483,0.0427380477917125,0.0607085604750491,2.19363173809778e-29
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BECN1,Beclin-1,39804,-0.0695153980840811,0.0061583465387012,-0.0815857572999355,-0.0574450388682267,2.21170049475739e-29
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINA4,Kallistatin,39921,-0.0279511997861593,0.00248870626077716,-0.0328290640572825,-0.0230733355150361,4.16348772911732e-29
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NSFL1C,NSFL1 cofactor p47,42213,-0.0748281237377147,0.00668828334895526,-0.087937159101667,-0.0617190883737624,6.32934003002295e-29
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MUC13,Mucin-13,41829,-0.060226977877187,0.0053887602653891,-0.0707889479973497,-0.0496650077570244,7.26515819210844e-29
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLUL1,Clusterin-like protein 1,42129,0.0514979061277694,0.0046355528987111,0.0424122224462956,0.0605835898092431,1.52115615183046e-28
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAMDC4,Apical endosomal glycoprotein,40020,-0.0629726012054623,0.00567375063923096,-0.0740931524583549,-0.0518520499525696,1.80761359569561e-28
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SH2D1A,SH2 domain-containing protein 1A,42103,-0.0661697392798646,0.00597180702948631,-0.0778744810576578,-0.0544649975020714,2.09824052050134e-28
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SMNDC1,Survival of motor neuron-related-splicing factor 30,40021,-0.0677265460776331,0.0061150683587072,-0.0797120800606992,-0.055741012094567,2.34569053176145e-28
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRCH4,Leucine-rich repeat and calponin homology domain-containing protein 4,39706,-0.0771202465070503,0.00698835309224379,-0.0908174185678481,-0.0634230744462525,3.67521081353575e-28
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSIP1,PC4 and SFRS1-interacting protein,42103,-0.0734106745176586,0.00665966982913851,-0.0864636273827701,-0.0603577216525471,3.94404528922197e-28
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MVK,Mevalonate kinase,41887,-0.0904984741329305,0.00823910724517399,-0.106647124333471,-0.0743498239323894,6.09422406477887e-28
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ERN1,Serine/threonine-protein kinase/endoribonuclease IRE1,40020,-0.0430924774055895,0.00392829584264975,-0.0507919372571831,-0.035393017553996,7.48491556870144e-28
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,S100A4,Protein S100-A4,42186,-0.0642886415883516,0.00586327134248582,-0.0757806534196238,-0.0527966297570793,7.48680304719123e-28
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DCTN1,Dynactin subunit 1,42223,-0.0730673574542826,0.00667540068627592,-0.0861511427993834,-0.0599835721091818,9.19723526848695e-28
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNAJC6,Putative tyrosine-protein phosphatase auxilin,39804,-0.0946295104233248,0.00864107834269713,-0.111566023975011,-0.0776929968716384,9.23857922512897e-28
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GMPR,GMP reductase 1,42256,-0.0554048122811594,0.00508402844928461,-0.0653695080417572,-0.0454401165205615,1.55087658691216e-27
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FMNL1,Formin-like protein 1,41829,-0.0693984326764196,0.00637307064145933,-0.0818896511336799,-0.0569072142191593,1.71669391657545e-27
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCLY,Selenocysteine lyase,42178,-0.0526061112348563,0.0048345948082048,-0.0620819170589378,-0.0431303054107749,1.86159842049474e-27
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HGF,Hepatocyte growth factor,42256,-0.0390447289292735,0.00359003780194365,-0.0460812030210831,-0.032008254837464,1.96942134218289e-27
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GRP,Gastrin-releasing peptide,39804,-0.0626556992989193,0.00576003392022142,-0.0739453657825532,-0.0513660328152853,2.05491401958285e-27
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ELN,Elastin,40080,-0.0411140153381129,0.00378280569682042,-0.0485283145038809,-0.0336997161723449,2.24682949683328e-27
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DCXR,L-xylulose reductase,42186,-0.0589885792647752,0.0054309562120294,-0.0696332534403528,-0.0483439050891976,2.30386803420031e-27
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BCHE,Cholinesterase,39922,-0.0310550555242025,0.00287027755540765,-0.0366807995328015,-0.0254293115156035,3.8405189114652e-27
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LCAT,Phosphatidylcholine-sterol acyltransferase,40102,-0.0247021917495469,0.00228587014314004,-0.0291824972301014,-0.0202218862689924,4.39823373894935e-27
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSME2,Proteasome activator complex subunit 2,41952,-0.0401738837465506,0.00373022123258938,-0.0474851173624258,-0.0328626501306754,6.23789158162112e-27
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PXN,Paxillin,41829,-0.0565713837953397,0.00526960726799698,-0.0668998140406138,-0.0462429535500656,9.05405734205896e-27
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL11,Eotaxin,42256,-0.0406635184620215,0.0037921183790388,-0.0480960704849376,-0.0332309664391055,1.0235664636319e-26
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL1R2,Interleukin-1 receptor type 2,42108,-0.0219999274717169,0.00205564405997156,-0.0260289898292612,-0.0179708651141727,1.28489801247971e-26
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NOMO1,Nodal modulator 1,42120,-0.0255734430105395,0.0023916152329208,-0.0302610088670643,-0.0208858771540148,1.41814046426151e-26
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDHR2,Cadherin-related family member 2,42094,-0.0778646832179321,0.00728509859570653,-0.092143476465517,-0.0635858899703473,1.4926963348819e-26
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FAM20A,Pseudokinase FAM20A,40080,-0.0309315133729423,0.00290295850616953,-0.0366213120450346,-0.02524171470085,2.22460560116649e-26
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LEPR,Leptin receptor,42144,0.0342102420847959,0.00321256295499988,0.0279136186929962,0.0405068654765957,2.26826042708463e-26
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LECT2,Leukocyte cell-derived chemotaxin-2,40080,-0.0735586938223491,0.00690696765698029,-0.0870963504300305,-0.0600210372146678,2.35216005749441e-26
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL18R1,Interleukin-18 receptor 1,42256,-0.0362397474052805,0.0034074607685608,-0.0429183705116596,-0.0295611242989013,2.61262428913875e-26
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SH3GLB2,Endophilin-B2,40054,-0.0729069750981705,0.00685797866799705,-0.0863486132874447,-0.0594653369088962,2.87881951822181e-26
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MNDA,Myeloid cell nuclear differentiation antigen,42121,-0.106790063666626,0.0100609050145941,-0.126509437495231,-0.0870706898380219,3.27591076354443e-26
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCG2,Secretogranin-2,42140,-0.0376418702420773,0.00354971939645519,-0.0445993202591295,-0.0306844202250251,3.64813181378406e-26
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTBS,Di-N-acetylchitobiase,39958,-0.0292027409969574,0.00275679877283179,-0.0346060665917077,-0.0237994154022071,4.31622600787694e-26
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINA5,Plasma serine protease inhibitor,39965,-0.0343896016186895,0.00325012483652119,-0.040759846298271,-0.028019356939108,4.89796492411181e-26
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SUMF2,Inactive C-alpha-formylglycine-generating enzyme 2,42213,-0.0565871369330957,0.00535356647814004,-0.0670801272302502,-0.0460941466359412,5.23256459682135e-26
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CARHSP1,Calcium-regulated heat-stable protein 1,41829,-0.0566285030748686,0.00537536404453582,-0.0671642166021588,-0.0460927895475784,7.63947497616838e-26
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGL1,Fibrinogen-like protein 1,40102,0.0709846571796478,0.00676008172934355,0.0577348969901345,0.0842344173691612,1.13816664106526e-25
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ELOA,Elongin-A,42094,-0.0581189446047445,0.00553828215026995,-0.0689739776192736,-0.0472639115902154,1.16725888605328e-25
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SMAD2,Mothers against decapentaplegic homolog 2,40020,-0.0748396030620519,0.0071537027853069,-0.0888608605212534,-0.0608183456028504,1.71393737473813e-25
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRKRA,Interferon-inducible double-stranded RNA-dependent protein kinase activator A,41861,-0.0732212463112989,0.0070086176978553,-0.0869581369990952,-0.0594843556235025,1.91241608144127e-25
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATXN3,Ataxin-3,40054,-0.0668001927097817,0.00640157591799845,-0.0793472815090587,-0.0542531039105048,2.26277194900834e-25
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADGRG1,Adhesion G-protein coupled receptor G1,42094,-0.0880930688437546,0.0084706624396791,-0.104695567225526,-0.0714905704619835,3.12626814150587e-25
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NUMB,Protein numb homolog,39784,-0.0880564881871,0.00847226453128229,-0.104662126668413,-0.0714508497057867,3.5073051495335e-25
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APOD,Apolipoprotein D,39633,0.0461872891750454,0.00446390015278112,0.0374380448755944,0.0549365334744964,5.70935217101409e-25
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,WWP2,NEDD4-like E3 ubiquitin-protein ligase WWP2,42004,-0.0570493996844598,0.00551740540945287,-0.0678635142869874,-0.0462352850819322,5.82952743171536e-25
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ASGR1,Asialoglycoprotein receptor 1,42004,-0.0325339676812162,0.00316072666405119,-0.0387289919427566,-0.0263389434196759,9.44227406735443e-25
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FYB1,FYN-binding protein 1,42099,-0.0973786335892679,0.00948223085275957,-0.115963806060677,-0.0787934611178591,1.201901221329e-24
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CA2,Carbonic anhydrase 2,42082,-0.0735762352036444,0.00717609988057726,-0.0876413909695758,-0.059511079437713,1.42630242509023e-24
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,INPPL1,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2",42094,-0.102698956927521,0.0100181501445408,-0.122334531210821,-0.0830633826442208,1.45061644427788e-24
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEP85,Centrosomal protein of 85 kDa,41861,-0.0676794133640744,0.00661228494457219,-0.0806394918554359,-0.0547193348727129,1.71401953708152e-24
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VAT1,Synaptic vesicle membrane protein VAT-1 homolog,42094,0.0208961297105891,0.00204313059036818,0.0168915937534675,0.0249006656677107,1.85117119771683e-24
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL2,C-C motif chemokine 2,41984,-0.0562886271491136,0.00550694765816182,-0.0670822445591108,-0.0454950097391165,1.97451419518316e-24
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADD1,Alpha-adducin,39863,-0.0748253944527559,0.00734160643655401,-0.0892149430684017,-0.06043584583711,2.78210338137527e-24
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CXCL13,C-X-C motif chemokine 13,42213,-0.0659246821884166,0.00647281120741228,-0.0786113921549447,-0.0532379722218885,2.85684519031287e-24
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APEX1,DNA-(apurinic or apyrimidinic site) endonuclease,42156,-0.0611454482716789,0.00601959827380098,-0.0729438608883288,-0.0493470356550289,3.76976594596368e-24
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KYNU,Kynureninase,42256,-0.0465552044736445,0.00459226949778466,-0.0555560526893024,-0.0375543562579866,4.61202878603148e-24
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LBP,Lipopolysaccharide-binding protein,42197,0.0615757369006016,0.00607409791389335,0.0496705049893706,0.0734809688118325,4.6305910227132e-24
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGF19,Fibroblast growth factor 19,42184,-0.0811234282093176,0.00800280755722974,-0.0968089310214879,-0.0654379253971473,4.65785805977751e-24
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PAXX,Protein PAXX,39863,-0.047399320320927,0.00469349716479412,-0.0565985747639235,-0.0382000658779305,7.14873187044956e-24
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RNF41,E3 ubiquitin-protein ligase NRDP1,41861,-0.0686546679570533,0.00681198281363097,-0.08200615427177,-0.0553031816423366,8.4530868442857e-24
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,F11R,Junctional adhesion molecule A,42120,-0.0578504520086842,0.00574265567225332,-0.0691060571263007,-0.0465948468910677,8.8273189045166e-24
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LAT2,Linker for activation of T-cells family member 2,42094,-0.12828227960159,0.0127406277559308,-0.153253910003214,-0.103310649199966,9.29330891395561e-24
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EGLN1,Egl nine homolog 1,42103,-0.057736743816318,0.00573775569698661,-0.0689827449824117,-0.0464907426502242,9.88710746407826e-24
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NFATC1,"Nuclear factor of activated T-cells, cytoplasmic 1",42103,-0.100238688151447,0.00996233944302806,-0.119764873459782,-0.080712502843112,9.97104450982175e-24
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FLI1,Friend leukemia integration 1 transcription factor,41861,-0.113965394660201,0.0113658434859617,-0.136242447892686,-0.0916883414277165,1.41995578027525e-23
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BACH1,Transcription regulator protein BACH1,42103,-0.0755517764463365,0.00753798733347661,-0.0903262316199506,-0.0607773212727223,1.4755951521655e-23
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IKBKG,NF-kappa-B essential modulator,42103,-0.0938783760320339,0.00938277790595138,-0.112268620727699,-0.0754881313363692,1.75730047001081e-23
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UBAC1,Ubiquitin-associated domain-containing protein 1,42094,-0.0355356949987777,0.00355450025400608,-0.0425025154966296,-0.0285688745009258,1.90446338123996e-23
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CA4,Carbonic anhydrase 4,42296,0.0249419109435805,0.0025001176986253,0.020041680254275,0.0298421416328861,2.34489651477458e-23
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDGFC,Platelet-derived growth factor C,41861,-0.0291971823976053,0.00293027151204022,-0.0349405145612041,-0.0234538502340065,2.66916664074324e-23
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GGT1,Glutathione hydrolase 1 proenzyme,42099,-0.0517986508479418,0.00520121485194833,-0.0619930319577605,-0.0416042697381231,2.79655752807231e-23
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FCAMR,High affinity immunoglobulin alpha and immunoglobulin mu Fc receptor,40080,-0.0758226021542744,0.00762166335975671,-0.0907610623393976,-0.0608841419691513,3.22246202720116e-23
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ZBTB16,Zinc finger and BTB domain-containing protein 16,41861,-0.0742451635547087,0.00746750767326068,-0.0888814785942997,-0.0596088485151178,3.30939405121622e-23
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NFX1,Transcriptional repressor NF-X1,39706,-0.069917927108383,0.00703413682820707,-0.0837048352916689,-0.0561310189250972,3.53519726963429e-23
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IFNGR2,Interferon gamma receptor 2,42004,-0.0536125518606211,0.00539640553829352,-0.0641895067156764,-0.0430355970055658,3.56066297263337e-23
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MCAM,Cell surface glycoprotein MUC18,42197,0.0344385010771747,0.00347793204293668,0.0276217542730188,0.0412552478813306,4.92229886668466e-23
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NEDD4L,E3 ubiquitin-protein ligase NEDD4-like,39784,-0.0513040413893583,0.00518004673853192,-0.0614569329968809,-0.0411511497818358,5.02718817712905e-23
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AKT1S1,Proline-rich AKT1 substrate 1,41829,-0.0679153784968127,0.00687513936411362,-0.0813906516504754,-0.05444010534315,6.25386024427199e-23
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NCS1,Neuronal calcium sensor 1,42223,-0.0295122513910934,0.00299004239590518,-0.0353727344870675,-0.0236517682951192,6.74523964640331e-23
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GPD1,Glycerol-3-phosphate dehydrogenase,40020,-0.052840184162796,0.00535476295301907,-0.0633355195507134,-0.0423448487748787,7.16279101696526e-23
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTSE,Cathepsin E,39863,-0.0522478433985147,0.00529815425587633,-0.0626322257400323,-0.0418634610569971,7.652367894978e-23
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SFRP4,Secreted frizzled-related protein 4,39863,-0.0409398719339817,0.00416135307020039,-0.0490961239515745,-0.0327836199163889,9.63841124135447e-23
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRIM1,Cysteine-rich motor neuron 1 protein,42184,0.0210314074931981,0.00214905713375035,0.0168192555110474,0.0252435594753487,1.54185863641896e-22
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TSNAX,Translin-associated protein X,39706,-0.039960802674584,0.00408854023449833,-0.0479743415342008,-0.0319472638149673,1.81713011909544e-22
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SEMA3F,Semaphorin-3F,42144,-0.0274469988757785,0.00281225545371275,-0.0329590195650555,-0.0219349781865015,2.00142059950033e-22
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BANK1,B-cell scaffold protein with ankyrin repeats,42103,-0.106602589870344,0.0109254401085708,-0.128016452483142,-0.0851887272575448,2.05215662187335e-22
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DDT,D-dopachrome decarboxylase,40097,-0.041721932297247,0.00427624814999413,-0.0501033786712354,-0.0333404859232585,2.13295181206247e-22
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NMNAT1,Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 1,42004,-0.0723523154588181,0.00743098461110598,-0.0869170452965858,-0.0577875856210504,2.51606102372146e-22
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TANK,TRAF family member-associated NF-kappa-B activator,41887,-0.0696376297999205,0.00716391124423578,-0.0836788958386226,-0.0555963637612183,2.94469039983399e-22
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MME,Neprilysin,42094,-0.0815350075483578,0.00840142227496142,-0.0980017952072822,-0.0650682198894334,3.42194612074618e-22
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSMD9,26S proteasome non-ATPase regulatory subunit 9,42094,-0.0545519066672368,0.00564398086948731,-0.065614109171432,-0.0434897041630417,5.01805758161261e-22
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DLK1,Protein delta homolog 1,42296,-0.0550294468658586,0.00569621584451651,-0.066194029921111,-0.0438648638106063,5.24321283538451e-22
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NAGPA,N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase,39863,-0.0215391554279474,0.00222961014406393,-0.0259091913103127,-0.0171691195455821,5.45848607720603e-22
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANGPTL2,Angiopoietin-related protein 2,42148,-0.0399943268018897,0.00414370464926984,-0.0481159879144586,-0.0318726656893208,5.72490807499408e-22
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GLRX,Glutaredoxin-1,42057,-0.0558762521923886,0.00579003563013818,-0.0672247220274594,-0.0445277823573177,5.81070908096293e-22
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STAB2,Stabilin-2,40097,-0.027732039765027,0.0028792058520492,-0.0333752832350435,-0.0220887962950106,7.16936706145582e-22
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IPCEF1,Interactor protein for cytohesin exchange factors 1,41984,-0.0883207747729975,0.00918158850871836,-0.106316688250085,-0.0703248612959095,7.85473647522563e-22
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CA1,Carbonic anhydrase 1,41879,-0.059757084420387,0.00621976550070253,-0.071947824801764,-0.0475663440390101,8.80747514831663e-22
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NRP2,Neuropilin-2,42120,0.0285716829612935,0.00297477158174807,0.0227411306610673,0.0344022352615197,9.03251050243039e-22
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NHLRC3,NHL repeat-containing protein 3,39604,-0.0319729931944371,0.00333569938180148,-0.038510963982768,-0.0254350224061063,1.1349210570855e-21
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MMP10,Stromelysin-2,42116,0.0581938601181273,0.00607629181955109,0.0462843281518072,0.0701033920844474,1.17660386529694e-21
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CAT,Catalase,39940,-0.0534908417056506,0.00558612114309843,-0.0644396391461235,-0.0425420442651777,1.23449162472558e-21
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KITLG,Kit ligand,42144,0.0372837452117498,0.00389751559285321,0.0296446146497576,0.0449228757737421,1.30942218287946e-21
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GPKOW,G-patch domain and KOW motifs-containing protein,41829,-0.0283740533010897,0.00296913133744207,-0.0341935507224761,-0.0225545558797032,1.44273158569964e-21
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IMPACT,Protein IMPACT,40054,-0.0549871700090416,0.00577073538874164,-0.0662978113709752,-0.043676528647108,1.9328391490521e-21
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TJAP1,Tight junction-associated protein 1,42186,-0.0810152756854195,0.0085075119758998,-0.0976899991581831,-0.0643405522126559,1.98029287738292e-21
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SNX15,Sorting nexin-15,39863,-0.0534158460599065,0.00560724958497084,-0.0644060552464494,-0.0424256368733637,1.98469031458587e-21
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNAJB2,DnaJ homolog subfamily B member 2,39863,-0.0526953409659592,0.00555849496329965,-0.0635899910940265,-0.0418006908378919,3.07796215326919e-21
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CPA2,Carboxypeptidase A2,42173,-0.0646973473300775,0.00683386271321083,-0.0780917182479707,-0.0513029764121843,3.36553151022439e-21
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LEP,Leptin,42144,-0.0647513498129022,0.00684455977961889,-0.0781666869809552,-0.0513360126448492,3.59503457424041e-21
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TGFB1,Transforming growth factor beta-1 proprotein,42248,-0.037213521090173,0.00393539259935886,-0.0449268905849164,-0.0295001515954297,3.73492090170843e-21
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NFKBIE,NF-kappa-B inhibitor epsilon,41861,-0.0484436928532733,0.00512499311512981,-0.0584886793589277,-0.0383987063476188,3.885801082098e-21
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTPRB,Receptor-type tyrosine-protein phosphatase beta,40080,-0.0287521901381002,0.00304207507495408,-0.0347146572850102,-0.0227897229911902,4.02399774783471e-21
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MENT,Protein MENT,39863,0.0226963900798381,0.00240434500657017,0.0179838738669605,0.0274089062927156,4.51530883700967e-21
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TXLNA,Alpha-taxilin,42004,-0.0854118592131499,0.00905554780629348,-0.103160732913485,-0.0676629855128147,4.70860989817514e-21
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NIT1,Deaminated glutathione amidase,39804,-0.0458625849235913,0.00486151523947031,-0.0553911547929531,-0.0363340150542295,4.78108814584713e-21
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EIF4B,Eukaryotic translation initiation factor 4B,42004,-0.0557748381846772,0.005925215425311,-0.0673882604182868,-0.0441614159510677,5.62839248043117e-21
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCS,Copper chaperone for superoxide dismutase,42004,-0.0461476090583715,0.00492118080171085,-0.0557931234297248,-0.0365020946870183,7.88891677076476e-21
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GLO1,Lactoylglutathione lyase,41876,-0.055899226130107,0.0059888437627743,-0.0676373599051447,-0.0441610923550694,1.18846458912089e-20
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SNAP29,Synaptosomal-associated protein 29,42186,-0.0878367841858222,0.00941665277674599,-0.106293423628244,-0.0693801447434001,1.25360203126286e-20
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ALPI,Intestinal-type alkaline phosphatase,39784,-0.120910077017633,0.0129943575966558,-0.146379017907078,-0.0954411361281876,1.60707539438079e-20
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,42094,-0.0322982027626043,0.00347936199041188,-0.0391177522638116,-0.025478653261397,1.91152004964279e-20
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDZK1,Na(+)/H(+) exchange regulatory cofactor NHE-RF3,39784,-0.0426690589191129,0.00459645129487529,-0.0516781034570685,-0.0336600143811574,1.96871081459536e-20
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CENPF,Centromere protein F,39881,-0.0522109088693889,0.00562868682991724,-0.0632431350560267,-0.0411786826827511,2.1015017296922e-20
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,YES1,Tyrosine-protein kinase Yes,42094,-0.108622435604739,0.011716050961175,-0.131585895488642,-0.0856589757208364,2.12867340286949e-20
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TREH,Trehalase,40097,-0.0709481239233109,0.00765084661542002,-0.0859437832895341,-0.0559524645570876,2.14593233688441e-20
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EEF1D,Elongation factor 1-delta,40080,-0.0871723753757713,0.00940436790244597,-0.105604936464565,-0.0687398142869772,2.22558217786413e-20
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AARSD1,Alanyl-tRNA editing protein Aarsd1,42094,-0.0526072087840862,0.00568238919233852,-0.0637446916010697,-0.0414697259671027,2.40946584733912e-20
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDH15,Cadherin-15,42194,-0.0601633660353979,0.00650133622431329,-0.072905985035052,-0.0474207470357439,2.49657863558333e-20
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RBP2,Retinol-binding protein 2,42094,0.0741897928909836,0.00801775067061717,0.058475001576574,0.0899045842053933,2.51817868951382e-20
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DPY30,Protein dpy-30 homolog,42156,-0.0577592046320431,0.0062491727633483,-0.0700075832482058,-0.0455108260158804,2.77426529080454e-20
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RRM2,Ribonucleoside-diphosphate reductase subunit M2,41861,-0.0487392884729545,0.00527653637800568,-0.0590812997738456,-0.0383972771720633,2.93505275449038e-20
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RABGAP1L,Rab GTPase-activating protein 1-like,41887,-0.0572917873839504,0.00620419826780458,-0.0694520159888474,-0.0451315587790534,3.0065884491555e-20
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ST13,Hsc70-interacting protein,39863,-0.0537459732861949,0.00581910229625624,-0.0651514137868572,-0.0423405327855327,3.04024496977574e-20
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ASAH2,Neutral ceramidase,42004,-0.0509230070363402,0.0055226141920097,-0.0617473308526792,-0.0400986832200012,3.40431022214999e-20
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LATS1,Serine/threonine-protein kinase LATS1,39784,-0.0804197176090505,0.00872373992960849,-0.0975182478710832,-0.0633211873470179,3.58415838349877e-20
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINE1,Plasminogen activator inhibitor 1,42296,-0.0628064459517197,0.00682088440676233,-0.0761753793889739,-0.0494375125144656,3.82240791683789e-20
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PBXIP1,Pre-B-cell leukemia transcription factor-interacting protein 1,40021,-0.0289430282103099,0.00314321405980085,-0.0351037277675196,-0.0227823286531003,3.93075637664592e-20
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BOLA2_BOLA2B,BolA-like protein 2,39804,-0.0510776070025262,0.00556365274239801,-0.0619823663776263,-0.0401728476274261,5.08410205352979e-20
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CA14,Carbonic anhydrase 14,42223,0.0342477093626763,0.00373221988264548,0.0269325583926911,0.0415628603326614,5.12851447830518e-20
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FABP2,"Fatty acid-binding protein, intestinal",42144,0.0751959717633413,0.00821022325489873,0.0591039341837398,0.0912880093429428,6.0258983003324e-20
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HEG1,Protein HEG homolog 1,39863,-0.0254574433009075,0.00278305887160145,-0.0309122386892464,-0.0200026479125687,6.89970385378611e-20
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HMBS,Porphobilinogen deaminase,42223,-0.0406640319518321,0.00447153507570298,-0.0494282407002099,-0.0318998232034543,1.09154628768847e-19
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPME1,Protein phosphatase methylesterase 1,42094,-0.0559867734126493,0.0061645673917488,-0.068069325500477,-0.0439042213248217,1.21907914627978e-19
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,42181,0.0304668440556028,0.00336858214409434,0.0238644230531779,0.0370692650580277,1.71602162194233e-19
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL13,C-C motif chemokine 13,42237,-0.0644822087413699,0.00714227361560499,-0.0784810650279557,-0.0504833524547841,1.98644537721607e-19
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HEPH,Hephaestin,40080,-0.0246915598877745,0.00273538997833064,-0.0300529242453025,-0.0193301955302464,2.06666635353947e-19
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGBP1,Immunoglobulin-binding protein 1,40054,-0.0564458038326382,0.00626468118567859,-0.0687245789565683,-0.0441670287087082,2.40165139675734e-19
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARHGEF12,Rho guanine nucleotide exchange factor 12,42103,-0.0961419168129905,0.0106985206715772,-0.117111017329282,-0.0751728162966991,2.90419003527569e-19
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CXCL17,C-X-C motif chemokine 17,42256,-0.0377030680224722,0.00419781252544862,-0.0459307805723515,-0.0294753554725929,3.0302829399919e-19
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STAMBP,STAM-binding protein,41985,-0.0585400475095997,0.00652311535838875,-0.0713253536120416,-0.0457547414071578,3.24697655538915e-19
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TTR,Transthyretin,40000,-0.0233129339226066,0.00259925252157262,-0.0284074688648889,-0.0182183989803242,3.48280286451418e-19
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LBR,Delta(14)-sterol reductase LBR,42213,-0.0616127676605476,0.00687287156325583,-0.075083595924529,-0.0481419393965662,3.53323583645606e-19
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDH2,Cadherin-2,42144,-0.0329445893395424,0.00368505707292825,-0.0401673012024817,-0.025721877476603,4.41178750367539e-19
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AMPD3,AMP deaminase 3,40054,-0.0653074139459605,0.00730744180018523,-0.0796299998743235,-0.0509848280175974,4.64029035683861e-19
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDCD5,Programmed cell death protein 5,42213,-0.0530069048684237,0.00594385070833709,-0.0646568522567644,-0.041356957480083,5.37749514823679e-19
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GET3,ATPase GET3,40080,-0.0494627380814956,0.00555468788913974,-0.0603499263442095,-0.0385755498187817,6.20353958689475e-19
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ABL1,Tyrosine-protein kinase ABL1,42094,-0.0615458398865978,0.006923518418186,-0.0751159359862424,-0.0479757437869533,6.95277574723574e-19
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLB,Beta-klotho,41829,0.0683847662003878,0.00771205927396707,0.0532691300234123,0.0835004023773633,8.49482993570633e-19
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGR,Tyrosine-protein kinase Fgr,41829,-0.0523643986749924,0.00590594770821313,-0.0639400561830901,-0.0407887411668947,8.56082011253991e-19
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,42186,-0.0338912841479447,0.00382715875935171,-0.041392515316274,-0.0263900529796153,9.40377328852727e-19
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FKBP4,Peptidyl-prolyl cis-trans isomerase FKBP4,42004,-0.0397302978839147,0.00450489472360567,-0.0485598915421818,-0.0309007042256476,1.29868546531658e-18
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NFKB1,Nuclear factor NF-kappa-B p105 subunit,39706,-0.0670678371031852,0.00760423673560407,-0.0819721411049692,-0.0521635331014012,1.32805963639364e-18
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLXNA4,Plexin-A4,42103,-0.0745267791512968,0.00845855014876986,-0.0911055374428857,-0.0579480208597079,1.39962311409043e-18
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NCF2,Neutrophil cytosol factor 2,42087,-0.0755242613475966,0.00858768098794345,-0.0923561160839657,-0.0586924066112274,1.61780243243696e-18
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BCR,Breakpoint cluster region protein,42103,-0.0827196604918257,0.00940621952947421,-0.101155850769595,-0.0642834702140562,1.62248814105881e-18
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,POSTN,Periostin,40097,0.0349231123214089,0.00397801758284379,0.0271261978590351,0.0427200267837827,1.89501599952342e-18
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MTSS2,Protein MTSS 2,40020,-0.088966286031992,0.0101604443112482,-0.108880756882038,-0.0690518151819456,2.32089284469824e-18
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AXIN1,Axin-1,42103,-0.085524134358004,0.00978378755608178,-0.104700357967924,-0.0663479107480837,2.58414294006251e-18
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TIMP4,Metalloproteinase inhibitor 4,42120,0.0373002415587554,0.0042786117001972,0.0289141626263689,0.0456863204911419,3.17867877892801e-18
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TOP2B,DNA topoisomerase 2-beta,39784,-0.0716174890195489,0.00822152582881775,-0.0877316796440317,-0.0555032983950661,3.46146920423082e-18
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CALCOCO1,Calcium-binding and coiled-coil domain-containing protein 1,42162,-0.0925301780367464,0.0106362427116917,-0.113377213751662,-0.0716831423218307,3.73128695381117e-18
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL23,C-C motif chemokine 23,42184,-0.0375902864407443,0.0043316644436658,-0.0460803487503293,-0.0291002241311594,4.50251204462207e-18
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HEXIM1,Protein HEXIM1,42103,-0.0721542717508914,0.00833556889718782,-0.0884919867893796,-0.0558165567124033,5.45160745472263e-18
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BLVRB,Flavin reductase,42120,-0.0588561688670096,0.00680415227715656,-0.0721923073302365,-0.0455200304037828,5.75111551700917e-18
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RILP,Rab-interacting lysosomal protein,42178,-0.0532281452826753,0.00615468761808679,-0.0652913330141254,-0.0411649575512252,5.83130058506974e-18
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DAAM1,Disheveled-associated activator of morphogenesis 1,39863,-0.0744507941817311,0.00861521262556803,-0.0913366109278445,-0.0575649774356178,6.32497062049934e-18
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AP3S2,AP-3 complex subunit sigma-2,40054,-0.0425332270856357,0.00492283024031834,-0.0521819743566596,-0.0328844798146117,6.40904921313532e-18
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TP53I3,Quinone oxidoreductase PIG3,39650,-0.0474420193755313,0.00549597042275323,-0.0582141214041277,-0.036669917346935,6.89594378711097e-18
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNPH1,2'-deoxynucleoside 5'-phosphate N-hydrolase 1,42167,-0.0457291789567777,0.00530193499876276,-0.0561209715543527,-0.0353373863592027,7.14806172097511e-18
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SARG,Specifically androgen-regulated gene protein,40026,-0.0963744077760689,0.0111824838606652,-0.118292076142973,-0.0744567394091651,7.73762345690458e-18
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHRDL2,Chordin-like protein 2,42144,-0.0420779572350534,0.00488596464525073,-0.0516544479397448,-0.0325014665303619,8.00308913976179e-18
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RABEP1,Rab GTPase-binding effector protein 1,39863,-0.0692227069086459,0.00807168311339094,-0.0850432058108922,-0.0534022080063997,1.11826023254372e-17
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PIK3AP1,Phosphoinositide 3-kinase adapter protein 1,42103,-0.0543075531205911,0.0063347983279153,-0.0667237578433051,-0.0418913483978772,1.12317106869202e-17
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRELD1,Protein disulfide isomerase CRELD1,39863,-0.0334510136505615,0.00390264675053293,-0.041100201281606,-0.025801826019517,1.16381683411366e-17
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CFP,Properdin,40113,-0.0196994773935411,0.00230774995123623,-0.0242226672979641,-0.0151762874891181,1.57035871684857e-17
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PQBP1,Polyglutamine-binding protein 1,41861,-0.0499610063131332,0.00588986145644266,-0.0615051347677608,-0.0384168778585056,2.44620384732458e-17
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATP6V1G1,V-type proton ATPase subunit G 1,39804,-0.063214327308815,0.0074512010727849,-0.0778186814114734,-0.0486099732061566,2.46994376725102e-17
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STIP1,Stress-induced-phosphoprotein 1,42096,-0.0566554060659633,0.00668665140458789,-0.0697612428189556,-0.0435495693129711,2.65101916763131e-17
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TGFBI,Transforming growth factor-beta-induced protein ig-h3,42091,-0.0237587900854118,0.00280749710717065,-0.0292614844154663,-0.0182560957553574,2.89445915618023e-17
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NPL,N-acetylneuraminate lyase,40080,-0.0398641512511545,0.00471299818243041,-0.0491016276887181,-0.0306266748135909,3.05871723940414e-17
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLIN1,Perilipin-1,41829,-0.030539690875431,0.0036137750719871,-0.0376226900165258,-0.0234566917343363,3.20506846276749e-17
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATRN,"Attractin, Isoform 2",40113,-0.0146343517012598,0.00173322799821969,-0.0180314785777704,-0.0112372248247492,3.47198659621347e-17
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SUOX,"Sulfite oxidase, mitochondrial",40054,-0.0540399911283254,0.00640596598057799,-0.0665956844502583,-0.0414842978063926,3.70363724017601e-17
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FUOM,Fucose mutarotase,39863,-0.0550265723238077,0.00654730433250201,-0.0678592888155116,-0.0421938558321037,4.84470945385387e-17
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SSNA1,Sjoegren syndrome nuclear autoantigen 1,40021,-0.0448100525632258,0.00535163956810808,-0.0552992661167176,-0.034320839009734,6.30144277100181e-17
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FUS,RNA-binding protein FUS,41852,-0.0344924020331129,0.00412087552011431,-0.0425693180525369,-0.0264154860136888,6.35469342859444e-17
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARSB,Arylsulfatase B,42094,-0.0476246821793167,0.0056946164516978,-0.0587861304246444,-0.036463233933989,6.73205788127656e-17
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNIP1,TNFAIP3-interacting protein 1,40054,-0.0763578186605485,0.00912823679888753,-0.0942491627863681,-0.058466474534729,6.74624504511697e-17
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRDX2,Peroxiredoxin-2,39911,-0.0540296727977677,0.00646065087344326,-0.0666925485097165,-0.041366797085819,6.87889187466303e-17
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AP2B1,AP-2 complex subunit beta,39768,-0.0419017783687678,0.00501392087573604,-0.0517290632852104,-0.0320744934523252,7.23431249709879e-17
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VNN1,Pantetheinase,40102,-0.0628828797422896,0.00752608975038649,-0.0776340156530471,-0.0481317438315321,7.31647900398002e-17
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PGF,Placenta growth factor,42256,-0.0230410613028814,0.00276388299661342,-0.0284582719762437,-0.0176238506295191,8.41395306533177e-17
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APLP1,Amyloid-like protein 1,42144,0.0443720358232792,0.00533513231216804,0.0339151764914299,0.0548288951551286,9.92184987731009e-17
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRKAR2A,cAMP-dependent protein kinase type II-alpha regulatory subunit,40036,-0.0687646068587726,0.00826819717324111,-0.0849702733183252,-0.05255894039922,1.01216864890998e-16
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,F9,Coagulation factor IX,42172,-0.0155711863329922,0.00187443895033088,-0.0192450866756407,-0.0118972859903437,1.07723134664636e-16
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLA2G15,Phospholipase A2 group XV,42186,-0.0228559797931879,0.00275804438525007,-0.0282617467882781,-0.0174502127980978,1.27440997156236e-16
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C9orf40,Uncharacterized protein C9orf40,40021,-0.0696797563871736,0.00840891512328245,-0.0861612300288072,-0.0531982827455401,1.30486792671489e-16
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGFBPL1,Insulin-like growth factor-binding protein-like 1,42144,-0.0301291070944211,0.00363745664558978,-0.0372585221197771,-0.0229996920690652,1.31823410154417e-16
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EFCAB14,EF-hand calcium-binding domain-containing protein 14,40021,-0.0251594329734616,0.00303902470982939,-0.0311159214047272,-0.019202944542196,1.39066816679773e-16
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AHSP,Alpha-hemoglobin-stabilizing protein,42099,-0.0714584803427042,0.00863398586554508,-0.0883810926391725,-0.0545358680462358,1.39335452329963e-16
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD63,CD63 antigen,41984,-0.0435546740829664,0.00526956977743057,-0.0538830308467304,-0.0332263173192025,1.52984033484152e-16
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARSA,Arylsulfatase A,42120,-0.0379863171236638,0.0046108930277869,-0.0470236674581261,-0.0289489667892014,1.91251583850194e-16
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TRAF2,TNF receptor-associated factor 2,42103,-0.0589321077852496,0.00716412724177552,-0.0729737971791296,-0.0448904183913696,2.12003077385125e-16
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RANBP1,Ran-specific GTPase-activating protein,39804,-0.0443866600763283,0.005397962729233,-0.054966667025625,-0.0338066531270316,2.21917004622939e-16
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CFI,Complement factor I,40113,-0.0165542688695363,0.00201510654103282,-0.0205038776899606,-0.0126046600491119,2.3593988963559e-16
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDC27,Cell division cycle protein 27 homolog,41861,-0.051239379974196,0.00625115053658267,-0.0634916350258981,-0.038987124922494,2.70517935748334e-16
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PKLR,Pyruvate kinase PKLR,42145,-0.0554384579896055,0.0067670907252678,-0.0687019558111304,-0.0421749601680806,2.80052209646031e-16
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FAM3B,Protein FAM3B,42094,-0.0299114252687881,0.00365539148139014,-0.0370759925723127,-0.0227468579652634,3.03124811659318e-16
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPP1R9B,Neurabin-2,42256,-0.0792856611004403,0.0096914411313332,-0.0982808857178534,-0.0602904364830273,3.07391496357513e-16
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANGPTL4,Angiopoietin-related protein 4,42162,0.0379374118467076,0.00463969591533676,0.0288436078526476,0.0470312158407677,3.18690510682888e-16
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UFD1,Ubiquitin recognition factor in ER-associated degradation protein 1,40021,-0.116587453467589,0.0142564307782687,-0.144530057792996,-0.0886448491421827,3.21141936266531e-16
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HDGFL2,Hepatoma-derived growth factor-related protein 2,40054,-0.0535561839303364,0.00655371581510007,-0.0664014669279325,-0.0407109009327403,3.37328562572152e-16
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GRHPR,Glyoxylate reductase/hydroxypyruvate reductase,40080,-0.0531340109185679,0.00650410218459393,-0.065882051200372,-0.0403859706367638,3.44470204769374e-16
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNAJA2,DnaJ homolog subfamily A member 2,42223,-0.0682097581838912,0.0083655719590441,-0.0846062792236176,-0.0518132371441648,3.85287351820771e-16
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,THBS2,Thrombospondin-2,42120,-0.0328992485864611,0.00403618067605755,-0.0408101627115339,-0.0249883344613883,3.93708446088711e-16
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AGR2,Anterior gradient protein 2 homolog,41739,-0.0855940226721504,0.0105062832674527,-0.106186337876358,-0.065001707467943,4.0845287039894e-16
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AKR7L,Aflatoxin B1 aldehyde reductase member 4,39784,-0.0578679599623616,0.0071099415977326,-0.0718034454939175,-0.0439324744308057,4.43163853427963e-16
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PAK4,Serine/threonine-protein kinase PAK 4,41829,-0.0511973489864124,0.00629244944833706,-0.0635305499051531,-0.0388641480676718,4.45423479566508e-16
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADGRD1,Adhesion G-protein coupled receptor D1,39863,-0.0322792632912255,0.00397399995375662,-0.0400683032005885,-0.0244902233818625,5.06583778343411e-16
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AK1,Adenylate kinase isoenzyme 1,42144,-0.0530681385174833,0.00653690152553417,-0.0658804655075303,-0.0402558115274364,5.15515075526268e-16
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AP1G2,AP-1 complex subunit gamma-like 2,40020,-0.0661320602216564,0.0081445283761349,-0.0820953358388808,-0.050168784604432,5.17546406719326e-16
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RASSF2,Ras association domain-containing protein 2,41861,-0.0478111081608344,0.00589027353010093,-0.0593560442798322,-0.0362661720418366,5.21957082167689e-16
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CPPED1,Serine/threonine-protein phosphatase CPPED1,42213,-0.0545175403327568,0.00671721060463811,-0.0676832731178475,-0.0413518075476661,5.24407588712444e-16
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADM,Pro-adrenomedullin,42223,-0.0225777955968815,0.00278325987271066,-0.0280329849473944,-0.0171226062463687,5.42290660686289e-16
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAN2B2,Epididymis-specific alpha-mannosidase,40080,-0.0504419982848298,0.00621699595484121,-0.0626273103563186,-0.038256686213341,5.44409317507831e-16
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTP4A3,Protein tyrosine phosphatase type IVA 3,39784,-0.0447561376275981,0.00552043590801714,-0.0555761920073117,-0.0339360832478845,5.74401767967596e-16
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNAJC9,DnaJ homolog subfamily C member 9,40021,-0.0639969682124096,0.00790558411651933,-0.0794919130807875,-0.0485020233440317,6.33149601782419e-16
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNAJA4,DnaJ homolog subfamily A member 4,40054,-0.0591629557138569,0.00731991274975584,-0.0735099847033783,-0.0448159267243354,7.02023925803796e-16
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SOD1,Superoxide dismutase [Cu-Zn],41888,-0.0400421301459781,0.00496017991144166,-0.0497640827724037,-0.0303201775195524,7.49173381402456e-16
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINA9,Serpin A9,42045,-0.0600390588714292,0.00744157429818781,-0.0746245444958773,-0.0454535732469811,7.77348488935729e-16
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UROD,Uroporphyrinogen decarboxylase,39863,-0.0574017195582649,0.00711433348550329,-0.0713458131898514,-0.0434576259266784,7.88287775784099e-16
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GAST,Gastrin,40054,-0.121623709508826,0.0150767982490233,-0.151174234076912,-0.0920731849407403,7.96645554381873e-16
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITGBL1,Integrin beta-like protein 1,40097,-0.0325420018194624,0.00403668493212063,-0.0404539042864188,-0.024630099352506,8.31960904415874e-16
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MTHFSD,Methenyltetrahydrofolate synthase domain-containing protein,39881,-0.0931423734090959,0.0115570096838156,-0.115794112389375,-0.0704906344288173,8.48553530653652e-16
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SELP,P-selectin,42197,-0.0466312271397525,0.00579343510330938,-0.0579863599422389,-0.0352760943372661,9.07048244417481e-16
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,F10,Coagulation factor X,40102,-0.0237512153082153,0.00295082299852284,-0.02953482838532,-0.0179676022311105,9.21273531948219e-16
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GAPDH,Glyceraldehyde-3-phosphate dehydrogenase,39625,-0.0273026594567562,0.00339671742975334,-0.0339602256190727,-0.0206450932944396,1.01231085839572e-15
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGSF8,Immunoglobulin superfamily member 8,42144,-0.0255487142051543,0.00317992188584114,-0.031781361101403,-0.0193160673089057,1.02152957610196e-15
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C19orf12,Protein C19orf12,41829,-0.0530243711363635,0.00660232949071817,-0.0659649369381712,-0.0400838053345559,1.05074765303413e-15
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITPR1,"Inositol 1,4,5-trisphosphate receptor type 1",39804,-0.0567705850542942,0.00707333880449145,-0.0706343291110975,-0.042906840997491,1.11340136961679e-15
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TOMM20,Mitochondrial import receptor subunit TOM20 homolog,40080,-0.064566734658366,0.00804533742180576,-0.0803355960051053,-0.0487978733116267,1.11630619264811e-15
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SIGLEC7,Sialic acid-binding Ig-like lectin 7,42144,-0.0229281350032836,0.00286279003632414,-0.0285392034744789,-0.0173170665320883,1.25462385833513e-15
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MLN,Promotilin,42103,-0.0734220169682204,0.00917835620655097,-0.0914115951330603,-0.0554324388033805,1.35562170511431e-15
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGF23,Fibroblast growth factor 23,42214,-0.0452520162747241,0.00566039164760011,-0.0563463839040203,-0.0341576486454279,1.41019083121415e-15
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SDCCAG8,Serologically defined colon cancer antigen 8,40020,-0.0935427451826208,0.0117016041085756,-0.116477889235429,-0.0706076011298127,1.43902992609384e-15
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RAPGEF2,Rap guanine nucleotide exchange factor 2,39881,-0.0436169617959993,0.00546147936694904,-0.0543214613552194,-0.0329124622367792,1.53337605259616e-15
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FOXO3,Forkhead box protein O3,41861,-0.0784301776952562,0.00982877782586166,-0.0976945822339451,-0.0591657731565674,1.59331886328572e-15
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PFKFB2,"6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 2",42076,-0.0630757968564337,0.00790857678778824,-0.0785766073604987,-0.0475749863523688,1.64363985353679e-15
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KAZN,Kazrin,40021,-0.0857272703921374,0.0107508533421098,-0.106798942942673,-0.0646555978416023,1.69085216763818e-15
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHAC2,Glutathione-specific gamma-glutamylcyclotransferase 2,41861,-0.0496000123709887,0.00622378338991302,-0.0617986278152182,-0.0374013969267592,1.72999307197053e-15
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD36,Platelet glycoprotein 4,39784,-0.0369850654468717,0.00464018315012097,-0.0460798244211088,-0.0278903064726346,1.74135374715599e-15
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NAA80,N-alpha-acetyltransferase 80,39768,-0.09921727736137,0.0124636295048991,-0.123645991190972,-0.0747885635317678,1.88831653946851e-15
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NTproBNP,N-terminal prohormone of brain natriuretic peptide,42144,0.0954126597205127,0.0119959751168699,0.0719005484914477,0.118924770949578,1.9595095396748e-15
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PARP1,Poly [ADP-ribose] polymerase 1,42103,-0.0479552273562169,0.00603265835698654,-0.0597792377359105,-0.0361312169765232,2.03139603291737e-15
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TRIM25,E3 ubiquitin/ISG15 ligase TRIM25,40021,-0.0891184705188355,0.0112130035349614,-0.11109595744736,-0.0671409835903112,2.08739170072317e-15
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEBPB,CCAAT/enhancer-binding protein beta,41876,-0.03133407850343,0.00394572959811031,-0.0390677085157262,-0.0236004484911338,2.1693110820302e-15
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAPK9,Mitogen-activated protein kinase 9,42103,-0.0345935628256974,0.00436344546071376,-0.0431459159286964,-0.0260412097226984,2.40857272886074e-15
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AIFM1,"Apoptosis-inducing factor 1, mitochondrial",42077,-0.0862646361540647,0.0108978939790368,-0.107624508352977,-0.0649047639551526,2.65869515885699e-15
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLF4,Krueppel-like factor 4,39719,-0.0329010295129588,0.00415657490750729,-0.0410479163316731,-0.0247541426942445,2.71203643721256e-15
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPIND1,Heparin cofactor 2,40092,-0.0229295914718829,0.00290068373182027,-0.0286149315862507,-0.0172442513575152,2.94028599243712e-15
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITIH4,Inter-alpha-trypsin inhibitor heavy chain H4,40113,0.0208352513218468,0.00263733433029921,0.0156660760344604,0.0260044266092333,3.05392626564987e-15
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AZU1,Azurocidin,41742,-0.0624768187686387,0.00791200102139477,-0.0779843407705725,-0.046969296766705,3.10725274126938e-15
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AMN,Protein amnionless,41887,-0.038409808060469,0.0048686364746988,-0.0479523355508787,-0.0288672805700594,3.28871600121557e-15
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACYP1,Acylphosphatase-1,39830,-0.0534221751372126,0.00677183738894122,-0.0666949764195374,-0.0401493738548878,3.34836783140539e-15
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,USP25,Ubiquitin carboxyl-terminal hydrolase 25,40020,-0.0581424476158097,0.00737300077858387,-0.0725935291418341,-0.0436913660897853,3.42414070279775e-15
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MDH1,"Malate dehydrogenase, cytoplasmic",40053,-0.0322805601614851,0.00410738039832871,-0.0403310257422093,-0.0242300945807608,4.2327041501206e-15
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,WDR46,WD repeat-containing protein 46,40020,-0.0292521965350409,0.00372296613758524,-0.036549210164708,-0.0219551829053738,4.29926164866618e-15
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PAMR1,Inactive serine protease PAMR1,42120,-0.0216960484462095,0.00276308442029911,-0.0271116939099957,-0.0162804029824232,4.41237880143162e-15
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLEKHO1,Pleckstrin homology domain-containing family O member 1,40054,-0.0558918616745698,0.00713712621170767,-0.0698806290495169,-0.0419030942996228,5.28477374661574e-15
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRSS2,Trypsin-2,42197,-0.0453781061450846,0.00579678052781586,-0.0567397959796037,-0.0340164163105655,5.33263767204763e-15
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OGFR,Opioid growth factor receptor,42094,-0.0263839516770701,0.00337394747982197,-0.0329968887375211,-0.019771014616619,5.69566152568391e-15
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MERTK,Tyrosine-protein kinase Mer,42256,0.0206279987406072,0.00264010986434981,0.0154533834064816,0.0258026140747328,5.99489490075232e-15
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NBN,Nibrin,41887,-0.043370660104347,0.00555768854447961,-0.054263729651527,-0.032477590557167,6.4800698719319e-15
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCT5,T-complex protein 1 subunit epsilon,41861,-0.0372141964928743,0.00477334590534527,-0.046569954467351,-0.0278584385183975,6.87450788004245e-15
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GASK1A,Golgi-associated kinase 1A,39706,-0.0348219151974404,0.00448135432468907,-0.043605369673831,-0.0260384607210498,8.55395306676633e-15
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MSTN,Growth/differentiation factor 8,41876,-0.0428972409064241,0.00552278555987379,-0.0537219006037767,-0.0320725812090714,8.63112718661174e-15
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,METAP2,Methionine aminopeptidase 2,42193,-0.0456092546410512,0.00588281570419167,-0.0571395734212668,-0.0340789358608355,9.64323591086906e-15
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FOXO1,Forkhead box protein O1,42103,-0.0679957891594656,0.0087728254443448,-0.0851905270303814,-0.0508010512885498,9.81856922613895e-15
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EIF4G1,Eukaryotic translation initiation factor 4 gamma 1,42256,-0.0784110183540854,0.0101208419707912,-0.0982478686168361,-0.0585741680913347,1.00633459600471e-14
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STAT5B,Signal transducer and activator of transcription 5B,42094,-0.109502996660948,0.014149568555404,-0.13723615102954,-0.0817698422923565,1.0767009170031e-14
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TAX1BP1,Tax1-binding protein 1,40054,-0.0503559255594507,0.00651954648421513,-0.0631342366685123,-0.037577614450389,1.22811975943787e-14
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEP20,Centrosomal protein 20,41861,-0.0596440984058844,0.00772873834137948,-0.0747924255549882,-0.0444957712567806,1.2782022435746e-14
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UMOD,Uromodulin,42267,0.0442653650452252,0.00573680907693666,0.0330212192544294,0.0555095108360211,1.28694147911102e-14
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DKK1,Dickkopf-related protein 1,42213,-0.046744533742,0.0060583573284541,-0.05861891410577,-0.0348701533782299,1.29047805471961e-14
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CPA1,Carboxypeptidase A1,42296,-0.0498740200666013,0.00647387434865138,-0.062562813789958,-0.0371852263432446,1.41448950694958e-14
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EHBP1,EH domain-binding protein 1,40080,-0.0590112589489457,0.00765960158153808,-0.0740240780487603,-0.0439984398491311,1.43081938119528e-14
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TARBP2,RISC-loading complex subunit TARBP2,41829,-0.0620329895493036,0.00806053977820458,-0.0778316475145846,-0.0462343315840227,1.50934415829246e-14
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENPP7,Ectonucleotide pyrophosphatase/phosphodiesterase family member 7,41718,-0.0683301139781716,0.00888292602120111,-0.0857406489797258,-0.0509195789766174,1.55306086851686e-14
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BLOC1S3,Biogenesis of lysosome-related organelles complex 1 subunit 3,40054,-0.0318011455974172,0.00413633460514019,-0.0399083614234919,-0.0236939297713424,1.62051634972778e-14
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IRAK1,Interleukin-1 receptor-associated kinase 1,41887,-0.0540567334262886,0.00703940150807803,-0.0678539603821215,-0.0402595064704556,1.71837620670278e-14
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PON2,Serum paraoxonase/arylesterase 2,41876,-0.0277821371017353,0.00361946057555558,-0.0348762798298242,-0.0206879943736464,1.76445364342644e-14
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,QDPR,Dihydropteridine reductase,42090,-0.033786608326057,0.00440270537797462,-0.0424159108668873,-0.0251573057852268,1.78597134757202e-14
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CIT,Citron Rho-interacting kinase,39768,-0.0360344726455006,0.00469554577426971,-0.0452377423630693,-0.026831202927932,1.81148454147409e-14
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HMOX1,Heme oxygenase 1,42013,0.0383862648788837,0.00500858805572272,0.0285694322896672,0.0482030974681002,1.93038533406403e-14
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BMPER,BMP-binding endothelial regulator protein,39863,-0.0183819391775365,0.00240299159608966,-0.0230918027058722,-0.0136720756492007,2.18967601136884e-14
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BMP6,Bone morphogenetic protein 6,41861,-0.0321117072939927,0.00420096383396728,-0.0403455964085685,-0.0238778181794168,2.25913297282275e-14
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ESM1,Endothelial cell-specific molecule 1,42126,0.0271676881123266,0.00355696725757344,0.0201960322874827,0.0341393439371706,2.36325766106973e-14
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDON,Cell adhesion molecule-related/down-regulated by oncogenes,42146,-0.0204003537113322,0.00267683540417118,-0.0256469511035077,-0.0151537563191567,2.69049447825823e-14
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD5,T-cell surface glycoprotein CD5,42208,-0.028479088616814,0.00374119021452506,-0.0358118214372831,-0.0211463557963449,2.87765023548727e-14
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANGPTL1,Angiopoietin-related protein 1,41957,-0.0229701425197303,0.00301874389182643,-0.0288868805477101,-0.0170534044917505,2.95182862276085e-14
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ERBIN,Erbin,42094,-0.0802096788536726,0.0105432637201319,-0.100874475745131,-0.059544881962214,2.98402133287441e-14
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARF6,ADP-ribosylation factor 6,40021,-0.084319579460402,0.0110837589293645,-0.106043746961956,-0.0625954119588475,3.02659680413785e-14
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SRPK2,SRSF protein kinase 2,42103,-0.0656174913203463,0.0086425124541729,-0.0825568157305252,-0.0486781669101674,3.35560354476278e-14
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GFER,FAD-linked sulfhydryl oxidase ALR,41861,-0.0493245510475722,0.00650733385544462,-0.0620789254042437,-0.0365701766909008,3.70028830520883e-14
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CNP,"2',3'-cyclic-nucleotide 3'-phosphodiesterase",39793,-0.0622513875176593,0.00821783604195466,-0.0783583461598904,-0.0461444288754282,3.88598318317537e-14
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYL4,Myosin light chain 4,39804,-0.040745256355564,0.00537984478112561,-0.0512897521265702,-0.0302007605845578,3.92965058658489e-14
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATG16L1,Autophagy-related protein 16-1,40021,-0.0660261497762886,0.00872587747276715,-0.0831288696229122,-0.048923429929665,4.13879616410349e-14
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TPP1,Tripeptidyl-peptidase 1,42053,-0.0352221398574092,0.00465878638893635,-0.0443533611797244,-0.0260909185350939,4.29151911363121e-14
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CFH,Complement factor H,39548,-0.0179265607300347,0.0023714440959418,-0.0225745911580806,-0.0132785303019888,4.3941340857206e-14
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DDI2,Protein DDI1 homolog 2,39863,-0.0613279766196073,0.00811935013386557,-0.0772419028819838,-0.0454140503572308,4.59050002998629e-14
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BTD,Biotinidase,40113,-0.0159824787476989,0.00211658705308992,-0.0201309893717551,-0.0118339681236426,4.66171022363125e-14
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CPB1,Carboxypeptidase B,42296,-0.0474050520630191,0.00629160552977705,-0.0597365989013821,-0.0350735052246561,5.21725055610013e-14
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PEBP1,Phosphatidylethanolamine-binding protein 1,42120,-0.0441832982099888,0.00586893777801518,-0.0556864162548986,-0.0326801801650791,5.47965448952751e-14
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EIF2AK2,"Interferon-induced, double-stranded RNA-activated protein kinase",39980,-0.0843921732360575,0.0112281018988426,-0.106399252957789,-0.062385093514326,6.08828188928877e-14
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GNAS,Neuroendocrine secretory protein 55,40054,-0.0669960168858358,0.00891391176882552,-0.0844672839527338,-0.0495247498189377,6.09729239518904e-14
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LTBP3,Latent-transforming growth factor beta-binding protein 3,41861,-0.040651714696805,0.00542051375318602,-0.0512759216530496,-0.0300275077405604,6.82713254380581e-14
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GMPR2,GMP reductase 2,39863,-0.0519367972546911,0.00693499086787569,-0.0655293793557275,-0.0383442151536548,7.48309822027125e-14
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STK11,Serine/threonine-protein kinase STK11,41876,-0.0559873417056627,0.00748831764036811,-0.0706644442807842,-0.0413102391305412,8.12631551637787e-14
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VEGFA,Vascular endothelial growth factor A,42219,-0.0452257720832439,0.00605975714503307,-0.0571028960875087,-0.0333486480789791,8.97356517442581e-14
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRRFIP1,Leucine-rich repeat flightless-interacting protein 1,40020,-0.0369780340239209,0.00495582792345276,-0.0466914567538883,-0.0272646112939535,9.20845708526455e-14
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SYAP1,Synapse-associated protein 1,39863,-0.0443382229207753,0.0059491117394676,-0.0559984819301318,-0.0326779639114188,9.83740049952692e-14
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LGALS3BP,Galectin-3-binding protein,40113,-0.0236185995766122,0.00316980665386545,-0.0298314206181884,-0.0174057785350359,9.95476884756042e-14
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TDP1,Tyrosyl-DNA phosphodiesterase 1,40020,-0.0518086702394297,0.00696713020560604,-0.0654642454424175,-0.0381530950364418,1.11495655894662e-13
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPCDC,Phosphopantothenoylcysteine decarboxylase,42213,-0.0355205184389244,0.00477793619908154,-0.0448852733891243,-0.0261557634887246,1.11706155986206e-13
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SH2B3,SH2B adapter protein 3,41861,-0.0747898991791243,0.0100731011097513,-0.0945331773542368,-0.0550466210040117,1.20247655348528e-13
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CAMKK1,Calcium/calmodulin-dependent protein kinase kinase 1,41861,-0.033598253915944,0.00453091826130306,-0.042478853708098,-0.02471765412379,1.29037376450655e-13
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TALDO1,Transaldolase,40069,-0.0335933877524392,0.00453767146340872,-0.0424872238207203,-0.0246995516841581,1.42745231923824e-13
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HDGF,Hepatoma-derived growth factor,42202,-0.0711601635337449,0.00962781676984354,-0.0900306844026383,-0.0522896426648516,1.54510389363611e-13
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CGREF1,Cell growth regulator with EF hand domain protein 1,42144,-0.0332617509170275,0.00450302759866417,-0.0420876850104092,-0.0244358168236457,1.59931824972431e-13
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NFE2,Transcription factor NF-E2 45 kDa subunit,39804,-0.0566437382200096,0.00766741419696414,-0.0716718700460593,-0.0416156063939599,1.60750438246343e-13
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GIT1,ARF GTPase-activating protein GIT1,39784,-0.0739370978894472,0.0100132309899104,-0.0935630306296716,-0.0543111651492228,1.65225099858663e-13
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCAMP3,Secretory carrier-associated membrane protein 3,42094,-0.0646005768756725,0.00875564760366511,-0.0817616461788562,-0.0474395075724889,1.7030578809625e-13
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SBSN,Suprabasin,40084,0.0266926912863925,0.00362097735771798,0.0195955756652652,0.0337898069075197,1.80712734531141e-13
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CNST,Consortin,42144,-0.0826909154659999,0.0112239537442368,-0.104689864804704,-0.0606919661272958,1.8457778099996e-13
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ZHX2,Zinc fingers and homeoboxes protein 2,40054,-0.0247420653803044,0.0033585840293686,-0.0313248900778668,-0.0181592406827419,1.87433339815209e-13
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LTBP2,Latent-transforming growth factor beta-binding protein 2,42296,0.0251333288887939,0.00341348133728042,0.0184429054677243,0.0318237523098636,1.90611725562188e-13
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSMG4,Proteasome assembly chaperone 4,39784,-0.0434263865995733,0.00590542295806909,-0.0550010155973887,-0.0318517576017579,2.07132002402635e-13
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TRIM5,Tripartite motif-containing protein 5,42103,-0.0649285305095949,0.00884115343119211,-0.0822571912347314,-0.0475998697844583,2.19902991046904e-13
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ST3GAL1,"CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1",42094,0.0317184700951189,0.00432260303272656,0.0232461681509748,0.0401907720392629,2.30091929218828e-13
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UBXN1,UBX domain-containing protein 1,39863,-0.0520020365227076,0.00708857958884422,-0.0658956525168423,-0.038108420528573,2.36007123532352e-13
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTPRF,Receptor-type tyrosine-protein phosphatase F,42296,0.0220038815994741,0.00300108347713094,0.0161217579842975,0.0278860052146508,2.40085695844428e-13
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TRAF3,"TNF receptor-associated factor 3, Isoform 2",39784,-0.0276305436351431,0.00376909181563367,-0.0350179635937851,-0.0202431236765012,2.45442988927676e-13
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KIT,Mast/stem cell growth factor receptor Kit,42172,0.0229050187240191,0.0031259463751326,0.0167781638287592,0.029031873619279,2.48554612267442e-13
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLK14,Kallikrein-14,42223,0.0357922515209583,0.0048931312665609,0.0262017142384989,0.0453827888034177,2.72844652384176e-13
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AHNAK,Neuroblast differentiation-associated protein AHNAK,39804,-0.0240755387938557,0.0032940089173038,-0.0305317962717711,-0.0176192813159402,2.88752719810999e-13
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KCTD5,BTB/POZ domain-containing protein KCTD5,39872,-0.0333390673268637,0.00456602381516531,-0.0422884740045877,-0.0243896606491396,3.0472193801868e-13
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGA,Fibrinogen alpha chain,39862,0.02332756401869,0.00319569688803732,0.0170639981181368,0.0295911299192431,3.08994018575711e-13
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDHR5,Cadherin-related family member 5,42144,-0.0292837054101604,0.00401461357857074,-0.037152348024159,-0.0214150627961617,3.17730688585603e-13
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PBLD,Phenazine biosynthesis-like domain-containing protein,41829,-0.0385603983455581,0.00529051037356819,-0.0489297986777517,-0.0281909980133644,3.3182359354035e-13
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KEL,Kell blood group glycoprotein,41829,-0.0273754395747918,0.00375790336462292,-0.0347409301694527,-0.0200099489801309,3.41354558852348e-13
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTPRS,Receptor-type tyrosine-protein phosphatase S,42296,0.0187729111441329,0.00257865796450589,0.0137187415337014,0.0238270807545644,3.52570539887097e-13
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RFC4,Replication factor C subunit 4,40020,-0.0158893887072758,0.00218281742383112,-0.0201677108579848,-0.0116110665565668,3.58819653080279e-13
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ERMAP,Erythroid membrane-associated protein,39784,-0.0337298246143494,0.00463614152282733,-0.042816661999091,-0.0246429872296078,3.69821144002235e-13
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",42094,-0.033171098481359,0.00456498517807056,-0.0421184694303773,-0.0242237275323407,3.90366129850047e-13
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PCDH9,Protocadherin-9,40021,-0.0259483460841684,0.00357283343609642,-0.0329510996189174,-0.0189455925494194,4.05566651663767e-13
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GPRC5C,G-protein coupled receptor family C group 5 member C,40020,-0.0425462104041464,0.00585933024639766,-0.0540304976870858,-0.0310619231212069,4.09783245186874e-13
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FKBPL,FK506-binding protein-like,40021,-0.0438435994489247,0.00604145547111642,-0.0556848521723129,-0.0320023467255365,4.22483940418316e-13
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLEC1B,C-type lectin domain family 1 member B,42213,-0.0714237476675077,0.00984630432353209,-0.0907225041416306,-0.0521249911933848,4.2796024695819e-13
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,41861,-0.0581078457639319,0.00801628811358649,-0.0738197704665614,-0.0423959210613024,4.4512870482352e-13
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEP43,Centrosomal protein 43,41779,-0.0517377402580164,0.00715625807388669,-0.0657640060828344,-0.0377114744331985,5.11959165696414e-13
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNMBP,Dynamin-binding protein,42004,-0.0448897794816294,0.00621543348522683,-0.057072029112674,-0.0327075298505849,5.4000639381617e-13
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CA5A,"Carbonic anhydrase 5A, mitochondrial",41876,-0.06902481414748,0.00955846793910983,-0.0877594113081352,-0.0502902169868247,5.44208360368768e-13
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCPEP1,Retinoid-inducible serine carboxypeptidase,39753,-0.0364861754321266,0.00506747543685606,-0.0464184272883644,-0.0265539235758887,6.42783083305031e-13
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NTRK3,NT-3 growth factor receptor,42213,0.0162430393854557,0.00225820079657098,0.0118169658241765,0.0206691129467348,6.68915815609168e-13
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RPL14,60S ribosomal protein L14,39804,-0.0298144638623238,0.00414994032698608,-0.0379483469032165,-0.0216805808214311,7.20812994407859e-13
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RLN2,Prorelaxin H2,39838,-0.0370188579162758,0.00517201907114664,-0.0471560152957233,-0.0268817005368284,8.75604510229512e-13
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GOLGA3,Golgin subfamily A member 3,40054,-0.057908769985814,0.00809250225048928,-0.073770074396773,-0.042047465574855,8.85164815587561e-13
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SYTL4,Synaptotagmin-like protein 4,40080,-0.0543727608118608,0.00763548616062674,-0.0693383136866892,-0.0394072079370324,1.13855970487399e-12
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GLOD4,Glyoxalase domain-containing protein 4,42111,-0.0256385886957562,0.00360690783911943,-0.0327081280604303,-0.0185690493310822,1.23752689767589e-12
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD207,C-type lectin domain family 4 member K,41880,-0.0293982748981414,0.00413755576714595,-0.0375078842017474,-0.0212886655945353,1.2654408051147e-12
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TPR,Nucleoprotein TPR,39706,-0.0359001198956346,0.00505755771131559,-0.0458129330098132,-0.025987306781456,1.34442813484835e-12
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TRIM21,E3 ubiquitin-protein ligase TRIM21,42103,-0.0578090757113748,0.00815731217795236,-0.0737974075801614,-0.0418207438425882,1.44399629042503e-12
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LEFTY2,Left-right determination factor 2,42193,-0.0365542773025245,0.00516065923245598,-0.0466691693981382,-0.0264393852069108,1.48053451384431e-12
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LAG3,Lymphocyte activation gene 3 protein,42094,0.030249520650589,0.00427753563685692,0.0218655508023495,0.0386334904988286,1.60916313456282e-12
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLRB1,Killer cell lectin-like receptor subfamily B member 1,42256,-0.0292434691454277,0.00415460145816213,-0.0373864880034255,-0.02110045028743,2.03566054675947e-12
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LDLRAP1,Low density lipoprotein receptor adapter protein 1,40054,-0.0704665552730231,0.0100457170430079,-0.0901561606773186,-0.0507769498687276,2.44354076682436e-12
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MRI1,Methylthioribose-1-phosphate isomerase,39768,-0.0497390903077184,0.00709273423202974,-0.0636408494024966,-0.0358373312129401,2.48076005156083e-12
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SNAP23,Synaptosomal-associated protein 23,42144,-0.0627341976408877,0.00894777468657643,-0.0802718360265774,-0.0451965592551979,2.48089122526126e-12
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SH3BP1,SH3 domain-binding protein 1,40021,-0.0344719873371843,0.00492743818360646,-0.044129766177053,-0.0248142084973157,2.79077507112764e-12
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TBC1D17,TBC1 domain family member 17,41829,-0.0326924995462496,0.00467469047985294,-0.0418548928867614,-0.0235301062057379,2.8158924258671e-12
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDC42BPB,Serine/threonine-protein kinase MRCK beta,40021,-0.0741049993288396,0.0106173399646226,-0.0949149856594998,-0.0532950129981793,3.13295847980357e-12
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LAMP1,Lysosome-associated membrane glycoprotein 1,39772,-0.019466706006237,0.00278915592919694,-0.024933451627463,-0.013999960385011,3.1414697901907e-12
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TGM2,Protein-glutamine gamma-glutamyltransferase 2,42126,-0.0539301703474164,0.00775197425898227,-0.0691240398950217,-0.0387363007998111,3.64435341013574e-12
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MFAP5,Microfibrillar-associated protein 5,42296,-0.0296710297734159,0.00426558246887787,-0.0380315714124165,-0.0213104881344152,3.66911983501762e-12
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KRT5,"Keratin, type II cytoskeletal 5",41829,-0.0370596680232766,0.00533701247818731,-0.0475202124805237,-0.0265991235660295,4.00091254962163e-12
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DGKA,Diacylglycerol kinase alpha,39784,-0.0393227438347311,0.00566233968126396,-0.0504209296100084,-0.0282245580594537,4.01763426943766e-12
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AZI2,5-azacytidine-induced protein 2,40054,-0.0394139775011404,0.00568780327733333,-0.0505620719247137,-0.0282658830775671,4.46067661416954e-12
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAP4K5,Mitogen-activated protein kinase kinase kinase kinase 5,41985,-0.0792887415446465,0.0114870996430524,-0.101803456845029,-0.0567740262442639,5.35373252736561e-12
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TP53,Cellular tumor antigen p53,41861,-0.0307330578575723,0.00446396663632543,-0.0394824324647701,-0.0219836832503744,6.06416892768965e-12
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EBAG9,Receptor-binding cancer antigen expressed on SiSo cells,42004,-0.067473976028903,0.00980257397463862,-0.0866870210191947,-0.0482609310386113,6.12095786155372e-12
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PAGR1,PAXIP1-associated glutamate-rich protein 1,39804,-0.0309046003325188,0.00449149454812429,-0.0397079296468424,-0.0221012710181952,6.2920690929309e-12
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGF2R,Cation-independent mannose-6-phosphate receptor,42120,-0.0166206907263271,0.00241749560718585,-0.0213589821164113,-0.0118823993362428,6.47608748774611e-12
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VEGFC,Vascular endothelial growth factor C,42186,-0.0393569160213612,0.00572933448019702,-0.0505864116025474,-0.028127420440175,6.74234448535791e-12
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PVR,Poliovirus receptor,42213,-0.0262400780475838,0.00382095747757047,-0.0337291547036219,-0.0187510013915457,6.83465455518874e-12
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHI3L1,Chitinase-3-like protein 1,41936,-0.0587142500226192,0.00856054272541035,-0.0754929137644235,-0.0419355862808149,7.26951491882365e-12
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PACS2,Phosphofurin acidic cluster sorting protein 2,39706,-0.0438511397683787,0.0063949136168075,-0.0563851704573214,-0.031317109079436,7.41718691501179e-12
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PON1,Serum paraoxonase/arylesterase 1,40102,0.019315222374281,0.00282279164996657,0.0137825507403465,0.0248478940082155,8.1940114122679e-12
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MTDH,Protein LYRIC,39784,-0.0665318836583414,0.0097286160679932,-0.085599971151608,-0.0474637961650747,8.42729315916524e-12
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SULT2A1,Bile salt sulfotransferase,42103,-0.0398727887400132,0.00583193882441845,-0.0513033888358734,-0.0284421886441531,8.45246950031211e-12
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TXNRD1,"Thioredoxin reductase 1, cytoplasmic",42120,-0.0319681927762986,0.00469329703007103,-0.0411670549552378,-0.0227693305973594,1.00891082188175e-11
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BAP18,Chromatin complexes subunit BAP18,40054,-0.0476188737839179,0.00699237340172628,-0.0613239256513014,-0.0339138219165344,1.02672375389743e-11
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINA12,Serpin A12,41774,-0.0728206832663319,0.0107019434622382,-0.0937964924523188,-0.051844874080345,1.0604322716137e-11
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SUGP1,SURP and G-patch domain-containing protein 1,40021,-0.0280861903189324,0.00412701402210191,-0.0361751378022521,-0.0199972428356126,1.06057369638347e-11
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,P4HB,Protein disulfide-isomerase,42074,-0.0269715519534633,0.00396540505494043,-0.0347437458611465,-0.0191993580457801,1.07947632433877e-11
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HNRNPUL1,Heterogeneous nuclear ribonucleoprotein U-like protein 1,40054,-0.0340187806907013,0.00500113824340509,-0.0438210116477752,-0.0242165497336273,1.08445908170742e-11
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APBB1IP,Amyloid beta A4 precursor protein-binding family B member 1-interacting protein,42094,-0.0312368069775566,0.00459977423319312,-0.0402523644746151,-0.022221249480498,1.16284113147303e-11
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NUDT5,ADP-sugar pyrophosphatase,42120,-0.0354805566565776,0.0052326386528898,-0.0457365284162416,-0.0252245848969135,1.24858541366601e-11
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PARK7,Parkinson disease protein 7,42120,-0.0362792142487808,0.00535983584841976,-0.0467844925116835,-0.025773935985878,1.35536779933722e-11
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C1QTNF1,Complement C1q tumor necrosis factor-related protein 1,42197,-0.0299943783475669,0.00443392284813942,-0.0386848671299202,-0.0213038895652136,1.3925525693471e-11
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAP3K5,Mitogen-activated protein kinase kinase kinase 5,41861,-0.0688034503201994,0.0101757646554846,-0.0887479490449492,-0.0488589515954495,1.42560245971201e-11
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLNS1A,Methylosome subunit pICln,39768,-0.023381911843047,0.00345894132588467,-0.0301614368417809,-0.016602386844313,1.45418665193388e-11
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HAO1,Hydroxyacid oxidase 1,42223,-0.0873121443593975,0.0129367851449761,-0.112668243243551,-0.0619560454752442,1.55020473158621e-11
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SGSH,N-sulphoglucosamine sulphohydrolase,39902,-0.0397579779158909,0.00589323884981688,-0.051308726061532,-0.0282072297702498,1.59412568875128e-11
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VSIR,V-type immunoglobulin domain-containing suppressor of T-cell activation,42121,-0.0426169868436936,0.00632211535305588,-0.0550083329356831,-0.0302256407517041,1.64048268958721e-11
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GCHFR,GTP cyclohydrolase 1 feedback regulatory protein,39577,-0.0342318586958757,0.00508047167259012,-0.0441895831741523,-0.024274134217599,1.69174920928912e-11
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MANSC1,MANSC domain-containing protein 1,42186,0.0196231829252395,0.00291681587840038,0.0139062238035747,0.0253401420469042,1.79706887178663e-11
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PCBP2,Poly(rC)-binding protein 2,40054,-0.0497740599165695,0.00742807318884107,-0.064333083366698,-0.035215036466441,2.17539359833607e-11
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SNCG,Gamma-synuclein,42004,-0.0478782770401216,0.00714749510615486,-0.0618873674481851,-0.033869186632058,2.19204205813288e-11
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LAT,Linker for activation of T-cells family member 1,42256,-0.0518555650796729,0.00776558015148524,-0.0670761021765839,-0.0366350279827618,2.52684318556783e-11
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APCS,Serum amyloid P-component,39995,-0.0234428267798564,0.00351051801077379,-0.030323442080973,-0.0165622114787398,2.54324730600271e-11
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BIRC2,Baculoviral IAP repeat-containing protein 2,41861,-0.0431540287131749,0.00649243754696268,-0.0558792063052217,-0.030428851121128,3.11776086456001e-11
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DKK3,Dickkopf-related protein 3,42296,0.0208016232404427,0.00313213037940552,0.0146626476968079,0.0269405987840775,3.23054254844727e-11
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VPS53,Vacuolar protein sorting-associated protein 53 homolog,42094,-0.0528150870117387,0.00795304026556247,-0.0684030459322411,-0.0372271280912362,3.24340406065974e-11
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEMIP2,Cell surface hyaluronidase,39784,-0.0237099806513222,0.00357196003630326,-0.0307110223224766,-0.0167089389801678,3.33959299543262e-11
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADAMTSL4,ADAMTS-like protein 4,39804,-0.0162415912407342,0.00244924204140687,-0.0210421056418917,-0.0114410768395767,3.48989994688516e-11
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRACR2A,EF-hand calcium-binding domain-containing protein 4B,41861,-0.0578467799973941,0.00874860103834074,-0.074994038032542,-0.0406995219622463,3.94063690412326e-11
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLEC4M,C-type lectin domain family 4 member M,40076,0.0336784755462856,0.00510391726253027,0.0236747977117263,0.0436821533808449,4.3447672781354e-11
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARG1,Arginase-1,41999,-0.0354110807782587,0.00536800924409792,-0.0459323788966906,-0.0248897826598267,4.3697727581021e-11
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLIP2,CAP-Gly domain-containing linker protein 2,42103,-0.0758306435910668,0.0114997562730746,-0.098370165886293,-0.0532911212958406,4.4447640055725e-11
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FOXJ3,Forkhead box protein J3,39784,-0.0297279496094078,0.00450958656605892,-0.0385667392788833,-0.0208891599399323,4.54077328091125e-11
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GZMA,Granzyme A,42256,-0.0242820313675746,0.00368789547931003,-0.0315103065070222,-0.0170537562281269,4.74667937707242e-11
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENTR1,Endosome-associated-trafficking regulator 1,39804,-0.0398832854323242,0.00605638908729103,-0.0517538080434147,-0.0280127628212338,4.75361739564515e-11
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ABRAXAS2,BRISC complex subunit Abraxas 2,39706,-0.0453335757282028,0.00689105797558519,-0.0588400493603498,-0.0318271020960558,4.97451092523752e-11
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,41887,-0.0313782469092775,0.00478099566517585,-0.0407489984130222,-0.0220074954055329,5.47419976480281e-11
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AAMDC,Mth938 domain-containing protein,39804,-0.0358772394864127,0.00546559500546987,-0.0465898056971336,-0.0251646732756917,5.47568983143739e-11
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLKB1,Plasma kallikrein,39873,-0.0166981165702287,0.00254453971292183,-0.0216854144075555,-0.0117108187329019,5.54267592030073e-11
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BAG4,BAG family molecular chaperone regulator 4,39784,-0.0332992156089431,0.00507823750547697,-0.043252561119678,-0.0233458700982083,5.73667158624119e-11
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLEC5A,C-type lectin domain family 5 member A,42111,0.0204762986433419,0.00312331442564012,0.0143546023690872,0.0265979949175965,5.73904065563988e-11
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COL4A1,Collagen alpha-1(IV) chain,42144,0.0270338289390385,0.00413767770002374,0.0189239806469919,0.035143677231085,6.66204678859157e-11
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TBC1D5,TBC1 domain family member 5,42103,-0.0530105649891254,0.00811929947824166,-0.0689243919664791,-0.0370967380117718,6.87076810976131e-11
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NCAM2,Neural cell adhesion molecule 2,42120,0.0184007172280132,0.00282018944227523,0.0128731459211538,0.0239282885348727,7.07068656633412e-11
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTRB1,Chymotrypsinogen B,42120,-0.0391546165634459,0.00600581169507469,-0.0509260074857923,-0.0273832256410995,7.31858150964751e-11
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LTA,Lymphotoxin-alpha,42103,-0.0275501146899182,0.0042391842181533,-0.0358589157574987,-0.0192413136223377,8.38721115291716e-11
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RAB11FIP3,Rab11 family-interacting protein 3,40080,-0.071522644281157,0.0110144163006821,-0.0931109002304939,-0.0499343883318201,8.74900689404999e-11
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CALCA,Calcitonin,41985,-0.0424363071517259,0.00654160886353838,-0.0552578605242611,-0.0296147537791907,9.07049298749293e-11
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GDNF,Glial cell line-derived neurotrophic factor,41829,-0.0256626919102923,0.00395732726292894,-0.0334190533456331,-0.0179063304749516,9.21245651016946e-11
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HBEGF,Proheparin-binding EGF-like growth factor,42178,-0.0487082562576608,0.00751481077453912,-0.0634372853757575,-0.0339792271395641,9.40140925094844e-11
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GFRA1,GDNF family receptor alpha-1,42193,-0.0199446697996026,0.0030826694847048,-0.025986701989624,-0.0139026376095812,1.01559985532873e-10
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CPQ,Carboxypeptidase Q,40086,-0.0238191504674488,0.0036845330559906,-0.0310408352571903,-0.0165974656777072,1.05888700258652e-10
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLSCR3,Phospholipid scramblase 3,40028,-0.0384794604071039,0.00596887390996889,-0.050178453270643,-0.0267804675435649,1.1918373859566e-10
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCN2,CCN family member 2,42132,-0.0367141331667818,0.0057013935303231,-0.0478888644862151,-0.0255394018473485,1.24103639159087e-10
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SKAP2,Src kinase-associated phosphoprotein 2,42184,-0.0692608161648073,0.0107779826784777,-0.0903856622146236,-0.0481359701149909,1.35455716293912e-10
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PALM2,Paralemmin-2,40054,-0.024955663075987,0.00388865229338777,-0.0325774215710271,-0.017333904580947,1.44244741799268e-10
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HNRNPK,Heterogeneous nuclear ribonucleoprotein K,41828,-0.0519035688516785,0.00808896467007023,-0.0677579396050161,-0.0360491980983408,1.44336457014509e-10
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,YTHDF3,YTH domain-containing family protein 3,41887,-0.0561426171197648,0.00877546809913867,-0.0733425345940766,-0.038942699645453,1.63298458633401e-10
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRG2,Bone marrow proteoglycan,40097,0.0349486344310188,0.00546550328410354,0.0242362479941759,0.0456610208678617,1.67768158100381e-10
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACAA1,"3-ketoacyl-CoA thiolase, peroxisomal",41861,-0.0539570407839247,0.00843980421876034,-0.070499057052695,-0.0374150245151545,1.68192038949849e-10
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FETUB,Fetuin-B,42172,-0.0212668139964253,0.00332710499138786,-0.0277879397795455,-0.0147456882133051,1.69346037274406e-10
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINA3,Alpha-1-antichymotrypsin,40076,0.0100587323626093,0.00157523501664081,0.0069712717299933,0.0131461929952253,1.77750863586507e-10
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,42186,-0.0202850585317643,0.00319051529780615,-0.0265384685154644,-0.0140316485480643,2.11339686156977e-10
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLK13,Kallikrein-13,41897,-0.0305014594490671,0.00479828255992767,-0.0399060932665254,-0.0210968256316089,2.1312328151178e-10
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,B4GAT1,"Beta-1,4-glucuronyltransferase 1",42120,0.0156651309934017,0.0024646061285068,0.0108345029815283,0.020495759005275,2.13978716326483e-10
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD74,HLA class II histocompatibility antigen gamma chain,42213,-0.0233945553019373,0.00368071628227493,-0.0306087592151961,-0.0161803513886784,2.14010676143496e-10
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ABCA2,ATP-binding cassette sub-family A member 2,39706,-0.0237115052379244,0.0037450557896522,-0.0310518145856427,-0.0163711958902061,2.52836510886966e-10
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PNLIP,Pancreatic triacylglycerol lipase,40102,-0.0428328484762652,0.00677025628658511,-0.0561025507979721,-0.0295631461545584,2.60407482920385e-10
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PNLIPRP1,Inactive pancreatic lipase-related protein 1,40054,-0.0537292727789502,0.00850608694132123,-0.0704012031839398,-0.0370573423739606,2.77897980065845e-10
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANGPTL3,Angiopoietin-related protein 3,42161,-0.0232921004049784,0.00369038866697436,-0.0305252621922481,-0.0160589386177087,2.85237956700203e-10
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NCAN,Neurocan core protein,42213,0.0248808348105141,0.00394944882359288,0.0171399151162721,0.0326217545047562,3.0757732635385e-10
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ASPSCR1,Tether containing UBX domain for GLUT4,40054,-0.04360180374221,0.00692605656503175,-0.0571768746096722,-0.0300267328747478,3.1858842049454e-10
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLC39A14,Zinc transporter ZIP14,41829,0.0225800310997291,0.00359060626045692,0.0155424428292336,0.0296176193702247,3.30813793762673e-10
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL18,Interleukin-18,42078,-0.0302221558731998,0.00480874353712543,-0.0396472932059657,-0.020797018540434,3.38783395372032e-10
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRTG,Protogenin,42223,-0.016222640140263,0.00258230368035494,-0.0212839553537587,-0.0111613249267673,3.4435779349175e-10
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HSPA1A,Heat shock 70 kDa protein 1A,42167,-0.0454301432060195,0.00724007566648011,-0.0596206915123205,-0.0312395948997185,3.61182513899148e-10
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AGRN,Agrin,42184,-0.0236928257087902,0.0037801195022617,-0.0311018599332231,-0.0162837914843572,3.77898385476642e-10
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,XCL1,Lymphotactin,42223,-0.0365890635939151,0.00583856193896102,-0.0480326449942787,-0.0251454821935515,3.80171114294486e-10
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CASC3,Protein CASC3,39768,-0.0272742689890062,0.00435329736642553,-0.0358067318272002,-0.0187418061508122,3.86840521602286e-10
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MTUS1,Microtubule-associated tumor suppressor 1,39881,-0.0366188505669138,0.00584816074584735,-0.0480812456287746,-0.025156455505053,3.95677730665437e-10
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTPRM,Receptor-type tyrosine-protein phosphatase mu,42088,-0.0158921339998801,0.00254048116707837,-0.0208714770873537,-0.0109127909124064,4.08614461394592e-10
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EPPK1,Epiplakin,39804,-0.0469185141552226,0.00749946111428523,-0.0616174579392217,-0.0322195703712236,4.0954492384777e-10
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CWC15,Spliceosome-associated protein CWC15 homolog,39955,-0.0384768677444319,0.00615960210776501,-0.0505496878756513,-0.0264040476132125,4.35194879630228e-10
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARHGEF1,Rho guanine nucleotide exchange factor 1,40054,-0.0578614093957408,0.00927534521881385,-0.076041086024616,-0.0396817327668657,4.59126649660966e-10
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LARP1,La-related protein 1,40020,-0.039589445113078,0.00634777829954486,-0.052031090580186,-0.0271477996459701,4.63451240139147e-10
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DDHD2,Phospholipase DDHD2,40054,-0.0421765577929921,0.00677091527809744,-0.0554475517380631,-0.0289055638479211,4.86552788321271e-10
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NIT2,Omega-amidase NIT2,40033,-0.0468511821052142,0.00752148600403343,-0.0615932946731198,-0.0321090695373087,4.86891135176641e-10
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FAM13A,Protein FAM13A,40021,-0.0432278100407306,0.00694749532318268,-0.0568449008741686,-0.0296107192072925,5.08767110942949e-10
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CMIP,C-Maf-inducing protein,40020,-0.0532776212005939,0.00856278399111711,-0.0700606778231834,-0.0364945645780044,5.09006592484315e-10
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRELD2,Protein disulfide isomerase CRELD2,42162,-0.0334362937543768,0.00537566426980155,-0.0439725957231879,-0.0228999917855658,5.12639514345084e-10
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,YJU2,Splicing factor YJU2,40020,-0.0209124977619027,0.00336348657021497,-0.027504931439524,-0.0143200640842814,5.23734356467057e-10
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RAB27B,Ras-related protein Rab-27B,40080,-0.0526870418632666,0.00847476355567068,-0.0692975784323811,-0.036076505294152,5.25536292152136e-10
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,42004,-0.0377708200571134,0.00607847758448041,-0.049684636122695,-0.0258570039915318,5.33004795145262e-10
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANXA2,Annexin A2,39640,-0.0464159184575855,0.00747376864413957,-0.0610645050000991,-0.031767331915072,5.48220432459654e-10
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CFC1,Cryptic protein,41861,-0.0306115913971273,0.00493652450780081,-0.0402871794324168,-0.0209360033618377,5.7835097434225e-10
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PECAM1,Platelet endothelial cell adhesion molecule,42120,-0.0192784668499639,0.00310927209141717,-0.0253726401491416,-0.0131842935507862,5.80661459532347e-10
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NAP1L4,Nucleosome assembly protein 1-like 4,40002,-0.0264821487331045,0.00427111157831564,-0.0348535274266032,-0.0181107700396059,5.8415396908187e-10
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VTI1A,Vesicle transport through interaction with t-SNAREs homolog 1A,39863,-0.0370848581607257,0.00598346976192514,-0.048812458894099,-0.0253572574273524,5.93407321305464e-10
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLPBP,Pyridoxal phosphate homeostasis protein,42144,-0.0428844701040491,0.00692156279827842,-0.0564507331886748,-0.0293182070194234,5.97553226013888e-10
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HS3ST3B1,Heparan sulfate glucosamine 3-O-sulfotransferase 3B1,42094,-0.0243353110651339,0.00392834795809993,-0.0320348730630098,-0.016635749067258,6.0135391198686e-10
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDCD6,Programmed cell death protein 6,42144,0.045453970213575,0.00734662242589089,0.0310545902588288,0.0598533501683211,6.31452637279177e-10
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KDR,Vascular endothelial growth factor receptor 2,42186,-0.0157617198576811,0.00254830411710334,-0.0207563959272037,-0.0107670437881586,6.38927522487383e-10
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENTPD5,Ectonucleoside triphosphate diphosphohydrolase 5,41876,0.0137543126394383,0.00222417327285542,0.0093949330246417,0.0181136922542349,6.44128696912853e-10
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SHMT1,"Serine hydroxymethyltransferase, cytosolic",42162,-0.0544209564825267,0.00880116445760434,-0.0716712388194312,-0.0371706741456222,6.46267173107857e-10
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TRIM24,Transcription intermediary factor 1-alpha,39867,-0.0415559783243881,0.00672026107318313,-0.0547276900278271,-0.0283842666209492,6.49135281372892e-10
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SIAE,Sialate O-acetylesterase,42154,-0.0293822356422303,0.00475372335224518,-0.0386995334126308,-0.0200649378718297,6.56536553054162e-10
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DFFA,DNA fragmentation factor subunit alpha,42256,-0.0427078734891671,0.00691462418407168,-0.0562605368899476,-0.0291552100883866,6.75017016694353e-10
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FCN2,Ficolin-2,42106,-0.0262084311980371,0.00424463780187824,-0.0345279212897185,-0.0178889411063558,6.83720500291164e-10
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BTN3A2,Butyrophilin subfamily 3 member A2,42103,-0.0249423813133522,0.00405012555890869,-0.0328806274088132,-0.0170041352178911,7.56545263593505e-10
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AREG,Amphiregulin,42094,-0.0272548948241079,0.00442576867736016,-0.0359294014317338,-0.018580388216482,7.57481489131949e-10
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL3,C-C motif chemokine 3,42103,-0.036253590253232,0.00588756207455991,-0.0477932119193694,-0.0247139685870946,7.60193726867505e-10
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OLFM4,Olfactomedin-4,39466,-0.078858295459073,0.0128121091586784,-0.103970029410083,-0.0537465615080634,7.78903201808961e-10
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TCOF1,Treacle protein,40080,-0.0205388170065309,0.00333937715823837,-0.0270839962366781,-0.0139936377763837,7.99538931136731e-10
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TIMD4,T-cell immunoglobulin and mucin domain-containing protein 4,42197,0.0282823476356017,0.00460225926998421,0.0192619194664327,0.0373027758047708,8.21352602493629e-10
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARHGAP25,Rho GTPase-activating protein 25,41861,-0.037756200438361,0.00614958819870607,-0.0498093933078249,-0.0257030075688971,8.51863389539396e-10
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KYAT1,Kynurenine--oxoglutarate transaminase 1,42128,-0.036092251369374,0.00588226939045581,-0.0476214993746674,-0.0245630033640806,8.72222404153551e-10
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RPE,Ribulose-phosphate 3-epimerase,39881,-0.0443547099506538,0.00723912429567058,-0.0585433935701681,-0.0301660263311395,9.26586579235299e-10
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OCLN,Occludin,40054,-0.0285135182430211,0.00465802312453512,-0.03764324356711,-0.0193837929189323,9.59735666013164e-10
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MPRIP,Myosin phosphatase Rho-interacting protein,39986,-0.0274666821317831,0.00448832785252406,-0.0362638047227302,-0.0186695595408359,9.70792663739837e-10
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RWDD1,RWD domain-containing protein 1,42213,-0.0397733019576994,0.0065042849756341,-0.0525217005099422,-0.0270249034054566,9.93585965806757e-10
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COCH,Cochlin,40080,-0.0296371802264289,0.00484964307028929,-0.0391424806441959,-0.0201318798086619,1.02263575418552e-09
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LHPP,Phospholysine phosphohistidine inorganic pyrophosphate phosphatase,42129,-0.0370511984054748,0.00606489983178266,-0.0489384020757688,-0.0251639947351808,1.03057256257373e-09
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FOLR2,Folate receptor beta,42213,0.0187881004982712,0.00307754092796261,0.0127561202794644,0.0248200807170779,1.05785317530915e-09
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CANT1,Soluble calcium-activated nucleotidase 1,42091,-0.0129694596829477,0.00212592510666562,-0.0171362728920124,-0.00880264647388312,1.08682830660764e-09
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GAS6,Growth arrest-specific protein 6,42222,0.0160028035307518,0.00262733257365166,0.0108532316863945,0.0211523753751091,1.15443496971235e-09
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IQGAP2,Ras GTPase-activating-like protein IQGAP2,42094,-0.0335199849575668,0.00551663432374918,-0.0443325882321152,-0.0227073816830184,1.26557360617347e-09
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CILP,Cartilage intermediate layer protein 1,40097,-0.0345474398138703,0.00569449639267186,-0.0457086527435072,-0.0233862268842335,1.34805520219368e-09
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FARSA,Phenylalanine--tRNA ligase alpha subunit,39768,-0.0437460677343422,0.00721323117320036,-0.0578840008338149,-0.0296081346348695,1.3672309585369e-09
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRSS22,Brain-specific serine protease 4,39784,-0.0230913156789156,0.00381376919638072,-0.0305663033038218,-0.0156163280540094,1.45431413652894e-09
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TPMT,Thiopurine S-methyltransferase,41861,-0.0456017605549027,0.00754146592267277,-0.0603830337633413,-0.0308204873464641,1.51906975503717e-09
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDLIM7,PDZ and LIM domain protein 7,42184,-0.0773431935075014,0.0127948383691606,-0.102421076711056,-0.0522653103039467,1.53624220238329e-09
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,WFIKKN2,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 2",42146,0.0214169005248921,0.00354722443052578,0.0144643406410616,0.0283694604087226,1.60652656725643e-09
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATXN2L,Ataxin-2-like protein,40054,-0.0301739186071626,0.00500196940847146,-0.0399777786477666,-0.0203700585665585,1.66799007726204e-09
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CSTB,Cystatin-B,41949,-0.0266691702951135,0.00442171237282048,-0.0353357265458417,-0.0180026140443854,1.67030663484503e-09
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,WFIKKN1,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 1",41968,-0.0260673560623016,0.00432287167453176,-0.0345401845443838,-0.0175945275802193,1.68380116309528e-09
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,USP8,Ubiquitin carboxyl-terminal hydrolase 8,41876,-0.0588017068354143,0.00977357962027453,-0.0779579228911524,-0.0396454907796762,1.83260486301756e-09
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HCLS1,Hematopoietic lineage cell-specific protein,42256,-0.0341066185575443,0.00567245946204414,-0.0452246391031508,-0.0229885980119378,1.87363789433267e-09
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NADK,NAD kinase,42144,-0.0340798069036896,0.00567387929388437,-0.045200610319703,-0.0229590034876762,1.94726947473023e-09
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EIF4G3,Eukaryotic translation initiation factor 4 gamma 3,40054,-0.0408426638769014,0.00680670397745893,-0.0541838036727209,-0.0275015240810819,2.03164957942652e-09
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRRC59,Leucine-rich repeat-containing protein 59,40080,-0.0302352444964045,0.0050423669503345,-0.0401182837190602,-0.0203522052737489,2.08348863977706e-09
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANG,Angiogenin,42127,-0.0208381557491237,0.00347590037410688,-0.0276509204823732,-0.0140253910158742,2.08857882818013e-09
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPP1R12A,Protein phosphatase 1 regulatory subunit 12A,42186,-0.0593053450741502,0.00990310397489207,-0.0787154288649387,-0.0398952612833618,2.1729621018984e-09
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BNIP3L,BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like,39784,-0.0272942646062521,0.00455776624155791,-0.0362274864397056,-0.0183610427727986,2.18639985909972e-09
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLAMF6,SLAM family member 6,41861,-0.0241143549019969,0.00402980188643581,-0.0320127665994111,-0.0162159432045827,2.23597666212485e-09
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SNRPB2,U2 small nuclear ribonucleoprotein B'',40054,-0.0266911030214534,0.00446686250142811,-0.0354461535242525,-0.0179360525186543,2.36791510099798e-09
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FN1,Fibronectin,40113,-0.0164578771492569,0.00275520251723032,-0.0218580740830284,-0.0110576802154855,2.39629540847535e-09
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITGA5,Integrin alpha-5,42120,-0.0154356935449564,0.00258976343285593,-0.0205116298733541,-0.0103597572165588,2.58379859439369e-09
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EREG,Proepiregulin,41985,-0.0496175433063472,0.00833363028831621,-0.0659514586714469,-0.0332836279412474,2.6870365248979e-09
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OPHN1,Oligophrenin-1,40054,-0.0657056785901639,0.0110396233227828,-0.0873433403028181,-0.0440680168775097,2.73397469662677e-09
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ILKAP,Integrin-linked kinase-associated serine/threonine phosphatase 2C,41813,-0.0353844194900238,0.00594671389059522,-0.0470399787155905,-0.0237288602644572,2.74837276975345e-09
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EIF4E,Eukaryotic translation initiation factor 4E,39784,-0.0555849222789444,0.00934098196521653,-0.0738932469307688,-0.03727659762712,2.75538273975018e-09
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PROC,Vitamin K-dependent protein C,42172,-0.0154556080883661,0.00260229092955832,-0.0205560983103004,-0.0103551178664318,2.93689147151274e-09
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RBPMS2,RNA-binding protein with multiple splicing 2,39804,-0.0626511339253516,0.0105537449605851,-0.0833364740480984,-0.0419657938026049,3.00493130277854e-09
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BRAP,BRCA1-associated protein,39916,-0.0668397380623964,0.0112673862282738,-0.088923815069813,-0.0447556610549798,3.08246188882843e-09
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CBLIF,Cobalamin binding intrinsic factor,42122,-0.0499203973440719,0.00843475575950358,-0.066452518632699,-0.0333882760554449,3.33291779379417e-09
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EVI5,Ecotropic viral integration site 5 protein homolog,39784,-0.0544579165338424,0.00921179636431957,-0.0725130374079087,-0.036402795659776,3.48921687502357e-09
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD226,CD226 antigen,39784,-0.0259105523273909,0.00438522594128676,-0.034505595172313,-0.0173155094824689,3.55651429529938e-09
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EPO,Erythropoietin,42103,-0.0453629625206726,0.00768079448201888,-0.0604173197054296,-0.0303086053359156,3.59280803462116e-09
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VPS28,Vacuolar protein sorting-associated protein 28 homolog,39881,-0.0401474124712623,0.00679899415905072,-0.0534734410230017,-0.0268213839195229,3.63592365745115e-09
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLC16A1,Monocarboxylate transporter 1,41829,-0.0350813916981915,0.00594866898376091,-0.0467407829063629,-0.0234220004900201,3.7882716514737e-09
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTSC,Dipeptidyl peptidase 1,42125,-0.0269820527398384,0.00457675056898761,-0.0359524838550541,-0.0180116216246227,3.82958258296511e-09
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLA2G2A,"Phospholipase A2, membrane associated",42111,0.0350536049019041,0.00595059797605037,0.0233904328688454,0.0467167769349629,3.93969495179901e-09
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APOE,Apolipoprotein E,40113,-0.044022290966158,0.00747522194105828,-0.0586737259706322,-0.0293708559616837,3.99761833503547e-09
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SMAD5,Mothers against decapentaplegic homolog 5,42094,-0.0121818318461346,0.00207237694192436,-0.0162436906523063,-0.00811997303996283,4.2502162665952e-09
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATP6AP2,Renin receptor,41861,-0.0245961441967946,0.00419406745981199,-0.0328165164180261,-0.0163757719755631,4.61703559578568e-09
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CA3,Carbonic anhydrase 3,42273,-0.0362177699207694,0.00617676915032115,-0.0483242374553988,-0.02411130238614,4.64022376202037e-09
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLC4A1,Band 3 anion transport protein,40097,-0.0284314881199389,0.00485623972110007,-0.037949717973295,-0.0189132582665828,4.91861034238687e-09
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLA2,Src-like-adapter 2,40054,-0.0626826840152427,0.0107091069750001,-0.0836725336862429,-0.0416928343442424,4.96115191079197e-09
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DENR,Density-regulated protein,39784,-0.0345669403980575,0.00591039568645572,-0.0461513159435107,-0.0229825648526043,5.10704092324189e-09
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GCC1,GRIP and coiled-coil domain-containing protein 1,40054,-0.0646384089170344,0.0110736613113366,-0.0863427850872542,-0.0429340327468147,5.46272550621213e-09
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NFAT5,Nuclear factor of activated T-cells 5,39784,-0.0524299137992968,0.00898719558495784,-0.0700448171458141,-0.0348150104527794,5.57507205383876e-09
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SOST,Sclerostin,42122,-0.0235600060825698,0.00404033801919531,-0.0314790686001926,-0.015640943564947,5.63463752577992e-09
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MEGF9,Multiple epidermal growth factor-like domains protein 9,42262,-0.0116314690383476,0.00199763642153859,-0.0155468364245632,-0.00771610165213197,5.92953035068443e-09
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SAMD9L,Sterile alpha motif domain-containing protein 9-like,42103,-0.0429093664647745,0.00737579398119757,-0.0573659226679217,-0.0284528102616272,6.11168873895451e-09
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NT5C1A,Cytosolic 5'-nucleotidase 1A,40054,-0.0194341240149262,0.00334124476199396,-0.0259829637484343,-0.012885284281418,6.18133772712439e-09
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITGA11,Integrin alpha-11,42103,0.020510531978776,0.00353076539163405,0.0135902318111732,0.0274308321463787,6.42945837792417e-09
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHL1,Neural cell adhesion molecule L1-like protein,42177,0.0184259363258291,0.0031731132188438,0.0122066344168952,0.0246452382347629,6.5131632750748e-09
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LYN,Tyrosine-protein kinase Lyn,42094,-0.0503452567813178,0.0086790755174426,-0.0673562447955053,-0.0333342687671303,6.75628565939839e-09
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DOK2,Docking protein 2,42144,-0.0721990458972118,0.0124643802294539,-0.0966292311469415,-0.0477688606474821,7.09876186458389e-09
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,WASF1,Wiskott-Aldrich syndrome protein family member 1,41876,-0.0553990149846899,0.00959634559733367,-0.0742078523554639,-0.0365901776139159,7.97303671075183e-09
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LAMB1,Laminin subunit beta-1,39804,-0.0181188040630722,0.00313894745688275,-0.0242711410785624,-0.011966467047582,8.0410864220932e-09
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VASN,Vasorin,41967,0.0165099164358954,0.00286156339716125,0.0109012521774593,0.0221185806943314,8.13303775162753e-09
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OGA,Protein O-GlcNAcase,40021,-0.0417723153214103,0.00724248099382993,-0.055967578069317,-0.0275770525735037,8.25709140741331e-09
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VSNL1,Visinin-like protein 1,40054,-0.0227840825787095,0.00395094078075222,-0.0305279265089839,-0.0150402386484352,8.30202686285268e-09
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NCK2,Cytoplasmic protein NCK2,42184,-0.0623281186432136,0.0108247294223678,-0.0835445883110545,-0.0411116489753727,8.70745834394712e-09
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEACAM20,Carcinoembryonic antigen-related cell adhesion molecule 20,39881,-0.0269115171121346,0.00467540358744335,-0.0360753081435236,-0.0177477260807457,8.85130754950784e-09
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NAGK,N-acetyl-D-glucosamine kinase,39793,-0.0330077964848145,0.00574232724939362,-0.044262757893626,-0.021752835076003,9.27125618610124e-09
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ERBB3,Receptor tyrosine-protein kinase erbB-3,42095,-0.0113032784324781,0.00196761758252524,-0.0151598088942276,-0.00744674797072864,9.41901574883448e-09
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NAMPT,Nicotinamide phosphoribosyltransferase,41861,-0.0311769927855578,0.00543728101843657,-0.0418340635816934,-0.0205199219894221,1.00370140281606e-08
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TACSTD2,Tumor-associated calcium signal transducer 2,40544,0.0188836651477665,0.00329725477806392,0.0124210457827612,0.0253462845127718,1.04764132212863e-08
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ALDH3A1,"Aldehyde dehydrogenase, dimeric NADP-preferring",42071,-0.0403296897477575,0.00704472589044315,-0.0541373524930261,-0.0265220270024889,1.05863062133402e-08
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DHPS,Deoxyhypusine synthase,40020,-0.0239661007862131,0.00419304377626044,-0.0321844665876836,-0.0157477349847427,1.12153150579528e-08
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TXN,Thioredoxin,39961,-0.0263725019071738,0.00461693136856705,-0.0354216873895652,-0.0173233164247823,1.14529942736143e-08
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TADA3,Transcriptional adapter 3,40020,-0.0234344874441276,0.0041028356824019,-0.0314760453816353,-0.0153929295066198,1.1474846101134e-08
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ZBTB17,Zinc finger and BTB domain-containing protein 17,41876,-0.0250327568411125,0.00438495789637316,-0.0336272743180039,-0.0164382393642211,1.16340117886968e-08
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LZTFL1,Leucine zipper transcription factor-like protein 1,39863,-0.0419209394206095,0.00734625624100204,-0.0563196016529735,-0.0275222771882455,1.18440993181773e-08
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADA,Adenosine deaminase,42256,-0.0205478183707974,0.00360154936709268,-0.0276068551302991,-0.0134887816112958,1.18678859082006e-08
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STX4,Syntaxin-4,42094,-0.0351985850549382,0.00616963722587361,-0.0472910740176504,-0.0231060960922259,1.18809202992571e-08
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD93,Complement component C1q receptor,41662,0.0191575081974669,0.00336112664463464,0.012569699973983,0.0257453164209508,1.22718212031801e-08
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FNDC1,Fibronectin type III domain-containing protein 1,40054,-0.0278441572619177,0.00488792810295687,-0.0374244963437132,-0.0182638181801222,1.25460002921504e-08
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AP3B1,AP-3 complex subunit beta-1,40021,-0.0450014565057838,0.00790554061667148,-0.0604963161144599,-0.0295065968971077,1.28527495808919e-08
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TDRKH,Tudor and KH domain-containing protein,41829,-0.0499007499824913,0.00876738110795545,-0.067084816954084,-0.0327166830108987,1.28625192041068e-08
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,USO1,General vesicular transport factor p115,42094,-0.0530080877367766,0.00931474563884565,-0.071264989188914,-0.0347511862846391,1.29219027022495e-08
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AMOT,Angiomotin,39863,-0.0227959224687494,0.00400566024568593,-0.0306470165502938,-0.014944828387205,1.29682552323587e-08
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLMAP,Sarcolemmal membrane-associated protein,40021,-0.0486903635672802,0.00856098136273096,-0.0654698870382328,-0.0319108400963275,1.32273205709741e-08
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSG1,Pregnancy-specific beta-1-glycoprotein 1,42004,0.0704675601553106,0.0124017259637718,0.0461601772663178,0.0947749430443033,1.35967866822177e-08
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NFATC3,"Nuclear factor of activated T-cells, cytoplasmic 3",41887,-0.0350354441422569,0.00617688849266944,-0.047142145587889,-0.0229287426966248,1.44203881851277e-08
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,POLR2F,"DNA-directed RNA polymerases I, II, and III subunit RPABC2",42094,-0.0200548148804292,0.00353745486022092,-0.0269882264064622,-0.0131214033543962,1.46475360361583e-08
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINE2,Glia-derived nexin,40080,-0.0375497365152036,0.0066239402807049,-0.0505326594653852,-0.0245668135650219,1.47467095261655e-08
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NT5E,5'-nucleotidase,42186,-0.0331738244057633,0.0058661732179298,-0.0446715239129057,-0.0216761248986209,1.59034564235119e-08
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCGB3A2,Secretoglobin family 3A member 2,42162,0.0510900149013596,0.00904519675519979,0.033361429261168,0.0688186005415512,1.65445275192696e-08
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRP11,Low-density lipoprotein receptor-related protein 11,42144,-0.0219224985203885,0.00389184211713418,-0.0295505090699715,-0.0142944879708055,1.80856744517868e-08
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FABP4,"Fatty acid-binding protein, adipocyte",42296,-0.0299131261704549,0.00532493081074715,-0.0403499905595193,-0.0194762617813905,1.97615106467085e-08
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HAGH,"Hydroxyacylglutathione hydrolase, mitochondrial",42178,-0.0416872362103831,0.00743495080197279,-0.0562597397822498,-0.0271147326385164,2.1014987479607e-08
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CES2,Cocaine esterase,42094,-0.0318725118063007,0.00569480780303222,-0.0430343351002438,-0.0207106885123575,2.22838175797352e-08
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL15,Interleukin-15,42103,-0.0193296559489513,0.003455926045778,-0.0261032709986762,-0.0125560408992264,2.2746356339778e-08
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ALPP,"Alkaline phosphatase, placental type",42094,-0.0586060113460463,0.0104846152443875,-0.0791558572250458,-0.0380561654670469,2.3205650929267e-08
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ERI1,3'-5' exoribonuclease 1,39881,-0.0199720386951494,0.00357604301983599,-0.0269810830140279,-0.0129629943762708,2.39475971157517e-08
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACP1,Low molecular weight phosphotyrosine protein phosphatase,39784,-0.025846216034387,0.00464018770512724,-0.0349409839364363,-0.0167514481323376,2.60839814060742e-08
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LYAR,Cell growth-regulating nucleolar protein,41861,-0.0315601106137685,0.00566949139679887,-0.0426723137514943,-0.0204479074760427,2.64953022780427e-08
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CXCL5,C-X-C motif chemokine 5,42115,-0.065059124717468,0.0117163116972942,-0.0880230956441646,-0.0420951537907714,2.86567280390359e-08
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GALNT10,Polypeptide N-acetylgalactosaminyltransferase 10,42094,-0.0159884009489699,0.00287995884476124,-0.0216331202847019,-0.0103436816132379,2.88644945290507e-08
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IFNLR1,Interferon lambda receptor 1,42103,-0.0209272842957686,0.00377124144547713,-0.0283189175289038,-0.0135356510626334,2.92673229447691e-08
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TRIM58,E3 ubiquitin-protein ligase TRIM58,40020,-0.0503113983290921,0.00906920059647767,-0.0680870314981884,-0.0325357651599959,2.96592214974944e-08
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BPIFB2,BPI fold-containing family B member 2,40043,-0.0395794480396057,0.00713496689439603,-0.053563983152622,-0.0255949129265895,2.97001455882708e-08
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UXS1,UDP-glucuronic acid decarboxylase 1,41861,-0.0305414805413011,0.00551629046820732,-0.0413534098589874,-0.0197295512236147,3.14542500848518e-08
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LTA4H,Leukotriene A-4 hydrolase,42223,0.0335517953840977,0.00607110650705524,0.0216524266302694,0.045451164137926,3.3301190973249e-08
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DCTN2,Dynactin subunit 2,42094,-0.0536508474188389,0.00971807644397102,-0.0726982772490221,-0.0346034175886557,3.44123393441261e-08
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KRT8,"Keratin, type II cytoskeletal 8",39719,-0.0469602895538372,0.00850564937285314,-0.0636313623246293,-0.030289216783045,3.44937013658964e-08
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,THBS4,Thrombospondin-4,42161,-0.026231912926688,0.00475411892673116,-0.035549986023081,-0.0169138398302949,3.50006891128868e-08
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPON2,Spondin-2,42072,0.0205817491973819,0.00373012197757125,0.0132707101213423,0.0278927882734216,3.50069756549163e-08
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CSNK2A1,Casein kinase II subunit alpha,40054,0.0256163786713441,0.00464390922954864,0.0165143165814288,0.0347184407612594,3.54498555054117e-08
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLSTN3,Calsyntenin-3,40054,-0.0175137563272754,0.0031755193065929,-0.0237377741681975,-0.0112897384863533,3.5627656000733e-08
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PADI4,Protein-arginine deiminase type-4,41813,-0.0410779819887217,0.00746003010439051,-0.0556996409933271,-0.0264563229841163,3.73388100187174e-08
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAVS,Mitochondrial antiviral-signaling protein,41861,-0.0517138020184985,0.00939990226773433,-0.0701376104632578,-0.0332899935737392,3.83829280491487e-08
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCN4,CCN family member 4,42223,-0.0227364277863213,0.00413370327758618,-0.0308384862103902,-0.0146343693622524,3.86389746014459e-08
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,YWHAQ,14-3-3 protein theta,39863,-0.0417747260465942,0.00761646127085799,-0.0567029901374758,-0.0268464619557125,4.23392949779462e-08
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BCAN,Brevican core protein,42004,0.0197100345399841,0.00359715181878418,0.0126596169751671,0.0267604521048011,4.34970710438035e-08
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGD3,"FYVE, RhoGEF and PH domain-containing protein 3",40054,-0.0450109808777014,0.00821525126851966,-0.0611128733639999,-0.0289090883914028,4.37395263009985e-08
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINB8,Serpin B8,42256,-0.0328260517384724,0.00599570833727537,-0.0445776400795321,-0.0210744633974126,4.45781881050745e-08
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLXNB2,Plexin-B2,42246,-0.0137086628125637,0.00250775737077739,-0.0186238672592874,-0.00879345836584004,4.67434369977396e-08
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GGCT,Gamma-glutamylcyclotransferase,40069,-0.0267799173767258,0.00490192395639882,-0.0363876883312675,-0.0171721464221841,4.78080243049665e-08
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CXCL10,C-X-C motif chemokine 10,42184,-0.0383022917352371,0.00702320212658837,-0.0520677679033503,-0.0245368155671239,5.024069624144e-08
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TRIM40,E3 ubiquitin ligase TRIM40,39768,-0.0405150293995735,0.00745002544156037,-0.0551170792650318,-0.0259129795341152,5.50072883781174e-08
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HSDL2,Hydroxysteroid dehydrogenase-like protein 2,39804,-0.0274976748225645,0.00506074549901827,-0.0374167360006403,-0.0175786136444887,5.6474001079891e-08
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,YARS1,"Tyrosine--tRNA ligase, cytoplasmic",40021,-0.081582030566684,0.0150245511974917,-0.111030150913768,-0.0521339102196002,5.75992933024866e-08
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SIRT2,NAD-dependent protein deacetylase sirtuin-2,42094,-0.049280592609008,0.00908147463721029,-0.0670802828979401,-0.0314809023200758,5.85090920726877e-08
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,39881,-0.0587657152455389,0.0108636509381573,-0.0800584710843272,-0.0374729594067506,6.46042741786726e-08
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TSC22D1,TSC22 domain family protein 1,40054,-0.0364877040962098,0.0067525273432812,-0.0497226576890409,-0.0232527505033786,6.671093888409e-08
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD22,B-cell receptor CD22,42256,-0.0244016350106705,0.00452092069715654,-0.0332626395770973,-0.0155406304442437,6.87593369995836e-08
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GIMAP8,GTPase IMAP family member 8,39665,-0.0294215178761483,0.00545115374393765,-0.0401057792142661,-0.0187372565380305,6.91275441781909e-08
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGFBP3,Insulin-like growth factor-binding protein 3,42197,-0.0176558649300658,0.0032869699755928,-0.0240983260822277,-0.0112134037779039,7.94417538988218e-08
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FCN1,Ficolin-1,40085,-0.0309560144293126,0.00576691117659438,-0.0422591603354376,-0.0196528685231876,8.13092439621897e-08
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MARS1,"Methionine--tRNA ligase, cytoplasmic",39847,-0.0471698722773373,0.00878749897401184,-0.0643933702664005,-0.0299463742882741,8.13592594329053e-08
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACHE,Acetylcholinesterase,39863,-0.018552815548132,0.00346496342530715,-0.025344143861734,-0.01176148723453,8.76208433019407e-08
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MEP1B,Meprin A subunit beta,42144,-0.0655332181175399,0.0122542625097125,-0.0895515726365763,-0.0415148635985035,9.05481877779709e-08
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLRF1,Killer cell lectin-like receptor subfamily F member 1,39784,-0.0248061476665042,0.00464424250912376,-0.0339088629843868,-0.0157034323486216,9.42105285684043e-08
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FABP5,Fatty acid-binding protein 5,42180,-0.0374554393723485,0.00701364262712465,-0.0512021789215128,-0.0237086998231842,9.43213140964786e-08
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNC,Tenascin,42197,0.0267980363101894,0.0050205143181933,0.0169578282465305,0.0366382443738483,9.57108765060578e-08
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DLG4,Disks large homolog 4,40054,-0.038648558355188,0.00724358534410539,-0.0528459856296346,-0.0244511310807415,9.71679545922418e-08
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GOLM2,Protein GOLM2,42213,-0.0127743654988846,0.00239853515412474,-0.0174754944009691,-0.00807323659680006,1.02124079974749e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,JAM3,Junctional adhesion molecule C,39863,-0.0279850934755924,0.0052551920932124,-0.0382852699782887,-0.0176849169728961,1.02875892451831e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SWAP70,Switch-associated protein 70,40021,-0.0196693072035695,0.00369518098539665,-0.0269118619349469,-0.012426752472192,1.04132098024383e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENOX2,Ecto-NOX disulfide-thiol exchanger 2,39706,-0.0157323010560661,0.00296007823641069,-0.021534054399431,-0.00993054771270112,1.08944851440793e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RGCC,Regulator of cell cycle RGCC,40054,-0.0414002684747789,0.00779339647289677,-0.0566753255616566,-0.0261252113879013,1.10436661555807e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NUB1,NEDD8 ultimate buster 1,42103,-0.0456433599829474,0.00860352009835484,-0.0625062593757229,-0.0287804605901719,1.14412254955406e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,REEP4,Receptor expression-enhancing protein 4,40054,-0.0339939771963075,0.00640778098966191,-0.0465532279360448,-0.0214347264565701,1.1482058067508e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TFPI,Tissue factor pathway inhibitor,42127,-0.017012120127723,0.00321103928201093,-0.0233057571204645,-0.0107184831349816,1.1899230386905e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRIG3,Leucine-rich repeats and immunoglobulin-like domains protein 3,39758,-0.01511682559915,0.0028540280531893,-0.0207107205834011,-0.009522930614899,1.20308457075755e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MICALL2,MICAL-like protein 2,39768,-0.0379140070705922,0.0071588763763321,-0.0519454047682031,-0.0238826093729813,1.20687581287904e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GORASP2,Golgi reassembly-stacking protein 2,40021,-0.0256830805210739,0.00484964579597259,-0.0351883862811802,-0.0161777747609676,1.2077411272323e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD209,CD209 antigen,42176,0.0212793123189606,0.00402370145249051,0.0133928574720792,0.029165767165842,1.25331029012465e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MIF,Macrophage migration inhibitory factor,42096,-0.0369126791617649,0.00699263071065591,-0.0506182353546505,-0.0232071229688793,1.32143586804234e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRKL,Crk-like protein,42145,-0.0570231273223152,0.0108192527006121,-0.078228862615515,-0.0358173920291154,1.38219546685615e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GCLM,Glutamate--cysteine ligase regulatory subunit,39706,-0.0250494941993796,0.00475594145328237,-0.034371139447813,-0.0157278489509461,1.41419660793024e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DSCAM,Down syndrome cell adhesion molecule,40054,-0.0197115157033434,0.0037445012949488,-0.0270507382414431,-0.0123722931652438,1.43548153193059e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD80,T-lymphocyte activation antigen CD80,40080,-0.0188491943598837,0.00358410672246371,-0.0258740435359125,-0.0118243451838548,1.47503643855407e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINI2,Serpin I2,40021,-0.0305242942217884,0.00580683224005276,-0.0419056854122918,-0.019142903031285,1.49522388878998e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VSTM2L,V-set and transmembrane domain-containing protein 2-like protein,41876,-0.0314776980959219,0.00598976716289891,-0.0432176417352037,-0.01973775445664,1.50224216475686e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DMP1,Dentin matrix acidic phosphoprotein 1,39804,0.0328718334568132,0.00626588531959865,0.0205906982303999,0.0451529686832266,1.58296404116272e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SMOC2,SPARC-related modular calcium-binding protein 2,42184,-0.0214635368400553,0.00409181653518684,-0.0294834972490215,-0.0134435764310891,1.58326626275635e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DECR1,"2,4-dienoyl-CoA reductase, mitochondrial",42103,-0.0518455555186508,0.00988621218696769,-0.0712225314051074,-0.0324685796321941,1.59417198466724e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MMP1,Interstitial collagenase,41651,-0.049811527671797,0.00950968307081694,-0.0684505064905982,-0.0311725488529958,1.64990200880379e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNAJB6,DnaJ homolog subfamily B member 6,39767,-0.0453527345477469,0.00866476845411994,-0.062335680717822,-0.0283697883776719,1.68919894479818e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TIMM8A,Mitochondrial import inner membrane translocase subunit Tim8 A,40054,-0.0463508172319504,0.00886127162910966,-0.0637189096250053,-0.0289827248388954,1.7199574367075e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EIF2S2,Eukaryotic translation initiation factor 2 subunit 2,39804,-0.0226177740016544,0.00432636017029006,-0.0310974399354229,-0.0141381080678859,1.74707597716584e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPARC,SPARC,42186,-0.0377187741861082,0.00723055037508109,-0.0518906529212671,-0.0235468954509492,1.85055586705829e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ZFYVE19,Abscission/NoCut checkpoint regulator,40021,-0.0485780480725162,0.00931967105648542,-0.0668446033432276,-0.0303114928018048,1.89825255890988e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DUT,"Deoxyuridine 5'-triphosphate nucleotidohydrolase, mitochondrial",40021,-0.0560362538091939,0.0108049298481092,-0.0772139163114879,-0.0348585913068998,2.18534250538369e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GIGYF2,GRB10-interacting GYF protein 2,40054,-0.0403287685276445,0.00777625058263638,-0.0555702196696118,-0.0250873173856772,2.1855631103516e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAEA,E3 ubiquitin-protein transferase MAEA,41861,-0.021325335106289,0.00411343820906366,-0.0293876739960538,-0.0132629962165242,2.20155849156734e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL4,C-C motif chemokine 4,42150,-0.0365928759858637,0.00705926036284183,-0.0504290262970336,-0.0227567256746937,2.20835221962394e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EGFL7,Epidermal growth factor-like protein 7,41861,-0.0214006848578507,0.0041311734940703,-0.0294977849062285,-0.013303584809473,2.24940055941781e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RNASE3,Eosinophil cationic protein,42088,-0.0589436103755818,0.011416976095114,-0.0813208835220051,-0.0365663372291584,2.46898596478271e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MITD1,MIT domain-containing protein 1,42004,-0.0510757302725834,0.00989946306483255,-0.0704786778796552,-0.0316727826655116,2.51384965204058e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL22,C-C motif chemokine 22,42021,-0.0282745356046454,0.00548111967133946,-0.0390175301604707,-0.01753154104882,2.52604399840236e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MATN2,Matrilin-2,42146,-0.0158021847041726,0.00306593980665693,-0.0218114267252202,-0.00979294268312504,2.5859229164929e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTRHD1,Putative peptidyl-tRNA hydrolase PTRHD1,39863,-0.0319601764222742,0.00620612568980615,-0.0441241827742943,-0.0197961700702541,2.65444351815866e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLRD1,Natural killer cells antigen CD94,42256,-0.0251335135007952,0.00488442875472041,-0.0347069938600472,-0.0155600331415432,2.70476188552694e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARID4B,AT-rich interactive domain-containing protein 4B,41829,-0.0223670344833887,0.00434839035214461,-0.0308898795735921,-0.0138441893931852,2.73339826139627e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL13RA1,Interleukin-13 receptor subunit alpha-1,41963,-0.0116615649324351,0.00226808075507788,-0.0161070032123877,-0.00721612665248242,2.76437312200047e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPART,Spartin,39863,-0.0406338836207579,0.00792081098017186,-0.0561586731418948,-0.0251090940996211,2.9480822193397e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADAMTS4,A disintegrin and metalloproteinase with thrombospondin motifs 4,39784,-0.0186743259041884,0.00364490187644404,-0.0258183335820188,-0.0115303182263581,3.05343975210254e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CAMSAP1,Calmodulin-regulated spectrin-associated protein 1,40054,-0.0567614175147177,0.0111031162457451,-0.078523525356378,-0.0349993096730573,3.23839598485844e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BAG3,BAG family molecular chaperone regulator 3,41984,-0.0214955012047279,0.00420893035548102,-0.0297450047014707,-0.0132459977079851,3.31816359666988e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SIL1,Nucleotide exchange factor SIL1,39804,-0.0163741543844611,0.00320690798305379,-0.0226596940312465,-0.0100886147376757,3.34932932066161e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITPA,Inosine triphosphate pyrophosphatase,39706,-0.0354854463773094,0.00695517877230978,-0.0491175967710365,-0.0218532959835822,3.41917545330593e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OTUD7B,OTU domain-containing protein 7B,40054,-0.032647013910279,0.00640347914172843,-0.0451978330280667,-0.0200961947924913,3.48446071941531e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CBLN4,Cerebellin-4,42223,-0.0172288812523094,0.00338216772283098,-0.0238579299890581,-0.0105998325155606,3.55422153479549e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLITRK6,SLIT and NTRK-like protein 6,41876,0.0187754095623923,0.00368899082233559,0.0115449875506146,0.0260058315741701,3.63997221948135e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINH1,Serpin H1,39881,-0.0678455818577699,0.0133345270447442,-0.0939812548654686,-0.0417099088500711,3.68077524462634e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DDX58,Antiviral innate immune response receptor RIG-I,41861,-0.0298652141550367,0.005878759453603,-0.0413875826840986,-0.0183428456259749,3.8242372467158e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STAT2,Signal transducer and activator of transcription 2,39784,-0.0400777106454144,0.00788843331110028,-0.055539039935171,-0.0246163813556579,3.82725446299079e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SEZ6L2,Seizure 6-like protein 2,42094,0.0124665212223269,0.00245698827881833,0.00765082419584297,0.0172822182488108,3.9515638051331e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MOCS2,Molybdopterin synthase catalytic subunit,39863,-0.0347705927083558,0.00685230143466162,-0.0482011035202926,-0.0213400818964191,3.95486025050378e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRLF1,Cytokine receptor-like factor 1,42184,-0.0132250425784552,0.00260705343623075,-0.0183348673134675,-0.00811521784344297,3.97427346482752e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SIGLEC8,Sialic acid-binding Ig-like lectin 8,39804,-0.0240077552137672,0.00473413952721801,-0.0332866686871145,-0.0147288417404199,4.01998610897558e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PODXL2,Podocalyxin-like protein 2,42186,0.0148756381119303,0.00294357937718069,0.00910622253265614,0.0206450536912045,4.39479598491791e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNAJC21,DnaJ homolog subfamily C member 21,40054,-0.0200314730072407,0.00396458900450655,-0.0278020674560736,-0.0122608785584079,4.42931111172892e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SEMA4C,Semaphorin-4C,42094,0.0146333604778221,0.00289791733531197,0.00895344250061068,0.0203132784550336,4.48748837120978e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OSMR,Oncostatin-M-specific receptor subunit beta,42211,0.010602995058824,0.00209987482841059,0.00648724039513928,0.0147187497225088,4.49319510206102e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,XIAP,E3 ubiquitin-protein ligase XIAP,39784,-0.0297763150165551,0.00589711418715044,-0.04133465882337,-0.0182179712097402,4.50804903152228e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OTUD6B,Deubiquitinase OTUD6B,40021,-0.0305616510276962,0.00605464490777134,-0.042428755046928,-0.0186945470084644,4.54578166527911e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BAG6,Large proline-rich protein BAG6,41876,-0.0186242364747535,0.0036928545944615,-0.025862231479898,-0.011386241469609,4.63852209724196e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,INPP5J,"Phosphatidylinositol 4,5-bisphosphate 5-phosphatase A",40054,-0.0224849920816881,0.00445968010523279,-0.0312259650879444,-0.0137440190754318,4.68515834049425e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CASP10,Caspase-10,41829,-0.0372647051649507,0.00739900388408989,-0.0517667527777669,-0.0227626575521345,4.80790335666661e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANGPT1,Angiopoietin-1,42067,-0.0436140609824312,0.0086723821529004,-0.0606119300021159,-0.0266161919627464,4.99486586405359e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,WASHC3,WASH complex subunit 3,40054,-0.0388096262201686,0.00773021426051133,-0.0539608461707708,-0.0236584062695664,5.23519751275942e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL15,C-C motif chemokine 15,42296,-0.0233546825233168,0.00465248590614446,-0.0324735548993599,-0.0142358101472737,5.23967301916114e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MCEMP1,Mast cell-expressed membrane protein 1,39784,-0.0472967362745128,0.00943241188163545,-0.0657842635625183,-0.0288092089865073,5.40952055738994e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CXCL8,Interleukin-8,42006,-0.0363407113637362,0.00725015280112402,-0.0505510108539392,-0.0221304118735331,5.44713959806473e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DTNB,Dystrobrevin beta,40001,-0.0221819804824793,0.00443106165665619,-0.0308668613295254,-0.0134970996354332,5.6443419295783e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATP6V1F,V-type proton ATPase subunit F,41810,-0.0343751066386421,0.00687155003870367,-0.0478433447145013,-0.0209068685627829,5.73455790004698e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,42004,-0.0177113689510571,0.00354227856021631,-0.024654234929081,-0.0107685029730331,5.80907337035755e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLXNB3,Plexin-B3,42107,-0.0242294182554884,0.00485841835444232,-0.0337519182301954,-0.0147069182807815,6.20886275928922e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRHBP,Corticotropin-releasing factor-binding protein,42126,-0.0141124821241069,0.00283829763213195,-0.0196755454830855,-0.00854941876512826,6.7058530970743e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDA,Cytidine deaminase,40063,-0.0241045532191335,0.00485268079155266,-0.0336158075705767,-0.0145932988676903,6.89366470522273e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PKD1,Polycystin-1,40080,-0.0137859091733944,0.00277548139986532,-0.0192258527171304,-0.00834596562965836,6.90172668924495e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LPP,Lipoma-preferred partner,39706,-0.0338113212995214,0.00681536754186193,-0.0471694416815708,-0.020453200917472,7.12139679043406e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DKK4,Dickkopf-related protein 4,41986,-0.023858255181037,0.00481115148467577,-0.0332881120910015,-0.0144283982710725,7.17849130280172e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ASS1,Argininosuccinate synthase,39706,-0.0398459717745963,0.00804397022721853,-0.0556121534199446,-0.024079790129248,7.4017038937843e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GOPC,Golgi-associated PDZ and coiled-coil motif-containing protein,42103,-0.0514312980774421,0.0103938061375454,-0.071803158107031,-0.0310594380478532,7.5822307136739e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SMPDL3A,Acid sphingomyelinase-like phosphodiesterase 3a,42167,-0.0334787039875957,0.0067695323719468,-0.0467469874366114,-0.02021042053858,7.69004781463329e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KIAA0319,Dyslexia-associated protein KIAA0319,40054,0.0160884409208039,0.00325406050324586,0.009710482334442,0.0224663995071658,7.76352656556946e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DBNL,Drebrin-like protein,42184,-0.0468324880693877,0.00947537829017361,-0.065404229518128,-0.0282607466206474,7.80708794213678e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTPRC,Receptor-type tyrosine-protein phosphatase C,40097,-0.0118607900030148,0.00240415474990175,-0.0165729333128222,-0.00714864669320737,8.19806578060452e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COMMD1,COMM domain-containing protein 1,39804,-0.0307044745848989,0.00623030315695357,-0.0429158687725279,-0.0184930803972699,8.4224823851911e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPINT2,Kunitz-type protease inhibitor 2,42184,-0.020621384237708,0.00418700784723585,-0.0288279196182903,-0.0124148488571258,8.53595967632149e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DEFB103A_DEFB103B,Beta-defensin 103,39724,-0.0218814426837497,0.00445694751604236,-0.0306170598151927,-0.0131458255523067,9.26731309347121e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CSDE1,Cold shock domain-containing protein E1,39706,-0.05939572341161,0.0121021495812688,-0.0831159365908968,-0.0356755102323233,9.3455439353233e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SUSD2,Sushi domain-containing protein 2,42120,0.0146968075784183,0.00299832751781041,0.00882008564350989,0.0205735295133267,9.61795283349378e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TBCC,Tubulin-specific chaperone C,42004,-0.0406031258178135,0.00829548203872081,-0.0568622706137063,-0.0243439810219208,9.97020908880278e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,F13B,Coagulation factor XIII B chain,40055,-0.0130719756260364,0.00267465179336677,-0.0183142931410352,-0.0078296581110375,1.03660241670725e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TBCA,Tubulin-specific chaperone A,39863,-0.0428130400729784,0.00876233555812802,-0.0599872177669094,-0.0256388623790475,1.04385178783561e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTPRH,Receptor-type tyrosine-protein phosphatase H,40021,-0.0248477501778593,0.00508618058291643,-0.0348166641203755,-0.0148788362353431,1.04725928423222e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DPP7,Dipeptidyl peptidase 2,42062,-0.0306656157339384,0.00627925710658063,-0.0429729596628364,-0.0183582718050404,1.05398329035352e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PROS1,Vitamin K-dependent protein S,40113,-0.0132013992338549,0.00270393660932076,-0.0185011149881236,-0.00790168347958622,1.06346710874768e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ICA1,Islet cell autoantigen 1,41887,-0.0397460768864813,0.00814684225831851,-0.0557138877127856,-0.0237782660601771,1.08078467702591e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HIP1R,Huntingtin-interacting protein 1-related protein,40021,-0.0224517886469337,0.00460228615471625,-0.0314722695101775,-0.0134313077836898,1.08473316159349e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDGFB,Platelet-derived growth factor subunit B,42184,-0.0430104771148232,0.00882774654178298,-0.0603128603367179,-0.0257080938929286,1.11669028426443e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NAPRT,Nicotinate phosphoribosyltransferase,40054,-0.0171267848484233,0.0035158856565344,-0.0240179207352307,-0.0102356489616158,1.12455466805193e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CALCOCO2,Calcium-binding and coiled-coil domain-containing protein 2,39804,-0.0383374142697097,0.00787319665563319,-0.0537688797147508,-0.0229059488246687,1.13576791559086e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GALNT3,Polypeptide N-acetylgalactosaminyltransferase 3,41887,-0.0217670270415594,0.00447106093066921,-0.0305303064656711,-0.0130037476174478,1.13845388354062e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL10RB,Interleukin-10 receptor subunit beta,42184,-0.0152331562222403,0.00313006789037833,-0.0213680892873819,-0.00909822315709881,1.14800062944358e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SFTPD,Pulmonary surfactant-associated protein D,42144,-0.0343187136169634,0.00705608602036827,-0.0481486422168852,-0.0204887850170416,1.1656363178955e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TIMP1,Metalloproteinase inhibitor 1,42016,-0.0147553681462488,0.00304131026676932,-0.0207163362691166,-0.00879440002338091,1.23879533063602e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FAM3C,Protein FAM3C,42122,-0.0156900726655409,0.00323953075074744,-0.0220395529370058,-0.00934059239407589,1.29169171131508e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ECHDC3,"Enoyl-CoA hydratase domain-containing protein 3, mitochondrial",40080,-0.0368297922847635,0.00760667618630477,-0.0517388776099208,-0.0219207069596061,1.30456414465763e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL20,C-C motif chemokine 20,42256,-0.0460491416455544,0.00952435349894681,-0.0647168745034901,-0.0273814087876186,1.34740952975741e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GSN,Gelsolin,40058,0.00977184625631375,0.00202374831002986,0.00580529956865522,0.0137383929439723,1.39380096508284e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COMT,Catechol O-methyltransferase,41741,-0.0414870175494603,0.00859292086799906,-0.0583291424507385,-0.0246448926481822,1.39505557589078e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GIPC2,PDZ domain-containing protein GIPC2,40054,-0.0154930452292965,0.00321752615010233,-0.0217993964834971,-0.00918669397509598,1.4903431769509e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RNASEH2A,Ribonuclease H2 subunit A,40054,-0.0238443124102464,0.00495267419526847,-0.0335515538329726,-0.0141370709875202,1.49610551853033e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RNASE4,Ribonuclease 4,39755,-0.014600030059244,0.00303406915643831,-0.020546805605863,-0.00865325451262487,1.51474100104835e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ING1,Inhibitor of growth protein 1,41810,-0.0234648720252292,0.00487964481781694,-0.0330289758681504,-0.013900768182308,1.53650100048196e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DAB2,Disabled homolog 2,42223,-0.0542527228426863,0.0112966185026212,-0.0763940951078239,-0.0321113505775487,1.58390491575363e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNM3,Dynamin-3,40054,-0.0273596887594275,0.00569955259204082,-0.0385308118398275,-0.0161885656790275,1.60523305810732e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ECHS1,"Enoyl-CoA hydratase, mitochondrial",39804,-0.0478662839885822,0.0099744316277966,-0.0674161699790635,-0.0283163979981008,1.61716408550263e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSPN,Persephin,42103,-0.0462813483379892,0.00965419926777907,-0.0652035789028362,-0.0273591177731422,1.65387085927162e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACADSB,"Short/branched chain specific acyl-CoA dehydrogenase, mitochondrial",40080,-0.0441999123122244,0.0092197826507473,-0.0622706863076891,-0.0261291383167597,1.65627911153995e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AHSG,Alpha-2-HS-glycoprotein,40102,-0.0134887611633878,0.00281652246217654,-0.0190091451892538,-0.00796837713752174,1.69689460984e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HBQ1,Hemoglobin subunit theta-1,42223,-0.0298722414278651,0.0062400827266662,-0.0421028035721309,-0.0176416792835994,1.7102149964918e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IRAK4,Interleukin-1 receptor-associated kinase 4,42103,-0.0513334394229616,0.0107320837452548,-0.072368323563661,-0.0302985552822623,1.7445523384329e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,THTPA,Thiamine-triphosphatase,40005,-0.0435092064011032,0.00909762726773537,-0.0613405558458645,-0.0256778569563418,1.75433580678364e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AMOTL2,Angiomotin-like protein 2,39975,-0.0239334184415686,0.00500480944738987,-0.0337428449584528,-0.0141239919246845,1.75784078297428e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NUCB2,Nucleobindin-2,42185,-0.0183309487698725,0.00383665087732898,-0.0258507844894373,-0.0108111130503077,1.79116271881567e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFSF11,Tumor necrosis factor ligand superfamily member 11,42103,-0.0297790751584278,0.00623434209890995,-0.0419983856722913,-0.0175597646445643,1.80227993994037e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL5,C-C motif chemokine 5,42197,-0.0491024916128134,0.0102923162053964,-0.0692754313753902,-0.0289295518502365,1.85497866964742e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRP1,Prolow-density lipoprotein receptor-related protein 1,42094,0.0131809971387783,0.0027644721587516,0.00776263170762517,0.0185993625699315,1.88099463515131e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,F3,Tissue factor,42141,0.0134613405696254,0.0028278924178537,0.00791867143063219,0.0190040097086187,1.95491628211799e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VAMP8,Vesicle-associated membrane protein 8,39784,-0.0433242140522231,0.00910383987825338,-0.0611677402135997,-0.0254806878908465,1.97231023028145e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ESYT2,Extended synaptotagmin-2,40054,-0.0404472468114874,0.00851095627832067,-0.0571287211169959,-0.0237657725059789,2.03621378633592e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TF,Serotransferrin,40113,-0.0105061610370985,0.00221122092027724,-0.0148401540408419,-0.00617216803335506,2.04695580855694e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HRC,Sarcoplasmic reticulum histidine-rich calcium-binding protein,39804,0.0173381805979665,0.00365455706852962,0.0101752487436484,0.0245011124522846,2.11996906359503e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C7orf50,Uncharacterized protein C7orf50,40054,-0.0111529818733969,0.00235157645114869,-0.0157620717176483,-0.00654389202914547,2.1350112795552e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CIAPIN1,Anamorsin,42186,-0.0304122995271569,0.00641966127630339,-0.0429948356287115,-0.0178297634256022,2.18803365100001e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ZBP1,Z-DNA-binding protein 1,39784,-0.019658799437959,0.00415191629878737,-0.0277965553835823,-0.0115210434923358,2.22034874607682e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ICAM4,Intercellular adhesion molecule 4,42103,0.0259087865362667,0.00547308703946358,0.0151815359389181,0.0366360371336153,2.22638158238034e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDH1,Cadherin-1,41716,-0.0196349620943822,0.00415193495256831,-0.027772754601416,-0.0114971695873483,2.2796525375366e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TLR3,Toll-like receptor 3,42256,-0.0300005136515969,0.00634455272947489,-0.0424358370013677,-0.0175651903018262,2.28496402611689e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL17,C-C motif chemokine 17,42112,-0.0447898451749886,0.00947906277347011,-0.06336880821099,-0.0262108821389872,2.32387195886396e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RAB44,Ras-related protein Rab-44,40020,-0.0205305631248794,0.00434522256072812,-0.0290471993439066,-0.0120139269058523,2.33173191054414e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NEXN,Nexilin,40102,-0.0338105290236643,0.007167091618035,-0.0478580285950129,-0.0197630294523157,2.41761828683685e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL1RAP,Interleukin-1 receptor accessory protein,42120,0.0219889213062866,0.00466167869096423,0.0128520310719967,0.0311258115405765,2.41907515485224e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MMP3,Stromelysin-1,42120,0.0247439248067008,0.00524886249257139,0.0144561543212608,0.0350316952921407,2.4525586265063e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RAB33A,Ras-related protein Rab-33A,39706,-0.0320795948718115,0.00680708256431847,-0.0454214766978757,-0.0187377130457473,2.47618812873034e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DLL1,Delta-like protein 1,42186,0.0154245834350716,0.00327461815452469,0.00900633185220318,0.02184283501794,2.49857589345556e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TTF2,Transcription termination factor 2,39768,-0.0239399523039517,0.00508346075916639,-0.0339035353919178,-0.0139763692159855,2.51631992215717e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SEZ6L,Seizure 6-like protein,42186,0.0137506033520346,0.00292254190149233,0.00802242122510962,0.0194787854789596,2.56464301632389e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AKR1C4,Aldo-keto reductase family 1 member C4,41876,-0.0264184249837927,0.00561637724548788,-0.0374265243849489,-0.0154103255826364,2.58033270214289e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CST3,Cystatin-C,42168,-0.0147812262025715,0.00314261997717896,-0.0209407613578423,-0.00862169104730076,2.58410886660593e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PIBF1,"Progesterone-induced-blocking factor 1, Isoform 4",40054,-0.037580290724188,0.00799064653040199,-0.0532419579237759,-0.0219186235246001,2.59480985538039e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDGFA,Platelet-derived growth factor subunit A,42296,-0.0348684922998447,0.00742128375340413,-0.0494142084565168,-0.0203227761431726,2.64815346566903e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GAS2,Growth arrest-specific protein 2,39881,-0.0257890172547308,0.00549137278927017,-0.0365521079217004,-0.0150259265877613,2.68243525454651e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,WFDC1,WAP four-disulfide core domain protein 1,39803,-0.0271025319081941,0.00577433142337777,-0.0384202214980145,-0.0157848423183737,2.71769224907425e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GLYR1,Putative oxidoreductase GLYR1,40020,-0.0284551223493593,0.00606309834232385,-0.040338795100314,-0.0165714495984046,2.72308586258911e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CX3CL1,Fractalkine,42004,0.0167819823284954,0.00358065542489931,0.00976389769569276,0.0238000669612981,2.80304999738193e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,POMC,Pro-opiomelanocortin,39804,-0.0339026779090492,0.00723879437864696,-0.0480907148911972,-0.0197146409269011,2.85559695762361e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NUDC,Nuclear migration protein nudC,42256,-0.0299974169599497,0.00641118145728916,-0.0425633326162364,-0.0174315013036629,2.91281653041959e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SELENOP,Selenoprotein P,40113,0.0110821533625464,0.00237676053785201,0.00642370270835643,0.0157406040167363,3.15766800917625e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,S100G,Protein S100-G,40054,0.0232982031751814,0.00499690000295608,0.0135042791693875,0.0330921271809754,3.16066019717311e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C4BPB,C4b-binding protein beta chain,42186,0.0194046902045618,0.00416857232542299,0.0112342884467327,0.0275750919623909,3.27191211692445e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TBL1X,F-box-like/WD repeat-containing protein TBL1X,41861,-0.0407223952803101,0.00874934381618387,-0.0578711091600305,-0.0235736814005897,3.28321260975901e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATP5IF1,"ATPase inhibitor, mitochondrial",42184,-0.0527739017137581,0.0113480531258264,-0.0750160858403778,-0.0305317175871384,3.34426792345907e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MPHOSPH8,M-phase phosphoprotein 8,41876,-0.0361782546404707,0.00781323074182844,-0.0514921868944545,-0.020864322386487,3.68613828415739e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SEPTIN8,Septin-8,40041,-0.0156125148596734,0.00337644481471613,-0.0222303466965171,-0.00899468302282984,3.80850150024924e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHMP1A,Charged multivesicular body protein 1a,42004,-0.0377239845175148,0.00816500501243741,-0.0537273943418921,-0.0217205746931375,3.87101097681808e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BOLA1,BolA-like protein 1,39719,-0.0260381790006114,0.00563605175459204,-0.0370848404396118,-0.014991517561611,3.88422001398001e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD244,Natural killer cell receptor 2B4,42256,-0.0131408464492437,0.00284514833526921,-0.0187173371863713,-0.00756435571211602,3.89865019309485e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LGALS8,Galectin-8,42213,-0.0286474287043865,0.00620840349871638,-0.0408158995618706,-0.0164789578469024,3.98189185305022e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RP2,Protein XRP2,42094,-0.0201506038973317,0.00436809977659098,-0.0287120794594501,-0.0115891283352134,4.00470734309896e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DAG1,Dystroglycan,42184,-0.0218678803629399,0.00474429029307322,-0.0311666893373634,-0.0125690713885164,4.07866142341706e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FHIT,Bis(5'-adenosyl)-triphosphatase,41829,-0.0348081855856844,0.00755989730887636,-0.0496255843110821,-0.0199907868602868,4.17852254075486e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GTPBP2,GTP-binding protein 2,39768,-0.0384347300450142,0.00835389141307976,-0.0548083572146505,-0.0220611028753779,4.25730030703193e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CACNB3,Voltage-dependent L-type calcium channel subunit beta-3,40054,-0.0395856542316269,0.00864367826496803,-0.0565272636309642,-0.0226440448322895,4.70770484310081e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,INSL5,Insulin-like peptide INSL5,40021,-0.0468616904328205,0.0102397277764134,-0.0669315568745907,-0.0267918239910504,4.78175160584377e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRADD,Death domain-containing protein CRADD,41985,-0.0353909767635539,0.0077365417129939,-0.0505545985210219,-0.0202273550060858,4.81794642195766e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTSF,Cathepsin F,42186,-0.0187749845512949,0.00410960914387691,-0.0268298184732936,-0.0107201506292961,4.95613282528108e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MPO,Myeloperoxidase,42120,-0.0220206982138839,0.00482722998028892,-0.0314820689752502,-0.0125593274525176,5.11915461186873e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AMBP,Protein AMBP,42208,-0.00991498429210232,0.00217491143092556,-0.0141778106967164,-0.00565215788748822,5.19158256281783e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TIMP3,Metalloproteinase inhibitor 3,42184,-0.0614328008465528,0.013480487598422,-0.08785455653946,-0.0350110451536456,5.23215503460124e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD248,Endosialin,40097,0.0192640152883477,0.00422752439412474,0.0109780674758632,0.0275499631008321,5.25013746499461e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EGFR,Epidermal growth factor receptor,42296,0.00771647315162729,0.00169356436097884,0.00439708700410876,0.0110358592991458,5.25202055482188e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADAMTS13,A disintegrin and metalloproteinase with thrombospondin motifs 13,42296,-0.0111296931071905,0.00244461423883733,-0.0159211370153117,-0.00633824919906936,5.34285798396606e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APOH,Beta-2-glycoprotein 1,42120,0.0172649699802097,0.00379351368070948,0.00982968316601909,0.0247002567944003,5.38318169242999e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HPSE,Heparanase,39984,-0.0440872433225657,0.00968835185808208,-0.0630764129644065,-0.0250980736807248,5.40926374795796e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDCP1,CUB domain-containing protein 1,42004,-0.025598775958867,0.0056307005776316,-0.0366349490910249,-0.014562602826709,5.51010503276998e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SF3B4,Splicing factor 3B subunit 4,42094,-0.0343419880832718,0.00755485552728392,-0.0491495049167483,-0.0195344712497953,5.52549817380318e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTPN1,Tyrosine-protein phosphatase non-receptor type 1,42004,-0.0367056889433488,0.0080888959418701,-0.0525599249894142,-0.0208514528972834,5.73646720059048e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UROS,Uroporphyrinogen-III synthase,39768,-0.0318811929384486,0.00703971064528832,-0.0456790258032137,-0.0180833600736835,5.99788269432724e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VEGFB,Vascular endothelial growth factor B,39784,-0.0139430457737164,0.0030803220818187,-0.019980477054081,-0.00790561449335171,6.06256218618439e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CA6,Carbonic anhydrase 6,42091,0.029353231132404,0.00648666551523867,0.0166393667225362,0.0420670955422718,6.08878627480897e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DXO,Decapping and exoribonuclease protein,40054,-0.0213709801364817,0.00472868298366183,-0.0306391987844589,-0.0121027614885045,6.2659999916869e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINB9,Serpin B9,42004,-0.0153202234599308,0.0033911331175071,-0.0219668443702447,-0.00867360254961692,6.30651311751231e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BPIFA2,BPI fold-containing family A member 2,39432,0.0531096297187673,0.0117588396828733,0.0300623039403356,0.076156955497199,6.355232567179e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPBP,Platelet basic protein,40048,-0.0392026259583089,0.00868447871329367,-0.0562242042363645,-0.0221810476802533,6.42549516423352e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACP5,Tartrate-resistant acid phosphatase type 5,42217,-0.0147716183209913,0.0032730907929679,-0.0211868762752084,-0.00835636036677422,6.44621827321771e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VIT,Vitrin,40080,-0.0180673129537704,0.00400669812906711,-0.0259204412867419,-0.0102141846207989,6.5728872436169e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PF4,Platelet factor 4,40040,-0.0456045853704494,0.0101196418031386,-0.0654390833046012,-0.0257700874362977,6.65826142522757e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PKN3,Serine/threonine-protein kinase N3,39881,-0.0349183621925351,0.00775681319600199,-0.050121716056699,-0.0197150083283712,6.81453418363898e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TPD52L2,Tumor protein D54,39863,-0.0497723660945114,0.011064291065221,-0.0714583765823445,-0.0280863556066783,6.91681456740342e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MINK1,Misshapen-like kinase 1,40054,-0.0430584964167429,0.00957367067365062,-0.0618228909370982,-0.0242941018963877,6.94394171984719e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLK10,Kallikrein-10,42144,-0.0189867910878198,0.00422647082629813,-0.0272706739073641,-0.0107029082682755,7.10509258586897e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EFNA4,Ephrin-A4,41984,-0.0159175133597153,0.00354404800140459,-0.0228638474424683,-0.00897117927696233,7.13973503419e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LPCAT2,Lysophosphatidylcholine acyltransferase 2,42094,-0.0184218241514086,0.00410371809882488,-0.0264651116251054,-0.0103785366777119,7.21591211300111e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BIN2,Bridging integrator 2,42120,-0.0420502955484215,0.00937148187522974,-0.0604184000238718,-0.0236821910729712,7.28400488997399e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINA1,Alpha-1-antitrypsin,39906,0.00379339895778508,0.000845631055991403,0.00213596208804193,0.00545083582752823,7.33700319169199e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPRR3,Small proline-rich protein 3,40054,-0.0326557809973829,0.00727990865839742,-0.0469244019678419,-0.018387160026924,7.34074237174285e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL12A_IL12B,Interleukin-12,42094,-0.0382120775758828,0.00851957149504114,-0.0549104377061635,-0.0215137174456022,7.34708990459483e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IFT20,Intraflagellar transport protein 20 homolog,39768,-0.019969376810979,0.00445279202353252,-0.0286968491771027,-0.0112419044448552,7.37908271752208e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLA2G1B,Phospholipase A2,42284,0.0211757727211651,0.00473050055458877,0.0119039916341712,0.0304475538081591,7.65413639654078e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARHGEF10,Rho guanine nucleotide exchange factor 10,40054,-0.0431123160810351,0.00963618483641632,-0.0619992383604111,-0.0242253938016592,7.7549383434721e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL12B,Interleukin-12 subunit beta,42256,-0.0262922544684453,0.00588452301535722,-0.0378259195785454,-0.0147585893583451,7.96049258893021e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DOK1,Docking protein 1,40054,-0.0625264181800938,0.0140170561336449,-0.0899998482020378,-0.0350529881581499,8.24988852452806e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD8A,T-cell surface glycoprotein CD8 alpha chain,42213,-0.0241387916832676,0.0054128218888064,-0.0347479225853282,-0.0135296607812071,8.28165155192688e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGFBP2,Fibroblast growth factor-binding protein 2,40097,-0.0237104707016629,0.00531973249339275,-0.0341371463887127,-0.0132837950146132,8.39130819433851e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APRT,Adenine phosphoribosyltransferase,41989,-0.0217782091500912,0.00489089822665226,-0.0313643696743297,-0.0121920486258528,8.54741170636558e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NDUFB7,NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 7,40021,-0.0408163885785256,0.00918966548497615,-0.0588281329290789,-0.0228046442279724,9.0197629870033e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DYNLT1,Dynein light chain Tctex-type 1,39768,-0.0370831769646934,0.00835043593902117,-0.0534500314051749,-0.0207163225242119,9.05065054645428e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACAN,Aggrecan core protein,42003,0.0128047500211799,0.00288700370984759,0.00714622274987863,0.0184632772924812,9.27070110311159e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PCSK7,Proprotein convertase subtilisin/kexin type 7,40020,-0.0211085442490056,0.00476086242979458,-0.030439834611403,-0.0117772538866082,9.35139862883698e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PIKFYVE,1-phosphatidylinositol 3-phosphate 5-kinase,39784,-0.0248823223897935,0.00563114611286522,-0.0359193687710093,-0.0138452760085777,1.00285458456217e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CSNK1D,Casein kinase I isoform delta,39784,-0.0286717641023984,0.00650559945844108,-0.0414227390409429,-0.0159207891638539,1.05724791754004e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CPXM2,Inactive carboxypeptidase-like protein X2,40080,-0.012239690170103,0.0027793018110798,-0.0176871217198194,-0.00679225862038656,1.07350735483893e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BLNK,B-cell linker protein,39784,-0.0187273198783856,0.00425249627566256,-0.0270622125786842,-0.010392427178087,1.07394390477919e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLITRK1,SLIT and NTRK-like protein 1,39784,0.0149652191096458,0.00341093841203165,0.00827977982206377,0.0216506583972278,1.15812942356897e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAP2K1,Dual specificity mitogen-activated protein kinase kinase 1,40021,-0.0289555721541866,0.00661483804205595,-0.0419206547166163,-0.0159904895917569,1.21248427733375e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCARA5,Scavenger receptor class A member 5,42213,-0.0140655359290766,0.00321699505671054,-0.0203708462402292,-0.00776022561792391,1.23921798517485e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLK4,Kallikrein-4,42223,0.0288115665488523,0.00660644817162691,0.0158629281324636,0.041760204965241,1.30387288050314e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NAGA,Alpha-N-acetylgalactosaminidase,39752,-0.0253088039461978,0.00581296391488033,-0.0367022132193633,-0.0139153946730324,1.35024436170686e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRPAP1,Alpha-2-macroglobulin receptor-associated protein,42213,-0.0259939455939781,0.00597352786632809,-0.0377020602119812,-0.0142858309759751,1.36225270709531e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HAVCR1,Hepatitis A virus cellular receptor 1,42208,-0.0299401503972932,0.00688805610376649,-0.0434407403606756,-0.0164395604339109,1.39265200399562e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IST1,IST1 homolog,39948,-0.0443176996914226,0.0101972877874423,-0.0643043837548095,-0.0243310156280357,1.39898338305028e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CETN2,Centrin-2,41829,-0.0302756964369954,0.00697130213100633,-0.0439394486137678,-0.016611944260223,1.41707443521451e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SART1,U4/U6.U5 tri-snRNP-associated protein 1,39706,-0.017015999560626,0.00391926859570964,-0.0246977660082169,-0.00933423311303514,1.42756152698085e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DUSP13,Dual specificity protein phosphatase 13 isoform A,40020,-0.0189184173696858,0.00435772686853641,-0.0274595620320171,-0.0103772727073544,1.42896935047267e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLA2G10,Group 10 secretory phospholipase A2,42004,0.0264996937300734,0.00610982216971196,0.014524442277438,0.0384749451827089,1.45394354542096e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GNE,Bifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase,41861,-0.0292107061975246,0.00674058362201531,-0.0424222500966746,-0.0159991622983746,1.47850230812408e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FSTL3,Follistatin-related protein 3,42085,-0.0152495356835594,0.00352923812427457,-0.0221668424071376,-0.00833222895998126,1.56548070817549e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BID,BH3-interacting domain death agonist,42103,-0.0300177778713811,0.00695125274289136,-0.0436422332474482,-0.016393322495314,1.58390333549093e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HS1BP3,HCLS1-binding protein 3,39804,-0.0394207429279628,0.00913160669578644,-0.0573186920517042,-0.0215227938042214,1.59631556267297e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTGR1,Prostaglandin reductase 1,40080,-0.0374051853862915,0.00867531827295389,-0.0544088092012811,-0.0204015615713019,1.63446102212354e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FSTL1,Follistatin-related protein 1,39804,-0.0100654656668176,0.00233547650915473,-0.0146429996247609,-0.00548793170887431,1.6486665125126e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TCL1A,T-cell leukemia/lymphoma protein 1A,41999,-0.045293333838564,0.0105135118508236,-0.0658998170661782,-0.0246868506109497,1.6588560141523e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPRY2,Protein sprouty homolog 2,41887,-0.0410236797688297,0.00952766050193457,-0.0596978943526214,-0.0223494651850379,1.67673822801305e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SETMAR,Histone-lysine N-methyltransferase SETMAR,41968,-0.013311903262586,0.00309328756635016,-0.0193747468926323,-0.00724905963253967,1.69387213722998e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HARS1,"Histidine--tRNA ligase, cytoplasmic",42120,-0.0339457525300189,0.00790664947944788,-0.0494427855097368,-0.0184487195503011,1.77306726437563e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HTRA2,"Serine protease HTRA2, mitochondrial",42186,-0.0270085643043843,0.00629384438054916,-0.0393444992902607,-0.0146726293185079,1.78943124899935e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGF16,Fibroblast growth factor 16,39784,-0.0211559229137895,0.00492959430385905,-0.0308179277493532,-0.0114939180782257,1.7895496083131e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GALNT2,Polypeptide N-acetylgalactosaminyltransferase 2,42223,-0.0118660673829443,0.00276705942645228,-0.0172895038587908,-0.00644263090709788,1.81316777177882e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GGT5,Glutathione hydrolase 5 proenzyme,42004,-0.0105224053819272,0.00246163362879278,-0.0153472072943611,-0.00569760346949336,1.92899020554775e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NPPB,Natriuretic peptides B,41876,0.0629481670021384,0.0147304892211669,0.0340764081286514,0.0918199258756255,1.9398529412534e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LY75,Lymphocyte antigen 75,42103,-0.0172444985574033,0.00404008074804516,-0.0251630568235718,-0.00932594029123481,1.98325712302315e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RRAS,Ras-related protein R-Ras,39768,-0.0573419580253551,0.01343324217783,-0.0836711126939019,-0.0310128033568084,1.9836524612685e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VCAN,Versican core protein,42213,0.0135191101886898,0.00316761282088394,0.00731058905975725,0.0197276313176223,1.98702426103703e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANKMY2,Ankyrin repeat and MYND domain-containing protein 2,39784,-0.0352512980085305,0.00826381182553155,-0.0514483691865723,-0.0190542268304886,2.0096882675712e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CFHR5,Complement factor H-related protein 5,39959,0.0187576760824192,0.00439899923061077,0.010135637590422,0.0273797145744163,2.02442094210684e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STAU1,Double-stranded RNA-binding protein Staufen homolog 1,39665,-0.0288475746314995,0.00677405558072996,-0.0421247235697302,-0.0155704256932687,2.07564367216427e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FNTA,Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha,40020,-0.0150272542758662,0.00353304020056433,-0.0219520130689723,-0.00810249548276011,2.12366372556796e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRYZL1,Quinone oxidoreductase-like protein 1,39804,-0.0401209409707827,0.00943330854230466,-0.0586102257136998,-0.0216316562278655,2.12625152304634e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD40,Tumor necrosis factor receptor superfamily member 5,42128,-0.0217440866096131,0.00511952367544175,-0.0317783530134789,-0.0117098202057472,2.1788758391978e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SUSD1,Sushi domain-containing protein 1,41876,-0.0216408170100927,0.00509910963749202,-0.031635071899577,-0.0116465621206083,2.21093797864876e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SATB1,DNA-binding protein SATB1,40054,-0.012881488860278,0.0030359431728802,-0.0188319374791232,-0.0069310402414328,2.2238777644147e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD274,Programmed cell death 1 ligand 1,42004,-0.0154214329223536,0.00364138860227384,-0.0225585545828104,-0.00828431126189691,2.30104792679161e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TIMM10,Mitochondrial import inner membrane translocase subunit Tim10,40080,-0.0176452858054656,0.00417004309504436,-0.0258185702717525,-0.00947200133917861,2.34102872893362e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TXNL1,Thioredoxin-like protein 1,39707,-0.0434347983340952,0.0102705598649406,-0.0635650956693788,-0.0233045009988116,2.36658348408634e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FAS,Tumor necrosis factor receptor superfamily member 6,42262,-0.0146700444130868,0.00347436613285459,-0.0214798020334818,-0.00786028679269182,2.4338726761258e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TSPAN8,Tetraspanin-8,40021,-0.0446975151119589,0.0105916358732205,-0.0654571214234711,-0.0239379088004468,2.46210750481714e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RAB10,Ras-related protein Rab-10,40080,-0.0233673357696406,0.00553796204742605,-0.0342217413825957,-0.0125129301566856,2.46848170826616e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RARRES1,Retinoic acid receptor responder protein 1,41861,-0.0144984148357973,0.00344274943198658,-0.021246203722491,-0.00775062594910362,2.5567199549625e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MOG,Myelin-oligodendrocyte glycoprotein,42223,0.0148412132460375,0.00353201223258636,0.00791846927016827,0.0217639572219068,2.66430457339257e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD164,Sialomucin core protein 24,42120,-0.0119317953728112,0.00284972322529347,-0.0175172528943864,-0.00634633785123601,2.84536663177179e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CR1,Complement receptor type 1,40080,-0.015675348771363,0.00374495743019207,-0.0230154653345395,-0.00833523220818653,2.86496328263822e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HS6ST2,Heparan-sulfate 6-O-sulfotransferase 2,39784,-0.0151519894052094,0.00362275614575391,-0.0222525914508871,-0.00805138735953172,2.90710549599702e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARL13B,ADP-ribosylation factor-like protein 13B,39706,-0.0299831840574375,0.00717140832559433,-0.0440391443756024,-0.0159272237392726,2.92667595258252e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARHGAP45,Rho GTPase-activating protein 45,39863,-0.0356429569382065,0.00853188118963612,-0.0523654440698933,-0.0189204698065197,2.96920856261552e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TWF2,Twinfilin-2,40097,-0.0357904224085256,0.00857083827125314,-0.0525892654201817,-0.0189915793968694,2.99201861460197e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD99,CD99 antigen,42120,0.00878386676058428,0.00210582654302406,0.00465644673625712,0.0129112867849114,3.04951115332955e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCRIB,Protein scribble homolog,39804,-0.0391982360142138,0.00940259310188847,-0.0576273184939152,-0.0207691535345123,3.08538118580626e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,42004,-0.0169587934112575,0.004072747125265,-0.0249413777767769,-0.00897620904573807,3.1480978602354e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLC9A3R1,Na(+)/H(+) exchange regulatory cofactor NHE-RF1,39863,-0.0363981742179518,0.0087422778670366,-0.0535330388373435,-0.01926330959856,3.15916839478052e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITGB6,Integrin beta-6,41887,-0.013507615275593,0.00324476108993514,-0.0198673470118659,-0.00714788353932015,3.16305284162247e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GBP1,Guanylate-binding protein 1,40038,-0.0280269300484012,0.00674152847859576,-0.0412403258664489,-0.0148135342303535,3.24428575321788e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NCAM1,Neural cell adhesion molecule 1,42197,0.0130720333359075,0.00314472381580057,0.00690837465693838,0.0192356920148766,3.24783451891055e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TBC1D23,TBC1 domain family member 23,42094,-0.038572875347368,0.00928149969212528,-0.0567646147439335,-0.0203811359508024,3.26116982475825e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UNC79,Protein unc-79 homolog,39665,-0.0239322296816913,0.00575997919576318,-0.0352217889053872,-0.0126426704579955,3.27992933991364e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CMC1,COX assembly mitochondrial protein homolog,40080,-0.0388446232275085,0.00936189863826184,-0.0571939445585017,-0.0204953018965153,3.36139249740526e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NACC1,Nucleus accumbens-associated protein 1,40020,-0.0238023241894554,0.00573785032085787,-0.0350485108183368,-0.012556137560574,3.37511967553739e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDK5RAP3,CDK5 regulatory subunit-associated protein 3,40054,-0.0249588427487232,0.00602696250210233,-0.0367716892528438,-0.0131459962446026,3.48110869795397e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STK24,Serine/threonine-protein kinase 24,41829,-0.0263401901388436,0.00636932893548713,-0.0388240748523984,-0.0138563054252888,3.56514023099259e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FAM3D,Protein FAM3D,40021,-0.0367742471803949,0.00889211626561753,-0.0542027950610053,-0.0193456992997846,3.56699116851012e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FAP,Prolyl endopeptidase FAP,42296,-0.0117241500611621,0.00284202519913993,-0.0172945194514764,-0.00615378067084788,3.72570835604586e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCARB2,Lysosome membrane protein 2,41824,-0.0150591749694751,0.00365044575990901,-0.0222140486588967,-0.00790430128005344,3.72628314123416e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SEMA7A,Semaphorin-7A,42262,-0.0121564753617274,0.00295102111012785,-0.017940476737578,-0.00637247398587686,3.8217791532358e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NT5C,"5'(3')-deoxyribonucleotidase, cytosolic type",40080,-0.0309957383942392,0.00752480980378213,-0.0457443656096522,-0.0162471111788263,3.83102791396653e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LTB,Lymphotoxin-beta,40020,-0.0152135268350096,0.00371197820992198,-0.0224890041264567,-0.00793804954356248,4.18877621110004e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SMS,Spermine synthase,39719,-0.0272134452872184,0.00664674047431058,-0.0402410566168672,-0.0141858339575697,4.26695279458015e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SEC31A,Protein transport protein Sec31A,39804,-0.0323234458779565,0.00790804706627948,-0.0478232181278643,-0.0168236736280487,4.39426168367621e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AGXT,Serine--pyruvate aminotransferase,42144,-0.0319804700678337,0.00782736953680689,-0.0473221143599752,-0.0166388257756922,4.42043234929798e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HNMT,Histamine N-methyltransferase,41949,-0.0203807128911091,0.00498879363875173,-0.0301587484230625,-0.0106026773591557,4.42892656030042e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITGAM,Integrin alpha-M,42120,0.0133821304856449,0.0032780507672901,0.00695715098175629,0.0198071099895335,4.48519975902841e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AKR1B1,Aldo-keto reductase family 1 member B1,41861,-0.0312796671895063,0.00766809323326336,-0.0463091299267025,-0.0162502044523101,4.54680725520989e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DCTN6,Dynactin subunit 6,41829,-0.0304485306241865,0.00746916107946433,-0.0450880863399366,-0.0158089749084364,4.59854425792422e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FLT3LG,Fms-related tyrosine kinase 3 ligand,42256,-0.0146873043063912,0.00360495311176677,-0.0217530124054541,-0.00762159620732836,4.64453689631769e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MPIG6B,Megakaryocyte and platelet inhibitory receptor G6b,42162,-0.0318157931729112,0.0078303724710039,-0.0471633232160788,-0.0164682631297435,4.8704999210064e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRRC38,Leucine-rich repeat-containing protein 38,39768,-0.0204025320261292,0.00502558200388091,-0.0302526727537357,-0.0105523912985226,4.94823486722302e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SEL1L,Protein sel-1 homolog 1,39804,-0.0137307249080925,0.00338284256172038,-0.0203610963290644,-0.00710035348712052,4.96515437366888e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SIGLEC6,Sialic acid-binding Ig-like lectin 6,42223,-0.0144050494162559,0.00355653137700298,-0.0213758509151817,-0.00743424791733007,5.14464442215927e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAPK13,Mitogen-activated protein kinase 13,39665,-0.0175608226674387,0.00433599603664287,-0.0260593748992587,-0.00906227043561869,5.15849169868075e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,REPS1,RalBP1-associated Eps domain-containing protein 1,39784,-0.0163266629337318,0.00403330950977679,-0.0242319495728943,-0.00842137629456928,5.20342488288195e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IRAG2,"Inositol 1,4,5-triphosphate receptor associated 2",41876,-0.0367886860395347,0.00909817746222921,-0.0546211138655039,-0.0189562582135654,5.29654664709591e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DARS1,"Aspartate--tRNA ligase, cytoplasmic",41985,-0.030478697273222,0.0075394125150191,-0.0452559458026595,-0.0157014487437846,5.31753900978997e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,L3HYPDH,Trans-3-hydroxy-L-proline dehydratase,40080,-0.0376663128166651,0.00933119086324503,-0.0559554469086254,-0.0193771787247049,5.46020535900857e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GALNT7,N-acetylgalactosaminyltransferase 7,42094,-0.00890395148016532,0.00220781738114979,-0.0132312735472189,-0.00457662941311173,5.54050568873211e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",39863,-0.0431678376760255,0.0107179647564634,-0.0641750485986937,-0.0221606267533574,5.67358163970317e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ROBO2,Roundabout homolog 2,42213,-0.00979142596709761,0.00243474418222766,-0.0145635245642638,-0.0050193273699314,5.8144632033812e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SULT1A1,Sulfotransferase 1A1,42213,0.052952781530874,0.0132244665309609,0.0270328271301907,0.0788727359315572,6.25856459140564e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FKBP5,Peptidyl-prolyl cis-trans isomerase FKBP5,42004,-0.0386847801891752,0.00966131034107732,-0.0576209484576867,-0.0197486119206636,6.26071780038499e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CSF2,Granulocyte-macrophage colony-stimulating factor,39706,-0.0152645774073305,0.00381337187768927,-0.0227387862876014,-0.0077903685270595,6.29983900876715e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ASAH1,Acid ceramidase,39992,-0.0188328357051539,0.00470566753623957,-0.0280559440761835,-0.00960972733412439,6.31861653130651e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VSIG2,V-set and immunoglobulin domain-containing protein 2,40020,-0.0275160660313085,0.00688259337798675,-0.0410059490521626,-0.0140261830104545,6.43253891644853e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SORCS2,VPS10 domain-containing receptor SorCS2,41861,-0.0156108218785046,0.00390672062873631,-0.0232679943108277,-0.00795364944618141,6.48167589417985e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GUCA2A,Guanylin,42072,0.015114808930598,0.00378881124153273,0.00768873889719386,0.0225408789640021,6.66274927717594e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RNASET2,Ribonuclease T2,42255,-0.0114718181319105,0.00287631351750502,-0.0171093926262204,-0.00583424363760071,6.68899144076248e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPP1CC,Serine/threonine-protein phosphatase PP1-gamma catalytic subunit,40020,-0.0339171909610268,0.00850371915425298,-0.0505844805033626,-0.0172499014186909,6.69262972140835e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NBL1,Neuroblastoma suppressor of tumorigenicity 1,42186,-0.0116893925023568,0.00293164192783518,-0.0174354106809138,-0.0059433743237999,6.71898366190583e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDIA5,Protein disulfide-isomerase A5,39665,-0.0251640341165329,0.00631087296829759,-0.0375333451343961,-0.0127947230986696,6.72526246890446e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINB1,Leukocyte elastase inhibitor,42079,-0.0365152192496521,0.00917910746075132,-0.0545062698727247,-0.0185241686265795,6.98542330803407e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYCBP2,E3 ubiquitin-protein ligase MYCBP2,40054,-0.0275539937604951,0.00693079527456168,-0.041138352498636,-0.0139696350223542,7.06600597573664e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANXA1,Annexin A1,39816,-0.0171194378038687,0.00431066651884377,-0.0255683441808025,-0.00867053142693492,7.19188911816912e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,S100P,Protein S100-P,41876,-0.0224540859410208,0.00565776919253184,-0.0335433135583832,-0.0113648583236584,7.2658676577979e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGFBP1,Fibroblast growth factor-binding protein 1,42186,0.0136224823488748,0.00343355926788608,0.0068927061838181,0.0203522585139315,7.30352504634319e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APP,Amyloid-beta precursor protein,42101,-0.027195132388892,0.00687876308070709,-0.0406775080270779,-0.0137127567507061,7.74298312315272e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD69,Early activation antigen CD69,42093,-0.0357918489364019,0.00906421655014738,-0.0535577133746907,-0.018025984498113,7.89951119021049e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD200R1,Cell surface glycoprotein CD200 receptor 1,42068,-0.0143557398986927,0.00365366738339801,-0.0215169279701528,-0.00719455182723263,8.56986068490771e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPINK6,Serine protease inhibitor Kazal-type 6,42223,-0.0218241607528198,0.00555468702131087,-0.0327113473145891,-0.0109369741910505,8.57532529867091e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TRIM26,Tripartite motif-containing protein 26,39665,-0.0229562089539784,0.00584600446993962,-0.0344143777150601,-0.0114980401928968,8.66281772033935e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCN4B,Sodium channel subunit beta-4,39804,-0.0178966948046406,0.0045636577985717,-0.0268414640898411,-0.00895192551944008,8.85284622101892e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MSRA,Mitochondrial peptide methionine sulfoxide reductase,42186,-0.0291040229075363,0.00743261730039013,-0.0436719528163009,-0.0145360929987716,9.05967285437696e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FCRL2,Fc receptor-like protein 2,42186,-0.021337617669568,0.00545527731997759,-0.0320299612167241,-0.0106452741224119,9.22404291322435e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD1C,T-cell surface glycoprotein CD1c,42186,-0.0102058918174363,0.00261115384771526,-0.0153237533589582,-0.00508803027591439,9.33131639348991e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GRSF1,G-rich sequence factor 1,39601,-0.0327166676334174,0.00838697892676484,-0.0491551463298765,-0.0162781889369583,9.64433914302569e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FCRLB,Fc receptor-like B,41861,-0.0263621686406994,0.00676288202090339,-0.03961741740167,-0.0131069198797287,9.74631706260296e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINA6,Corticosteroid-binding globulin,40113,0.00635247826976469,0.00163017882307176,0.00315732777654405,0.00954762876298534,9.80548269184321e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDLIM5,PDZ and LIM domain protein 5,40054,-0.0468355176699203,0.0120590899112952,-0.0704713338960589,-0.0231997014437818,0.000103431320192908
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HYAL1,Hyaluronidase-1,42059,0.00935815317245638,0.0024101786239429,0.00463420306952829,0.0140821032753845,0.000103792326808638
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYDGF,Myeloid-derived growth factor,40080,-0.0392482134182986,0.0101278657016883,-0.0590988301936077,-0.0193975966429895,0.000107131368047392
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,S100A12,Protein S100-A12,41947,-0.0301525689765769,0.00781284000719786,-0.0454657353906847,-0.0148394025624691,0.000114244282045883
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CSF1R,Macrophage colony-stimulating factor 1 receptor,40102,-0.0163066690125457,0.00422645602694748,-0.0245905228253628,-0.00802281519972867,0.000114865456493102
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TBCB,Tubulin-folding cofactor B,42004,-0.0396250391640666,0.0102818723310323,-0.0597775089328899,-0.0194725693952432,0.000116830927276161
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,S100A14,Protein S100-A14,40054,-0.0218351438679297,0.00566565455010811,-0.0329398267861416,-0.0107304609497179,0.000116897156263589
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SUGT1,Protein SGT1 homolog,41861,-0.0319649013597211,0.00829789273442914,-0.0482287711192022,-0.0157010316002399,0.000117652122953905
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL26,C-C motif chemokine 26,42103,-0.0373408726983254,0.00969428084073935,-0.0563416631461746,-0.0183400822504763,0.000117797570869441
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEBPA,CCAAT/enhancer-binding protein alpha,39784,-0.0148695246152423,0.00386345871970301,-0.0224419037058602,-0.00729714552462442,0.000119414942561709
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD302,CD302 antigen,42094,-0.0128422397658858,0.00334158968050846,-0.0193917555396824,-0.00629272399208918,0.000122046286629791
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SORBS1,Sorbin and SH3 domain-containing protein 1,40054,-0.0163577493882175,0.00427150065214744,-0.0247298906664265,-0.00798560811000854,0.000129121175965986
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCARF2,Scavenger receptor class F member 2,42213,0.0120721629464039,0.00315263880377216,0.00589299089101049,0.0182513350017973,0.000129150011484626
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STX6,Syntaxin-6,41861,-0.0263383982099832,0.00688751401051891,-0.0398379256706003,-0.0128388707493662,0.000131890940082248
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,F12,Coagulation factor XII,40113,-0.0163890854912352,0.00428678532080147,-0.0247911847200061,-0.00798698626246431,0.000132481933614871
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GNPDA2,Glucosamine-6-phosphate isomerase 2,39863,-0.0145480949219159,0.00380630500369671,-0.0220084527291614,-0.00708773711467031,0.000133069420488517
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FUCA1,Tissue alpha-L-fucosidase,42227,-0.0333835044792784,0.00873755065345213,-0.0505091037600446,-0.0162579051985122,0.000133694701938881
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KAZALD1,Kazal-type serine protease inhibitor domain-containing protein 1,42094,-0.0180669610485696,0.00473400790559988,-0.0273456165435454,-0.00878830555359388,0.000136034565735381
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NECAP2,Adaptin ear-binding coat-associated protein 2,39706,-0.0271098728290963,0.00710766910801205,-0.0410409042807999,-0.0131788413773927,0.000137422025142373
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRKAB1,5'-AMP-activated protein kinase subunit beta-1,41887,-0.0210578415636438,0.00552329531507024,-0.0318835003811814,-0.0102321827461061,0.000138190632112467
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APOBR,Apolipoprotein B receptor,39804,0.0168036692234579,0.0044081397134182,0.00816371538515824,0.0254436230617576,0.000138646826870961
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDH17,Cadherin-17,42144,-0.0275431155837572,0.00722631302007672,-0.0417066891031076,-0.0133795420644068,0.000138763793605368
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PHACTR2,Phosphatase and actin regulator 2,40054,-0.0446477555533441,0.0117136114487539,-0.0676064339929017,-0.0216890771137865,0.000138825439481768
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SOD2,"Superoxide dismutase [Mn], mitochondrial",42120,0.0149654604963158,0.00392786131307428,0.00726685232269016,0.0226640686699414,0.000139566134920044
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPING1,Plasma protease C1 inhibitor,40092,0.00722517888016452,0.00189908232679807,0.00350297751964029,0.0109473802406887,0.00014283107460788
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CNTN1,Contactin-1,42296,0.0109897494700883,0.00289237397418345,0.00532069648068877,0.0166588024594879,0.000145608580622878
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTHRC1,Collagen triple helix repeat-containing protein 1,40097,-0.0115605199993518,0.00304744544184355,-0.0175335130653652,-0.00558752693333847,0.000149334267820686
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STX16,Syntaxin-16,41861,-0.0228883648702801,0.00603492552382888,-0.0347168188969847,-0.0110599108435755,0.000149740210544622
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GSTP1,Glutathione S-transferase P,41759,0.027669223633839,0.00730835346772116,0.0133448508371056,0.0419935964305725,0.00015382114946205
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RAD23B,UV excision repair protein RAD23 homolog B,41861,-0.0182110034859654,0.00481635670679178,-0.0276510626312773,-0.00877094434065349,0.000156870139465217
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DMD,Dystrophin,39804,-0.0202114729443631,0.00535768455672682,-0.0307125346755476,-0.00971041121317848,0.000162546519387959
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HSD11B1,Corticosteroid 11-beta-dehydrogenase isozyme 1,42103,0.0154660580327013,0.00410318577039828,0.00742381392272068,0.0235083021426819,0.000164448024925161
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD28,T-cell-specific surface glycoprotein CD28,41861,-0.014872544107404,0.00394619125003712,-0.0226070789574768,-0.00713800925733126,0.000164755333614841
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFSF8,Tumor necrosis factor ligand superfamily member 8,40097,-0.0144540443550202,0.0038369778242964,-0.0219745208906411,-0.0069335678193992,0.000166064767367471
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,JPT2,Jupiter microtubule associated homolog 2,40021,-0.0338382327706993,0.00898617094558228,-0.0514511278240405,-0.016225337717358,0.000167035822947958
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLITRK2,SLIT and NTRK-like protein 2,42223,-0.015527796268109,0.00412875597165182,-0.0236201579725465,-0.0074354345636714,0.000170050901588726
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL25,C-C motif chemokine 25,42256,-0.01868834400067,0.00497804883683878,-0.028445319720874,-0.00893136828046605,0.000174684493780709
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLEC1A,C-type lectin domain family 1 member A,41876,0.0137035386572082,0.00365022424492841,0.00654909913714855,0.0208579781772679,0.000174697987283293
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DRG2,Developmentally-regulated GTP-binding protein 2,42094,-0.0219086549312341,0.0058379480548399,-0.0333510331187204,-0.0104662767437479,0.000175636599842469
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SNU13,NHP2-like protein 1,39706,-0.0247512052911257,0.00660912933719049,-0.0377050987920191,-0.0117973117902324,0.000181355307751536
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RALY,RNA-binding protein Raly,40020,-0.0183100448199949,0.00489289234486584,-0.0279001138159319,-0.00871997582405781,0.000183379745706142
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EDA2R,Tumor necrosis factor receptor superfamily member 27,42223,0.0160552322419242,0.0042953901610361,0.00763626752629344,0.0244741969575549,0.00018644453689768
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CPXM1,Probable carboxypeptidase X1,42186,-0.0268548801295696,0.00719490420913233,-0.040956892379469,-0.0127528678796702,0.000190407775660585
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LYPD8,Ly6/PLAUR domain-containing protein 8,41861,-0.019657788361799,0.00526896162812029,-0.0299849531529147,-0.00933062357068323,0.000191656310392927
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CBS,Cystathionine beta-synthase,39804,-0.0198158798904638,0.00531673004529261,-0.0302366707792373,-0.00939508900169029,0.000194717210134201
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OMD,Osteomodulin,42184,0.0163239620491256,0.00438133806238822,0.00773653944684468,0.0249113846514065,0.000195526478411277
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EGFLAM,Pikachurin,40021,-0.0119681486673918,0.00321626064249021,-0.0182720195266726,-0.00566427780811103,0.000199330982433487
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NDUFA5,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 5,39774,-0.0135920940458981,0.00365617774482114,-0.0207582024257475,-0.00642598566604866,0.000202186887677989
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SMAD3,Mothers against decapentaplegic homolog 3,40020,-0.0199159958835929,0.00535849494369954,-0.030418645973244,-0.00941334579394179,0.000202847267032153
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLIC5,Chloride intracellular channel protein 5,39768,0.012205191452885,0.00328423951978266,0.00576808199411097,0.018642300911659,0.000203210868315328
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COL2A1,Collagen alpha-1(II) chain,39804,-0.0311637922304918,0.00838583535352897,-0.0476000295234086,-0.014727554937575,0.00020324720392444
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,B3GNT7,"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7",39804,-0.0142377167361613,0.00383365344843234,-0.0217516774950887,-0.00672375597723395,0.000205154575730236
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LONP1,"Lon protease homolog, mitochondrial",39804,-0.0332827623454486,0.00896678381176677,-0.0508576586165115,-0.0157078660743857,0.000206856666103608
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FCRL3,Fc receptor-like protein 3,41887,-0.0217983503837375,0.0058765150821124,-0.0333163199446778,-0.0102803808227973,0.000208636267026476
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AKR1B10,Aldo-keto reductase family 1 member B10,39768,-0.0249799093242516,0.00674032292067688,-0.0381909422487783,-0.0117688763997249,0.00021159911919837
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADAM22,Disintegrin and metalloproteinase domain-containing protein 22,42004,-0.0140559575285328,0.00379714203232775,-0.0214983559118952,-0.00661355914517045,0.00021504056253026
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GPI,Glucose-6-phosphate isomerase,40102,-0.0179747259258079,0.00486261541555241,-0.0275054521402907,-0.00844399971132521,0.000219651117266507
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IFI30,Gamma-interferon-inducible lysosomal thiol reductase,39754,-0.0150474382944836,0.00407425741719713,-0.02303298283219,-0.00706189375677727,0.000222482859674055
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FCGR2B,Low affinity immunoglobulin gamma Fc region receptor II-b,41861,-0.0222796849530126,0.0060389783225023,-0.0341160824651171,-0.010443287440908,0.000225801435281825
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MED18,Mediator of RNA polymerase II transcription subunit 18,41861,-0.0288818757336136,0.00783205877311411,-0.0442327109289173,-0.01353104053831,0.000227282586565812
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANXA3,Annexin A3,42186,-0.0264844964667384,0.00718330927451771,-0.0405637826447931,-0.0124052102886837,0.000227882926653895
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GPIHBP1,Glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1,40021,0.0269410210530709,0.00731319323551135,0.0126071623114687,0.0412748797946732,0.000230818052329672
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LAMP3,Lysosome-associated membrane glycoprotein 3,42248,-0.0200630533641895,0.00544847545401251,-0.030742065254054,-0.00938404147432499,0.000232049527227691
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UBE2B,Ubiquitin-conjugating enzyme E2 B,40020,-0.0107640386465249,0.00293372621783469,-0.0165141420334809,-0.00501393525956893,0.000244605618886123
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPP1R2,Protein phosphatase inhibitor 2,42144,-0.0299184310652395,0.0081644563158493,-0.0459207654443042,-0.0139160966861749,0.000248837873060377
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LACTB2,Endoribonuclease LACTB2,42144,-0.0247507319214814,0.00675480396423401,-0.0379901476913801,-0.0115113161515827,0.000249135061259189
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL14,C-C motif chemokine 14,42127,-0.0153873116280852,0.00420282853835173,-0.0236248555632546,-0.00714976769291576,0.000252056724458028
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL7,C-C motif chemokine 7,42103,-0.0224424882617749,0.00613770265707982,-0.0344723854696514,-0.0104125910538985,0.000256701749159717
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PNMA1,Paraneoplastic antigen Ma1,39804,-0.0211050670771323,0.00578050032450197,-0.0324348477131562,-0.00977528644110843,0.000262395910084399
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,40080,-0.0107446309275985,0.00294543961300335,-0.0165176925690851,-0.00497156928611194,0.000265640883442653
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AIF1,Allograft inflammatory factor 1,41861,-0.0197030534808215,0.00541548525702336,-0.0303174045845873,-0.00908870237705575,0.000275555264106517
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SAFB2,Scaffold attachment factor B2,40054,-0.0103783693643715,0.00285262817260017,-0.0159695205826679,-0.00478721814607517,0.000275846324787501
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PHYKPL,5-phosphohydroxy-L-lysine phospho-lyase,39863,-0.0158331946525661,0.00435379232855882,-0.0243666276165414,-0.0072997616885908,0.000277514085439827
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL18,C-C motif chemokine 18,41991,-0.0262672483079476,0.00722698951914894,-0.0404321477654795,-0.0121023488504157,0.000279498387240637
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANXA11,Annexin A11,42079,-0.0249947592688689,0.00688380417241224,-0.0384870154467969,-0.0115025030909409,0.000283473020475706
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SMTN,Smoothelin,40031,-0.0345981510774244,0.00953252635591445,-0.0532819027350167,-0.0159143994198321,0.000285295875154489
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LGALS9,Galectin-9,42128,-0.0121527060500262,0.00334851125123267,-0.0187157881024422,-0.00558962399761019,0.00028530170154112
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LETM1,Mitochondrial proton/calcium exchanger protein,40054,-0.0199133389924629,0.00549384632950575,-0.0306812777982942,-0.00914540018663165,0.0002906616487505
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PCDH1,Protocadherin-1,42226,-0.00814750361994555,0.00225565208532612,-0.0125685817071847,-0.00372642553270635,0.000304940658221084
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCDC80,Coiled-coil domain-containing protein 80,42144,-0.0140550363194407,0.00390901772298362,-0.0217167110564886,-0.00639336158239281,0.000324920955764248
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FRMD4B,FERM domain-containing protein 4B,39706,-0.0261560379015583,0.00727473108713847,-0.0404145108323497,-0.0118975649707669,0.000325296821969233
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COL5A1,Collagen alpha-1(V) chain,39863,-0.0153907856273325,0.00428562307951199,-0.023790606863176,-0.006990964391489,0.000330562517267548
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BCL2L11,"Bcl-2-like protein 11, Isoform BimL ",42103,-0.0158416783122204,0.00441543901836353,-0.0244959387882129,-0.00718741783622788,0.000334723701885249
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SMPD1,Sphingomyelin phosphodiesterase,42149,-0.0183516475090336,0.00511948301675443,-0.0283858342218723,-0.00831746079619494,0.00033874747305826
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DPEP2,Dipeptidase 2,42094,0.0110009486313178,0.00307755496722966,0.00496894089554766,0.0170329563670879,0.000352079407415681
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEP112,Centrosomal protein of 112 kDa,39706,-0.0165755391838969,0.00463715969401613,-0.0256643721841685,-0.00748670618362527,0.000352467252454641
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYO9B,Unconventional myosin-IXb,41887,-0.0244540454911477,0.00684880213111354,-0.0378776976681302,-0.0110303933141651,0.000357538113012363
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NRCAM,Neuronal cell adhesion molecule,42144,-0.0107782563533367,0.00302358844590368,-0.0167044897073079,-0.00485202299936551,0.000365551598302534
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HSPB1,Heat shock protein beta-1,41963,-0.0249557099101034,0.0070050660798547,-0.0386856394266186,-0.0112257803935882,0.000368645692373853
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACY3,N-acyl-aromatic-L-amino acid amidohydrolase,39706,-0.020648729806434,0.00579624919796897,-0.0320093782344532,-0.00928808137841486,0.000369064730428918
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TK1,"Thymidine kinase, cytosolic",39881,-0.0167516189258208,0.00470625025885819,-0.0259758694331828,-0.00752736841845871,0.000373258237377727
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENPP6,Glycerophosphocholine cholinephosphodiesterase ENPP6,39804,-0.0136662958419498,0.00384077667198814,-0.0211942181190466,-0.00613837356485307,0.000375018661655313
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDZD2,PDZ domain-containing protein 2,39706,-0.0223739870317961,0.00629025865520083,-0.0347028939959897,-0.0100450800676024,0.000376870382814514
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NPC2,NPC intracellular cholesterol transporter 2,39942,-0.0125864107929189,0.00354108170058909,-0.0195269309260735,-0.00564589065976428,0.000380472738760522
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLU,Clusterin,40113,0.01142157811085,0.00321351795254877,0.0051230829238544,0.0177200732978456,0.000380690596469367
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPP1,Osteopontin,42274,0.0174332789780634,0.00491695634830769,0.0077960445353803,0.0270705134207465,0.000393174152636755
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EGF,Pro-epidermal growth factor,42107,-0.0376730930808608,0.0106367400915554,-0.0585211036603094,-0.0168250825014122,0.000398823446260799
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CORO1A,Coronin-1A,41866,-0.0327182158106502,0.00924256599945365,-0.0508336451695794,-0.0146027864517211,0.000401638427252692
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADAM15,Disintegrin and metalloproteinase domain-containing protein 15,41876,0.011375014704152,0.00321805221445054,0.00506763236382894,0.0176823970444751,0.000409612897973433
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARHGAP1,Rho GTPase-activating protein 1,41861,-0.0165732302073016,0.0046942834764949,-0.0257740258212316,-0.00737243459337161,0.000416226800836204
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NECTIN1,Nectin-1,39784,-0.0119588429131238,0.00339744459529597,-0.018617834319904,-0.00529985150634375,0.000433437500689841
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFSF14,Tumor necrosis factor ligand superfamily member 14,42004,-0.0210162243438153,0.00597315876886362,-0.032723615530788,-0.00930883315684256,0.000435590157111119
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OPLAH,5-oxoprolinase,39804,-0.0245996938053264,0.00700027625457504,-0.0383202352642935,-0.0108791523463594,0.000443079724121128
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VIM,Vimentin,41876,-0.0419344192118434,0.0119363222620054,-0.065329610845374,-0.0185392275783128,0.000444323170444278
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MMP7,Matrilysin,41854,-0.0183961850594437,0.00524575797309069,-0.0286778706867014,-0.00811449943218592,0.00045498344965455
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DBN1,Drebrin,39784,-0.0181546633745209,0.00518020756884168,-0.0283078702094506,-0.0080014565395912,0.000459147692985908
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDH5,Cadherin-5,42296,0.0109312994095098,0.00312060728978701,0.00481490912152726,0.0170476896974923,0.000461687399467015
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PKD2,Polycystin-2,39706,-0.0211599138811356,0.0060457875527744,-0.0330096574845734,-0.00931017027769774,0.000467284862117635
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLIT2,Slit homolog 2 protein,41829,-0.0190402372424254,0.00544223546314423,-0.0297070187501881,-0.00837345573466267,0.000469306565044508
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITGB7,Integrin beta-7,42223,-0.0166806061270553,0.00477725810087395,-0.0260440320047682,-0.00731718024934231,0.000481601742563146
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARAF,Serine/threonine-protein kinase A-Raf,39881,-0.0247450520211751,0.00709357151363144,-0.0386484521878927,-0.0108416518544575,0.00048791810160268
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPL,Periplakin,39784,-0.0119465920531494,0.00342559495722593,-0.0186607581693122,-0.00523242593698653,0.00048962826060782
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,42122,0.0117692464997428,0.00337795332901556,0.00514845797487229,0.0183900350246133,0.000495364629215518
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BCAT1,"Branched-chain-amino-acid aminotransferase, cytosolic",40080,-0.0109989751590123,0.00315699272074415,-0.0171866808916708,-0.00481126942635374,0.000495914727885579
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PARD3,Partitioning defective 3 homolog,39881,-0.0269976701561971,0.00776561087709281,-0.042218267475299,-0.0117770728370952,0.000509894740113194
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ZNRD2,Protein ZNRD2,40021,-0.0251262047729751,0.00722929281165411,-0.0392956186838172,-0.0109567908621331,0.000511689543542289
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RCOR1,REST corepressor 1,41876,-0.0159918208968315,0.00460430624632051,-0.0250162611396197,-0.00696738065404326,0.000515947448618067
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDC37,Hsp90 co-chaperone Cdc37,42186,-0.0300105993083329,0.00865591766794741,-0.0469761979375098,-0.0130450006791559,0.000527883606972886
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RRM2B,Ribonucleoside-diphosphate reductase subunit M2 B,41861,-0.0239370944055138,0.00690881531885819,-0.0374783724304758,-0.0103958163805517,0.00053254521251602
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD72,B-cell differentiation antigen CD72,39863,-0.0158784154034715,0.00459378179048522,-0.0248822277128225,-0.00687460309412042,0.000549367256765638
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CSPG4,Chondroitin sulfate proteoglycan 4,40097,0.0118242556578957,0.00342732467538703,0.0051066992941371,0.0185418120216543,0.000562717353171001
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ART3,Ecto-ADP-ribosyltransferase 3,42197,0.0129344224966432,0.0037517173032813,0.00558105658221183,0.0202877884110745,0.000567380106318135
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BDNF,Brain-derived neurotrophic factor,40097,-0.0297738891351989,0.0086428540615395,-0.0467138830958164,-0.0128338951745815,0.000573391544569375
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BRDT,Bromodomain testis-specific protein,39706,-0.0133250460605481,0.00387125418794359,-0.0209127042689175,-0.00573738785217866,0.000579573310067774
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSAPL1,Proactivator polypeptide-like 1,40021,0.0182780391278747,0.00531413245954256,0.00786233950717129,0.0286937387485781,0.000584953532695061
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SNX9,Sorting nexin-9,42144,-0.0239127624930819,0.00696550243903915,-0.0375651472735986,-0.0102603777125651,0.000598748487897131
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CR2,Complement receptor type 2,42197,-0.0170339448591103,0.00496836985523245,-0.0267719497753659,-0.00729593994285465,0.000608858364767622
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GRAP2,GRB2-related adapter protein 2,42144,-0.0450377119586484,0.013169287399122,-0.0708495152609275,-0.0192259086563693,0.000628362018738715
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HDDC2,5'-deoxynucleotidase HDDC2,40021,-0.0156055786228637,0.00456334638476212,-0.0245497375369975,-0.00666141970872995,0.000629061371798116
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",42186,0.012438788949668,0.00364464591728205,0.00529528295179519,0.0195822949475408,0.000644731086180996
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MCTS1,Malignant T-cell-amplified sequence 1,40021,-0.00973892812989772,0.00285569802875315,-0.0153360962662539,-0.00414175999354155,0.000651165924573343
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENAH,Protein enabled homolog,41887,-0.0166000301771171,0.00487913702378853,-0.0261631387437426,-0.00703692161049153,0.000670404475443838
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TOR1AIP1,Torsin-1A-interacting protein 1,39804,-0.0183340318076101,0.00539546366301455,-0.0289091405871186,-0.00775892302810158,0.000681186001077911
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NGRN,Neugrin,40054,-0.00820556031971676,0.00241706897046517,-0.0129430155018285,-0.00346810513760503,0.000689146993664459
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITGAL,Integrin alpha-L,39784,-0.0157279220294472,0.00463527262316884,-0.0248130563708581,-0.00664278768803624,0.000693607374940652
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAP2,Microtubule-associated protein 2,40054,-0.0163827644946143,0.00483193709355828,-0.0258533611979885,-0.0069121677912401,0.000700094379467236
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD14,Monocyte differentiation antigen CD14,41927,0.0146749565266234,0.00433768810872633,0.00617308783351975,0.023176825219727,0.000718810061262774
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SESTD1,SEC14 domain and spectrin repeat-containing protein 1,41829,-0.0223549429891763,0.00661431512734699,-0.0353190006387764,-0.0093908853395762,0.000727628175971184
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRSS27,Serine protease 27,42111,-0.0141441027822345,0.00418515931114018,-0.0223470150320692,-0.00594119053239973,0.000728100585484697
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VCAM1,Vascular cell adhesion protein 1,42172,0.00980022506922723,0.0029079683010926,0.00410060719908574,0.0154998429393687,0.000753522522461601
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CPB2,Carboxypeptidase B2,40092,-0.00776046063974327,0.00230566424980106,-0.0122795625693533,-0.00324135871013318,0.000765789432205187
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TMEM106A,Transmembrane protein 106A,40020,-0.0243866518112838,0.00725042788015363,-0.0385974904563849,-0.0101758131661826,0.000772340370479623
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CXADR,Coxsackievirus and adenovirus receptor,42103,-0.0180509476885335,0.00537422019461738,-0.0285844192699836,-0.00751747610708348,0.00078507299832033
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRYGD,Gamma-crystallin D,40054,-0.0338658368639716,0.0100831479265963,-0.0536288068001004,-0.0141028669278428,0.000785915407116903
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPARCL1,SPARC-like protein 1,42153,0.00968971663079568,0.00288516311999955,0.00403479691559656,0.0153446363459948,0.00078602721746189
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ABHD14B,Protein ABHD14B,41969,-0.0197893729420054,0.00590115863824123,-0.0313556438729582,-0.00822310201105258,0.000800363070666736
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTX3,Pentraxin-related protein PTX3,42103,0.0169435813626656,0.00506933613941263,0.00700768252941686,0.0268794801959144,0.000833031812108213
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTSH,Pro-cathepsin H,41854,-0.0257927740600906,0.00771836844725755,-0.0409207762167154,-0.0106647719034658,0.000834962836654301
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CASP3,Caspase-3,42296,-0.0299858602723864,0.00898968391571496,-0.0476056407471877,-0.0123660797975851,0.000853564213420714
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APOA4,Apolipoprotein A-IV,40113,-0.012367077296801,0.0037120517666091,-0.0196426987593548,-0.00509145583424716,0.000866344256428267
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL10RA,Interleukin-10 receptor subunit alpha,41887,-0.0200503089908914,0.00601930050296203,-0.031848137976697,-0.00825248000508587,0.00086780518040263
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPP1R14D,Protein phosphatase 1 regulatory subunit 14D,40054,0.0134834837666867,0.0040512701902375,0.00554299419382116,0.0214239733395522,0.000876961178741337
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRRC37A2,Leucine-rich repeat-containing protein 37A2,40021,-0.0149643787916573,0.00449626473049312,-0.0237770576634239,-0.00615169991989082,0.000877068595167359
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CST5,Cystatin-D,41876,-0.0197185057967185,0.00592831991439684,-0.0313380128289363,-0.00809899876450065,0.000883033186092568
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PALM3,Paralemmin-3,39706,-0.0247346487192443,0.00743604694362575,-0.0393093007287508,-0.0101599967097379,0.000883034673069678
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CERT,Ceramide transfer protein,41829,-0.0210855390799475,0.00634030788591894,-0.0335125425363487,-0.00865853562354643,0.000884692549498809
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD200,OX-2 membrane glycoprotein,42103,0.00949856901238398,0.00285877028108042,0.00389537926146637,0.0151017587633016,0.000894284458537165
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TCN2,Transcobalamin-2,42274,0.0105959959523259,0.00319626810737584,0.00433131046186927,0.0168606814427825,0.000918546429392465
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNAJB14,DnaJ homolog subfamily B member 14,40021,-0.0216697640206208,0.00655313333815729,-0.0345139053634091,-0.00882562267783251,0.000946825960273441
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DPEP1,Dipeptidase 1,41985,0.0171660733676855,0.00519266240840524,0.00698845504721128,0.0273436916881598,0.000949552741756473
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTSS,Cathepsin S,39477,-0.0083845310619494,0.00253739977795589,-0.0133578346267429,-0.00341122749715585,0.000955124609703991
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,POF1B,Protein POF1B,39784,-0.0159680196601152,0.00483430217146469,-0.025443251916186,-0.00649278740404437,0.000959508863077719
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PAFAH2,"Platelet-activating factor acetylhydrolase 2, cytoplasmic",39881,-0.0168614480183841,0.00510492782666407,-0.0268671065586457,-0.00685578947812251,0.000959792173749121
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GYS1,"Glycogen [starch] synthase, muscle",41876,-0.0315553550634385,0.00956150872713458,-0.0502959121686222,-0.0128147979582547,0.000968657757655978
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CNTN4,Contactin-4,42120,0.00824011052411797,0.00249799658949337,0.00334403720871096,0.013136183839525,0.000974004226684409
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLEC4D,C-type lectin domain family 4 member D,42103,-0.0213421381199511,0.00647023756440372,-0.0340238037461824,-0.00866047249371983,0.000974626505682996
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CASP2,Caspase-2,42103,-0.0229969693751115,0.00699034063437006,-0.0366980370184768,-0.00929590173174619,0.00100519711237956
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LYZL2,Lysozyme-like protein 2,39665,-0.012308803258513,0.0037453225089217,-0.0196496353759996,-0.0049679711410265,0.00101793819016295
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TXNDC5,Thioredoxin domain-containing protein 5,42213,-0.0228033440733605,0.00694538738701309,-0.0364163033519061,-0.00919038479481479,0.00102893398512852
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LSM8,U6 snRNA-associated Sm-like protein LSm8,39881,-0.0295149131274414,0.00898962473412187,-0.0471345776063203,-0.0118952486485626,0.00102958346619992
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MEGF10,Multiple epidermal growth factor-like domains protein 10,42126,-0.0129594969657746,0.00395059196771142,-0.020702657222489,-0.00521633670906022,0.00103936612052281
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RCC1,Regulator of chromosome condensation,40020,-0.0176994005167861,0.00540312115401068,-0.0282895179786471,-0.00710928305492518,0.00105704442656949
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C1QTNF5,Complement C1q tumor necrosis factor-related protein 5,39863,-0.0128154359319848,0.00391263951293844,-0.0204842093773441,-0.00514666248662543,0.0010585126766083
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGSF21,Immunoglobulin superfamily member 21,39804,-0.0135178511775923,0.00412913364184223,-0.021610953115603,-0.00542474923958148,0.00106461131284738
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MINDY1,Ubiquitin carboxyl-terminal hydrolase MINDY-1,40020,-0.0364255287252575,0.0111328733831454,-0.0582459605562224,-0.0146050968942925,0.00107165901556201
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITGAV,Integrin alpha-V,42223,0.00557424894308246,0.00170613956829016,0.00223021538923376,0.00891828249693117,0.00108909273919885
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEACAM19,Carcinoembryonic antigen-related cell adhesion molecule 19,40021,-0.0138515172051794,0.00424192968999568,-0.0221656993975709,-0.00553733501278783,0.00109656597325198
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CASP7,Caspase-7,40054,-0.0281921378727376,0.00864687109131394,-0.0451400052117129,-0.0112442705337623,0.00111603429933625
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGHMBP2,DNA-binding protein SMUBP-2,39706,-0.0185828516542725,0.0057039595825889,-0.0297626124361467,-0.00740309087239824,0.00112601624137468
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OPTC,Opticin,42094,0.0156533025516185,0.00482164282037342,0.00620288262368658,0.0251037224795504,0.00117145393935198
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFAIP2,Tumor necrosis factor alpha-induced protein 2,40021,-0.0154754685819522,0.00477210412497508,-0.0248287926669033,-0.00612214449700103,0.0011867710226062
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VSIG10,V-set and immunoglobulin domain-containing protein 10,40020,-0.0112628045638127,0.00347374336560347,-0.0180713415603955,-0.00445426756722989,0.0011894173708568
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEACAM6,Carcinoembryonic antigen-related cell adhesion molecule 6,40097,0.0133211691645097,0.00410984734259406,0.00526586837302537,0.0213764699559941,0.0011935121469674
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PHLDB1,Pleckstrin homology-like domain family B member 1,40021,-0.017652461055827,0.00545158769574465,-0.0283375729394865,-0.00696734917216744,0.0012071635026558
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD101,Immunoglobulin superfamily member 2,40021,-0.0146318694583781,0.00451891499933074,-0.0234889428570664,-0.00577479605968991,0.001207687225476
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ERBB4,Receptor tyrosine-protein kinase erbB-4,42186,0.00807073289385298,0.00249453291519668,0.00318144838006749,0.0129600174076385,0.00121789908255475
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ECE1,Endothelin-converting enzyme 1,41829,-0.0119248574422685,0.00368902561292499,-0.0191553476436014,-0.00469436724093547,0.00123017297671256
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCRG1,Scrapie-responsive protein 1,40080,-0.00955598935847074,0.00295622286170044,-0.0153501861674036,-0.00376179254953787,0.00123077641680367
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ROBO1,Roundabout homolog 1,42146,-0.00824700787210182,0.00255220272200897,-0.0132493252072394,-0.00324469053696422,0.00123523703530917
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DSG3,Desmoglein-3,42155,-0.0118110508821682,0.00365730844291851,-0.0189793754302884,-0.00464272633404788,0.00124342810490079
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,WARS,"Tryptophan--tRNA ligase, cytoplasmic",42120,-0.0130348934801188,0.00404123749653644,-0.0209557189733303,-0.00511406798690739,0.00126078452903096
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SIGLEC9,Sialic acid-binding Ig-like lectin 9,42208,-0.00984589950354502,0.00305843888448638,-0.0158404397171383,-0.00385135928995171,0.00128838653801113
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IMMT,MICOS complex subunit MIC60,40020,-0.0150294096885403,0.00467081042075067,-0.0241841981132116,-0.00587462126386902,0.00129589453195426
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PIGR,Polymeric immunoglobulin receptor,41977,-0.0119685416405756,0.00371994165123796,-0.019259627277002,-0.00467745600414923,0.00129680268781946
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VIPR1,Vasoactive intestinal polypeptide receptor 1,39804,0.00785138629377541,0.00244308569182906,0.00306293833779045,0.0126398342497604,0.00131420446387334
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BRK1,Protein BRICK1,41829,0.015051585428945,0.00468604241676425,0.00586694229208703,0.0242362285658029,0.00132142929400965
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BMP4,Bone morphogenetic protein 4,41984,-0.0155863041861928,0.00485285718303025,-0.0250979042649321,-0.00607470410745355,0.00132242271037035
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GPR15L,Protein GPR15L,40021,-0.0202322872117571,0.00630948993422079,-0.0325988874828299,-0.00786568694068439,0.00134683404950259
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPOCK1,Testican-1,42004,0.0085814115582417,0.0026763375103651,0.00333579003792611,0.0138270330785573,0.00134736493321931
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ISLR2,Immunoglobulin superfamily containing leucine-rich repeat protein 2,41635,-0.0125169116025712,0.00390542830812817,-0.0201715510865024,-0.00486227211864,0.00135401713048711
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADAM23,Disintegrin and metalloproteinase domain-containing protein 23,42256,-0.0118963196938397,0.00371333033399383,-0.0191744471484676,-0.00461819223921181,0.00136009183348357
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGFR4,Fibroblast growth factor receptor 4,39863,0.0176652161931096,0.00551493797145913,0.00685593776904971,0.0284744946171695,0.00136328785211557
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TSPYL1,Testis-specific Y-encoded-like protein 1,39784,-0.0133643524132444,0.00418100848240894,-0.021559129038766,-0.00516957578772291,0.00139542208775499
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TFF2,Trefoil factor 2,42162,-0.0193161076922551,0.00604517939441443,-0.0311646593053074,-0.00746755607920281,0.00140024365538889
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYOM3,Myomesin-3,39863,0.0307175419560446,0.00961895790402313,0.0118643844641593,0.0495706994479299,0.00140998073098831
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TGFBR2,TGF-beta receptor type-2,42186,-0.0119431634507068,0.00374297531770811,-0.0192793950734147,-0.0046069318279989,0.00142206575013959
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GSR,"Glutathione reductase, mitochondrial",40061,-0.00744764997246283,0.00233668620520386,-0.0120275549346624,-0.00286774501026328,0.00144029259996133
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRTAC1,Cartilage acidic protein 1,42296,0.00990791191175438,0.00311013941547001,0.00381203865743316,0.0160037851660756,0.00144752230329845
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LGALS4,Galectin-4,42126,-0.0187584322874241,0.00588942445342072,-0.0303017042161287,-0.00721516035871948,0.00145045128741019
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SMARCA2,Probable global transcription activator SNF2L2,41829,-0.0240020839426171,0.00753657607137224,-0.0387737730425066,-0.00923039484272748,0.00145232629664875
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EFNA1,Ephrin-A1,42099,0.010069946296376,0.00316498326918258,0.00386657908877811,0.0162733135039738,0.0014677314544594
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TYMP,Thymidine phosphorylase,42073,0.0214963035395142,0.00676232650408517,0.00824214359150725,0.0347504634875211,0.00148219284942435
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTF1,Cardiotrophin-1,41876,-0.0275710336593854,0.00868260299094169,-0.0445889355216311,-0.0105531317971397,0.00149970500124204
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANPEP,Aminopeptidase N,42176,0.00916951161366628,0.00289132597641895,0.00350251269988515,0.0148365105274474,0.00152066213960188
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RBPMS,RNA-binding protein with multiple splicing,39784,-0.0210112822491004,0.00662852100216537,-0.0340031834133446,-0.00801938108485632,0.00152962647711961
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,S100A11,Protein S100-A11,42043,-0.0150091569923339,0.00474079948488558,-0.0243011239827096,-0.00571719000195812,0.00154935867446437
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRDX1,Peroxiredoxin-1,41787,0.0294317555658617,0.00930502887596238,0.0111938989689755,0.047669612162748,0.00156526158929808
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PCYT2,Ethanolamine-phosphate cytidylyltransferase,40021,-0.0248090210120895,0.00784562527891754,-0.0401864465587678,-0.00943159546541108,0.00157042722379439
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEP170,Centrosomal protein of 170 kDa,39804,-0.0252073734842573,0.0079749002733266,-0.0408381780199774,-0.00957656894853716,0.00157758020094755
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAGED1,Melanoma-associated antigen D1,41861,-0.0158772327987891,0.00503163709639349,-0.0257392415077203,-0.00601522408985784,0.00160609035861778
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,42256,-0.0136510839150713,0.00432740240488719,-0.0221327926286502,-0.00516937520149244,0.00161100540159383
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CA12,Carbonic anhydrase 12,42094,0.0108913618463215,0.00345281428721895,0.00412384584337241,0.0176588778492707,0.00161228935557058
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EBI3_IL27,Interleukin-27,42193,0.0101044889230543,0.00320514751011323,0.00382239980323234,0.0163865780428762,0.00162201489517368
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSMD1,26S proteasome non-ATPase regulatory subunit 1,40054,-0.0160833194046258,0.00510826272412188,-0.0260955143439047,-0.00607112446534692,0.00164560233531105
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PAFAH1B3,Platelet-activating factor acetylhydrolase IB subunit alpha1,40054,-0.0378089300008965,0.0120122980909563,-0.0613530342591709,-0.0142648257426221,0.00165108160126074
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NDRG1,Protein NDRG1,41829,-0.0211170986169203,0.00672359685821987,-0.0342953484590313,-0.00793884877480938,0.00168907789376847
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRKG1,cGMP-dependent protein kinase 1,39863,-0.0404674050888244,0.0128905256446793,-0.0657328353523958,-0.0152019748252529,0.00169805863165898
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CSF3R,Granulocyte colony-stimulating factor receptor,39784,-0.00980247362094847,0.00312272931155659,-0.0159230230715994,-0.00368192417029756,0.00169949093212121
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AOC3,Membrane primary amine oxidase,42197,0.00985610336365059,0.00314030195475113,0.00370111153233838,0.0160110951949628,0.00170145451275551
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRG3,Proteoglycan 3,40097,0.0161934099808291,0.00516721484737989,0.00606566887996448,0.0263211510816937,0.00172971291479617
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FLT3,Receptor-type tyrosine-protein kinase FLT3,41861,-0.00998991512304894,0.00318953824717085,-0.0162414100875038,-0.00373842015859407,0.00173963028321478
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DGKZ,Diacylglycerol kinase zeta,41887,-0.0113568296497688,0.00362933895928872,-0.0184703340099747,-0.00424332528956288,0.00175696107669253
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TMED8,Protein TMED8,40021,-0.0330204173059382,0.0105558618917416,-0.0537099066137518,-0.0123309279981247,0.00176371435692722
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRTAP,Cartilage-associated protein,39768,-0.0155905031293573,0.004992218673455,-0.0253752517293292,-0.00580575452938554,0.00179524939554941
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HMCN2,Hemicentin-2,39849,-0.0189985709835807,0.0060844350167897,-0.0309240636164885,-0.00707307835067289,0.00179810014076167
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPP1R14A,Protein phosphatase 1 regulatory subunit 14A,40054,-0.0260286898780989,0.00833687780592859,-0.0423689703777189,-0.00968840937847882,0.00180028367733457
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHGB,Secretogranin-1,42166,0.013967505136221,0.00447823310360744,0.00519016825315042,0.0227448420192916,0.00181877681349898
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STC2,Stanniocalcin-2,42101,-0.00806195544879598,0.00258913071019423,-0.0131366516407767,-0.00298725925681529,0.00185117982406788
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,39784,-0.0108627635271484,0.0034922759189683,-0.0177076243283263,-0.00401790272597051,0.00187259867968519
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTH1R,Parathyroid hormone/parathyroid hormone-related peptide receptor,42103,-0.0123703309813526,0.00397946299574297,-0.0201700784530088,-0.00457058350969633,0.00188421104628526
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARHGAP5,Rho GTPase-activating protein 5,39665,-0.0257661549959479,0.00829598515333238,-0.0420262858964794,-0.00950602409541644,0.00190234454088654
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TACC3,Transforming acidic coiled-coil-containing protein 3,42094,-0.0371376523693966,0.0119580426322124,-0.0605754159285329,-0.0136998888102604,0.00190264421951632
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLAMF1,Signaling lymphocytic activation molecule,41887,-0.019510797982085,0.00628342706845347,-0.0318263150362538,-0.00719528092791623,0.00190620326837136
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL36A,Interleukin-36 alpha,39784,0.01861988812404,0.00600161936479557,0.00685671416904072,0.0303830620790393,0.00192413166547574
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLEC11A,C-type lectin domain family 11 member A,42101,0.0157441616600517,0.00508684159595037,0.00577395213198893,0.0257143711881144,0.00197183435780961
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LAP3,Cytosol aminopeptidase,41887,-0.0155326890925329,0.00502569511560865,-0.0253830515191259,-0.00568232666593993,0.00200147882165711
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HMOX2,Heme oxygenase 2,41829,-0.0145372928064296,0.00470394022279174,-0.0237570156431014,-0.00531756996975777,0.00200287782744692
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL8,C-C motif chemokine 8,42208,-0.0193773943821921,0.00627123257245497,-0.0316690102242038,-0.00708577854018031,0.00200655561889454
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRRT3,Proline-rich transmembrane protein 3,39804,0.0127953568071161,0.00415203212657799,0.0046573738390232,0.0209333397752089,0.00206342938183855
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C8B,Complement component C8 beta chain,40113,0.00965964916401263,0.00314973347074572,0.00348617156135103,0.0158331267666742,0.00216882031747681
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COL3A1,Collagen alpha-1(III) chain,40097,-0.00742160102976544,0.00242092265369772,-0.012166609431013,-0.00267659262851792,0.00217758867857808
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGF2,Fibroblast growth factor 2,42103,-0.0218620200943858,0.00713165269520596,-0.0358400593769895,-0.00788398081178216,0.00217761432414088
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CACYBP,Calcyclin-binding protein,39847,-0.0323201466549074,0.0105515633348594,-0.0530012107912319,-0.0116390825185829,0.00219627683168926
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACSL1,Long-chain-fatty-acid--CoA ligase 1,39706,0.0123825749854188,0.0040431006807836,0.0044580976510829,0.0203070523197546,0.00219946051356323
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STX3,Syntaxin-3,40054,-0.01239782927765,0.00404857662993842,-0.0203330394723293,-0.00446261908297067,0.00220203463016092
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TIA1,Nucleolysin TIA-1 isoform p40,41716,-0.0384023455019396,0.0125477381499242,-0.0629959122757909,-0.0138087787280882,0.00221435854177782
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRKAR1A,cAMP-dependent protein kinase type I-alpha regulatory subunit,42144,-0.0262746985561788,0.00859060692322046,-0.0431122881256909,-0.00943710898666671,0.00222873909482281
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPIF,"Peptidyl-prolyl cis-trans isomerase F, mitochondrial",40097,-0.0200386269812141,0.00656856827218985,-0.0329130207947062,-0.007164233167722,0.00228869184113359
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GP1BA,Platelet glycoprotein Ib alpha chain,42093,-0.0104307127190116,0.00342369562589304,-0.017141156145762,-0.00372026929226125,0.00231894764897049
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNAJB8,DnaJ homolog subfamily B member 8,41876,-0.0183811527670503,0.00603329379495966,-0.0302064086051712,-0.00655589692892936,0.00231905831086571
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPINK2,Serine protease inhibitor Kazal-type 2,39863,-0.0118975574513421,0.00390903399676169,-0.019559264084995,-0.0042358508176892,0.00234330529940392
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL2RA,Interleukin-2 receptor subunit alpha,42024,0.0131774294207298,0.00433134236479228,0.00468799838573693,0.0216668604557227,0.00235218632173866
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SDK2,Protein sidekick-2,39863,-0.0128087071021682,0.00421123409028017,-0.0210627259191173,-0.00455468828521903,0.00235929825093647
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ERP29,Endoplasmic reticulum resident protein 29,39863,-0.0372750000684969,0.0122601337033578,-0.0613048621270782,-0.0132451380099157,0.00236882636159464
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NFYA,Nuclear transcription factor Y subunit alpha,39706,-0.0123786698242624,0.00407466145873803,-0.0203650062833889,-0.00439233336513585,0.00238767909145286
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDK1,Cyclin-dependent kinase 1,39665,-0.0116376129912741,0.00383519223599993,-0.019154589773834,-0.00412063620871422,0.00241583847959528
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MTR,Methionine synthase,39706,-0.0210340002451053,0.0069328463646339,-0.0346223791197877,-0.00744562137042282,0.0024195341637505
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PZP,Pregnancy zone protein,40113,0.0159602200709566,0.00526519807793602,0.00564043183820198,0.0262800083037112,0.00244100700728399
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLASP1,CLIP-associating protein 1,39665,-0.0228267705068916,0.00754894480879871,-0.037622702332137,-0.0080308386816461,0.00250196294763401
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STOML2,"Stomatin-like protein 2, mitochondrial",39665,-0.0291443711377184,0.00964230008327192,-0.0480432793009314,-0.0102454629745055,0.00251257650192397
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BCAM,Basal cell adhesion molecule,42120,0.0077410601940516,0.0025613637298793,0.00272078728348818,0.012761333104615,0.00251401436664802
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NID1,Nidogen-1,42161,-0.0120119800455159,0.00397639788776465,-0.0198057199055346,-0.00421824018549722,0.00252582837527909
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHM,Rab proteins geranylgeranyltransferase component A 1,39768,-0.019041765324187,0.00630971882710278,-0.0314088142253084,-0.00667471642306554,0.00255183682080963
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL7R,Interleukin-7 receptor subunit alpha,42120,0.0164577774013677,0.00545884193946533,0.00575844720001567,0.0271571076027198,0.00257576122107113
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAX,Protein max,41829,-0.0326985623293798,0.0108674099633979,-0.0539986858576396,-0.0113984388011199,0.00262743009581879
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPRED2,"Sprouty-related, EVH1 domain-containing protein 2",39784,-0.0134732200045168,0.00448830369868009,-0.0222702952539298,-0.00467614475510381,0.00268969006132892
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ESAM,Endothelial cell-selective adhesion molecule,42296,-0.0101475169955565,0.00338104331114554,-0.0167743618854017,-0.00352067210571121,0.00269338016317406
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CGA,Glycoprotein hormones alpha chain,42120,0.0195577027419277,0.00654696309945573,0.00672565506699447,0.0323897504168609,0.00281987212486291
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADGRF5,Adhesion G protein-coupled receptor F5,40080,-0.0087338673355983,0.00293079036540587,-0.0144782164517938,-0.0029895182194028,0.00288849010874228
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AMIGO2,Amphoterin-induced protein 2,42094,-0.00724773794963725,0.00243719417243402,-0.0120246385276079,-0.00247083737166657,0.0029467684697666
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FOLR3,Folate receptor gamma,42137,0.0573454152647569,0.0192910938204998,0.0195348713765772,0.0951559591529366,0.00295797115654052
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLEC3B,Tetranectin,39847,-0.00648787048113001,0.0021860842414446,-0.0107725955943614,-0.00220314536789858,0.00300602018855176
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CA7,Carbonic anhydrase 7,39881,0.0108790690793747,0.00366631971351449,0.00369308244088634,0.0180650557178631,0.0030109350805246
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DTX3,Probable E3 ubiquitin-protein ligase DTX3,42094,-0.00774109284362565,0.00261160016332797,-0.0128598291637485,-0.00262235652350283,0.00304105994589369
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NPR1,Atrial natriuretic peptide receptor 1,39706,0.0126556946889243,0.00427101217518834,0.00428451082555519,0.0210268785522935,0.00305179961633919
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NPTXR,Neuronal pentraxin receptor,42144,0.0105085772125012,0.00354969173978422,0.00355118140252412,0.0174659730224783,0.00307777044421382
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDP1,"[Pyruvate dehydrogenase [acetyl-transferring]]-phosphatase 1, mitochondrial",41861,-0.0152487337951047,0.00515612308451647,-0.025354735040757,-0.00514273254945242,0.00310815080407922
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ELAC1,Zinc phosphodiesterase ELAC protein 1,40054,-0.0259291817453959,0.00876849854709893,-0.0431154388977098,-0.00874292459308199,0.00311232573381794
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGF2BP3,Insulin-like growth factor 2 mRNA-binding protein 3,39706,-0.0138007957527709,0.00466829919763549,-0.0229506621801365,-0.00465092932540536,0.00312066858185456
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SEPTIN9,Septin-9,42094,-0.00874889807810806,0.00296148387246682,-0.014553406468143,-0.0029443896880731,0.00314018473456429
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FASLG,Tumor necrosis factor ligand superfamily member 6,42256,-0.0111926179375249,0.00379035233620123,-0.0186217085164793,-0.0037635273585705,0.00315341059600234
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NID2,Nidogen-2,42120,-0.022635675218359,0.00766555793218199,-0.0376601687654357,-0.00761118167128227,0.00315363709946222
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MDM1,Nuclear protein MDM1,39768,-0.00959525760327953,0.00325117582024911,-0.0159675622109678,-0.00322295299559128,0.00317114317454173
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MSR1,Macrophage scavenger receptor types I and II,42213,-0.0141163896216993,0.0047926457640052,-0.0235099753191495,-0.00472280392424908,0.00323079701424184
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFSF10,Tumor necrosis factor ligand superfamily member 10,42256,-0.00777441104067381,0.00264159314280507,-0.0129519336005717,-0.00259688848077588,0.00325539526255867
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCG3,Secretogranin-3,42146,0.010463676557108,0.00355882201397541,0.00348838540971619,0.0174389677044998,0.003285718197703
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLPP,"ATP-dependent Clp protease proteolytic subunit, mitochondrial",41985,-0.0291576613405028,0.00991702495908973,-0.0485950302603187,-0.00972029242068693,0.00328627604860372
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EHD3,EH domain-containing protein 3,39804,-0.0355682706716016,0.012104443700001,-0.0592929803236036,-0.0118435610195995,0.00330570896763768
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RBM17,Splicing factor 45,40054,-0.0232203389569502,0.00790558786886059,-0.0387152911799169,-0.00772538673398341,0.00331879772288314
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GPC5,Glypican-5,42004,-0.0171459293306084,0.00584459541976954,-0.0286013363533567,-0.00569052230786009,0.00335608137239832
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CXCL1,Growth-regulated alpha protein,42116,-0.0290900836937055,0.00991961938470573,-0.0485325376877287,-0.00964762969968223,0.00336747543433882
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TSPAN1,Tetraspanin-1,41876,-0.020813605759382,0.00710427155770384,-0.0347379780124815,-0.00688923350628248,0.0033985986494431
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ALDH5A1,"Succinate-semialdehyde dehydrogenase, mitochondrial",40054,-0.0145095347264202,0.00495585466496794,-0.0242230098697573,-0.004796059583083,0.0034212625314319
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NAA10,N-alpha-acetyltransferase 10,39706,-0.0156139850909505,0.00533504215603848,-0.0260706677167859,-0.00515730246511509,0.00343329995882811
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PEAR1,Platelet endothelial aggregation receptor 1,42296,0.00691653865524925,0.0023647208960961,0.0022816856989009,0.0115513916115976,0.00345173338023895
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GFAP,Glial fibrillary acidic protein,41841,0.0149098887691917,0.00509871064773493,0.00491641589963123,0.0249033616387522,0.00345903516836189
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL24,C-C motif chemokine 24,42162,-0.025171365153246,0.00861106811296406,-0.0420490586546555,-0.00829367165183641,0.00347118588428088
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGF1R,Insulin-like growth factor 1 receptor,42094,-0.00660785484163027,0.00226104402816008,-0.011039501136824,-0.00217620854643651,0.00347859297800988
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TGFB2,Transforming growth factor beta-2 proprotein,40020,-0.0157724893858975,0.00539747649096435,-0.0263515433081876,-0.00519343546360734,0.00348290445131559
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLRK1,NKG2-D type II integral membrane protein,40054,-0.0147953153489316,0.00507323501792712,-0.0247388559840687,-0.00485177471379442,0.00354880809908249
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLTA,Clathrin light chain A,41876,-0.0143717919268883,0.00494563932749339,-0.0240652450087753,-0.00467833884500125,0.00366770616963062
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PINLYP,phospholipase A2 inhibitor and Ly6/PLAUR domain-containing protein,39863,-0.0212594780386658,0.00732019187527942,-0.0356070541142134,-0.00691190196311812,0.00368919911295651
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BGLAP,Osteocalcin,40097,-0.0271230707441811,0.0093393454677769,-0.0454281878610238,-0.00881795362733838,0.00368964451841612
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FUT8,"Alpha-(1,6)-fucosyltransferase",42004,-0.0177127872279681,0.00609988934065666,-0.0296685703356552,-0.00575700412028107,0.00369307029440959
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GGACT,Gamma-glutamylaminecyclotransferase,40080,-0.0210630453817647,0.00725569876402427,-0.0352842149592522,-0.00684187580427709,0.00370389184320233
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HLA_A,,40054,0.0100019770791988,0.00344648334511806,0.00324686972276736,0.0167570844356302,0.0037143680417657
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BLMH,Bleomycin hydrolase,42296,-0.00941807850099779,0.00325885188409409,-0.0158054281938222,-0.00303072880817338,0.00385875379397232
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGFBP7,Insulin-like growth factor-binding protein 7,42296,-0.00945039009924718,0.00327875407890066,-0.0158767480938925,-0.00302403210460189,0.0039541110421988
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OBP2B,Odorant-binding protein 2b,41971,0.0183446065546092,0.00637440959881417,0.00585076374093345,0.030838449368285,0.0040105673149862
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTPRR,Receptor-type tyrosine-protein phosphatase R,40054,0.0112548481307658,0.00391431761647822,0.0035827856024685,0.0189269106590631,0.00404424915773245
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LY9,T-lymphocyte surface antigen Ly-9,41965,-0.00916772381527398,0.00318889306510461,-0.015417954222879,-0.00291749340766894,0.00404833151932271
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UBE2L6,Ubiquitin/ISG15-conjugating enzyme E2 L6,40080,-0.0180560657873062,0.00628657624528188,-0.0303777552280587,-0.0057343763465537,0.00408461293487112
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KIFBP,KIF-binding protein,42094,-0.0242224330569579,0.00844244775225884,-0.0407696306513853,-0.00767523546253062,0.00412278149530359
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NARS1,"Asparagine--tRNA ligase, cytoplasmic",40054,-0.0140600526539991,0.00490395021589135,-0.0236717950771462,-0.00444831023085208,0.00415065894759315
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATP6V1G2,V-type proton ATPase subunit G 2,39706,-0.0297532248882323,0.0103827026275468,-0.0501033220382241,-0.00940312773824059,0.00416975491789537
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KIF20B,Kinesin-like protein KIF20B,39719,-0.0233415184531241,0.0081470814257366,-0.0393097980475679,-0.00737323885868038,0.004178137943105
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PGA4,Pepsin A-4,40102,-0.0240651707551847,0.00841757719778595,-0.0405636220628452,-0.00756671944752428,0.0042589322964041
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TOP1,DNA topoisomerase 1,40021,-0.0333447781572535,0.0116700661905743,-0.0562181078907791,-0.0104714484237279,0.00428087905226517
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD70,CD70 antigen,42103,0.0129035958042608,0.00451630877640397,0.00405163060250903,0.0217555610060126,0.00428199390850479
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IFIT3,Interferon-induced protein with tetratricopeptide repeats 3,39881,-0.0113450674817753,0.00397558832044848,-0.0191372205898543,-0.00355291437369629,0.00432987384242433
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PCDH7,Protocadherin-7,40021,-0.0107900114260652,0.0037815880516614,-0.0182019240073215,-0.00337809884480887,0.0043349576458653
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDRG1,p53 and DNA damage-regulated protein 1,39768,-0.0151951727487921,0.00533683531197898,-0.0256553699602709,-0.00473497553731328,0.00441871054618827
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MMP13,Collagenase 3,41829,0.00984018780192015,0.00345840890528995,0.00306170634755184,0.0166186692562885,0.00444419061295054
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,XPNPEP2,Xaa-Pro aminopeptidase 2,42186,-0.0287560561872023,0.0101500294486731,-0.0486501139066016,-0.00886199846780305,0.00461698462340109
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD99L2,CD99 antigen-like protein 2,42120,-0.00712744314232852,0.0025170110172576,-0.0120607847361534,-0.00219410154850363,0.00463714825661274
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BCL2L1,Bcl-2-like protein 1,40054,-0.0290017390455578,0.0102463683811153,-0.0490846210725438,-0.00891885701857191,0.00465692704908487
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IDO1,"Indoleamine 2,3-dioxygenase 1",39804,-0.0188600449645725,0.00667332306677417,-0.0319397581754499,-0.00578033175369513,0.00471941202917839
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,40021,0.0104126530446982,0.00369380931953147,0.00317278677841651,0.0176525193109799,0.00482689066412318
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GZMH,Granzyme H,41876,-0.0228215196085289,0.00809616770885072,-0.0386900083178763,-0.00695303089918152,0.0048277433605181
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DIABLO,"Diablo homolog, mitochondrial",42111,-0.0317906281579102,0.0112869988267803,-0.0539131458583996,-0.00966811045742086,0.00486129985481644
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NECTIN2,Nectin-2,42122,-0.00925532356893737,0.00328619236941968,-0.015696260613,-0.00281438652487479,0.00486345249501909
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPRING1,SREBP regulating gene protein,39665,-0.0173087521792011,0.00615458613696082,-0.0293717410076443,-0.00524576335075791,0.00492749170681435
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EPHA4,Ephrin type-A receptor 4,39863,-0.00848589418601805,0.00302167717318698,-0.0144083814454645,-0.00256340692657156,0.00498882376404536
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PMS1,PMS1 protein homolog 1,39768,-0.015082053912935,0.00538036053031266,-0.0256275605523478,-0.0045365472735222,0.00506954723383728
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BSG,Basigin,42248,-0.0063444841272386,0.00226442933404112,-0.0107827656219592,-0.001906202632518,0.00508927739279365
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CETN3,Centrin-3,40021,-0.0219515553243575,0.00784368328342916,-0.0373251745598787,-0.00657793608883638,0.00514108920659155
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PM20D1,N-fatty-acyl-amino acid synthase/hydrolase PM20D1,42080,-0.0532705707552525,0.0190356136335016,-0.0905803734769156,-0.0159607680335895,0.00514217900094757
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APPL2,DCC-interacting protein 13-beta,39863,-0.0321155222056156,0.0114921433433835,-0.0546401231586472,-0.00959092125258402,0.00520626271272515
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TXNDC9,Thioredoxin domain-containing protein 9,40054,-0.0152445618632997,0.00545920235978188,-0.0259445984884722,-0.00454452523812719,0.00524016681410646
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NOTCH2,Neurogenic locus notch homolog protein 2,40097,0.0061302041605559,0.0021959291607264,0.00182618300553214,0.0104342253155796,0.0052535836766707
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RAD51,DNA repair protein RAD51 homolog 1,39881,-0.0156793994660082,0.00562834864429762,-0.0267109628088315,-0.00464783612318486,0.00534914695643453
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DPP6,Dipeptidyl aminopeptidase-like protein 6,42094,0.00982013001847067,0.00352685224554553,0.00290749961720142,0.0167327604197399,0.00537067361135215
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PAPPA,Pappalysin-1,41887,-0.013499839477813,0.0048523263286512,-0.0230103990819694,-0.00398927987365667,0.00540818645705507
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DSC2,Desmocollin-2,42003,0.0102599639678359,0.0036919049392619,0.00302383028688254,0.0174960976487892,0.00545986833521846
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PENK,Proenkephalin-A,39863,-0.0094797414106423,0.00341327066588945,-0.0161697519157856,-0.00278973090549898,0.00549050330250834
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCGN,Secretagogin,41887,-0.0130451309738829,0.00470060814001751,-0.0222583229283172,-0.00383193901944854,0.00552483675796394
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTGDS,Prostaglandin-H2 D-isomerase,42066,-0.00944435581010046,0.00340715142279854,-0.0161223725987856,-0.00276633902141533,0.00558065539351893
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLEC2L,C-type lectin domain family 2 member L,39768,-0.0142098836939375,0.00513210668519659,-0.0242688127969228,-0.0041509545909522,0.00563575694485398
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLGN,Calmegin,39768,-0.0133173126267089,0.0048138914739421,-0.0227525399156354,-0.00388208533778239,0.00567714830528276
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C2orf69,UPF0565 protein C2orf69,39768,-0.0176045674388052,0.00636472086832646,-0.0300794203407251,-0.00512971453688534,0.00568538784771362
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLC,Galectin-10,42121,0.0189205479748294,0.0068415076588833,0.00551119296341808,0.0323299029862406,0.00569070918074518
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF14,Tumor necrosis factor receptor superfamily member 14,42146,-0.00916399654745518,0.00331536253427316,-0.0156621071146306,-0.00266588598027979,0.00571605557726685
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLRC1,NKG2-A/NKG2-B type II integral membrane protein,39719,0.0177149934012204,0.00642136940022547,0.0051291093767785,0.0303008774256623,0.00581219988933782
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANGPT2,Angiopoietin-2,42223,-0.0108123951159348,0.00392244059413311,-0.0185003786804357,-0.00312441155143396,0.00584963317397882
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RAB39B,Ras-related protein Rab-39B,39706,-0.0264939464215307,0.00965200716092373,-0.0454118804569412,-0.00757601238612017,0.00606292286932878
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",40054,-0.0275543476318174,0.0100481986051674,-0.0472488168979456,-0.00785987836568928,0.00611258541783041
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PROCR,Endothelial protein C receptor,39706,0.00990729580947341,0.00361907263171219,0.00281391345131752,0.0170006781676293,0.00620078446243303
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTRL,Chymotrypsin-like protease CTRL-1,40054,0.0200652782670216,0.00733019970267903,0.00569808684977072,0.0344324696842725,0.0062038297397178
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IFNAR1,Interferon alpha/beta receptor 1,40021,-0.00731877338444877,0.00267528510910575,-0.012562332198296,-0.00207521457060149,0.00623494422189319
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD163,Scavenger receptor cysteine-rich type 1 protein M130,42197,-0.0122744625680089,0.00448698732682278,-0.0210689577285816,-0.00347996740743627,0.00623570159582923
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PCDH12,Protocadherin-12,40054,-0.00730998958117775,0.00267534681021694,-0.0125536693292029,-0.00206630983315256,0.00629855727843359
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,THPO,Thrombopoietin,41876,-0.0110139278651409,0.00403199363997893,-0.0189166353994996,-0.00311122033078222,0.00631084291408302
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BCL2L15,Bcl-2-like protein 15,39784,-0.015925421519705,0.00583498042432802,-0.0273619831513879,-0.00448885988802204,0.00635734476117816
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTSB,Cathepsin B,42164,0.0151776457217188,0.00557619242541546,0.00424830856790447,0.0261069828755331,0.00650012376846187
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GBA,Lysosomal acid glucosylceramidase,39768,-0.0155466545092282,0.00571541725741248,-0.0267488723337566,-0.00434443668469972,0.00653637080347334
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PCDH17,Protocadherin-17,42144,-0.010554976564106,0.00388120753146964,-0.0181621433257865,-0.00294780980242548,0.00654661927026425
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EPN1,Epsin-1,39881,-0.0125795430636153,0.00462840807123618,-0.0216512228832382,-0.00350786324399238,0.00658039169533559
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DTD1,D-aminoacyl-tRNA deacylase 1,39863,-0.0242341894290142,0.00893190972219579,-0.041740732484518,-0.0067276463735105,0.00667408453347385
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINF2,Alpha-2-antiplasmin,39899,-0.00379508644115014,0.00139948506577247,-0.00653807717006417,-0.0010520957122361,0.00670311586138992
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LIPF,Gastric triacylglycerol lipase,39804,-0.0175378911252612,0.00647374546426265,-0.030226432235216,-0.00484935001530644,0.00675784624665481
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STX8,Syntaxin-8,42103,-0.0134432435705212,0.00496423249559295,-0.0231731392618834,-0.00371334787915899,0.00677749923254328
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGFBP4,Insulin-like growth factor-binding protein 4,41928,-0.0135560774083533,0.00500650009498379,-0.0233688175945215,-0.00374333722218502,0.00678426031640312
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FLT4,Vascular endothelial growth factor receptor 3,42186,-0.00923132626609467,0.00341423412756021,-0.0159232251561127,-0.00253942737607665,0.00686455934030697
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITGB1,Integrin beta-1,42146,0.00599333437260707,0.00222041392431026,0.00164132308095895,0.0103453456642552,0.00695972318386642
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ORM1,Alpha-1-acid glycoprotein 1,40057,-0.00557956127303021,0.00206742540266385,-0.00963171506225135,-0.00152740748380907,0.00696982465249832
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENPP2,Ectonucleotide pyrophosphatase/phosphodiesterase family member 2,42296,-0.00770860475791359,0.00286047007737748,-0.0133151261095735,-0.00210208340625372,0.00705051841169098
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COL6A3,Collagen alpha-3(VI) chain,42296,-0.0106734135981394,0.00396189935250807,-0.0184387363290552,-0.00290809086722357,0.0070687067043607
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CASP9,Caspase-9,39784,-0.0175552589453423,0.00652025081861976,-0.030334950549837,-0.00477556734084753,0.00710469536427442
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NCR1,Natural cytotoxicity triggering receptor 1,42075,0.010865455373673,0.00403681370334411,0.00295330051511855,0.0187776102322275,0.00712037366890275
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPAG1,Sperm-associated antigen 1,40054,-0.0159481581067164,0.00593360401516864,-0.0275780219764469,-0.00431829423698585,0.00720407397036806
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FCRL6,Fc receptor-like protein 6,42103,-0.0196045849682825,0.00730096412959708,-0.0339144746622928,-0.00529469527427222,0.00725779729242352
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATOX1,Copper transport protein ATOX1,42186,-0.0192703400217894,0.00719897390282798,-0.0333803288713323,-0.00516035117224656,0.00744184075094942
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NELL2,Protein kinase C-binding protein NELL2,42184,-0.00805497844762853,0.00301083050835306,-0.0139562062440005,-0.00215375065125654,0.00747483075646415
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDAP1,28 kDa heat- and acid-stable phosphoprotein,40080,-0.0268526355516438,0.01004761758031,-0.0465459660090514,-0.00715930509423611,0.00753921103912939
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTSL,Cathepsin L1,42144,-0.00689271664696155,0.00258010268783749,-0.011949717915123,-0.00183571537880007,0.00756099343667959
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,INHBB,Inhibin beta B chain,39863,0.0150866385838867,0.00566000656833086,0.00399302570995818,0.0261802514578151,0.00769941111561464
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LYPD3,Ly6/PLAUR domain-containing protein 3,42084,-0.00948254729491061,0.00355838227950601,-0.0164569765627424,-0.00250811802707884,0.00771190906539257
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CFHR4,Complement factor H-related protein 4,40083,0.0206402528210724,0.00774733511485337,0.0054554759959598,0.035825029646185,0.00772911929121335
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CNTNAP4,Contactin-associated protein-like 4,39768,-0.0285768044327015,0.0107388525891571,-0.0496249555074495,-0.00752865335795352,0.00780111576165647
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL3RA,Interleukin-3 receptor subunit alpha,41887,-0.00905341152321402,0.00340326475622836,-0.0157238104454216,-0.00238301260100644,0.00781892377055842
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,THSD1,Thrombospondin type-1 domain-containing protein 1,39700,-0.00948567424864017,0.0035719126635042,-0.0164866230691084,-0.00248472542817194,0.00792801643575708
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C2CD2L,Phospholipid transfer protein C2CD2L,41810,-0.0118199226271635,0.00447520149420755,-0.0205913175558103,-0.00304852769851676,0.00827136447729095
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LY6D,Lymphocyte antigen 6D,42059,0.0112417284848466,0.00425826900936958,0.00289552122648224,0.019587935743211,0.00830119183605873
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLSTN2,Calsyntenin-2,42256,-0.0108767464187453,0.00413326653967082,-0.0189779488365001,-0.0027755440009905,0.00851053829193236
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTGES2,Prostaglandin E synthase 2,39690,-0.0148971650047279,0.00566226151038466,-0.0259951975650818,-0.00379913244437398,0.00852692875679525
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATP1B2,Sodium/potassium-transporting ATPase subunit beta-2,39706,0.00889887330142013,0.00338315296675491,0.0022678934865805,0.0155298531162598,0.00854215731496734
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",40054,-0.0114245115057404,0.00434428571202135,-0.0199393115013022,-0.00290971151017852,0.0085560845508828
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GNPDA1,Glucosamine-6-phosphate isomerase 1,39804,-0.00916047931911329,0.00348365121929603,-0.0159884357089335,-0.00233252292929307,0.00856181094502913
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD300A,CMRF35-like molecule 8,39863,-0.00849535394009571,0.00323637050192753,-0.0148386401238737,-0.00215206775631776,0.00867818543993357
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACTN2,Alpha-actinin-2,39706,0.0161889762805109,0.00617028523340835,0.00409521722303057,0.0282827353379913,0.00871060607994976
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSAP,Prosaposin,40013,-0.00785545474150561,0.00299478265517744,-0.0137252287456534,-0.00198568073735783,0.00872695419468963
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LACRT,Extracellular glycoprotein lacritin,39989,-0.0140951502822832,0.00537401885137142,-0.0246282272309712,-0.00356207333359526,0.00873247077774697
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DDR1,Epithelial discoidin domain-containing receptor 1,42213,-0.00636166261346782,0.00242562623678621,-0.0111158900375688,-0.00160743518936685,0.00873405469191563
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CNPY4,Protein canopy homolog 4,42094,-0.0200895527760429,0.00766592994248551,-0.0351147754633144,-0.00506433008877126,0.00878707883294181
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COL18A1,Collagen alpha-1(XVIII) chain,42197,-0.00660418380490434,0.00252314711598859,-0.011549552152242,-0.00165881545756671,0.00886948886261163
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STX5,Syntaxin-5,39784,-0.011231935859968,0.00429312807290602,-0.0196464668828638,-0.00281740483707222,0.00890252374918283
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NRGN,Neurogranin,40102,-0.0245896270050606,0.00940351674294333,-0.0430205198212295,-0.00615873418889168,0.00893660411123826
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KIF22,Kinesin-like protein KIF22,39706,-0.0338883690174741,0.0129675150604252,-0.0593046985359075,-0.00847203949904078,0.0089792944343595
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NENF,Neudesin,40020,-0.0298402535832894,0.0114348119289115,-0.0522524849639558,-0.00742802220262292,0.00907736157071394
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRISP3,Cysteine-rich secretory protein 3,40010,0.00740345532066336,0.00284052510215766,0.00183602612043435,0.0129708845208924,0.00916334169490207
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRYM,Ketimine reductase mu-crystallin,39719,-0.0203411725009928,0.0078174536423867,-0.0356633816400707,-0.00501896336191487,0.00928062078236348
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL17D,Interleukin-17D,41887,-0.00915024845484268,0.00352944127137527,-0.0160679533467382,-0.00223254356294715,0.00953769115772418
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CELA3A,Chymotrypsin-like elastase family member 3A,42285,-0.0160034496101881,0.00617517735320657,-0.0281067972224729,-0.00390010199790318,0.00956431305682585
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTSV,Cathepsin L2,42179,-0.011279157329221,0.00435320115067256,-0.0198114315845392,-0.00274688307390275,0.00958036735247779
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TARS1,"Threonine--tRNA ligase 1, cytoplasmic",40020,-0.010145246017535,0.00391664402023407,-0.0178218682971938,-0.0024686237378762,0.00960234660889915
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,XRCC4,DNA repair protein XRCC4,41829,-0.00991477397257772,0.00382950403427295,-0.0174206018797527,-0.00240894606540273,0.00963516875433942
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UBQLN3,Ubiquilin-3,39706,-0.0145799169265685,0.00563580593107197,-0.0256260965514695,-0.0035337373016674,0.00969442712160337
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GOT1,"Aspartate aminotransferase, cytoplasmic",40097,-0.0109360898310223,0.00423567666582382,-0.0192380160960369,-0.00263416356600757,0.00983875515502442
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL21,C-C motif chemokine 21,42184,-0.0113594774281199,0.0044031752580709,-0.0199897009339389,-0.00272925392230099,0.00989555840493311
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ICAM1,Intercellular adhesion molecule 1,42104,-0.00782121926003838,0.00303353922354807,-0.0137669561381926,-0.00187548238188417,0.00994121897042867
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NECTIN4,Nectin-4,42186,0.00928480050167311,0.00360428116757696,0.00222040941322227,0.0163491915901239,0.0100046263353852
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RNF149,E3 ubiquitin-protein ligase RNF149,39804,-0.00863052374816291,0.00335057095194121,-0.0151976428139677,-0.00206340468235815,0.0100131894889172
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MEPE,Matrix extracellular phosphoglycoprotein,42126,-0.00689274142963536,0.00267761680363409,-0.0121408703647582,-0.00164461249451255,0.0100580221432919
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FRZB,Secreted frizzled-related protein 3,41963,-0.0066412738655034,0.00258202494521563,-0.011702042758126,-0.00158050497288076,0.0101190319837177
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CXCL12,Stromal cell-derived factor 1,41887,0.0107462170378298,0.00417839705406553,0.00255655881186134,0.0189358752637982,0.0101268967533516
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LCN2,Neutrophil gelatinase-associated lipocalin,41770,0.0107844061261855,0.00419596196242083,0.0025603206798407,0.0190084915725303,0.0101757737419466
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TG,Thyroglobulin,40020,0.0307804542632854,0.0119802221942386,0.00729921876257782,0.0542616897639929,0.0102044988041914
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RNASE6,Ribonuclease K6,40041,-0.00908595355219659,0.0035406119307825,-0.0160255529365303,-0.00214635416786289,0.0102949605289059
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CXCL11,C-X-C motif chemokine 11,42213,-0.0212455741003283,0.00828479698979685,-0.0374837762003301,-0.00500737200032643,0.0103464025167425
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FLRT2,Leucine-rich repeat transmembrane protein FLRT2,42004,-0.00771418610449449,0.00301255946503319,-0.0136188026559595,-0.00180956955302944,0.0104582570412626
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DAPK2,Death-associated protein kinase 2,39784,-0.014367996643227,0.00561690512059922,-0.0253771306796015,-0.00335886260685258,0.0105416548734639
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYBPC2,"Myosin-binding protein C, fast-type",39804,-0.0225041229867943,0.00880362858501716,-0.039759235013428,-0.00524901096016069,0.0105950383721428
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL19,C-C motif chemokine 19,42213,-0.0347329318994577,0.013591349554393,-0.0613719770260681,-0.00809388677284734,0.0106142636913366
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RBFOX3,RNA binding protein fox-1 homolog 3,40054,-0.0106593594833357,0.00417808384829711,-0.0188484038259981,-0.00247031514067339,0.0107471462675047
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNR,Tenascin-R,42004,0.0111835460605575,0.00441106620482595,0.00253785629909861,0.0198292358220163,0.0112456608889107
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CPE,Carboxypeptidase E,42093,0.0101576419038924,0.00400748478975808,0.00230297171596653,0.0180123120918182,0.0112671268257162
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SNX2,Sorting nexin-2,40020,-0.0215238000303383,0.00850525114524112,-0.0381940922750109,-0.00485350778566568,0.0113992385786593
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD48,CD48 antigen,42162,-0.00816718198450006,0.00322763635597272,-0.0144933492422066,-0.00184101472679354,0.0114052784661156
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ZNRF4,E3 ubiquitin-protein ligase ZNRF4,40020,-0.0144689466069189,0.00572963300609127,-0.0256990272988578,-0.00323886591498007,0.0115746612882331
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HSPB6,Heat shock protein beta-6,42223,-0.0103564150489517,0.00410136602765514,-0.0183950924631557,-0.00231773763474758,0.0115778552573767
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAP2K6,Dual specificity mitogen-activated protein kinase kinase 6,42103,-0.0259008719975061,0.0102601909246836,-0.046010846209886,-0.00579089778512623,0.01160133601714
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COX6B1,Cytochrome c oxidase subunit 6B1,40080,-0.00857072750719061,0.00339661784110033,-0.0152280984757473,-0.00191335653863397,0.0116396294944783
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRIG1,Leucine-rich repeats and immunoglobulin-like domains protein 1,42178,0.00917752629313673,0.00363829126364238,0.00204647541639765,0.0163085771698758,0.0116648232772065
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GPR158,Probable G-protein coupled receptor 158,40054,0.0094352211983597,0.00374425103569923,0.00209648916838922,0.0167739532283302,0.0117522998697868
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GMFG,Glia maturation factor gamma,40080,-0.0185801342943891,0.00737334582628566,-0.033031892113909,-0.00412837647486925,0.0117528240085863
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLC9A3R2,Na(+)/H(+) exchange regulatory cofactor NHE-RF2,40021,-0.0133933310149972,0.00531644371848742,-0.0238135607032326,-0.0029731013267619,0.0117755440382938
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DDX53,Probable ATP-dependent RNA helicase DDX53,39768,-0.00953960572783181,0.00379438837069708,-0.0169766069343981,-0.00210260452126554,0.0119471924583104
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NRXN3,Neurexin-3,39768,-0.00931551203898819,0.00370710705075409,-0.0165814418584662,-0.00204958221951017,0.0119897888147813
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RNF5,E3 ubiquitin-protein ligase RNF5,39804,-0.0189229015723737,0.00754560510608962,-0.0337122875803093,-0.004133515564438,0.0121632006705236
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDIA4,Protein disulfide-isomerase A4,40097,-0.0154998980235042,0.00619833175321399,-0.0276486282598036,-0.00335116778720473,0.0124108972396742
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GADD45GIP1,Growth arrest and DNA damage-inducible proteins-interacting protein 1,39804,-0.0136712544193353,0.00546737656302192,-0.0243873124828583,-0.00295519635581234,0.0124162696564898
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CNDP1,Beta-Ala-His dipeptidase,42197,-0.0119737010745695,0.00478970662343144,-0.0213615260564951,-0.00258587609264386,0.0124356908826923
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FCAR,Immunoglobulin alpha Fc receptor,42103,-0.0126805118579243,0.00507642677729203,-0.0226303083414167,-0.0027307153744319,0.0125047551023741
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SV2A,Synaptic vesicle glycoprotein 2A,39768,-0.0161916784751939,0.00648440177421124,-0.0289011059526479,-0.00348225099773984,0.0125392919509165
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EDIL3,EGF-like repeat and discoidin I-like domain-containing protein 3,41876,-0.00868648319350131,0.00347914854389849,-0.0155056143395423,-0.00186735204746026,0.0125471366034428
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LMOD1,Leiomodin-1,40054,0.00920407214885912,0.00369189127621724,0.00196796524747333,0.0164401790502449,0.012679849794902
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ASRGL1,Isoaspartyl peptidase/L-asparaginase,39804,-0.026209750224012,0.0105145090154148,-0.0468181878942249,-0.00560131255379898,0.0126919269425764
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PCSK9,Proprotein convertase subtilisin/kexin type 9,42296,-0.0101748379571705,0.00408636120093446,-0.0181841059110021,-0.00216557000333899,0.0127883799476271
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STXBP3,Syntaxin-binding protein 3,41861,-0.0112243269218271,0.00451454698219256,-0.0200728390069245,-0.00237581483672969,0.0129222334445254
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEACAM16,Carcinoembryonic antigen-related cell adhesion molecule 16,40021,-0.0203798706411587,0.00820643579718452,-0.0364644848036404,-0.00429525647867709,0.013028470785695
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C1S,Complement C1s subcomponent,40113,-0.0053457702624301,0.00215750326557347,-0.0095744766629541,-0.0011170638619061,0.0132361004544082
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DLL4,Delta-like protein 4,39804,-0.0220688709445534,0.00890976585349437,-0.0395320120174023,-0.00460572987170439,0.0132672343704775
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AMFR,E3 ubiquitin-protein ligase AMFR,41829,-0.0161416509802322,0.0065268488161145,-0.0289342746598166,-0.00334902730064776,0.0134071386973148
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BATF,Basic leucine zipper transcriptional factor ATF-like,39768,-0.0216700044300939,0.0087749052730242,-0.0388688187652213,-0.00447119009496645,0.0135442576715404
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FCGR3B,Low affinity immunoglobulin gamma Fc region receptor III-B,42162,0.0126478610409422,0.00512209585711781,0.00260855316099128,0.0226871689208931,0.0135515151547071
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADGRE5,Adhesion G protein-coupled receptor E5,42240,-0.00801219556485811,0.00324502985649959,-0.0143724540835973,-0.00165193704611891,0.0135593048833247
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GGA1,ADP-ribosylation factor-binding protein GGA1,41829,-0.0167899436465425,0.00680466612120346,-0.0301270892441013,-0.00345279804898369,0.0136223622400029
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SELL,L-selectin,40113,0.00608763480917119,0.00246731404185148,0.00125169928714229,0.0109235703312001,0.0136283754947021
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL31RA,Interleukin-31 receptor subunit alpha,39733,-0.00981709230870451,0.00398019588447167,-0.017618276242269,-0.00201590837514004,0.0136604486666274
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TEK,Angiopoietin-1 receptor,42186,-0.00560752129605194,0.00227834642609758,-0.0100730802912032,-0.00114196230090068,0.0138592850809399
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCT,Secretin,39768,-0.0127966268198289,0.00520091951908994,-0.0229904290772452,-0.00260282456241261,0.0138919800255128
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,A1BG,Alpha-1B-glycoprotein,40113,-0.00431919752557356,0.00176041844020649,-0.00776961766837827,-0.000868777382768849,0.014162624986154
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GP1BB,Platelet glycoprotein Ib beta chain,39706,-0.0175197886944682,0.00715840595567851,-0.0315502643675981,-0.00348931302133831,0.0144036450503779
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LUZP2,Leucine zipper protein 2,40020,-0.0116858643077433,0.00478768816796643,-0.0210697331169575,-0.0023019954985291,0.0146700478059775
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MGLL,Monoglyceride lipase,42162,-0.0216842944838805,0.00889057042846865,-0.039109812523679,-0.00425877644408193,0.0147404004019272
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NLGN2,Neuroligin-2,39719,0.0121367980260659,0.0049793012184869,0.00237736763783153,0.0218962284143002,0.0148077013052767
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CAPS,Calcyphosin,40054,-0.0260976835891695,0.0107231784789259,-0.0471151134078643,-0.00508025377047473,0.0149587569229736
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UNC5D,Netrin receptor UNC5D,39784,0.00662657058415047,0.00272587754847994,0.00128385058912978,0.0119692905791711,0.0150742728836079
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RPS10,40S ribosomal protein S10,39706,0.0103457619779674,0.00425671183691303,0.00200260677761785,0.0186889171783169,0.0150963447365079
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ULBP2,UL16-binding protein 2,42004,-0.0101007005124994,0.00416495100983278,-0.0182640044917717,-0.00193739653322719,0.0153150890800267
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCND2,G1/S-specific cyclin-D2,39881,-0.00931250196450491,0.00384038267768922,-0.0168396520127758,-0.00178535191623403,0.0153295296768555
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NFIC,Nuclear factor 1 C-type,40054,-0.0119361697856539,0.00492467354516013,-0.0215885299341678,-0.00228380963714009,0.015377468778318
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CASP8,Caspase-8,42178,-0.0153983914788088,0.0063661678520202,-0.0278760804687684,-0.00292070248884923,0.015586099691546
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MKI67,Proliferation marker protein Ki-67,39784,-0.0096995259313344,0.00401603050152717,-0.0175709457143277,-0.00182810614834115,0.0157433001703146
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,WAS,Wiskott-Aldrich syndrome protein,41887,-0.0165872372368607,0.0068750868992377,-0.0300624075593666,-0.00311206691435485,0.0158507315377343
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AK2,"Adenylate kinase 2, mitochondrial",40054,-0.0263113267129156,0.0109059785919831,-0.0476870447532024,-0.00493560867262876,0.0158573975460751
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GDF2,Growth/differentiation factor 2,42144,-0.00897840123751031,0.00372303698665831,-0.0162755537313606,-0.00168124874366002,0.0158973939689811
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD300C,CMRF35-like molecule 6,42213,-0.00901528210955702,0.00373955498185585,-0.0163448098739945,-0.00168575434511955,0.0159317710675318
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AKAP12,A-kinase anchor protein 12,39863,0.00544683823844874,0.00226138199367646,0.00101452953084288,0.0098791469460546,0.0160292546797606
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FDX1,"Adrenodoxin, mitochondrial",39706,-0.015471900178529,0.00643503960807562,-0.0280845778103572,-0.00285922254670082,0.0162197334345153
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VWC2L,von Willebrand factor C domain-containing protein 2-like,40054,0.0113564636840413,0.00473249941920693,0.00208076482239569,0.0206321625456869,0.0164263419197463
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DYNLT3,Dynein light chain Tctex-type 3,40020,-0.0108352503016898,0.00451715148599104,-0.0196888672142323,-0.00198163338914741,0.0164706073259028
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRKD2,Serine/threonine-protein kinase D2,39706,-0.0113692262602311,0.00476366404389913,-0.0207060077862734,-0.00203244473418878,0.017019981658526
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRH,Corticoliberin,41840,-0.0212901385140907,0.00894114079377451,-0.0388147744698887,-0.00376550255829265,0.0172737041905566
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BGN,Biglycan,41843,0.029667061905745,0.0124631194130442,0.00523934785617845,0.0540947759553115,0.0173091331829153
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTPRN2,Receptor-type tyrosine-protein phosphatase N2,41967,0.00859637564760636,0.00361444448914897,0.00151206444887437,0.0156806868463384,0.0174054293923951
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FES,Tyrosine-protein kinase Fes/Fps,41861,-0.0117534863130799,0.00494321591832061,-0.0214421895129883,-0.00206478311317154,0.0174357269654937
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAPRE3,Microtubule-associated protein RP/EB family member 3,39665,-0.0354315302396792,0.0149378551727718,-0.0647097263783118,-0.00615333410104658,0.0177134698421044
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATP1B3,Sodium/potassium-transporting ATPase subunit beta-3,39706,0.00956809977970638,0.00404399675022609,0.00164186614926324,0.0174943334101495,0.0179994374865976
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF8,Tumor necrosis factor receptor superfamily member 8,42213,0.0114531365630998,0.00485076315193003,0.00194564078531693,0.0209606323408826,0.0182354686567559
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SNX5,Sorting nexin-5,39804,-0.00710908108857603,0.00302452876536828,-0.0130371574686979,-0.0011810047084542,0.0187676448499649
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL36G,Interleukin-36 gamma,39739,-0.0167977558741966,0.00714660759911397,-0.03080510676846,-0.00279040497993325,0.0187689629019374
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRISP2,Cysteine-rich secretory protein 2,42223,0.0145179216561549,0.00617743722646939,0.00241014469227485,0.0266256986200349,0.0187805366990349
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLC27A4,Long-chain fatty acid transport protein 4,41829,-0.0163074117901855,0.00694250126935403,-0.0299147142781194,-0.00270010930225162,0.0188430389417304
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SUSD5,Sushi domain-containing protein 5,39816,0.00846729572167557,0.00361475775578339,0.00138237052034014,0.015552220923011,0.0191772939940251
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FAM172A,Cotranscriptional regulator FAM172A,39804,-0.0147300600384044,0.00629159873642614,-0.0270615935617996,-0.00239852651500912,0.0192388945769904
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MZT1,Mitotic-spindle organizing protein 1,41861,-0.012526518072653,0.00535816497580305,-0.023028521425227,-0.00202451472007905,0.0194111718235335
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLEC10A,C-type lectin domain family 10 member A,42004,0.00884057789734424,0.00378280019974054,0.00142628950585279,0.0162548662888357,0.0194521195815934
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADGRG2,Adhesion G-protein coupled receptor G2,42144,0.00658014936536168,0.00281749377100042,0.00105786157420085,0.0121024371565225,0.0195344913795136
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPP1R12B,Protein phosphatase 1 regulatory subunit 12B,39881,-0.0176160538070891,0.00757015964756091,-0.0324535667163085,-0.00277854089786977,0.0199817976580455
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SIRT1,NAD-dependent protein deacetylase sirtuin-1,39784,-0.0201057571997971,0.00866138434196829,-0.037082070510055,-0.00312944388953925,0.0202890080228467
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITGB5,Integrin beta-5,42186,0.00900984542781435,0.00388505308191978,0.00139514138725159,0.0166245494683771,0.0204047835000182
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEND1,Cell cycle exit and neuronal differentiation protein 1,39719,0.014364152580852,0.00619780224497077,0.00221646018070931,0.0265118449809947,0.0204890452470831
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NPTX2,Neuronal pentraxin-2,40097,0.00790457796575781,0.00341088214081788,0.00121924896975477,0.0145899069617608,0.0204971898916123
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPINK4,Serine protease inhibitor Kazal-type 4,42103,-0.0167550080066221,0.00724204464668567,-0.030949415514126,-0.00256060049911818,0.0207067178499074
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STAM,Signal transducing adapter molecule 1,40020,-0.00899671971355595,0.00388927945996743,-0.0166197074550921,-0.00137373197201979,0.0207297479613234
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINA11,Serpin A11,42296,0.00979164721194836,0.00424769292311985,0.00146616908263346,0.0181171253412633,0.0211726968727666
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NAAA,N-acylethanolamine-hydrolyzing acid amidase,41953,-0.0142580007964378,0.0061992803326256,-0.0264085902483839,-0.00210741134449161,0.0214674260798086
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BCL7B,B-cell CLL/lymphoma 7 protein family member B,40020,-0.0105727891271862,0.00460836898119929,-0.0196051923303368,-0.00154038592403557,0.0217947147249997
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYOM2,Myomesin-2,39706,0.0119845807383484,0.00523734412169605,0.0017193862598242,0.0222497752168727,0.022140185811235
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HBZ,Hemoglobin subunit zeta,40080,-0.0252033752768026,0.0110179373743574,-0.0467985325305431,-0.00360821802306221,0.0221865754171226
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DCTD,Deoxycytidylate deaminase,39863,-0.0222647897551347,0.00974536720969281,-0.0413657094861326,-0.00316387002413679,0.0223526804082379
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PGD,"6-phosphogluconate dehydrogenase, decarboxylating",40080,-0.0124422819648782,0.00544770907977081,-0.023119791761229,-0.00176477216852741,0.0223937792895897
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TPM3,Tropomyosin alpha-3 chain,39706,0.010418312523528,0.00456308038462318,0.00147467496966653,0.0193619500773894,0.0224399096281898
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PMVK,Phosphomevalonate kinase,41821,-0.0254498146703065,0.0111607364711207,-0.0473248581537031,-0.00357477118690986,0.0226065605474302
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,USP47,Ubiquitin carboxyl-terminal hydrolase 47,39706,-0.0198358309537644,0.00871676332679111,-0.036920687074275,-0.00275097483325387,0.0228902399482172
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BAX,Apoptosis regulator BAX,41813,0.0209584098965264,0.00921725300290708,0.00289259401082857,0.0390242257822243,0.0229932990386179
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GRK5,G protein-coupled receptor kinase 5,41876,-0.0120341424597054,0.00529968415990729,-0.0224215234131237,-0.00164676150628715,0.0231801286521947
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEP290,Centrosomal protein of 290 kDa,39881,-0.0128706779029142,0.00567294575063634,-0.0239896515741614,-0.00175170423166694,0.0233014314767673
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CYB5R2,NADH-cytochrome b5 reductase 2,39904,-0.013120449081702,0.00578479029496508,-0.0244586380598335,-0.00178226010357043,0.0233432933249391
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DBI,Acyl-CoA-binding protein,42073,-0.0178984609121691,0.0079159502095721,-0.0334137233229305,-0.00238319850140782,0.0237719776454361
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PGLYRP2,N-acetylmuramoyl-L-alanine amidase,39998,-0.00706357865196456,0.00312750061459319,-0.0131934798565672,-0.000933677447361919,0.0239320015898981
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADGRE1,Adhesion G protein-coupled receptor E1,40021,-0.0131383331675793,0.00582060337195663,-0.0245467157766143,-0.00172995055854429,0.0240147017758358
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGF5,Fibroblast growth factor 5,41887,0.00775520490484295,0.00344080113660799,0.00101123467709129,0.0144991751325946,0.0242197521449947
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADAM8,Disintegrin and metalloproteinase domain-containing protein 8,42186,-0.00701663986499336,0.00312328132219231,-0.0131382712564903,-0.000895008473496434,0.0246848655511378
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OMG,Oligodendrocyte-myelin glycoprotein,42094,0.0154168759327019,0.00687566423098712,0.00194057403996716,0.0288931778254367,0.0249629123248098
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TFPI2,Tissue factor pathway inhibitor 2,42142,0.00878122606814513,0.00391863542280272,0.0011007006394518,0.0164617514968385,0.0250501636823693
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CIRBP,Cold-inducible RNA-binding protein,40021,-0.0219838897852022,0.00981676347606441,-0.0412247461982884,-0.00274303337211594,0.0251486013037652
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RRP15,RRP15-like protein,39719,0.0213961991522469,0.00955984541973901,0.0026589021295584,0.0401334961749353,0.0252332556947299
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SYT1,Synaptotagmin-1,40054,0.00981537621649445,0.00439042955007419,0.00121013429834903,0.0184206181346399,0.025396254113937
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RABEPK,Rab9 effector protein with kelch motifs,41861,-0.0133481490397762,0.00597555712343173,-0.0250602410017024,-0.00163605707785004,0.0255141765529353
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLK7,Kallikrein-7,39606,-0.00908435296202986,0.00406718352010109,-0.017056032661428,-0.00111267326263172,0.0255323106746582
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SEMA6C,Semaphorin-6C,39784,-0.006073500485855,0.00272440693785026,-0.0114133380840415,-0.000733662887668482,0.0258153287515195
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MCEE,"Methylmalonyl-CoA epimerase, mitochondrial",40054,0.00949229410555272,0.00425842494699641,0.00114578120943976,0.0178388070016657,0.0258301439203143
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL22RA1,Interleukin-22 receptor subunit alpha-1,41887,-0.00995996778228809,0.00446997000707747,-0.0187211089961599,-0.00119882656841624,0.0258849205326457
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GAL,Galanin peptides,42184,0.0148888057395148,0.00668514841399397,0.0017859148480866,0.027991696630943,0.0259545456526333
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VWF,von Willebrand factor,42296,0.0166007571117131,0.00745839128983692,0.00198231018363278,0.0312192040397935,0.026045698502638
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL7,Interleukin-7,42103,-0.0146537409625126,0.00658610826340118,-0.0275625131587789,-0.00174496876624625,0.0261020209157919
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENTPD2,Ectonucleoside triphosphate diphosphohydrolase 2,41861,-0.010148818241981,0.00456349145833155,-0.0190932615003108,-0.00120437498365114,0.0261717102721005
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MORF4L2,Mortality factor 4-like protein 2,39665,-0.00848408427283097,0.00381584359077481,-0.0159631377107496,-0.00100503083491234,0.0262111996188731
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENO1,Alpha-enolase,42095,0.0181074541260034,0.00816691809672825,0.00210029465641606,0.0341146135955908,0.0266287710611853
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FABP1,"Fatty acid-binding protein, liver",42126,0.0217638685955389,0.00981685426686822,0.00252283423247718,0.0410049029586006,0.026641094425533
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD83,CD83 antigen,42103,-0.00815717011181072,0.00368145851580575,-0.01537282880279,-0.00094151142083145,0.0267264087751669
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AKT2,RAC-beta serine/threonine-protein kinase,40054,-0.0287766121732853,0.0129998486957222,-0.0542563156169009,-0.00329690872966969,0.0268762304130998
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSTPIP2,Proline-serine-threonine phosphatase-interacting protein 2,39532,-0.0244285210219093,0.0110437506855162,-0.046074272365521,-0.00278276967829763,0.026990047016094
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FCER1A,High affinity immunoglobulin epsilon receptor subunit alpha,40054,0.00545252828235586,0.00246616286155297,0.000618849073712052,0.0102862074909997,0.027061026585226
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RSPO3,R-spondin-3,42223,0.0068431980162744,0.00309790828918293,0.000771297769475858,0.0129150982630729,0.0271938047874614
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RELT,Tumor necrosis factor receptor superfamily member 19L,42120,-0.00710280488983299,0.00321568802748157,-0.0134055534236969,-0.00080005635596912,0.0272061803238295
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EIF2AK3,Eukaryotic translation initiation factor 2-alpha kinase 3,39706,-0.0153386549007442,0.00695870416307539,-0.028977715060372,-0.00169959474111645,0.0275290514761548
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SEZ6,Seizure protein 6 homolog,39768,0.00719682200061056,0.00326661955531081,0.000794247672201376,0.0135993963290197,0.0276063307710624
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DDX25,ATP-dependent RNA helicase DDX25,39768,0.00867930619737809,0.00395000480956347,0.000937296770633683,0.0164213156241225,0.0280213509108944
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AIDA,"Axin interactor, dorsalization-associated protein",39768,-0.0192984818071661,0.00878413918505132,-0.0365153946098667,-0.0020815690044655,0.0280442763248418
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINB6,Serpin B6,42182,-0.0131862003839956,0.00600363147145387,-0.0249533180680451,-0.00141908269994599,0.0280830302014238
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DCC,Netrin receptor DCC,39768,-0.00531857967538019,0.00242476578581108,-0.0100711206155699,-0.000566038735190476,0.0282973451510687
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DDX4,Probable ATP-dependent RNA helicase DDX4,39784,-0.0123260502664477,0.00562142980836681,-0.0233440526908466,-0.00130804784204873,0.0283514329995053
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL24,Interleukin-24,41887,0.0114148677036261,0.0052092021737039,0.00120483144316644,0.0216249039640857,0.0284489918665318
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL1R1,Interleukin-1 receptor type 1,42099,0.00537882236187025,0.00245574104837409,0.000565569907057027,0.0101920748166835,0.0285199405750801
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAPKAPK2,MAP kinase-activated protein kinase 2,39881,-0.0167634848090932,0.00765758011941404,-0.0317723418431448,-0.00175462777504172,0.0286085071550263
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HSPA2,Heat shock-related 70 kDa protein 2,40020,-0.00776676046952016,0.00356407949217072,-0.0147523562741748,-0.000781164664865543,0.0293399980056522
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RTBDN,Retbindin,42094,-0.0067757876048342,0.00310944977695691,-0.0128703091676697,-0.000681266041998652,0.0293426160351398
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RECK,Reversion-inducing cysteine-rich protein with Kazal motifs,39804,0.0047219170724435,0.00216768389050799,0.000473256647047836,0.00897057749783916,0.0294038902530477
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEACAM3,Carcinoembryonic antigen-related cell adhesion molecule 3,41861,-0.0108281743117756,0.00498149650265218,-0.0205919074569739,-0.00106444116657731,0.0297477101523971
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DIPK2B,Divergent protein kinase domain 2B,39863,0.00624432514788206,0.00287940378953866,0.000600693720386286,0.0118879565753778,0.030133765115442
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLK1,Kallikrein-1,42021,0.0292909773354899,0.013510332963916,0.00281072472621455,0.0557712299447652,0.0301737723917548
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LPO,Lactoperoxidase,41661,-0.0136342404071767,0.00629488073140779,-0.025972206640736,-0.00129627417361741,0.0303358016536778
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLEC14A,C-type lectin domain family 14 member A,42120,0.00752369385529247,0.00347548825694537,0.000711736871679546,0.0143356508389054,0.0304221975548751
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FCRL1,Fc receptor-like protein 1,42144,-0.0105967172863609,0.00489662865153714,-0.0201941094433737,-0.000999325129348104,0.030476099002157
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BTC,Probetacellulin,41861,-0.0168635595486015,0.00780369957072357,-0.0321588107072197,-0.00156830838998334,0.0307163498345042
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AHNAK2,Protein AHNAK2,39804,-0.0067526281555423,0.00312485560796724,-0.0128773451471581,-0.000627911163926514,0.0307222130904892
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYL3,Myosin light chain 3,39804,0.0164185935351584,0.00761081283930838,0.00150140037011398,0.0313357867002028,0.0310068575794097
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NOS2,"Nitric oxide synthase, inducible",39706,0.00894153504625678,0.00415140801415921,0.000804775338504735,0.0170782947540088,0.0312741283542177
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,B3GAT3,Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 3,39706,0.00464377899310813,0.00216590351237771,0.000398608108847818,0.00888894987736844,0.0320527253577547
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPTBN2,"Spectrin beta chain, non-erythrocytic 2",39719,-0.00723858696220155,0.00337755649128108,-0.0138585976851125,-0.000618576239290636,0.0321244650599383
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,WIF1,Wnt inhibitory factor 1,42223,0.0076504009341317,0.00357372014133197,0.000645909457121053,0.0146548924111424,0.0323136219530438
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STX7,Syntaxin-7,39784,-0.0110732602284293,0.00517341358395094,-0.0212131508529731,-0.000933369603885462,0.0323438887523101
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GGH,Gamma-glutamyl hydrolase,41953,-0.00760660777803859,0.00355514848591562,-0.0145746988104332,-0.000638516745643971,0.032405747353845
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHCHD6,MICOS complex subunit MIC25,40020,-0.00641827444741574,0.00300036757190756,-0.0122989948883546,-0.000537554006476925,0.0324447945590831
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPM1A,Protein phosphatase 1A,41861,-0.00708235014387109,0.00331158440606476,-0.013573055579758,-0.000591644707984161,0.0324823560388484
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRTFDC1,Phosphoribosyltransferase domain-containing protein 1,41829,-0.0244478037889684,0.0114635468713193,-0.0469163556567543,-0.00197925192118244,0.0329721640831719
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VASH1,Tubulinyl-Tyr carboxypeptidase 1,42103,-0.0180365897404492,0.00845763091766964,-0.0346135463390817,-0.00145963314181669,0.0329778620623466
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LEO1,RNA polymerase-associated protein LEO1,40054,-0.00722842763195965,0.00339060958909181,-0.0138740224265796,-0.000582832837339692,0.0330377602222343
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDH3,Cadherin-3,42213,-0.00830111882786382,0.00390185019391546,-0.0159487452079381,-0.000653492447789514,0.033398736484097
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VAV3,Guanine nucleotide exchange factor VAV3,39719,-0.0217802940795978,0.010240513847034,-0.0418517012197845,-0.00170888693941107,0.0334536545474473
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AOC1,Amiloride-sensitive amine oxidase [copper-containing],41887,-0.0125884753041906,0.00592152242164726,-0.0241946592506192,-0.000982291357761976,0.0335320903567464
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AKT3,RAC-gamma serine/threonine-protein kinase,41813,-0.0125031174567266,0.00589032271449745,-0.0240481499771416,-0.000958084936311653,0.0338022677451707
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SIRPB1,Signal-regulatory protein beta-1,42109,-0.0106383097766505,0.00501676276743362,-0.0204711648008205,-0.000805454752480643,0.0339784700214816
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,39863,-0.00659200396087551,0.00311167686315742,-0.0126908906126641,-0.000493117309086966,0.0341580648937199
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CNTN5,Contactin-5,42144,0.00837348816427741,0.00396558204620222,0.00060094735372106,0.0161460289748338,0.034744962371064
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APOC1,Apolipoprotein C-I,40092,-0.00802435769575085,0.0038001894174973,-0.0154727289540456,-0.000575986437456138,0.0347462367260929
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EXTL1,Exostosin-like 1,39706,-0.0104126993981901,0.00493172443767893,-0.0200788792960408,-0.000746519500339386,0.0347639849742053
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CFD,Complement factor D,40113,0.00460788174562163,0.00218456833114785,0.000326127816571833,0.00888963567467142,0.0349425125516957
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NUBP1,Cytosolic Fe-S cluster assembly factor NUBP1,40020,-0.0211477576853074,0.0100401138331958,-0.0408263807983713,-0.00146913457224358,0.0351989583116608
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TFF1,Trefoil factor 1,42067,-0.0181408402502495,0.00862638356555723,-0.0350485520387417,-0.00123312846175736,0.035489634198861
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LGMN,Legumain,42184,-0.00776716959936689,0.00369574955956474,-0.0150108387361138,-0.000523500462620004,0.0356032130424349
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SIGLEC10,Sialic acid-binding Ig-like lectin 10,42103,-0.00771229511472696,0.00367165404648149,-0.0149087370458307,-0.000515853183623242,0.0357045683002991
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDHR1,Cadherin-related family member 1,41829,-0.00933223413944052,0.00444978646823732,-0.0180538156171857,-0.000610652661695372,0.0359928735328214
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TMPRSS5,Transmembrane protease serine 5,41948,0.00829412295719508,0.00396687391292662,0.000519050087858902,0.0160691958265313,0.0365616019718825
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NMT1,Glycylpeptide N-tetradecanoyltransferase 1,40054,-0.0143982621328834,0.00688632221743047,-0.0278954536790471,-0.000901070586719651,0.0365647588107715
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FDX2,"Ferredoxin-2, mitochondrial",39706,0.0122617970306059,0.00586966845151624,0.000757246865634094,0.0237663471955777,0.0367307984696493
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ASGR2,Asialoglycoprotein receptor 2,40102,0.00583411869016509,0.00280025270879766,0.000345623380921676,0.0113226139994085,0.037235656126556
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARHGAP30,Rho GTPase-activating protein 30,39881,-0.00825911196198183,0.0039681555160929,-0.0160366967735239,-0.000481527150439751,0.0374258248414772
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CXCL16,C-X-C motif chemokine 16,42280,-0.00516802246736667,0.00248324079927874,-0.010035174433953,-0.000300870500780345,0.0374386210268595
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LY96,Lymphocyte antigen 96,42004,-0.0077361936872213,0.0037217302916217,-0.0150307850587998,-0.00044160231564276,0.0376689164382693
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RBP1,Retinol-binding protein 1,39768,-0.0148126450175678,0.00713219171196632,-0.0287917407730218,-0.000833549262113849,0.0378375180670674
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLC28A1,Sodium/nucleoside cotransporter 1,39665,-0.0126227057397322,0.0061067946657168,-0.0245920232845371,-0.000653388194927228,0.0387592730315593
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,42126,-0.00630367708326048,0.00305267094054814,-0.0122869121267348,-0.000320442039786129,0.0389456260994257
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ASPN,Asporin,40080,0.00603983861168402,0.00292702111095661,0.000302877234209058,0.011776799989159,0.0390910510682361
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LILRB2,Leukocyte immunoglobulin-like receptor subfamily B member 2,42240,0.00743757448071774,0.00361014070696531,0.000361698695065728,0.0145134502663698,0.0394002015262043
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRUNE2,Protein prune homolog 2,39881,-0.00641428696829071,0.00312431963814498,-0.0125379534590549,-0.000290620477526548,0.0400950442511304
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SOX9,Transcription factor SOX-9,39768,-0.00593102254082746,0.00288924801697627,-0.011593948654101,-0.000268096427553973,0.0401173989844133
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PECR,Peroxisomal trans-2-enoyl-CoA reductase,39804,-0.00600257516560621,0.0029259016395772,-0.0117373423791775,-0.000267807952034886,0.0402398504620122
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NPHS1,Nephrin,39784,-0.00715060667172882,0.00348660657462071,-0.0139843555579854,-0.000316857785472223,0.0403033282839911
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FIS1,Mitochondrial fission 1 protein,42133,-0.0160410541821693,0.00782278744604322,-0.031373717576414,-0.000708390787924611,0.0403304250166953
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRR5,Proline-rich protein 5,39784,-0.0102236765908865,0.00499058262166958,-0.0200052185293588,-0.000442134652414078,0.0405264491143192
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDE1C,"Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C",39665,-0.0117479340342969,0.00573594215820229,-0.0229903806643733,-0.000505487404220378,0.0405725104703456
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RNF31,E3 ubiquitin-protein ligase RNF31,39784,-0.00748021196642171,0.00365763852827477,-0.0146491834818402,-0.000311240451003166,0.0408703264070603
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD276,CD276 antigen,42126,0.00775230110152934,0.00381178743391085,0.000281197731064068,0.0152234044719946,0.0419951040080624
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CELA2A,Chymotrypsin-like elastase family member 2A,40097,-0.0133635636737383,0.00657262525042461,-0.0262459091645706,-0.000481218182906099,0.0420549256767876
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FH,"Fumarate hydratase, mitochondrial",39719,-0.0181024549335192,0.00894516850618075,-0.0356349852056335,-0.000569924661404948,0.0430248944934402
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DPP10,Inactive dipeptidyl peptidase 10,42103,-0.00755655288757977,0.00373569520052981,-0.0148785154806182,-0.000234590294541336,0.0431146594184696
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VEGFD,Vascular endothelial growth factor D,42237,0.00758500804584114,0.0037546952340905,0.00022580538702377,0.0149442107046585,0.0433893248142924
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNF,Tumor necrosis factor,41859,-0.00809149323468016,0.00400809098035637,-0.0159473515561787,-0.000235634913181675,0.0435301023214391
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PNLIPRP2,Pancreatic lipase-related protein 2,42126,-0.0623382784936455,0.0308870409452148,-0.122876878746266,-0.00179967824102457,0.0435841242506853
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCRN1,Secernin-1,42103,-0.011542464073162,0.00574622198282156,-0.0228050591594923,-0.000279868986831786,0.0445892268241094
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LEG1,Protein LEG1 homolog,39518,0.0146104919747186,0.00727682371047704,0.000347917502183574,0.0288730664472536,0.0446893080425744
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SRC,Proto-oncogene tyrosine-protein kinase Src,42171,-0.024726300035075,0.0123162199607524,-0.0488660911581497,-0.000586508912000266,0.0447042885755067
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCAR2,Cell cycle and apoptosis regulator protein 2,40054,-0.011133640025419,0.00557134299940498,-0.0220534723042528,-0.000213807746585262,0.045700761889458
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TUBB3,Tubulin beta-3 chain,39719,0.00584344543864638,0.00292741371843351,0.000105714550516707,0.0115811763267761,0.0459474607500466
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRRN1,Leucine-rich repeat neuronal protein 1,41887,-0.00821105384896458,0.00411546703234283,-0.0162773692323565,-0.000144738465572633,0.0460457487704686
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFAIP8L2,Tumor necrosis factor alpha-induced protein 8-like protein 2,39863,-0.0129015051845846,0.00648725177088759,-0.0256165186555243,-0.000186491713644947,0.0467545911664151
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MATN3,Matrilin-3,41984,0.00677605152237263,0.00341130367402783,8.98963212780778e-05,0.0134622067234672,0.0470155059773637
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTK7,Inactive tyrosine-protein kinase 7,41829,-0.00790653131667178,0.00398260192746343,-0.0157124310945001,-0.000100631538843459,0.047136270306165
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EDAR,Tumor necrosis factor receptor superfamily member EDAR,42103,-0.0185837121535391,0.00937603256228599,-0.0369607359756196,-0.000206688331458552,0.047495451918997
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EPHB4,Ephrin type-B receptor 4,42296,0.00544327123548888,0.00275240985069023,4.85479281360302e-05,0.0108379945428417,0.0479904433459857
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IFNG,Interferon gamma,41887,-0.0231534668790846,0.0117393549443598,-0.0461626025700298,-0.000144331188139397,0.0485976535040948
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLA2G4A,Cytosolic phospholipase A2,42184,-0.0177085245311928,0.00899061811857136,-0.0353301360435927,-8.69130187929334e-05,0.0488977521074469
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRL,Prolactin,42213,0.0153914307845678,0.00781957813204117,6.50576457671068e-05,0.0307178039233685,0.0490524336574708
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NTRK2,BDNF/NT-3 growth factors receptor,42144,-0.00519617644842972,0.00264747197856073,-0.0103852215264088,-7.13137045067931e-06,0.0497031569809358
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ODAM,Odontogenic ameloblast-associated protein,41813,0.0114742404362561,0.0058538684187249,6.58335555321979e-07,0.0229478225369569,0.0500046200101258
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GLRX5,"Glutaredoxin-related protein 5, mitochondrial",39863,-0.0179457785262209,0.0091632182846937,-0.0359056863642205,1.41293117787815e-05,0.050202306666326
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ECM1,Extracellular matrix protein 1,39855,-0.00758322017859457,0.00387212929695971,-0.0151725936006356,6.15324344647224e-06,0.0502078550608298
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADAMTS16,A disintegrin and metalloproteinase with thrombospondin motifs 16,41876,0.00644615764949946,0.00329767570685472,-1.72867359357985e-05,0.0129096020349347,0.0506335905350918
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLK11,Kallikrein-11,42057,-0.00667249257207183,0.00341504507412566,-0.0133659809173581,2.09957732144762e-05,0.0507403672874506
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AHSA1,Activator of 90 kDa heat shock protein ATPase homolog 1,40020,-0.0133629388963042,0.00685456943353929,-0.0267978949860412,7.20171934328624e-05,0.0512622971626254
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VPS4B,Vacuolar protein sorting-associated protein 4B,40020,-0.018890519070727,0.00974301612699336,-0.037986830679634,0.000205792538179962,0.0525421562867296
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLEC7A,C-type lectin domain family 7 member A,42256,0.0122650809023714,0.00633394255050911,-0.000149446496626491,0.0246796083013692,0.0528396052340747
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EPGN,Epigen,40020,-0.00916328589179453,0.00473376220262929,-0.0184414598089479,0.00011488802535888,0.0529267717649867
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNPEP,Aspartyl aminopeptidase,40054,-0.0114200994459451,0.00592573681306257,-0.0230345435995477,0.000194344707657557,0.0539803552787412
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACRV1,Acrosomal protein SP-10,39784,-0.0161293500055769,0.00838039301677719,-0.0325549203184602,0.000296220307306357,0.0542995213376824
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GPA33,Cell surface A33 antigen,42094,-0.027723786741217,0.0144229635179115,-0.0559927952363235,0.000545221753889519,0.0546028895968022
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ELAVL4,ELAV-like protein 4,39719,-0.016851469273284,0.00880694615266434,-0.0341130837325061,0.000410145185938082,0.0557202090770679
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPM1B,Protein phosphatase 1B,39784,-0.0120768335832671,0.00633776592076668,-0.0244988547879697,0.000345187621435625,0.0567376400362992
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRC1,Protein regulator of cytokinesis 1,40020,-0.00881507687190945,0.00463146346576909,-0.0178927452648169,0.00026259152099797,0.057027556321288
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL5RA,Interleukin-5 receptor subunit alpha,42103,0.0114270259125639,0.00600463568412004,-0.000342060028311398,0.0231961118534392,0.0570583318496063
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPIE,Peptidyl-prolyl cis-trans isomerase E,39881,-0.0124594825207856,0.006559700690172,-0.0253164958735228,0.000397530831951478,0.0575390619775916
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DGCR6,Protein DGCR6,39719,-0.00869821329873427,0.00458052767552874,-0.0176760475427706,0.00027962094530206,0.0575977878616617
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF4,Tumor necrosis factor receptor superfamily member 4,42248,-0.00797228088779988,0.00420029905364607,-0.0162048670329462,0.000260305257346414,0.0577145670351251
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL12RB1,Interleukin-12 receptor subunit beta-1,41887,-0.00766851927849321,0.00404438952115438,-0.0155955227399558,0.000258484182969367,0.0579710701385157
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GIMAP7,GTPase IMAP family member 7,39863,0.00628531255014646,0.00331821755513886,-0.000218393857925714,0.0127890189582186,0.0582276937974179
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCARF1,Scavenger receptor class F member 1,42296,-0.00822412402440257,0.00434898349842027,-0.0167481316813063,0.000299883632501153,0.0586403614540874
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EIF5,Eukaryotic translation initiation factor 5,39706,-0.00861719841771742,0.00457456440044351,-0.0175833446425867,0.000348947807151853,0.059630438123514
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLC12A2,Solute carrier family 12 member 2,39706,0.00535311106470984,0.00284558289711943,-0.000224231413644251,0.0109304535430639,0.0599723067206338
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EIF1AX,"Eukaryotic translation initiation factor 1A, X-chromosomal",40054,-0.0106235730618594,0.00566295235098965,-0.0217229596697991,0.000475813546080324,0.0606851253337075
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CA9,Carbonic anhydrase 9,42223,-0.00946926745417462,0.00504965339250149,-0.0193665881034775,0.000428053195128291,0.0607832752172535
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCGB2A2,Mammaglobin-A,39706,0.00620271969721201,0.00330775790019973,-0.000280485787179468,0.0126859251816035,0.0607924111647454
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GRN,Progranulin,42063,-0.00479644413221731,0.00255799619904042,-0.00981011668233655,0.000217228417901915,0.0608045278080635
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADAMTS1,A disintegrin and metalloproteinase with thrombospondin motifs 1,39784,-0.00607322447597123,0.00324070397167449,-0.0124250042604532,0.000278555308510762,0.0609517600297056
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NUDT16,U8 snoRNA-decapping enzyme,40002,-0.0167701308933545,0.00895971279381543,-0.0343311679692327,0.00079090618252374,0.0612714548368699
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FCRL5,Fc receptor-like protein 5,42120,-0.011482804092788,0.00615147906893896,-0.0235397030679084,0.000574094882332368,0.0619697943845408
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CYB5A,Cytochrome b5,39665,-0.0141537777389033,0.00760373378428499,-0.0290570959561019,0.000749540478295261,0.0627122281158582
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTPN6,Tyrosine-protein phosphatase non-receptor type 6,42162,0.0170413341457629,0.00916737341582146,-0.000926717749247154,0.035009386040773,0.0630623469321607
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KIAA1549L,UPF0606 protein KIAA1549L,39881,0.00555710340337747,0.00298987558782447,-0.000303052748758499,0.0114172595555134,0.0631056056786735
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPRR1B,Cornifin-B,39881,-0.0160990177876985,0.00866239979068596,-0.0330773213774429,0.00087928580204602,0.0631263723890604
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF10C,Tumor necrosis factor receptor superfamily member 10C,42168,0.00950952549668172,0.00513141146509149,-0.000548040974897593,0.019567091968261,0.0638765601069131
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KIAA2013,Uncharacterized protein KIAA2013,40020,-0.0103862630686951,0.00560731838143891,-0.0213766070963154,0.00060408095892517,0.0640143800502275
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL20RB,Interleukin-20 receptor subunit beta,39784,-0.00791132057004747,0.00427616500040226,-0.0162926039708359,0.000469962830740958,0.0643273894767732
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,REG3A,Regenerating islet-derived protein 3-alpha,42296,0.0125928141441234,0.00681940749568976,-0.0007732245474285,0.0259588528356754,0.0648256236880474
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ELOB,Elongin-B,39706,-0.00771222977361868,0.00418801576762043,-0.0159207406781547,0.000496281130917364,0.0655765210274086
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MNAT1,CDK-activating kinase assembly factor MAT1,39881,-0.00842385932783713,0.00458403931159848,-0.0174085763785702,0.000560857722895899,0.0661417564806692
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TGFBR3,Transforming growth factor beta receptor type 3,42296,0.00603797442572051,0.0033020746823964,-0.000434091951776422,0.0125100408032174,0.0674913256020228
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL33,Interleukin-33,41887,-0.00733871788545142,0.00402834371215218,-0.0152342715612697,0.000556835790366853,0.0685133336643408
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LIF,Leukemia inhibitory factor,41829,-0.00977302703008314,0.00536672761498516,-0.0202918131554541,0.000745759095287776,0.0686243767254633
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CABP2,Calcium-binding protein 2,39768,-0.0122174367688385,0.00671096503434692,-0.0253709282361585,0.000936054698481487,0.0687083168923775
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TFF3,Trefoil factor 3,42123,0.00816068984573581,0.00448583887767265,-0.000631554354502585,0.0169529340459742,0.0689022825845094
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,WNT9A,Protein Wnt-9a,41887,0.00561719406212648,0.00308974537560107,-0.000438706874051619,0.0116730949983046,0.0690858652936248
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DCUN1D1,DCN1-like protein 1,39719,-0.0141221669784955,0.00778953250423128,-0.0293896506867888,0.00114531672979782,0.0698653542781203
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SOD3,Extracellular superoxide dismutase,40102,0.0110552614697048,0.00610017855268091,-0.000901088493549784,0.0230116114329594,0.0699696694737587
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BRSK2,Serine/threonine-protein kinase BRSK2,40054,-0.0071295804451304,0.00393587750877501,-0.0148439003623294,0.000584739472068613,0.070101385294642
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,42120,0.00724321333480319,0.00399991772334692,-0.000596625402956781,0.0150830520725632,0.0701887384773808
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COL9A2,Collagen alpha-2(IX) chain,39881,-0.00843603992757473,0.00465868229942273,-0.0175670572344433,0.000694977379293818,0.0701966263339291
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL6ST,Interleukin-6 receptor subunit beta,42144,-0.00329215189936909,0.0018198357649848,-0.00685902999873931,0.000274726200001124,0.0704682932011423
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLK8,Kallikrein-8,41683,-0.00704066956510044,0.00389429758854089,-0.0146734928386406,0.00059215370843971,0.0706393589489055
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GSTT2B,Glutathione S-transferase theta-2B,40054,0.0449972704673583,0.0249003677007234,-0.00380745022605952,0.0938019911607761,0.070775503745827
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HSD17B14,17-beta-hydroxysteroid dehydrogenase 14,40054,-0.0119960749432476,0.00664812620747975,-0.0250264023099079,0.00103425242341269,0.0711916972893468
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RAB2B,Ras-related protein Rab-2B,40020,-0.0112934892282868,0.00627912357260095,-0.0236005714305846,0.00101359297401111,0.0721134127004099
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C1QA,Complement C1q subcomponent subunit A,42207,0.00411701631295414,0.00229220033598687,-0.000375696345580124,0.0086097289714884,0.072502128608721
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPIB,Peptidyl-prolyl cis-trans isomerase B,42161,-0.0172653801270956,0.00965645034836906,-0.036192022809899,0.00166126255570772,0.073805249635657
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,QPCT,Glutaminyl-peptide cyclotransferase,42189,-0.00505292713548169,0.00283435621854328,-0.0106082653238265,0.00050241105286314,0.0746515758194523
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COL24A1,Collagen alpha-1(XXIV) chain,40021,-0.0102673707809122,0.00575993183879841,-0.021556837184957,0.00102209562313271,0.0746874763867047
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ROBO4,Roundabout homolog 4,39804,0.00335667003980559,0.00188590197729194,-0.000339697835686614,0.00705303791529779,0.0751250107676451
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATP1B4,Protein ATP1B4,39665,0.00782056811662213,0.00440063972477578,-0.000804685743938391,0.0164458219771826,0.0755736605795842
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CALB2,Calretinin,41829,-0.00592896295031727,0.00333687741072234,-0.0124692426753331,0.000611316774698515,0.075625247107028
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IFIT1,Interferon-induced protein with tetratricopeptide repeats 1,39881,-0.00968044061387646,0.00546915982146139,-0.0203999938639408,0.00103911263618787,0.0767548032000708
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TMEM132A,Transmembrane protein 132A,39804,-0.0115221744659573,0.00651424453399134,-0.0242900937525803,0.00124574482066576,0.0769616536667727
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL13RA2,Interleukin-13 receptor subunit alpha-2,39719,0.00534905621487565,0.00302469388715798,-0.000579343803953992,0.0112774562337053,0.0770126601466818
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRHR1,Corticotropin-releasing factor receptor 1,41876,-0.0109909732760732,0.00621574675472454,-0.0231738369153333,0.0011918903631869,0.077043718493184
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KIF1C,Kinesin-like protein KIF1C,39706,-0.0065402570970942,0.00370459563644624,-0.0138012645445288,0.000720750350340438,0.0775181578890532
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL1RL2,Interleukin-1 receptor-like 2,41887,-0.00702640686602864,0.00398069600845783,-0.014828571042606,0.000775757310548701,0.0775676115817575
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD3D,T-cell surface glycoprotein CD3 delta chain,39719,0.00627882334078901,0.00356197188333599,-0.000702641550549523,0.0132602882321276,0.0779736996343225
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATXN10,Ataxin-10,41829,0.0132234655604104,0.00750661473700248,-0.0014894993241145,0.0279364304449352,0.0781652966231429
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MBL2,Mannose-binding protein C,39957,0.0199173657309882,0.0113115566864026,-0.00225328537436088,0.0420880168363373,0.0783010032081188
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UBE2Z,Ubiquitin-conjugating enzyme E2 Z,39784,-0.0107359446242779,0.00609811901342699,-0.0226882578905948,0.00121636864203905,0.0783462035227249
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CUZD1,CUB and zona pellucida-like domain-containing protein 1,39768,-0.00733194516372151,0.00417270081583919,-0.0155104387627663,0.000846548435323301,0.0789259230844563
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,40021,-0.0056495634071123,0.00321681709049534,-0.0119545249044832,0.000655398090258574,0.0790724936123997
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SAT2,Thialysine N-epsilon-acetyltransferase,39881,-0.012293130267663,0.00701148844093442,-0.0260356476118945,0.00144938707656841,0.0795819435455052
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCER2,Coiled-coil domain-containing glutamate-rich protein 2,39804,-0.0117682220436958,0.00671680187357626,-0.0249331537159053,0.00139670962851368,0.0797928349855451
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CYTH3,Cytohesin-3,39665,-0.013655955086659,0.0077959284147211,-0.0289359747795124,0.00162406460619431,0.0798584923193072
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HAVCR2,Hepatitis A virus cellular receptor 2,42120,0.00670557700877229,0.00382963630311925,-0.000800510145341444,0.014211664162886,0.079974854060091
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RNF4,E3 ubiquitin-protein ligase RNF4,39881,-0.0121829465176811,0.00695821718822373,-0.0258210522065996,0.0014551591712374,0.0799966782550962
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARNT,Aryl hydrocarbon receptor nuclear translocator,41887,-0.00668317067134485,0.00381854384617368,-0.0141675166098453,0.000801175267155566,0.0801099918162412
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL1B,Interleukin-1 beta,41815,0.0103192481962931,0.00590057837114842,-0.00124588541115783,0.021884381803744,0.0803406238541109
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TPK1,Thiamin pyrophosphokinase 1,40080,-0.00495979934172333,0.00284065279061501,-0.0105274788113288,0.0006078801278821,0.0808379629344499
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPON1,Spondin-1,42146,-0.00615624083620865,0.00352601143355145,-0.0130672232459695,0.000754741573552179,0.0808432916657331
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C1QL2,Complement C1q-like protein 2,39784,0.00799528635661347,0.00459176612518736,-0.00100457524875376,0.0169951479619807,0.0816736291328132
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SHH,Sonic hedgehog protein,39784,0.00767209712576836,0.00441102534560482,-0.000973512551617092,0.0163177068031538,0.0820110337947245
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STXBP1,Syntaxin-binding protein 1,40054,-0.0137520538838449,0.00792006232045339,-0.0292753760319336,0.00177126826424371,0.0825291283222534
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CNTN2,Contactin-2,42223,-0.00802011912828206,0.00462146936057095,-0.0170781990750011,0.00103796081843699,0.0826928122925567
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MESD,LRP chaperone MESD,42120,-0.0216275657669133,0.0124760768378395,-0.0460806763690788,0.00282554483525222,0.083026604210817
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,F2,Prothrombin,40113,-0.00267441740675531,0.00154584889734338,-0.00570428124554833,0.000355446432037704,0.0836471119991767
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL4R,Interleukin-4 receptor subunit alpha,42103,0.00679591823848364,0.00392950697544331,-0.000905915433385256,0.0144977519103525,0.0837510183525157
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UGDH,UDP-glucose 6-dehydrogenase,39706,-0.0172173043030315,0.00997586963145797,-0.0367700087806891,0.00233540017462616,0.0843956756801349
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCN3,CCN family member 3,42282,-0.00638487345892428,0.00370292961432648,-0.0136426155030042,0.000872868585155611,0.084681603385451
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PADI2,Protein-arginine deiminase type-2,41887,-0.00995354804819547,0.00577525186850078,-0.021273041710457,0.00136594561406605,0.0848255808024469
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LILRA6,Leukocyte immunoglobulin-like receptor subfamily A member 6,40080,-0.0133032035866302,0.00772483341400121,-0.0284438770780726,0.00183746990481218,0.0850735278601535
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADGRB3,Adhesion G protein-coupled receptor B3,41984,0.0061448286215843,0.00357323364685236,-0.000858709326246323,0.0131483665694149,0.0855142997002501
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PITHD1,PITH domain-containing protein 1,39651,-0.0143619085950167,0.00836531068815986,-0.03075791754381,0.00203410035377665,0.0860378351464403
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LXN,Latexin,41974,-0.012065551169808,0.00702982487914292,-0.0258440079329281,0.00171290559331213,0.0861245449749501
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FMR1,Synaptic functional regulator FMR1,41861,-0.00633814710135998,0.00370165587575003,-0.01359339261783,0.000917098415110085,0.0868757376970661
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SSBP1,"Single-stranded DNA-binding protein, mitochondrial",39784,-0.00628681592471361,0.00368583791267768,-0.0135110582335619,0.000937426384134641,0.0880992279897984
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CACNB1,Voltage-dependent L-type calcium channel subunit beta-1,39719,-0.0107269929132077,0.00630050098401048,-0.0230759748418682,0.00162198901545284,0.0886796135280653
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GM2A,Ganglioside GM2 activator,39851,0.00717946483250594,0.00422010620478676,-0.00109194332887612,0.015450872993888,0.0889248168565358
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,INSR,Insulin receptor,39784,-0.00305634709093169,0.00179953168478528,-0.00658342919311084,0.000470735011247454,0.0894593119715713
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FCGR2A,Low affinity immunoglobulin gamma Fc region receptor II-a,42096,-0.0106702694381963,0.00628435765681331,-0.0229876104455504,0.00164707156915774,0.089548992417802
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CSF2RB,Cytokine receptor common subunit beta,39784,0.00768681360477192,0.00452890333554616,-0.00118983693289856,0.0165634641424424,0.0896732639818759
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SAA4,Serum amyloid A-4 protein,40113,-0.00559417795171504,0.00330526000551595,-0.0120724875625263,0.000884131659096221,0.0905777459604693
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SSH3,Protein phosphatase Slingshot homolog 3,39665,-0.00508045614951908,0.00300481727703448,-0.0109698980125067,0.000808985713468493,0.0909104216233952
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITM2A,Integral membrane protein 2A,42103,0.0108643183478209,0.00642729542048422,-0.00173318067632817,0.02346181737197,0.0909869566019025
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYL6B,Myosin light chain 6B,39768,-0.0160286579983958,0.00948748949822869,-0.034624137414924,0.00256682141813244,0.0911623255747739
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,JCHAIN,Immunoglobulin J chain,41887,0.0109447297464233,0.00648225071973598,-0.00176048166425919,0.0236499411571058,0.0913561457114658
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITGB1BP2,Integrin beta-1-binding protein 2,41876,-0.019065494058522,0.0113373744822368,-0.0412867480437061,0.00315575992666212,0.0926613799960186
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PGLYRP4,Peptidoglycan recognition protein 4,39706,-0.0102956694382326,0.00612888641169717,-0.0223082868051591,0.00171694792869386,0.0930143264773089
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COL1A1,Collagen alpha-1(I) chain,42296,0.00434805764761125,0.00259859220483811,-0.000745183073871438,0.00944129836909393,0.0943047471223726
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF19,Tumor necrosis factor receptor superfamily member 19,42223,-0.00606696818420273,0.00363122093110498,-0.0131841612091685,0.00105022484076303,0.0947893279173278
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EFCAB2,Dynein regulatory complex protein 8,39881,-0.00605428316272908,0.00362382678447465,-0.0131569836602994,0.00104841733484123,0.0948126432259823
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FOLH1,Glutamate carboxypeptidase 2,39784,-0.017647839826604,0.0105700788228666,-0.0383651943194226,0.00306951466621449,0.0950274076466632
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,B2M,Beta-2-microglobulin,40113,-0.00542625965235193,0.00325258628865395,-0.0118013287781137,0.000948809473409818,0.095286693490943
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NT5C3A,Cytosolic 5'-nucleotidase 3A,42079,-0.0149189165788688,0.00898734724404155,-0.0325341171771902,0.00269628401945262,0.09694057363487
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL19,Interleukin-19,41783,-0.0125052171488955,0.00753433749965785,-0.0272725186482248,0.00226208435043394,0.0969869790138825
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYH7B,Myosin-7B,39665,0.00773623207794858,0.0046615067339536,-0.00140032112060047,0.0168727852764976,0.0970250883349128
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDCD1,Programmed cell death protein 1,42192,-0.00779306525075803,0.00469740226362156,-0.0169999736874563,0.00141384318594023,0.0971367058434697
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYOM1,Myomesin-1,39719,-0.00829158495629022,0.00499849419571546,-0.0180886335798925,0.00150546366731209,0.0971825580966761
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DBH,Dopamine beta-hydroxylase,40085,-0.018935557843408,0.0114203732196284,-0.0413194893538797,0.00344837366706371,0.0973360314601984
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TDO2,"Tryptophan 2,3-dioxygenase",39768,-0.00670377031695868,0.00405007086870142,-0.0146419092196135,0.0012343685856961,0.0979089542731235
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EDF1,Endothelial differentiation-related factor 1,40054,-0.0115097907308633,0.00695617448889609,-0.0251438927290997,0.002124311267373,0.0980315139625352
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDGFRA,Platelet-derived growth factor receptor alpha,42144,0.00497666959500883,0.00301021138508263,-0.000923344719753127,0.0108766839097708,0.0983016908235506
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RAB37,Ras-related protein Rab-37,41887,-0.0138424266567823,0.0083891092874989,-0.0302850808602802,0.0026002275467155,0.0989580162702885
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CASP1,Caspase-1,41829,-0.0118703521124484,0.00719493686608954,-0.0259724283699839,0.00223172414508711,0.0990045749282861
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,REXO2,"Oligoribonuclease, mitochondrial",39706,0.0081545433027859,0.00496369986410602,-0.0015743084308619,0.0178833950364337,0.100446841960102
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLIRP,"SRA stem-loop-interacting RNA-binding protein, mitochondrial",39665,-0.00984415261141183,0.00602491461192053,-0.0216529852507761,0.00196468002795241,0.102308357209912
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,METAP1D,"Methionine aminopeptidase 1D, mitochondrial",42103,-0.0138005691910519,0.00846619322765161,-0.030394307917249,0.00279316953514526,0.103109063923098
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRNN,Cornulin,41727,0.0116844422614535,0.0071837219199842,-0.00239565270171555,0.0257645372246225,0.103864965576189
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EPCAM,Epithelial cell adhesion molecule,42125,0.016671036660016,0.0102523444515193,-0.00342355846496172,0.0367656317849938,0.103958989241998
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD40LG,CD40 ligand,42256,-0.0130504806321284,0.00803484897685065,-0.0287987846267557,0.00269782336249884,0.104349853173291
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CKAP4,Cytoskeleton-associated protein 4,42215,-0.00489007318180332,0.00301221351984008,-0.0107940116806899,0.00101386531708324,0.10452488658727
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENSA,Alpha-endosulfine,40020,-0.00893222380069496,0.00550235775678719,-0.0197168450039978,0.00185239740260793,0.104544834595653
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NEDD9,Enhancer of filamentation 1,39784,-0.00565093449143604,0.00348129565069316,-0.0124742739667946,0.00117240498392255,0.104570566503523
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDC26,Anaphase-promoting complex subunit CDC26,40002,-0.0116189078324919,0.0071587533863415,-0.0256500644697213,0.00241224880473741,0.104611071738443
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MTHFD2,"Bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase, mitochondrial",40054,0.00439563103008411,0.00271168032285078,-0.00091926240270343,0.00971052446287165,0.105046889434087
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD109,CD109 antigen,42120,0.00567915616066813,0.00350367668750011,-0.00118805014683208,0.0125463624681683,0.105060624399263
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,THAP12,52 kDa repressor of the inhibitor of the protein kinase,39651,-0.0146298765214593,0.00907196190910721,-0.0324109218633094,0.00315116882039087,0.106851292943391
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OSM,Oncostatin-M,42044,-0.0116643435788712,0.00725838834687287,-0.025890784738742,0.00256209758099961,0.108075507247112
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AMBN,Ameloblastin,41887,0.00478445067075169,0.00298725161548015,-0.00107056249558941,0.0106394638370928,0.109263902704504
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SRPX,Sushi repeat-containing protein SRPX,40080,0.00613340272485675,0.00383533612770759,-0.00138385608545013,0.0136506615351636,0.109809060365026
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FKBP7,Peptidyl-prolyl cis-trans isomerase FKBP7,41810,-0.0080327969810841,0.00503411795880726,-0.0178996681803463,0.00183407421817813,0.110587272114587
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CXCL3,C-X-C motif chemokine 3,42128,-0.0153974093561525,0.00965347563916453,-0.0343182216089149,0.00352340289661002,0.110733988088571
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GBP6,Guanylate-binding protein 6,39706,-0.00753275736907319,0.00472283302108635,-0.0167895100904024,0.00172399535225605,0.110749935456949
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BCL2,Apoptosis regulator Bcl-2,40021,-0.00944453479065057,0.00592933842009923,-0.0210660380940451,0.00217696851274393,0.111223487654672
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PI3,Elafin,41959,-0.00942411118284371,0.00593220574889494,-0.0210512344506778,0.00220301208499037,0.112167530404401
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HRAS,GTPase Hras,39865,-0.0164417304916796,0.0103586697040633,-0.0367447231116436,0.00386126212828447,0.112487148922807
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GATD3,"Glutamine amidotransferase-like class 1 domain-containing protein 3B, mitochondrial",39804,0.0125251044307337,0.00790309831579775,-0.00296496826822985,0.0280151771296973,0.11303369904121
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,REG1B,Lithostathine-1-beta,42296,-0.00966728766401033,0.00610188005040822,-0.0216269725628104,0.00229239723478978,0.113146651958514
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEACAM21,Carcinoembryonic antigen-related cell adhesion molecule 21,42103,-0.0142868387496039,0.00902014856924922,-0.0319663299453324,0.00339265244612457,0.113245378338213
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL34,Interleukin-34,41813,-0.00600653103994697,0.00379757740106269,-0.0134497827460298,0.0014367206661359,0.113748976418971
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NXPH1,Neurexophilin-1,41829,0.00639491456579508,0.00405215796511384,-0.00154731504582805,0.0143371441774182,0.114556103990671
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BMP10,Bone morphogenetic protein 10,39863,0.00469100608945677,0.00298375789583252,-0.00115715938637497,0.0105391715652885,0.115938340888498
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MRPS16,"28S ribosomal protein S16, mitochondrial",39784,-0.00460142275084635,0.00292947280456321,-0.0103431894477902,0.00114034394609754,0.116274306507452
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NUDT15,Nucleotide triphosphate diphosphatase NUDT15,39706,-0.00858184740650675,0.00546508600389307,-0.0192934159741372,0.00212972116112367,0.116374459142793
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LYSMD3,LysM and putative peptidoglycan-binding domain-containing protein 3,39768,-0.0175631829702234,0.0112264325920518,-0.039566990850645,0.00444062491019825,0.117742049791912
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LYVE1,Lymphatic vessel endothelial hyaluronic acid receptor 1,40113,0.00321017700728909,0.0020533207430178,-0.000814331649025791,0.00723468566360398,0.117985761891311
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPINK5,Serine protease inhibitor Kazal-type 5,42120,0.00557675981233666,0.00358660127012956,-0.00145297867711728,0.0126064983017906,0.119997457918557
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PER3,Period circadian protein homolog 3,39784,-0.0199309008910751,0.0128373316838136,-0.0450920709913497,0.00523026920919955,0.12055494478216
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PODXL,Podocalyxin,42094,-0.00246007147012695,0.00158502265058432,-0.00556671586527222,0.000646572925018309,0.120669196913307
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SFTPA1,Pulmonary surfactant-associated protein A1,41861,-0.00933732838915099,0.00601854245122382,-0.0211336715935497,0.0024590148152477,0.120824406148724
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EPHA2,Ephrin type-A receptor 2,41650,-0.00544858379244053,0.00351329408662896,-0.0123346402022333,0.00143747261735224,0.120963609905283
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",39719,-0.00920417014568545,0.00593841950924695,-0.0208434723838095,0.00243513209243857,0.121186945929792
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,YY1,Transcriptional repressor protein YY1,39784,-0.00454367512056179,0.00293271433570195,-0.0102917952185376,0.00120444497741404,0.121337797539351
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NEFL,Neurofilament light polypeptide,41782,0.00745991885199046,0.00481539417154538,-0.00197825372423848,0.0168980914282194,0.121363270044979
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCNE1,G1/S-specific cyclin-E1,39784,-0.0142803593111672,0.00922711100597091,-0.0323654968828701,0.00380477826053582,0.121735920516264
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ST8SIA1,"Alpha-N-acetylneuraminide alpha-2,8-sialyltransferase",39784,-0.00758335453849142,0.00490660387603628,-0.0172002981355225,0.00203358905853968,0.122245484399178
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TP53INP1,Tumor protein p53-inducible nuclear protein 1,41876,0.00494315714187362,0.00320064142707439,-0.00133010005519219,0.0112164143389394,0.122509866727276
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NME3,Nucleoside diphosphate kinase 3,42146,0.00386131677297734,0.00250077145274522,-0.00104019527440328,0.00876282882035796,0.122600592105581
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,L1CAM,Neural cell adhesion molecule L1,42186,-0.00469626715313962,0.00304172041351555,-0.0106580391636301,0.00126550485735086,0.122624569055776
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL22,Interleukin-22,40020,-0.0112290593966228,0.0072739638484973,-0.0254860285396775,0.00302790974643188,0.122682211521979
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VASP,Vasodilator-stimulated phosphoprotein,40102,-0.0115530085966,0.00748402766057896,-0.0262217028113348,0.00311568561813473,0.122692784733334
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DOC2B,Double C2-like domain-containing protein beta,39768,-0.00578968014793707,0.00375643832269912,-0.0131522992604273,0.00157293896455321,0.123281369995811
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MRC1,Macrophage mannose receptor 1,40102,0.00467128545675894,0.003031343847013,-0.00127014848338653,0.0106127193969044,0.123347030681377
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLC34A3,Sodium-dependent phosphate transport protein 2C,39665,-0.00808526453191386,0.0052528987956279,-0.0183809461713445,0.00221041710751683,0.123785568608987
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NMI,N-myc-interactor,39991,0.0115393759156247,0.00750326173175862,-0.00316701707862216,0.0262457689098716,0.124098795492818
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FADD,FAS-associated death domain protein,42144,-0.0120537100817743,0.00783971530387802,-0.0274195520773752,0.00331213191382667,0.12419073326586
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EPHX2,Bifunctional epoxide hydrolase 2,41876,-0.00991103587702813,0.00645241804641243,-0.0225577752479965,0.00273570349394023,0.124558698945702
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,QSOX1,Sulfhydryl oxidase 1,39922,-0.00683396237572715,0.00445055811573823,-0.0155570562825741,0.00188913153111979,0.124683356175594
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RNASE1,Ribonuclease pancreatic,40102,-0.00420571571461162,0.00274113362893632,-0.0095783376273268,0.00116690619810357,0.124985371335786
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DCDC2C,Doublecortin domain-containing protein 2C,39665,-0.0100813926597497,0.0065712725547575,-0.0229610868670744,0.00279830154757498,0.125020165086481
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NEK7,Serine/threonine-protein kinase Nek7,39881,-0.0121194974640423,0.00790420156692812,-0.0276117325352214,0.00337273760713686,0.125232016591668
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MST1,Hepatocyte growth factor-like protein,39944,0.0104553600641566,0.00682054411152743,-0.00291290639443719,0.0238236265227503,0.12532457586865
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADA2,Adenosine deaminase 2,42083,-0.00706489962779119,0.004616673139127,-0.0161135789804801,0.00198377972489772,0.125966776328914
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACP6,Lysophosphatidic acid phosphatase type 6,42193,-0.0108953137529754,0.0071240737511528,-0.0248584983052349,0.00306787079928414,0.126198153127037
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FKBP1B,Peptidyl-prolyl cis-trans isomerase FKBP1B,42174,-0.0176339812817288,0.0115350392125907,-0.0402426581384065,0.00497469557494892,0.126355312579515
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RNF168,E3 ubiquitin-protein ligase RNF168,39784,-0.00636137832252026,0.00416694448063895,-0.0145285895045726,0.00180583285953209,0.126883153456895
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HSBP1,Heat shock factor-binding protein 1,39804,0.0148750945870837,0.00977643876010774,-0.00428672538272742,0.0340369145568949,0.128157978649717
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,JAM2,Junctional adhesion molecule B,42213,-0.00451621712519632,0.00296843411884552,-0.0103343479981335,0.0013019137477409,0.12818027241334
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COX5B,"Cytochrome c oxidase subunit 5B, mitochondrial",42094,-0.0108118080988105,0.00713993302763256,-0.0248060768329703,0.0031824606353493,0.12998110274441
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,S100A13,Protein S100-A13,39784,-0.00558754395946388,0.00369332341062393,-0.0128264578442868,0.00165136992535902,0.130340751653158
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HLA_E,,42103,-0.00486129640598448,0.00321361127776504,-0.011159974510404,0.00143738169843499,0.13037509098284
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRYBB1,Beta-crystallin B1,40080,-0.00998247254124362,0.00660482443835367,-0.0229279284404168,0.00296298335792957,0.130717874809352
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATP2B4,Plasma membrane calcium-transporting ATPase 4,39706,-0.00959111643206131,0.00635231945658838,-0.0220416625669745,0.00285942970285192,0.131109071329653
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HYOU1,Hypoxia up-regulated protein 1,42296,-0.00362421702683655,0.00240277718803906,-0.0083336603153931,0.00108522626172,0.131490356079862
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGFBP6,Insulin-like growth factor-binding protein 6,42105,-0.00510349157010817,0.00338554778911285,-0.0117391652367694,0.00153218209655302,0.131723785589136
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENDOU,Poly(U)-specific endoribonuclease,39227,-0.00856698911405877,0.00570418143175059,-0.0197471847202899,0.00261320649217239,0.133159885551897
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OMP,Olfactory marker protein,39719,-0.0078305639234755,0.00522655038625899,-0.0180746026805431,0.00241347483359211,0.134104023338311
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HPGDS,Hematopoietic prostaglandin D synthase,41861,-0.00596539364956185,0.00398634478422335,-0.0137786294266396,0.00184784212751591,0.134559513658146
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SUMF1,Formylglycine-generating enzyme,39784,-0.00992982600294938,0.0066393193713293,-0.0229428919707548,0.00308323996485605,0.13478536696493
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLEC12A,C-type lectin domain family 12 member A,39784,-0.00320185803467458,0.0021417940416072,-0.00739977435622469,0.000996058286875535,0.134959355785448
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENO2,Gamma-enolase,42213,-0.00999061804955749,0.00669917516136611,-0.0231210013658351,0.00313976526672009,0.135901566302349
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DHRS4L2,Dehydrogenase/reductase SDR family member 4-like 2,40054,-0.00725550819087375,0.00488526258895486,-0.0168306228652253,0.00231960648347777,0.137524420420943
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MDGA1,MAM domain-containing glycosylphosphatidylinositol anchor protein 1,42004,-0.0106685908638634,0.00718675529369215,-0.0247546312395,0.0034174495117732,0.137706364286294
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TLR1,Toll-like receptor 1,39784,-0.00414111708024545,0.00278973893273419,-0.00960900538840447,0.00132677122791357,0.137729878562097
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SNAP25,Synaptosomal-associated protein 25,39719,-0.00729492233403689,0.00491443773788221,-0.016927220300286,0.00233737563221224,0.137736506196054
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DCTPP1,dCTP pyrophosphatase 1,42144,0.00487712390933046,0.00330683448417111,-0.00160427167964493,0.0113585194983058,0.140274008189909
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPINT3,Kunitz-type protease inhibitor 3,40021,-0.0227368743227743,0.0154323941937019,-0.0529843669424299,0.0075106182968813,0.140693503846664
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COL28A1,Collagen alpha-1(XXVIII) chain,39768,-0.0116846839593714,0.00794523000037321,-0.0272573347601029,0.00388796684136006,0.14141447867587
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C1GALT1C1,C1GALT1-specific chaperone 1,39706,0.00499701921301741,0.00339926498092812,-0.00166554014960169,0.0116595785756365,0.141583739595809
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MSLNL,Mesothelin-like protein,39768,0.00601276296166425,0.00410474405906804,-0.00203253539410911,0.0140580613174376,0.142996322395393
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MUC16,Mucin-16,42094,-0.0292728454191778,0.0200002259412086,-0.0684732882639466,0.0099275974255911,0.143320602072391
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRR4,Proline-rich protein 4,39783,0.0106083933172829,0.007249556808378,-0.00360073802713795,0.0248175246617038,0.143410581257977
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DKKL1,Dickkopf-like protein 1,42094,0.0133518867951458,0.00912987976685989,-0.00454267754789961,0.0312464511381911,0.143645473019831
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EDNRB,Endothelin receptor type B,39784,-0.00676860229023785,0.00462923169275664,-0.0158418964080409,0.00230469182756517,0.143731489363501
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TCL1B,T-cell leukemia/lymphoma protein 1B,41876,-0.0118460613885351,0.00811048509407667,-0.0277426121729253,0.00405048939585519,0.144153849527552
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PILRB,Paired immunoglobulin-like type 2 receptor beta,42144,-0.00883346114034221,0.00606479794984325,-0.020720465122035,0.00305354284135057,0.145274916750956
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RGS8,Regulator of G-protein signaling 8,41887,-0.00976751604724247,0.00670835003577427,-0.02291588211736,0.00338085002287509,0.145410825617458
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDXDC1,Pyridoxal-dependent decarboxylase domain-containing protein 1,39665,0.00875480490447283,0.00602778955938945,-0.00305966263193049,0.0205692724408762,0.146418381254821
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CNTNAP2,Contactin-associated protein-like 2,42103,0.00626382539481682,0.00431992011458979,-0.00220321802977917,0.0147308688194128,0.147086607514035
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DAPP1,Dual adapter for phosphotyrosine and 3-phosphotyrosine and 3-phosphoinositide,42103,-0.0179178533259319,0.0123655082704744,-0.0421542495360617,0.00631854288419796,0.147356636980201
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MB,Myoglobin,42296,0.00800977180635366,0.00552791844121063,-0.00282494833841916,0.0188444919511265,0.147370710320333
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STEAP4,Metalloreductase STEAP4,39719,-0.0109433698060584,0.00755281368659791,-0.0257468846317904,0.00386014501967346,0.147391676657381
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BTLA,B- and T-lymphocyte attenuator,39665,-0.0131648303706597,0.00908940909108859,-0.0309800721891933,0.00465041144787394,0.147543452637274
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RGMB,RGM domain family member B,42213,-0.00429029488579709,0.00296728698713838,-0.0101061773805883,0.00152558760899413,0.14823928506852
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MSMB,Beta-microseminoprotein,42074,0.0108709954585712,0.00752914766846963,-0.00388613397162927,0.0256281248887717,0.148804165916541
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GATA3,Trans-acting T-cell-specific transcription factor GATA-3,39665,-0.00403073400439451,0.00279301254725507,-0.00950503859701444,0.00144357058822542,0.149008341946424
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GABARAPL1,Gamma-aminobutyric acid receptor-associated protein-like 1,39881,-0.00942378651642034,0.00655706366639443,-0.0222756313025534,0.00342805826971275,0.150691548762475
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAG,Myelin-associated glycoprotein,39768,0.00734601080542837,0.00511759645439256,-0.00268447824518105,0.0173764998560378,0.151190879495895
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SIGLEC1,Sialoadhesin,42184,-0.00644684415379025,0.00449390701479302,-0.0152549019027846,0.00236121359520407,0.151432474834092
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CYTL1,Cytokine-like protein 1,40097,0.00380838646517246,0.00265865370572273,-0.00140257479804408,0.00901934772838901,0.152043965581347
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,42146,-0.00531725605442024,0.00371377308115782,-0.0125962512934896,0.00196173918464909,0.152234774717296
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNER,Delta and Notch-like epidermal growth factor-related receptor,42097,0.00371358627814133,0.00259606555063163,-0.00137470220109666,0.00880187475737933,0.152607226118932
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ECI2,Enoyl-CoA delta isomerase 2,39706,-0.00912863675869667,0.00638562371999947,-0.0216444592498956,0.0033871857325023,0.152872857162441
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ABO,Histo-blood group ABO system transferase,40102,0.0215093019999921,0.0150803399684002,-0.0080481643380724,0.0510667683380565,0.15380630619823
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,WASF3,Wiskott-Aldrich syndrome protein family member 3,41829,-0.0124839663523412,0.00878493376492052,-0.0297024365315855,0.00473450382690298,0.155322395245545
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CXCL14,C-X-C motif chemokine 14,41887,-0.00822827195216986,0.00579082775107284,-0.0195782943442726,0.0031217504399329,0.155366140341243
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RBP7,Retinoid-binding protein 7,40021,-0.00884054735063809,0.00622312817666368,-0.0210378785768989,0.00335678387562272,0.155463209057065
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NUDT10,Diphosphoinositol polyphosphate phosphohydrolase 3-alpha,39804,0.00378325304700052,0.00266458263883968,-0.00143932892512525,0.00900583501912628,0.155686703760063
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VSIG4,V-set and immunoglobulin domain-containing protein 4,42101,0.00647548507822662,0.0045736542029412,-0.00248887715953813,0.0154398473159914,0.156851446609579
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCP2,Non-specific lipid-transfer protein,41861,-0.0108589552489434,0.00767433750428749,-0.0259006567573469,0.0041827462594601,0.157101954020269
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD86,T-lymphocyte activation antigen CD86,40021,-0.00440580823501914,0.00314641417247205,-0.0105727800130644,0.00176116354302609,0.161463147147726
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ISM2,Isthmin-2,40097,-0.00626491521275001,0.00448031728389302,-0.0150463370891803,0.0025165066636803,0.162045573041996
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NOP56,Nucleolar protein 56,39706,-0.016273866748388,0.0116624416279783,-0.0391322523392255,0.00658451884244945,0.162922254233847
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLK6,Kallikrein-6,42163,0.00460194030161306,0.0033010461099707,-0.00186811007392951,0.0110719906771556,0.163315690292409
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL2RB,Interleukin-2 receptor subunit beta,41887,0.00567546800351871,0.00407230694044942,-0.00230625359976214,0.0136571896067996,0.163440493177846
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,F2R,Proteinase-activated receptor 1,42162,-0.00805470003411788,0.00580043172824261,-0.0194235462214734,0.00331414615323764,0.164966699182424
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RAC3,Ras-related C3 botulinum toxin substrate 3,39768,0.0102848300373345,0.00741319791560328,-0.00424503787724794,0.0248146979519169,0.165358961046642
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD34,Hematopoietic progenitor cell antigen CD34,42177,0.0034920346984909,0.00252094631819606,-0.00144902008517337,0.00843308948215516,0.166012711417417
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CPTP,Ceramide-1-phosphate transfer protein,39706,0.00575366097370398,0.00416048943687212,-0.00240089832256537,0.0139082202699733,0.166716049305663
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FSHB,Follitropin subunit beta,39804,0.00770958767163103,0.00558317913070788,-0.00323344342455642,0.0186526187678185,0.167351154126396
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VGF,Neurosecretory protein VGF,40054,0.00448748081560028,0.00327615180776667,-0.00193377672762239,0.010908738358823,0.170795955006579
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PILRA,Paired immunoglobulin-like type 2 receptor alpha,42120,-0.00613082568201641,0.00448565260787152,-0.0149227047934446,0.00266105342941177,0.171723258103728
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AHCY,Adenosylhomocysteinase,42144,-0.00946346911536918,0.006976686956126,-0.0231377755493761,0.00421083731863779,0.174982319937684
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL18BP,Interleukin-18-binding protein,42197,-0.00454254759737316,0.00336305539117574,-0.0111341361640776,0.0020490409693313,0.176808512487016
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GLP1R,Glucagon-like peptide 1 receptor,39719,0.00533636534841727,0.00395720668789169,-0.00241975975985045,0.013092490456685,0.177520777800865
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD79B,B-cell antigen receptor complex-associated protein beta chain,42256,-0.00666435681180912,0.00496776745427667,-0.0164011810221914,0.00307246739857315,0.179775171733223
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CST1,Cystatin-SN,38671,-0.0153524508550761,0.0114565553387359,-0.0378072993189984,0.00710239760884629,0.180258553753743
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLSTN1,Calsyntenin-1,41829,0.0074080298431717,0.00552985918638926,-0.00343049416215124,0.0182465538484946,0.180385960819713
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SHISA5,Protein shisa-5,40097,-0.00387349401698059,0.00289178871130362,-0.00954139989113568,0.0017944118571745,0.180442282524833
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GRPEL1,"GrpE protein homolog 1, mitochondrial",42094,-0.00820536642749122,0.00615643255469886,-0.020271974234701,0.00386124137971855,0.182617086447013
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HIF1A,Hypoxia-inducible factor 1-alpha,39784,-0.00860633844878282,0.00646578412571269,-0.0212792753351797,0.00406659843761405,0.18319833967285
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLXDC1,Plexin domain-containing protein 1,41861,-0.00439119827357734,0.00329978765081027,-0.0108587820691655,0.00207638552201078,0.18329465421736
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARMCX2,Armadillo repeat-containing X-linked protein 2,39719,0.00864929704613179,0.00650299777694143,-0.0040965785966734,0.021395172688937,0.183531385824826
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL15RA,Interleukin-15 receptor subunit alpha,41887,0.00500074901898493,0.00376185635264252,-0.00237248943219441,0.0123739874701643,0.183762967311116
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TST,Thiosulfate sulfurtransferase,41796,-0.0102712919992536,0.00772862797133387,-0.025419402823068,0.00487681882456075,0.183874360417882
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OLR1,Oxidized low-density lipoprotein receptor 1,42032,0.00797156154438689,0.00600067944270989,-0.00378977016332448,0.0197328932520983,0.18405536374883
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ROR1,Inactive tyrosine-protein kinase transmembrane receptor ROR1,42144,0.00454195730348392,0.00344326519893206,-0.00220684248642292,0.0112907570933908,0.187164231373524
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MICB_MICA,MHC class I polypeptide-related sequence A_MHC class I polypeptide-related sequence B,42103,-0.0206854454579382,0.0156906453126136,-0.0514391102706608,0.0100682193547844,0.187416656180698
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GHRHR,Growth hormone-releasing hormone receptor,41829,0.00770918860628486,0.00585514142913801,-0.00376688859482564,0.0191852658073954,0.187978898669701
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTAG1A_CTAG1B,Cancer/testis antigen 1,39867,0.00689984519562568,0.00524521525389445,-0.00338077670200745,0.0171804670932588,0.188385252791736
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SEMA4D,Semaphorin-4D,42213,-0.00407032457161249,0.00309553735729659,-0.0101375777919138,0.00199692864868882,0.188566401578069
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGFBP3,Fibroblast growth factor-binding protein 3,40054,0.00502120768547317,0.00382585401270794,-0.0024774661794344,0.0125198815503807,0.189399115595011
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EDN1,Endothelin-1,39804,-0.00411986705483919,0.00315916938005224,-0.0103118390397416,0.0020721049300632,0.192228398095091
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITIH5,Inter-alpha-trypsin inhibitor heavy chain H5,40020,0.00606450923280511,0.00465621707816362,-0.00306167624039559,0.0151906947060058,0.19278889007255
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TRDMT1,tRNA (cytosine(38)-C(5))-methyltransferase,39881,-0.0122617752174215,0.00941904142013427,-0.0307230964008847,0.00619954596604166,0.193010386973727
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EFNB2,Ephrin-B2,39768,-0.00735213249210696,0.0056560072816535,-0.0184379067641478,0.00373364177993389,0.193670330030377
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APOM,Apolipoprotein M,42172,0.00381028396300204,0.00293517765402277,-0.00194266423888258,0.00956323216488666,0.194260843770084
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CSPG5,Chondroitin sulfate proteoglycan 5,39719,0.00697166031213361,0.00537574410947515,-0.0035647981424377,0.0175081187667049,0.194703130328956
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEP164,Centrosomal protein of 164 kDa,41887,-0.00890425985643699,0.00686924079292363,-0.0223679718105673,0.00455945209769333,0.194912610927199
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SFTPA2,Pulmonary surfactant-associated protein A2,41861,-0.00705543792402813,0.00544511599301572,-0.0177278652703389,0.00361698942228267,0.195089741022604
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RPA2,Replication protein A 32 kDa subunit,39784,-0.0043062996578471,0.00332389988130228,-0.0108211434251996,0.00220854410950536,0.195156607994117
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IDI2,Isopentenyl-diphosphate delta-isomerase 2,41829,0.00653308106396014,0.00504924108194987,-0.00336343145666159,0.0164295935845819,0.195732644351391
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLAU,Urokinase-type plasminogen activator,42120,0.00396831032444273,0.0030734751238052,-0.00205570091821545,0.00999232156710091,0.196675557551327
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ZCCHC8,Zinc finger CCHC domain-containing protein 8,39706,-0.00807754049895466,0.00625707941098304,-0.0203414161444814,0.00418633514657209,0.196751409661072
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CA11,Carbonic anhydrase-related protein 11,41861,-0.00436677892531403,0.00339580920457694,-0.0110225649662848,0.00228900711565678,0.198490382255086
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GID8,Glucose-induced degradation protein 8 homolog,40054,-0.00456359515473926,0.00355461581842773,-0.0115306421588576,0.00240345184937908,0.199221674216173
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PMM2,Phosphomannomutase 2,39706,-0.00796455168332411,0.00622519882407077,-0.0201659413785028,0.0042368380118546,0.200782645515923
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARID3A,AT-rich interactive domain-containing protein 3A,39719,-0.00539159811554623,0.00422395782516052,-0.0136705554528608,0.00288735922176838,0.201830747876502
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CREBZF,CREB/ATF bZIP transcription factor,39665,0.00345601444267793,0.00271053013696084,-0.00185662462576531,0.00876865351112117,0.202325973147913
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TPBGL,Trophoblast glycoprotein-like,39768,-0.00558258512209585,0.00439985515942322,-0.0142063012345654,0.00304113099037366,0.204536370280707
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CST7,Cystatin-F,42150,-0.0123713356544868,0.00975550412531454,-0.0314921237401033,0.00674945243112974,0.204771088601082
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CNTF,Ciliary neurotrophic factor,39719,0.00450164173677685,0.00358247999500602,-0.00252001905343495,0.0115233025269887,0.208936780804443
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VSTM2B,V-set and transmembrane domain-containing protein 2B,39881,-0.00530690598907577,0.00422679768981577,-0.0135914294611147,0.00297761748296313,0.209310897917385
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,42280,-0.00373118618408598,0.00297552074474658,-0.00956320684378929,0.00210083447561733,0.209878676846703
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CSF1,Macrophage colony-stimulating factor 1,42184,-0.00361722796053272,0.00289217468247019,-0.0092858903381743,0.00205143441710885,0.211068359576336
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GAGE2A,G antigen 2A,39665,-0.00867440450739928,0.00695234449056563,-0.0223009997089079,0.00495219069410935,0.212170725116751
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCGB3A1,Secretoglobin family 3A member 1,39863,0.00346692852588611,0.00278155224814767,-0.00198491388048332,0.00891877093225554,0.212644708589835
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL21R,Interleukin-21 receptor,39784,-0.00727314134261571,0.00584033419965997,-0.0187201963739492,0.00417391368871783,0.213038154911028
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TAGLN3,Transgelin-3,39665,-0.0079041467642516,0.00635628807815311,-0.0203624713974317,0.00455417786892849,0.213705539868107
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RNF43,E3 ubiquitin-protein ligase RNF43,39881,-0.00734156507471669,0.00591368684334062,-0.0189323912876643,0.00424926113823093,0.214465647150241
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DEFB104A_DEFB104B,Beta-defensin 104,39719,-0.00691254925681237,0.00557158668153681,-0.0178328591526245,0.00400776063899977,0.214752098160527
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CGB3_CGB5_CGB8,Choriogonadotropin subunit beta 3,40102,-0.00483889304153512,0.00391805283721674,-0.0125182766024799,0.00284049051940968,0.216847816637027
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL28,C-C motif chemokine 28,42049,-0.00754325780694752,0.00611166046863481,-0.0195221123254717,0.0044355967115767,0.2171359273672
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PAM,Peptidyl-glycine alpha-amidating monooxygenase,42226,-0.00364937539114399,0.00295854207471096,-0.00944811785757747,0.00214936707528949,0.217409791705806
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNNI3,"Troponin I, cardiac muscle",41876,-0.0106967711305704,0.00873581987438277,-0.0278189780843607,0.00642543582321979,0.220796781927905
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL25,Interleukin-25,39622,-0.00445959229592744,0.00364370274373543,-0.0116012496736489,0.00268206508179399,0.221010926318409
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AGT,Angiotensinogen,40102,0.00304147570597592,0.00249131441789416,-0.00184150055309663,0.00792445196504847,0.222176123385294
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDKN2D,Cyclin-dependent kinase 4 inhibitor D,42094,-0.0117530254778826,0.00963129460367321,-0.030630362901082,0.00712431194531694,0.222375181157724
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KDM3A,Lysine-specific demethylase 3A,39784,-0.0111149902365731,0.00911906474384737,-0.028988357134514,0.00675837666136772,0.222919197609051
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD82,CD82 antigen,39881,0.00519384380537737,0.00427584880616379,-0.00318681985470365,0.0135745074654584,0.22451002380818
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LGALS7_LGALS7B,Galectin-7,42030,-0.00546200086901629,0.00449790518022546,-0.0142778950222582,0.00335389328422561,0.224639010057776
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KIAA1549,UPF0606 protein KIAA1549,39881,-0.00889086180954212,0.0073237987344089,-0.0232455073289836,0.00546378370989932,0.224786535098735
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LILRA2,Leukocyte immunoglobulin-like receptor subfamily A member 2,42120,0.00446475302197724,0.00368348317442402,-0.00275487399989383,0.0116843800438483,0.225495940029791
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GPC1,Glypican-1,42223,-0.00376495012008066,0.00311079071278567,-0.00986209991714057,0.00233219967697925,0.226190671136243
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLINT1,Clathrin interactor 1,39665,-0.00582461329469131,0.00482196976977445,-0.0152756740434492,0.00362644745406662,0.227100564394291
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MRPL28,"39S ribosomal protein L28, mitochondrial",40054,0.00464658854378442,0.00384879818605232,-0.00289705590087812,0.012190232988447,0.227349476506126
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCIN,Adseverin,39719,-0.00912189797662272,0.0075988068789205,-0.0240155594593069,0.00577176350606146,0.229996221752026
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NMRK2,Nicotinamide riboside kinase 2,39665,0.00528780639513256,0.00441505089990526,-0.00336569336868175,0.0139413061589469,0.23106976662476
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NGFR,Tumor necrosis factor receptor superfamily member 16,40080,0.00367229370199161,0.00307582919782381,-0.00235633152574306,0.00970091892972629,0.232535316380699
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARHGEF5,Rho guanine nucleotide exchange factor 5,39719,0.00918154325271975,0.00773539759861667,-0.00597983604056892,0.0243429225460084,0.23527346599059
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLB1,"Phospholipase B1, membrane-associated",40054,-0.00741616158677976,0.00625104731597054,-0.019668214326082,0.00483589115252251,0.235495436882663
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GFOD2,Glucose-fructose oxidoreductase domain-containing protein 2,41861,-0.0151978808146214,0.0128222390933876,-0.0403294694376611,0.0099337078084183,0.235930927696336
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IFNW1,Interferon omega-1,39706,0.00454115370457115,0.00383498773988716,-0.00297542226560769,0.01205772967475,0.236385317863455
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYLPF,"Myosin regulatory light chain 2, skeletal muscle isoform",39768,0.00616752822948221,0.00520949137026193,-0.00404307485623118,0.0163781313151956,0.236478396998041
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRDX6,Peroxiredoxin-6,42223,0.00746531052565898,0.00630647174272303,-0.00489537409007815,0.0198259951413961,0.236532091793044
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD33,Myeloid cell surface antigen CD33,42186,-0.00987318657612864,0.00834858905886472,-0.0262364211315035,0.00649004797924621,0.236982460530657
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TLR4,Toll-like receptor 4,39784,-0.00360945145301272,0.00306039452219337,-0.00960782471651173,0.00238892181048629,0.238262549095876
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ICOSLG,ICOS ligand,42094,-0.00235938354381534,0.00201055308632673,-0.00630006759301573,0.00158130050538504,0.240617123110749
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRKCQ,Protein kinase C theta type,41887,-0.0053223631763404,0.00453576991775161,-0.0142124722151336,0.00356774586245277,0.240649435425538
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLXDC2,Plexin domain-containing protein 2,40054,-0.00332706657927645,0.00284103081276597,-0.00889548697229776,0.00224135381374486,0.241593417582877
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FZD8,Frizzled-8,39719,0.00558382058842535,0.00477258476773288,-0.00377044555633109,0.0149380867331818,0.242036196043581
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ICAM3,Intercellular adhesion molecule 3,42296,0.00328099838309506,0.00280487529601188,-0.00221655719708822,0.00877855396327834,0.24212351378965
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GIPC3,PDZ domain-containing protein GIPC3,40021,-0.0117493677882002,0.0100568740841983,-0.031460840993229,0.00796210541682854,0.2427146351142
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HLA_DRA,,42059,0.00449569146894561,0.00385223218098022,-0.00305468360577562,0.0120460665436668,0.243217689470087
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNXB,Tenascin-X,42120,-0.00312821337203955,0.00268266654796243,-0.00838623980604591,0.00212981306196681,0.24360217557278
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLC1A4,Neutral amino acid transporter A,39768,-0.00630707878830739,0.00541378993688246,-0.016918107064597,0.00430394948798224,0.244044263447043
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DUOX2,Dual oxidase 2,41876,-0.00864223081943454,0.00744161702519463,-0.023227800188816,0.00594333854994693,0.245526428428086
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDIA3,Protein disulfide-isomerase A3,39863,-0.00298649242558379,0.002571849226305,-0.00802731690914159,0.002054332057974,0.245576894655584
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NME1,Nucleoside diphosphate kinase A,39784,0.00264123947340819,0.00227570977969126,-0.00181915169478667,0.00710163064160305,0.245821703128041
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PALLD,Palladin,39784,0.00471431122273463,0.00406454144281671,-0.00325219000518613,0.0126808124506554,0.246130738702311
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEP350,Centrosome-associated protein 350,39665,-0.00458937841294147,0.00396245911766551,-0.0123557982835659,0.00317704145768294,0.246802845083632
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CPVL,Probable serine carboxypeptidase CPVL,42200,-0.00497929307941048,0.00430039335637648,-0.0134080640579084,0.00344947789908742,0.246938674249055
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COPB2,Coatomer subunit beta',39706,-0.00522030003509921,0.00451945037642272,-0.0140784227728877,0.00363782270268934,0.24808634219331
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MANF,Mesencephalic astrocyte-derived neurotrophic factor,42184,-0.0140829447147992,0.0121950137311065,-0.0379851716277679,0.00981928219816955,0.248188781722191
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TEF,Thyrotroph embryonic factor,39706,-0.00521565114906253,0.00451737809972067,-0.014069712224515,0.00363840992639,0.248290815941215
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PEPD,Xaa-Pro dipeptidase,40102,0.0031738448058156,0.00275025401816124,-0.00221665306978042,0.00856434268141163,0.248517750015981
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSCA,Prostate stem cell antigen,40021,-0.0318218843803239,0.0276216052929884,-0.0859602307545812,0.0223164619939335,0.249319806337137
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANXA10,Annexin A10,41829,-0.0103222512624581,0.00897985182379976,-0.0279227608371056,0.00727825831218943,0.25037568188518
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DTX2,Probable E3 ubiquitin-protein ligase DTX2,39768,0.0075987633184498,0.00661078570377347,-0.00535837666094621,0.0205559032978458,0.250396739209837
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DDX39A,ATP-dependent RNA helicase DDX39A,39784,-0.00292362356695118,0.00254609697060266,-0.00791397362933239,0.00206672649543003,0.250880333679893
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FKBP14,Peptidyl-prolyl cis-trans isomerase FKBP14,40054,-0.0117774312293772,0.010269095610552,-0.031904858626059,0.00834999616730465,0.251456049476908
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LTO1,Protein LTO1 homolog,41887,-0.00505090285994905,0.00440443362707787,-0.0136835927690217,0.00358178704912358,0.251495443963484
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDNF,Cerebral dopamine neurotrophic factor,42094,-0.00398656728708107,0.00347805970342361,-0.0108035643057913,0.00283042973162921,0.25173185440622
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINA7,Thyroxine-binding globulin,40113,0.00219340384176224,0.00191618797355376,-0.00156232458640313,0.00594913226992761,0.252370767319911
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MCFD2,Multiple coagulation factor deficiency protein 2,42076,-0.0051477099520521,0.00450215398605873,-0.0139719317647272,0.00367651186062301,0.252898677708521
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FOS,Proto-oncogene c-Fos,39651,-0.00426225193709892,0.00372824473802809,-0.011569611623634,0.00304510774943613,0.252968089526176
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OGT,UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit,39881,-0.00746872903574414,0.0065350100039118,-0.0202773486434113,0.00533989057192298,0.253114222609396
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTPRZ1,Receptor-type tyrosine-protein phosphatase zeta,40080,-0.00380700706571338,0.0033333033110864,-0.0103402815554427,0.00272626742401596,0.25343241923052
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TINAGL1,Tubulointerstitial nephritis antigen-like,42116,0.00264788445124362,0.00232340695834277,-0.00190599318710822,0.00720176208959545,0.254450810545884
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NCLN,Nicalin,41887,-0.00613793065707526,0.00539755530540008,-0.0167171390556594,0.00444127774150891,0.255489258022015
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C3,Complement C3,39575,-0.00553942746100267,0.00487203731524072,-0.0150886205988745,0.00400976567686914,0.255571305012585
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MFAP3L,Microfibrillar-associated protein 3-like,39768,0.00797924100041915,0.0070318696708053,-0.00580322355435923,0.0217617055551975,0.256516120715596
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GPR101,Probable G-protein coupled receptor 101,39719,0.00715506532097743,0.00630955877973982,-0.00521166988731262,0.0195218005292675,0.256818669585253
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRTM2,Leucine-rich repeat and transmembrane domain-containing protein 2,40054,0.00316197442691431,0.00279062871737752,-0.00230765785914564,0.00863160671297426,0.257210361841056
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,H2AP,Huntingtin-interacting protein M,39665,0.00617592984353555,0.00548320369901167,-0.00457114940652733,0.0169230090935984,0.260049128537499
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDIA2,Protein disulfide-isomerase A2,39665,0.00489834018502859,0.00435580823998404,-0.00363904396534013,0.0134357243353973,0.260803989293096
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL6,Interleukin-6,42094,-0.0089759173715546,0.00798844878105791,-0.0246332769824281,0.0066814422393189,0.261198547901732
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PGM2,Phosphoglucomutase-2,39768,-0.00698160990279774,0.00621581965999714,-0.0191646164363921,0.00520139663079666,0.261377977078008
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TREM2,Triggering receptor expressed on myeloid cells 2,42126,-0.00611129157511481,0.00544588870520434,-0.0167852334373153,0.00456265028708569,0.261804861288152
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LTBR,Tumor necrosis factor receptor superfamily member 3,42075,0.00353482082096622,0.00315146776662402,-0.00264205600161687,0.00971169764354931,0.262035296427167
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MRPL46,"39S ribosomal protein L46, mitochondrial",41829,-0.00328313806606807,0.00293529730826615,-0.00903632079026971,0.00247004465813358,0.263373603794496
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BTNL10,Butyrophilin-like protein 10,39665,0.00494862219628186,0.00445602316131788,-0.00378518319990119,0.0136824275924649,0.266788980323938
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TMOD4,Tropomodulin-4,39665,0.00475207161688536,0.00428486134726802,-0.00364625662375996,0.0131503998575307,0.267439505923677
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KHDC3L,KH domain-containing protein 3,39665,0.00792922618898216,0.00715630173300331,-0.00609712520770434,0.0219555775856686,0.26788461853485
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NFU1,"NFU1 iron-sulfur cluster scaffold homolog, mitochondrial",40021,0.0117133818499321,0.010574255609189,-0.00901215914407844,0.0324389228439425,0.268004612284372
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BRD1,Bromodomain-containing protein 1,39881,0.00348560578600399,0.00315654257179507,-0.00270121765471435,0.00967242922672232,0.269510439404812
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PCDHB15,Protocadherin beta-15,40020,-0.00462241791252701,0.00419074160529192,-0.0128362714588992,0.00359143563384516,0.270048582511196
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GFRA2,GDNF family receptor alpha-2,42094,-0.00244393527120241,0.0022196071453189,-0.00679436527602745,0.00190649473362264,0.270888220730517
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NRTN,Neurturin,41887,-0.00558889948591154,0.00508929649431968,-0.0155639206147781,0.00438612164295504,0.272152230314152
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C7,Complement component C7,39833,0.00375436247102977,0.00342700569216619,-0.00296256868561597,0.0104712936276755,0.27331251246127
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SH3GL3,Endophilin-A3,39831,-0.00971061204375315,0.00886873797854069,-0.0270933384816929,0.0076721143941866,0.273573836814866
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GPNMB,Transmembrane glycoprotein NMB,41834,-0.00330482262022273,0.00302045740424656,-0.00922491913254599,0.00261527389210052,0.273911621137142
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPINK8,Serine protease inhibitor Kazal-type 8,39706,0.00431111877215347,0.00394169546065701,-0.00341460433073428,0.0120368418750412,0.274102014249126
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OGN,Mimecan,42120,0.00505699823207418,0.00462555191454601,-0.004009083520436,0.0141230799845844,0.274293643256925
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNM1,Dynamin-1,40021,0.0128655755946317,0.0118010672173779,-0.010264516151429,0.0359956673406923,0.275647371006153
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COL9A1,Collagen alpha-1(IX) chain,42103,0.00548208364867377,0.00504464064399146,-0.00440541201354949,0.015369579310897,0.277183337268483
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SMPD3,Sphingomyelin phosphodiesterase 3,39784,-0.00618900096544981,0.00570063292351171,-0.0173622414955328,0.00498423956463315,0.277650132662418
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GABRA4,Gamma-aminobutyric acid receptor subunit alpha-4,39719,0.0072462335740268,0.00667548805971632,-0.00583772302301718,0.0203301901710708,0.277725703206012
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C5,Complement C5,40113,0.00169307572819928,0.00156336141356329,-0.00137111264238477,0.00475726409878332,0.278845023433307
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,M6PR,Cation-dependent mannose-6-phosphate receptor,39804,-0.0044542823422895,0.00411792199905309,-0.0125254094604335,0.00361684477585455,0.279418412192136
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HSD17B3,Testosterone 17-beta-dehydrogenase 3,39706,-0.0054913306718784,0.00509721451277901,-0.0154818711169253,0.00449920977316845,0.281362093093407
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,S100A3,Protein S100-A3,40020,-0.00482224278879046,0.00450339357871556,-0.0136488942030729,0.00400440862549203,0.284282345212819
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,INPP1,Inositol polyphosphate 1-phosphatase,42094,-0.00587081617057103,0.00549521937278205,-0.0166414461412238,0.00489981380008178,0.285382772160872
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GC,Vitamin D-binding protein,40113,0.00286041593766148,0.0026879474881698,-0.00240796113915132,0.00812879301447428,0.287278115355033
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FCER2,Low affinity immunoglobulin epsilon Fc receptor,42120,-0.00597611545863773,0.00563540658712305,-0.0170215123693989,0.00506928145212344,0.288955822645003
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SSB,Lupus La protein,41829,-0.00643349495769809,0.00608324926649813,-0.0183566635200344,0.00548967360463825,0.290269267932563
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RANBP2,E3 SUMO-protein ligase RanBP2,39719,0.00355740008906989,0.00336659007635828,-0.00304111646059234,0.0101559166387321,0.290683035844012
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ERVV_1,,39706,0.00480744565531636,0.00455226035162644,-0.00411498463387145,0.0137298759445042,0.290966519311215
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HDAC8,Histone deacetylase 8,39784,-0.00647189548260474,0.00612901575611608,-0.0184847663645922,0.00554097539938277,0.291018032461012
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MFAP3,Microfibril-associated glycoprotein 3,41876,-0.00531975493938345,0.00504104591364128,-0.0152002049301204,0.00456069505135346,0.291313759759092
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FRMD7,FERM domain-containing protein 7,39768,-0.00367368928386425,0.00349486586123839,-0.0105236263718915,0.00317624780416298,0.29320570542885
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ECSCR,Endothelial cell-specific chemotaxis regulator,39719,-0.00563757009368097,0.00536410659322222,-0.0161512190163965,0.00487607882903458,0.29329178994019
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TTN,Titin,39706,-0.00717070722272026,0.0068256289143167,-0.020548939894781,0.00620752544934047,0.293486586654939
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C1QTNF6,Complement C1q tumor necrosis factor-related protein 6,40054,-0.00354080747963992,0.00337252099841344,-0.0101509486365303,0.00306933367725043,0.293787770031104
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL10,Interleukin-10,41887,0.00924156806174523,0.00881460280280878,-0.00803505343175999,0.0265181895552504,0.294456631683777
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITGA2,Integrin alpha-2,39863,-0.00380460703573918,0.00363236927097213,-0.0109240508068446,0.00331483673536619,0.2949308048409
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NGF,Beta-nerve growth factor,42004,-0.00130757961288032,0.0012503321319776,-0.00375823059155642,0.00114307136579578,0.295679662492032
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPTLC1,Serine palmitoyltransferase 1,40054,-0.0041662456830654,0.00400014189451024,-0.0120065237963055,0.00367403243017466,0.297655385858642
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CAMLG,Guided entry of tail-anchored proteins factor CAMLG,39768,-0.00591333543589217,0.00567826868095414,-0.0170427420505623,0.00521607117877796,0.297714860715721
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SHD,SH2 domain-containing adapter protein D,39674,0.00945229012553649,0.00907967606984606,-0.00834387497136179,0.0272484552224348,0.297881809590373
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C1R,Complement C1r subcomponent,40113,-0.00206011212555902,0.0019939905993984,-0.00596833370037988,0.00184810944926184,0.30155172339482
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C1RL,Complement C1r subcomponent-like protein,40093,-0.00213303183531587,0.00206506736906908,-0.00618056387869127,0.00191450020805954,0.301668234955041
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDH23,Cadherin-23,40054,0.00279498840262344,0.00270676396416869,-0.00251026896714718,0.00810024577239407,0.301816901405057
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TPPP3,Tubulin polymerization-promoting protein family member 3,41829,-0.00426974599890804,0.00413703864476662,-0.0123783417426506,0.00383884974483454,0.302055398234537
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TMED4,Transmembrane emp24 domain-containing protein 4,39706,-0.00615426838106567,0.00596829914789503,-0.0178521347109399,0.00554359794880859,0.302489751686874
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RALB,Ras-related protein Ral-B,39784,0.00320922214774729,0.00311519596158218,-0.00289656193695379,0.00931500623244837,0.302947601560868
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BEX3,Protein BEX3,39665,-0.00509832847079228,0.00495986647071519,-0.0148196667533941,0.00462300981180949,0.304012861824218
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TXNDC15,Thioredoxin domain-containing protein 15,42186,-0.00295019310856481,0.00287150221844939,-0.00857833745672561,0.00267795123959599,0.304249356238201
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FBLN2,Fibulin-2,40097,0.0034685643115122,0.00338000327686652,-0.00315624211114618,0.0100933707341706,0.304819397500825
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FUT1,"Galactoside alpha-(1,2)-fucosyltransferase 1",39847,-0.00677189942444318,0.00660232370873097,-0.0197124538935559,0.00616865504466953,0.30506373081522
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADGRE2,Adhesion G protein-coupled receptor E2,42184,-0.00301811153454091,0.00294471741232634,-0.00878975766270054,0.00275353459361872,0.30541813703122
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GBP2,Guanylate-binding protein 2,41887,0.00645338570106256,0.00629719798368393,-0.00588912234695793,0.0187958937490831,0.305475806515775
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADRA2A,Alpha-2A adrenergic receptor,39706,-0.0074036065714328,0.00724831298234649,-0.0216103000168319,0.00680308687396632,0.307076730605998
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DDA1,DET1- and DDB1-associated protein 1,39706,-0.00426614022390082,0.00419787930789192,-0.012493983667369,0.00396170321956735,0.309528594890779
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF13C,Tumor necrosis factor receptor superfamily member 13C,41887,-0.00455383807967043,0.00448997159430301,-0.0133541824045043,0.00424650624516346,0.310495091222117
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTLA4,Cytotoxic T-lymphocyte protein 4,40097,-0.00316328928054695,0.00311915357926962,-0.0092768302959154,0.0029502517348215,0.310533736247957
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KRT19,"Keratin, type I cytoskeletal 19",42071,-0.00740480950855992,0.00732819389608331,-0.0217680695448832,0.00695845052776337,0.312296377384862
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NFKB2,Nuclear factor NF-kappa-B p100 subunit,39881,-0.00549443334863807,0.00545230572962152,-0.0161809525786962,0.00519208588142011,0.313608561431474
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ALDH2,"Aldehyde dehydrogenase, mitochondrial",40020,-0.00549598256255351,0.00545423976956552,-0.0161862925109019,0.0051943273857949,0.31364346469482
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LIFR,Leukemia inhibitory factor receptor,42103,-0.00251915879555196,0.00251010590745956,-0.0074389663741727,0.00240064878306878,0.315587095035646
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPT1,Palmitoyl-protein thioesterase 1,39768,-0.00805604561872806,0.00805021801038691,-0.0238344729190864,0.00772238168163029,0.316983205686951
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLMP,CXADR-like membrane protein,42223,0.00229118874843551,0.00228987227386745,-0.00219696090834468,0.00677933840521571,0.317050946215959
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD7,T-cell antigen CD7,39752,-0.0046370295123251,0.00464307555275509,-0.0137374575957251,0.00446339857107487,0.317963976555698
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CALB1,Calbindin,42094,0.00474583046027533,0.00475389935219059,-0.00457181227001823,0.0140634731905689,0.318151334002368
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MGMT,Methylated-DNA--protein-cysteine methyltransferase,42103,-0.0123599342753522,0.0123834297235329,-0.0366314565334767,0.0119115879827724,0.318248283758617
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KRT14,"Keratin, type I cytoskeletal 14",41486,0.00303671006869482,0.00304378498852973,-0.00292910850882345,0.00900252864621309,0.318456319101694
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TP53BP1,TP53-binding protein 1,39784,-0.00900353780296226,0.00902655235303894,-0.0266955804149186,0.00868850480899406,0.318568752320693
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGF6,Fibroblast growth factor 6,39784,-0.00427875131346519,0.00429018539383962,-0.0126875146853908,0.00413001205846047,0.31862480109869
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLC13A1,Solute carrier family 13 member 1,40020,-0.00639285854260791,0.00644513095029519,-0.0190253152051865,0.00623959811997066,0.32127353748306
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PVALB,Parvalbumin alpha,42158,0.011325653105529,0.0114219024868957,-0.0110612757687865,0.0337125819798445,0.321424244374392
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL17RA,Interleukin-17 receptor A,42120,-0.00453338724970746,0.0045746405694404,-0.0134996827658106,0.00443290826639572,0.321712835249107
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AMY2B,Alpha-amylase 2B,41315,0.00515873065288766,0.00521560810128818,-0.00506386122563716,0.0153813225314125,0.322636523878928
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TFAP2A,Transcription factor AP-2-alpha,39719,-0.00626226318943145,0.00634499531250043,-0.0186984540019323,0.00617392762306939,0.323684424973895
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TSC1,Hamartin,39784,-0.00755044137428988,0.007651207592927,-0.0225468082564268,0.00744592550784705,0.323748518795459
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LYPLA2,Acyl-protein thioesterase 2,39719,-0.011467127365447,0.0116306667872871,-0.0342632342685297,0.0113289795376356,0.32418573750746
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD2,T-cell surface antigen CD2,39706,-0.00395175961995143,0.00401611763310144,-0.0118233501808302,0.00391983094092739,0.325150418086392
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL18RAP,Interleukin-18 receptor accessory protein,41935,0.0175499316052277,0.0178833997295267,-0.0175015318646446,0.0526013950751,0.326437228672721
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BTN2A1,Butyrophilin subfamily 2 member A1,42184,-0.00285456140126118,0.00291973572924014,-0.00857724343057185,0.00286812062804949,0.328251810606452
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL17A,Interleukin-17A,41865,-0.004377609204172,0.00448054417406578,-0.0131594757853409,0.00440425737699692,0.328574816931028
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ICAM5,Intercellular adhesion molecule 5,42144,-0.00464813340223534,0.00476161513965236,-0.013980899075954,0.00468463227148329,0.328999756727827
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GIPR,Gastric inhibitory polypeptide receptor,39784,-0.00492453407455945,0.00505380668932367,-0.0148299951856338,0.00498092703651494,0.329869930523542
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HMGCS1,"Hydroxymethylglutaryl-CoA synthase, cytoplasmic",39706,0.00440383040873451,0.00452145409030018,-0.00445821960825384,0.0132658804257229,0.330086184992854
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IKZF2,Zinc finger protein Helios,41861,-0.00890615508002488,0.00917378696986494,-0.0268867775409602,0.0090744673809104,0.331653243521107
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FOSB,Protein fosB,41829,-0.00387848749693841,0.00400013811793206,-0.0117187582080852,0.00396178321420843,0.332270259421557
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SMC3,Structural maintenance of chromosomes protein 3,39665,-0.00557366564245421,0.00574994765569059,-0.0168435630476078,0.00569623176269934,0.332396979873625
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITGA6,Integrin alpha-6,42103,-0.00510552488157137,0.00528603698484718,-0.0154661573718719,0.00525510760872912,0.334136764592309
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DDX1,ATP-dependent RNA helicase DDX1,40021,-0.00498244960745243,0.0051750508825539,-0.0151255493372581,0.00516065012235322,0.335678072001468
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GART,Trifunctional purine biosynthetic protein adenosine-3,40054,-0.00271175436855664,0.0028360117169783,-0.00827033733383412,0.00284682859672083,0.338999614794342
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATXN2,Ataxin-2,39719,-0.0108915436958305,0.011419731271611,-0.033274216988188,0.011491129596527,0.340233215975439
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SUSD4,Sushi domain-containing protein 4,40020,0.00415846408002166,0.00436352770065411,-0.00439405021326039,0.0127109783733037,0.340608772042603
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FXYD5,FXYD domain-containing ion transport regulator 5,41887,-0.00647575914684522,0.00684589026426392,-0.0198937040648025,0.00694218577111206,0.344200347421304
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFSF12,Tumor necrosis factor ligand superfamily member 12,42256,-0.00276158749781912,0.0029198417530576,-0.00848447733381202,0.00296130233817378,0.344267896751896
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENPEP,Glutamyl aminopeptidase,39706,-0.004706442076981,0.00498923634446897,-0.0144853453121402,0.00507246115817817,0.345539374087458
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FXN,"Frataxin, mitochondrial",42223,-0.00715232243327246,0.00759433389186413,-0.0220372168613262,0.00773257199478123,0.346313937885287
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CNPY2,Protein canopy homolog 2,41876,-0.0060574888110445,0.00643257438219615,-0.018665334600149,0.00655035697805996,0.346369485252909
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MANEAL,"Glycoprotein endo-alpha-1,2-mannosidase-like protein",39665,0.00504522940459746,0.00536779709281796,-0.00547565289732574,0.0155661117065207,0.347287010387529
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PXDNL,Peroxidasin-like protein,40020,0.00542267691672086,0.00578252444635666,-0.00591107099813819,0.0167564248315799,0.348383633138562
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LYPD1,Ly6/PLAUR domain-containing protein 1,41829,0.00599337081020116,0.00639618329154677,-0.00654314844123052,0.0185298900616328,0.348764640478846
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGF12,Fibroblast growth factor 12,39784,0.00452850547115282,0.00484588863149591,-0.00496943624657916,0.0140264471888848,0.350064944540619
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BSND,Barttin,39665,-0.0033172195490667,0.00355081641509983,-0.0102768197226624,0.00364238062452897,0.350215472788049
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,42057,-0.0027676538447857,0.00296364862142105,-0.00857640514277097,0.00304109745319957,0.350389998349228
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TIGAR,"Fructose-2,6-bisphosphatase TIGAR",41810,-0.00452185202878439,0.0048477930810738,-0.014023526467689,0.00497982241012025,0.350959132705912
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FBN2,Fibrillin-2,39768,-0.00590598655307502,0.00633482715717926,-0.0183222477811464,0.00651027467499632,0.351200576110162
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MELTF,Melanotransferrin,40080,-0.00290728260135578,0.00313195647980044,-0.00904591730176466,0.00323135209905309,0.353291199201105
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARNTL,Aryl hydrocarbon receptor nuclear translocator-like protein 1,39706,-0.00511946628574821,0.00555983950809873,-0.0160167517216217,0.00577781915012529,0.357179172391009
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPINT1,Kunitz-type protease inhibitor 1,42075,-0.00250428952919716,0.00272191680881747,-0.0078392464744794,0.00283066741608508,0.357565786129955
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CADPS,Calcium-dependent secretion activator 1,39768,0.0041112949569965,0.00447981093029498,-0.00466913446638165,0.0128917243803747,0.35877671896527
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GDF15,Growth/differentiation factor 15,42296,-0.00442612205905109,0.00483028391558491,-0.0138934785335975,0.00504123441549534,0.359512005738889
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSMA1,Proteasome subunit alpha type-1,41861,-0.00439365991976043,0.00480095984960804,-0.0138035412249922,0.00501622138547133,0.360123584434667
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VWC2,Brorin,41965,0.00391883295970168,0.00428306973557195,-0.00447598372201935,0.0123136496414227,0.360230458869421
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MUC2,Mucin-2,40097,0.00871905102717412,0.00961930787463276,-0.0101347924071061,0.0275728944614543,0.364738132667465
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AFP,Alpha-fetoprotein,41968,0.00630167069279816,0.00695717102384494,-0.00733438451393792,0.0199377258995342,0.365069063954493
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NELL1,Protein kinase C-binding protein NELL1,42186,0.00412522611419875,0.00455606926851567,-0.00480466965209196,0.0130551218804895,0.365251592484202
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SIRT5,"NAD-dependent protein deacylase sirtuin-5, mitochondrial",41829,-0.00498204754644532,0.00553842324179193,-0.0158373571003575,0.00587326200746686,0.368380867934903
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHIT1,Chitotriosidase-1,42204,0.014371073666199,0.0159990480232589,-0.0169870604593885,0.0457292077917866,0.369071278001088
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HMGCL,"Hydroxymethylglutaryl-CoA lyase, mitochondrial",39804,-0.00450317277041652,0.00502472046412772,-0.0143516248801068,0.00534527933927381,0.370164344523428
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,42120,0.00281018733269491,0.00313672554972775,-0.00333779474477148,0.0089581694101613,0.370323723864881
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TFRC,Transferrin receptor protein 1,42180,-0.00352634098058162,0.00394622029273238,-0.0112609327543371,0.00420825079317383,0.371552706096705
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TLR2,Toll-like receptor 2,39881,-0.00217667856745529,0.0024359773890503,-0.00695119424999388,0.0025978371150833,0.371580419045531
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLHL41,Kelch-like protein 41,40054,0.00444518758245743,0.00498482605910945,-0.00532507149339709,0.0142154466583119,0.372550043987455
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PHOSPHO1,Phosphoethanolamine/phosphocholine phosphatase,42004,-0.00281576397408584,0.00316290922617418,-0.00901506605738723,0.00338353810921556,0.373351090685531
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LILRA3,Leukocyte immunoglobulin-like receptor subfamily A member 3,40097,0.0131015439324568,0.014766447444982,-0.015840693059708,0.0420437809246215,0.374963399323593
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TGOLN2,Trans-Golgi network integral membrane protein 2,40102,0.00251555794745134,0.00283718675355082,-0.00304532808950828,0.00807644398441096,0.375293307097193
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GADD45B,Growth arrest and DNA damage-inducible protein GADD45 beta,39881,-0.00437019068450974,0.00492901627645338,-0.0140310625863584,0.00529068121733889,0.375300602477311
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNAJA1,DnaJ homolog subfamily A member 1,39665,0.00435682044161043,0.00491996555157484,-0.00528631203947627,0.0139999529226971,0.375886432230391
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHRM1,Muscarinic acetylcholine receptor M1,39768,0.00342418678982529,0.00387882381493495,-0.0041783078874472,0.0110266814670978,0.377369824931953
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHP1,Calcineurin B homologous protein 1,39719,-0.00679074587728292,0.00769741858040619,-0.021877686294879,0.00829619454031322,0.377682964942259
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL6R,Interleukin-6 receptor subunit alpha,42091,0.00311300531941349,0.00353450954350919,-0.00381463338586453,0.0100406440246915,0.37847169812228
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CALY,Neuron-specific vesicular protein calcyon,39706,0.00356733384974948,0.00405568716656042,-0.00438181299670894,0.0115164806962079,0.379102636932808
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ZNF75D,Zinc finger protein 75D,39881,0.00561901873921156,0.00641339644842069,-0.00695123829969299,0.0181892757781161,0.380974844303201
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KIR3DL1,Killer cell immunoglobulin-like receptor 3DL1,41861,-0.0115441407022817,0.0132119336866847,-0.0374395307281837,0.0143512493236203,0.382262171445942
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDGFRB,Platelet-derived growth factor receptor beta,42296,-0.0031225802044008,0.00359672675904831,-0.0101721646521355,0.00392700424333389,0.385315664345078
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PMCH,Pro-MCH,39706,0.00761266739329963,0.00877392384491076,-0.00958422334272545,0.0248095581293247,0.385607495896918
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRTM1,Leucine-rich repeat and transmembrane domain-containing protein 1,39768,0.00370023469407235,0.00426680559656265,-0.00466270427519044,0.0120631736633351,0.385844298611495
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPESP1,Sperm equatorial segment protein 1,40080,-0.00285923802530673,0.00330842445492675,-0.00934374995696316,0.00362527390634971,0.387480869591731
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITGAX,Integrin alpha-X,39881,-0.00490131219176158,0.0056733347225656,-0.0160210482479902,0.006218423864467,0.387650757638777
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PAIP2B,Polyadenylate-binding protein-interacting protein 2B,39651,0.00463638763239335,0.00539927872309493,-0.00594619866487272,0.0152189739296594,0.390522974172026
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYH4,Myosin-4,39706,0.00404777413372555,0.00473039707509559,-0.00522380413346181,0.0133193524009129,0.392186359758806
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CREB3,Cyclic AMP-responsive element-binding protein 3,39665,-0.005133939744611,0.00600173349349556,-0.0168973373918623,0.00662945790264029,0.392344067994926
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MILR1,Allergin-1,41887,-0.00456070874668394,0.00534940121257849,-0.0150455351233378,0.00592411762996989,0.393917027902156
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TSPAN7,Tetraspanin-7,39719,-0.00833473876872213,0.00978009186638062,-0.0275037188268281,0.0108342412893839,0.394114289736109
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DDC,Aromatic-L-amino-acid decarboxylase,42122,0.00421352795701064,0.00494425572163507,-0.0054772132573941,0.0139042691714154,0.394115153439863
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTTG1,Securin,39881,-0.00362997856331124,0.00426095489528497,-0.0119814501580698,0.00472149303144729,0.394279425896969
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FST,Follistatin,42162,0.00433646705145798,0.00509789641212754,-0.00565540991631199,0.014328344019228,0.394985891148024
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDH4,Cadherin-4,39719,0.00438081133958204,0.0051514463382192,-0.0057160234833276,0.0144776461624917,0.395119775183945
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HPCAL1,Hippocalcin-like protein 1,42256,-0.00637649632643465,0.00749944717208079,-0.021075412783713,0.00832242013084371,0.395194921293672
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSMC3,26S proteasome regulatory subunit 6A,39665,-0.00270851831596832,0.00319027773987032,-0.00896146268611414,0.0035444260541775,0.395905494900455
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDC123,Cell division cycle protein 123 homolog,39665,-0.00555354839102644,0.00655725406887906,-0.0184057663660294,0.00729866958397651,0.397052373451283
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FZD10,Frizzled-10,39768,-0.00537290081737399,0.00634521138324939,-0.0178095151285428,0.00706371349379481,0.397145468162228
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATP1B1,Sodium/potassium-transporting ATPase subunit beta-1,39706,0.0042656220011616,0.00504647119241477,-0.00562546153597136,0.0141567055382945,0.397980307921736
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PBK,Lymphokine-activated killer T-cell-originated protein kinase,39665,0.00270479523796588,0.00320284481917892,-0.0035727806076248,0.00898237108355656,0.398410614941356
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,XG,Glycoprotein Xg,42237,0.00301827133076706,0.0035893171807624,-0.00401679034352724,0.0100533330050614,0.400417108459666
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HTR1B,5-hydroxytryptamine receptor 1B,39719,-0.00379220665273942,0.00451400523516264,-0.0126396569136582,0.00505524360817935,0.400872538811042
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NEO1,Neogenin,40054,-0.00194767339438643,0.00231951314066503,-0.00649391915008989,0.00259857236131703,0.401100366672178
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENG,Endoglin,42296,-0.00151845636598843,0.00180862628705148,-0.00506336388860932,0.00202645115663247,0.401168567596455
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RYR1,Ryanodine receptor 1,39706,0.00299000576046582,0.00357341907461254,-0.00401389562577476,0.0099939071467064,0.40276041198047
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITIH1,Inter-alpha-trypsin inhibitor heavy chain H1,40113,0.00162181046708236,0.00194924751962385,-0.00219871467138038,0.00544233560554509,0.405416561851353
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SFRP1,Secreted frizzled-related protein 1,41966,0.00381246039725257,0.00459727840327601,-0.0051982052731684,0.0128231260676735,0.40695787025551
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LMNB1,Lamin-B1,40007,-0.00514746296086816,0.00621230221492128,-0.0173235753021139,0.00702864938037755,0.407353692217088
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RAB3GAP1,Rab3 GTPase-activating protein catalytic subunit,39719,-0.005014131493761,0.00606031345343743,-0.0168923458624984,0.00686408287497637,0.408045206530648
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GSAP,Gamma-secretase-activating protein,41861,-0.00733766336631422,0.00891857780679959,-0.0248180758676414,0.010142749135013,0.410671818830834
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD5L,CD5 antigen-like,40055,0.00408073958745644,0.00496692567134797,-0.00565443472838558,0.0138159139032985,0.41133254337666
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD177,CD177 antigen,42105,0.0112688155536062,0.0137171676492211,-0.0156168330388672,0.0381544641460796,0.411369955336083
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RGMA,Repulsive guidance molecule A,42213,-0.00273359854170631,0.0033289045138269,-0.00925825138880703,0.00379105430539442,0.411564132428413
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDH22,Cadherin-22,39881,0.00240346585240279,0.00292780774241122,-0.0033350373227232,0.00814196902752879,0.41171600118788
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRDX3,"Thioredoxin-dependent peroxide reductase, mitochondrial",41887,-0.00607683762994903,0.00741468669692857,-0.020609623555929,0.00845594829603096,0.412477988796242
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,POLR2A,DNA-directed RNA polymerase II subunit RPB1,39784,-0.00247689308768994,0.00303050274755697,-0.0084166784729016,0.00346289229752171,0.413763480381613
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NPTN,Neuroplastin,41861,0.00666908059311129,0.00821483576333726,-0.00943199750302974,0.0227701586892523,0.416902311430039
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PI16,Peptidase inhibitor 16,40102,0.00211463201587058,0.00260657841689334,-0.00299426168124037,0.00722352571298152,0.417229845545018
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NTF3,Neurotrophin-3,42103,-0.00302289476244186,0.00372859559447787,-0.0103309421276185,0.00428515260273476,0.417534076517655
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FOLR1,Folate receptor alpha,42109,0.00256227745481105,0.0031645092101604,-0.00364016059710333,0.00876471550672542,0.418132195571705
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IMPG1,Interphotoreceptor matrix proteoglycan 1,39719,0.00254126408784276,0.0031467819767943,-0.00362642858667408,0.0087089567623596,0.419353234742007
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KIR2DL2,Killer cell immunoglobulin-like receptor 2DL2,40020,0.00755888933582004,0.00942606726843704,-0.0109162025103166,0.0260339811819566,0.422620674994175
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NTF4,Neurotrophin-4,41861,-0.00323224818627111,0.0040320917976809,-0.0111351481097257,0.00467065173718346,0.422781705860571
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OSCAR,Osteoclast-associated immunoglobulin-like receptor,42146,-0.00289668978618343,0.00362044714080658,-0.00999276618216432,0.00419938660979746,0.423672331254486
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,REG1A,Lithostathine-1-alpha,42085,0.00435465845418861,0.00545008108948673,-0.00632750048120539,0.0150368173895826,0.424300487323354
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RILPL2,RILP-like protein 2,40080,-0.00798810631633063,0.0100036209599385,-0.02759520339781,0.0116189907651488,0.424585347196715
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GTF2IRD1,General transcription factor II-I repeat domain-containing protein 1,39881,-0.00586615133680081,0.0073581065096005,-0.0202880400956178,0.00855573742201617,0.4253313830011
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANP32C,Acidic leucine-rich nuclear phosphoprotein 32 family member C,39804,0.0032536793139384,0.00410130706743679,-0.00478488253823771,0.0112922411661145,0.42760483140092
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RAB6A,Ras-related protein Rab-6A,42103,-0.00376903018386506,0.00477573796385192,-0.0131294765930148,0.00559141622528471,0.430007440335529
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RAB6B,Ras-related protein Rab-6B,41829,0.00404291894593949,0.00512354473678878,-0.00599922873816652,0.0140850666300455,0.430076376207441
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MED21,Mediator of RNA polymerase II transcription subunit 21,39706,-0.00393410005244408,0.00500189173877093,-0.0137378078604351,0.00586960775554694,0.431579212905874
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITGB2,Integrin beta-2,42081,0.00233446186945028,0.00297080835728782,-0.00348832251083385,0.00815724624973441,0.43199898332667
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GFRA3,GDNF family receptor alpha-3,41983,-0.00233921101602316,0.00298119836119041,-0.00818235980395636,0.00350393777191003,0.432670640164991
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,JUN,Transcription factor AP-1,41887,-0.00390793561593131,0.00498957303923308,-0.0136874987728281,0.00587162754096553,0.433512283926601
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BCL7A,B-cell CLL/lymphoma 7 protein family member A,39665,-0.00520967002154214,0.00667237657207754,-0.0182875281028141,0.00786818805972984,0.434948505609395
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IVD,"Isovaleryl-CoA dehydrogenase, mitochondrial",41829,0.00413600492510563,0.00529746840374714,-0.00624703314623877,0.01451904299645,0.434963455378923
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RASGRF1,Ras-specific guanine nucleotide-releasing factor 1,39665,-0.00367762244411695,0.00471392051202122,-0.0129169066476785,0.00556166175944464,0.435313062288342
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TRIAP1,TP53-regulated inhibitor of apoptosis 1,42223,-0.0049699318293101,0.00637967328224971,-0.0174740914625195,0.00753422780389933,0.435978504287866
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NPDC1,Neural proliferation differentiation and control protein 1,42144,-0.002806299509148,0.00361948233369042,-0.00990048488318122,0.00428788586488522,0.438157820472155
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,WASL,Neural Wiskott-Aldrich syndrome protein,39784,-0.00492766115385518,0.00637217541113816,-0.017417124959686,0.00756180265197561,0.439356739222041
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL4,Interleukin-4,41887,-0.00755240506259585,0.00977165303521264,-0.0267048450116126,0.0116000348864209,0.439602350738644
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TREML2,Trem-like transcript 2 protein,42120,0.00279251182428364,0.00362096212989537,-0.00430457395031129,0.00988959759887857,0.440598263625483
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CSRP3,Cysteine and glycine-rich protein 3,39706,0.00802013971124705,0.010405934090348,-0.012375491105835,0.0284157705283291,0.44088578168851
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HTR1A,5-hydroxytryptamine receptor 1A,39719,0.00622087819716891,0.00811913174018466,-0.00969262001359303,0.0221343764079308,0.443574531414759
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DPP4,Dipeptidyl peptidase 4,41959,-0.0022436714023539,0.00293512428813205,-0.00799651500709272,0.00350917220238491,0.444630374330343
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BOC,Brother of CDO,41876,0.00185724830179454,0.00242995590162762,-0.0029054652653956,0.00661996186898467,0.444694613086945
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PFDN4,Prefoldin subunit 4,39665,-0.00415530910101516,0.00543714000342639,-0.0148121035077309,0.00650148530570057,0.444738252154934
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDSN,Corneodesmosin,42213,0.00354390960404842,0.0046461915716655,-0.00556262587641595,0.0126504450845128,0.445622860776861
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PAEP,Glycodelin,42004,0.00714746673648235,0.00938882148052511,-0.0112546233653469,0.0255495568383116,0.446507373400048
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLK,STE20-like serine/threonine-protein kinase,39881,-0.00629323933792431,0.00831072693248522,-0.0225822641255953,0.00999578544974673,0.448921020595058
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD160,CD160 antigen,42256,0.00386270660182751,0.00511360983352062,-0.00615996867187291,0.0138853818755279,0.450036037293824
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRYBB2,Beta-crystallin B2,40054,0.00636039934841423,0.0084675408476619,-0.0102359807130031,0.0229567794098316,0.452578234170396
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL20RA,Interleukin-20 receptor subunit alpha,41887,-0.00349874954453201,0.00466306024067973,-0.0126383476162643,0.00564084852720026,0.453080790593341
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HGFAC,Hepatocyte growth factor activator,40000,0.00216435187784245,0.00288957800020979,-0.00349922100256873,0.00782792475825363,0.453861420438086
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BLOC1S2,Biogenesis of lysosome-related organelles complex 1 subunit 2,39719,-0.00587045357457387,0.00785795349215936,-0.0212720424192062,0.00953113527005848,0.45503705479467
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SIGLEC5,Sialic acid-binding Ig-like lectin 5,42120,0.00922482202387497,0.012351553039806,-0.0149842219341448,0.0334338659818947,0.455164535209447
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",42296,-0.00227146831893619,0.00304193716931502,-0.00823366517079363,0.00369072853292126,0.45524738354161
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TMEM25,Transmembrane protein 25,40054,-0.00353207240541479,0.00473766857262872,-0.0128179028077671,0.00575375799693749,0.455967727184894
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RTKN2,Rhotekin-2,39706,0.00401000264860682,0.00539545137037072,-0.0065650820373198,0.0145850873345334,0.457365635454913
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACTA2,"Actin, aortic smooth muscle",41876,0.00338990606274137,0.00456529257446873,-0.00555806738321735,0.0123378795087001,0.4577748125941
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PALM,Paralemmin-1,39959,-0.00243430324065399,0.00328329252322136,-0.00886955658616785,0.00400095010485988,0.458454164732442
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ZP4,Zona pellucida sperm-binding protein 4,39665,-0.00241932934960917,0.00326414607256713,-0.00881705565184075,0.0039783969526224,0.458599153520114
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRND,Prion-like protein doppel,40054,-0.00398387423892405,0.00544309565220828,-0.0146523417172523,0.00668459323940417,0.464237266006821
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MZB1,Marginal zone B- and B1-cell-specific protein,42168,-0.00402205740149955,0.00550154130488335,-0.0148050783590709,0.00676096355607182,0.464744537728837
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FBP1,"Fructose-1,6-bisphosphatase 1",42144,-0.00553247085117389,0.0075854719103642,-0.0203999957954877,0.00933505409313993,0.46580022800115
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,THBD,Thrombomodulin,42144,-0.00227834082212455,0.00314762852835001,-0.00844769273769057,0.00389101109344148,0.469184575758413
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DEFB118,Beta-defensin 118,39719,-0.00429730935456255,0.00593715318952712,-0.0159341296060357,0.0073395108969106,0.469204835469684
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL20,Interleukin-20,41887,0.00366864188493785,0.00507785774953219,-0.00628395930414524,0.0136212430740209,0.470013790792801
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACE,Angiotensin-converting enzyme,40102,0.00201044353838391,0.00278839705418707,-0.00345481468782275,0.00747570176459057,0.470922922881027
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PNPT1,"Polyribonucleotide nucleotidyltransferase 1, mitochondrial",41887,-0.00850913622112319,0.0118218819708836,-0.031680024884055,0.0146617524418086,0.471674650280395
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MSLN,Mesothelin,42061,-0.00444854136157136,0.00621022636257131,-0.0166205850322111,0.00772350230906841,0.47380359817419
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HADH,"Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial",39706,-0.00517897871405128,0.00725577779235295,-0.0194003031870631,0.0090423457589605,0.475383367851135
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL17F,Interleukin-17F,41887,-0.00561272544032333,0.00786548312096695,-0.0210290723574186,0.0098036214767719,0.475494229375451
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AMIGO1,Amphoterin-induced protein 1,39768,-0.00375558997748303,0.00527074283187542,-0.0140862459279589,0.00657506597299279,0.476149123202312
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARTN,Artemin,41887,0.0032996298902691,0.0046598547971774,-0.00583368551219861,0.0124329452927368,0.478897933147222
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEACAM8,Carcinoembryonic antigen-related cell adhesion molecule 8,41876,-0.00359060447482532,0.00507952819070126,-0.0135464797285998,0.00636527077894916,0.479655559927671
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TCP11,T-complex protein 11 homolog,39881,-0.00433011424666889,0.0061427371224347,-0.0163698790066409,0.00770965051330312,0.480877817127662
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PGLYRP1,Peptidoglycan recognition protein 1,42240,0.00311761217897244,0.00443525621226039,-0.00557548999705794,0.0118107143550028,0.48212069489766
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL1A,Interleukin-1 alpha,41887,-0.00422524398660124,0.00603386570334845,-0.0160516207651642,0.00760113279196172,0.48378096995281
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL12RB2,Interleukin-12 receptor subunit beta-2,39784,-0.00303670876682045,0.00433972176854691,-0.0115425634331724,0.0054691458995315,0.484100476188023
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITGB1BP1,Integrin beta-1-binding protein 1,41861,-0.00299632826806307,0.00429256658099313,-0.0114097587668096,0.00541710223068346,0.485172991491253
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATF2,Cyclic AMP-dependent transcription factor ATF-2,41829,-0.00485141898397289,0.00695199182092037,-0.0184773229529768,0.00877448498503104,0.485286412546309
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DUSP3,Dual specificity protein phosphatase 3,41829,-0.00620292261919469,0.0088926751250347,-0.0236325658642627,0.0112267206258733,0.48548295543587
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LSM1,U6 snRNA-associated Sm-like protein LSm1,41861,-0.00407806754542762,0.00586028383385611,-0.0155642238597856,0.00740808876893035,0.486515336320517
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TMPRSS11B,Transmembrane protease serine 11B,39719,0.00561460273289815,0.00809179208630667,-0.0102453097562629,0.0214745152220592,0.487782853220088
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,YAP1,Transcriptional coactivator YAP1,40054,-0.00206957214993664,0.00299302632484228,-0.0079359037466275,0.00379675944675422,0.489288316735898
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NXPH3,Neurexophilin-3,39784,-0.00220261379319272,0.00318656955827006,-0.00844829012740203,0.00404306254101659,0.489443792687893
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VSIG10L,V-set and immunoglobulin domain-containing protein 10-like,39706,-0.00244678825913893,0.00354585861412164,-0.00939667114281734,0.00450309462453949,0.490183560588549
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TERF1,Telomeric repeat-binding factor 1,39784,0.00208862910624145,0.00305142520176275,-0.00389216428921354,0.00806942250169644,0.493689247876427
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KCNIP4,Kv channel-interacting protein 4,41829,0.0035269150913888,0.00515802995970809,-0.00658282362963907,0.0136366538124167,0.494131857208248
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COL4A4,Collagen alpha-4(IV) chain,39864,0.00378903705840333,0.00556556031009395,-0.00711946114938081,0.0146975352661875,0.496012413920826
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTNNA1,Catenin alpha-1,39719,0.0024730696130044,0.00363975021882402,-0.00466084081589068,0.00960698004189947,0.496860528352056
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPM1F,Protein phosphatase 1F,40080,-0.0036570005664696,0.00539008001459283,-0.0142215573950716,0.00690755626213235,0.497488986575672
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APOL1,Apolipoprotein L1,40102,-0.00408688134894461,0.00602625673509739,-0.0158983445497355,0.00772458185184627,0.497672530239604
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OXCT1,"Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial",39804,0.00486654123492066,0.00718018709649394,-0.00920662547420745,0.0189397079440488,0.497930033663163
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MARCO,Macrophage receptor MARCO,42144,-0.00184572169752603,0.00272443051519877,-0.00718560550731562,0.00349416211226355,0.498119491741604
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARL2BP,ADP-ribosylation factor-like protein 2-binding protein,39706,-0.0028275536888853,0.00419773838104777,-0.0110551209157389,0.00540001353796834,0.500586959451239
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LAYN,Layilin,41985,0.00264982419889807,0.00394341713002254,-0.00507927337594612,0.0103789217737422,0.501620389890401
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MRPL58,"Peptidyl-tRNA hydrolase ICT1, mitochondrial",40054,-0.00504085049932438,0.00751295820490206,-0.0197662485809324,0.00968454758228366,0.502264006767001
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",42094,-0.00243225168248681,0.00366775087280897,-0.00962104339319239,0.00475654002821878,0.507249361924965
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GP6,Platelet glycoprotein VI,42099,-0.00596570097230128,0.00899808102043556,-0.023601939772355,0.0116705378277524,0.507344299198952
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TIE1,Tyrosine-protein kinase receptor Tie-1,42296,0.00283493543682516,0.00427985789010354,-0.00555358602777777,0.0112234569014281,0.507732906592935
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFAIP8,Tumor necrosis factor alpha-induced protein 8,41887,0.00255569457603052,0.00386043479028041,-0.00501075761291909,0.0101221467649801,0.507968839680342
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRX,Cone-rod homeobox protein,41876,-0.00729035340451616,0.0110251866905009,-0.028899719317898,0.0143190125088656,0.50846699650304
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RGS10,Regulator of G-protein signaling 10,40054,-0.00403037523376517,0.00614014563524605,-0.0160650606788474,0.00800431021131709,0.511582411894129
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MMP15,Matrix metalloproteinase-15,40080,-0.00330842586495021,0.00505934798648412,-0.0132247479184591,0.00660789618855867,0.513174992237905
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MMUT,"Methylmalonyl-CoA mutase, mitochondrial",39706,0.00334755357497362,0.0051340109682871,-0.0067151079228691,0.0134102150728163,0.51439300919521
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,USP28,Ubiquitin carboxyl-terminal hydrolase 28,40054,-0.00256866227043333,0.00394294419207233,-0.0102968328868951,0.00515950834602844,0.514764709284173
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFSF13,Tumor necrosis factor ligand superfamily member 13,42184,0.00186406185660433,0.00287729690129195,-0.0037754400699279,0.00750356378313655,0.517092285106661
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PHLDB2,Pleckstrin homology-like domain family B member 2,39665,-0.00642635268083598,0.0100062885216965,-0.0260386781833612,0.0131859728216892,0.520737008504171
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DIPK1C,Divergent protein kinase domain 1C,39768,0.00281161328868757,0.00439288957359418,-0.00579845027555702,0.0114216768529322,0.522162201638058
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TAP1,Antigen peptide transporter 1,39881,-0.00409980637945013,0.00641984042852916,-0.0166826936193673,0.00848308086046703,0.523087107430786
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPACA5_SPACA5B,Sperm acrosome-associated protein 5,40054,0.0019604674460317,0.00307242578876129,-0.00406148709994043,0.00798242199200383,0.523432093152389
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL13,Interleukin-13,41887,0.00316153322098548,0.00496191703471505,-0.00656382416705602,0.012886890609027,0.524032362210164
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CFB,Complement factor B,39922,0.00213255422217496,0.00335273727524459,-0.00443881083730443,0.00870391928165435,0.524748522530472
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OSBPL2,Oxysterol-binding protein-related protein 2,40054,-0.00264048386798051,0.00415680209507755,-0.0107878159743325,0.00550684823837149,0.52529831778276
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AMY2A,Pancreatic alpha-amylase,41633,0.00322067287578789,0.00510017734390815,-0.00677567471827209,0.0132170204698479,0.527736674574035
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACVRL1,Serine/threonine-protein kinase receptor R3,41984,-0.00175833999891028,0.0027894294273728,-0.00722562167656096,0.00370894167874041,0.528471447468249
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SOWAHA,Ankyrin repeat domain-containing protein SOWAHA,39768,-0.00340906734070721,0.00542000086946396,-0.0140322690448566,0.00721413436344216,0.529376317554827
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDCL2,Phosducin-like protein 2,39665,0.00347717044416849,0.00552896310030331,-0.00735959723242599,0.014313938120763,0.529427587624604
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCDC134,Coiled-coil domain-containing protein 134,40020,-0.00317587938863067,0.00505486153210785,-0.013083407991562,0.00673164921430071,0.529832361324069
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TJP3,Tight junction protein ZO-3,39719,0.00272497760145484,0.00434692777904072,-0.00579500084546497,0.0112449560483747,0.530755187615982
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GNGT1,Guanine nucleotide-binding protein G(T) subunit gamma-T1,39768,-0.00333362509641252,0.00532345566003901,-0.013767598190089,0.00710034799726393,0.531187778436812
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KRT17,"Keratin, type I cytoskeletal 17",39706,-0.00257368998275742,0.0041211630024605,-0.01065116946758,0.00550378950206516,0.532309050255027
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATP5PO,"ATP synthase subunit O, mitochondrial",41829,0.0026596035706058,0.0042612617989913,-0.00569246955541714,0.0110116766966287,0.532550053869042
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANK2,Ankyrin-2,39706,-0.00474170800699923,0.0076089044447831,-0.0196551607187741,0.0101717447047756,0.533180545594103
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCDC28A,Coiled-coil domain-containing protein 28A,39768,-0.00194440608324099,0.00313028467244686,-0.00807976404123683,0.00419095187475486,0.534508068905071
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCDC50,Coiled-coil domain-containing protein 50,40054,-0.00486913598169754,0.00784005815749519,-0.0202356499703881,0.010497378006993,0.534574065104721
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTPN9,Tyrosine-protein phosphatase non-receptor type 9,39764,-0.00247335922602938,0.00398461644726771,-0.0102832074626741,0.00533648901061532,0.534792609936457
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STX1B,Syntaxin-1B,39768,-0.00260965427734097,0.00420832962678147,-0.0108579803458327,0.00563867179115071,0.53519450963679
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAMDC2,MAM domain-containing protein 2,40080,0.00234738690759205,0.00379271723846623,-0.00508633887980176,0.00978111269498586,0.535982299010914
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,THRAP3,Thyroid hormone receptor-associated protein 3,39706,0.00709139025879285,0.0114844234827334,-0.0154180797673646,0.0296008602849503,0.536932207564746
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SKIV2L,Helicase SKI2W,39706,-0.00252204251990634,0.00410013173259084,-0.0105583007157844,0.0055142156759717,0.538493704118466
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MPI,Mannose-6-phosphate isomerase,42094,-0.00538991008380477,0.00876649280095683,-0.0225722359736802,0.0117924158060706,0.538677288316417
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TAFA5,Chemokine-like protein TAFA-5,42094,0.00247713649637531,0.00403162471681628,-0.0054248479485846,0.0103791209413352,0.538944457938186
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BCAT2,"Branched-chain-amino-acid aminotransferase, mitochondrial",39719,0.00352116604919308,0.00574728034514984,-0.00774350342730061,0.0147858355256868,0.540110124054707
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARFIP1,Arfaptin-1,40054,-0.00434266331815244,0.00708830183354718,-0.0182357349119049,0.00955040827560004,0.54011919983536
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,REG3G,Regenerating islet-derived protein 3-gamma,40020,-0.00260916846206036,0.00426073896712977,-0.0109602168376347,0.00574187991351399,0.540302782643055
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EP300,Histone acetyltransferase p300,39784,-0.00197388925249711,0.00322466346964871,-0.00829422965300859,0.00434645114801436,0.540469815463554
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SYNGAP1,Ras/Rap GTPase-activating protein SynGAP,39719,-0.00370339908272649,0.00605699365952828,-0.0155751066554019,0.00816830848994894,0.540931272090648
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLC44A4,Choline transporter-like protein 4,39768,-0.00449065065028298,0.00734920131149285,-0.018895085220809,0.009913783920243,0.541186713288976
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COMP,Cartilage oligomeric matrix protein,42022,-0.00214083867260963,0.00350648246871949,-0.00901354431129983,0.00473186696608058,0.541516695876753
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UNG,Uracil-DNA glycosylase,40020,0.00215338673775521,0.00353622921481432,-0.00477762252328084,0.00908439599879127,0.542570366514658
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PNMA2,Paraneoplastic antigen Ma2,39719,-0.00281443311247461,0.00463202915584736,-0.0118932102579354,0.00626434403298621,0.54346416277724
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EVPL,Envoplakin,39881,-0.00221107060231194,0.00364425344267687,-0.0093538073499586,0.00493166614533472,0.544044325534481
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SNED1,"Sushi, nidogen and EGF-like domain-containing protein 1",39804,-0.00210136558696419,0.00346369194880622,-0.00889020180662438,0.004687470632696,0.544073795574221
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SAG,S-arrestin,39719,-0.00329048029969592,0.0054471908990607,-0.0139669744618549,0.00738601386246306,0.545810649247898
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DEFB116,Beta-defensin 116,39719,0.00480893707288903,0.00799477213053187,-0.0108608163029534,0.0204786904487315,0.547513167897624
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DHODH,Dihydroorotate dehydrogenase,39706,-0.00302908223667692,0.00504736495026621,-0.0129219175391987,0.00686375306584485,0.548431598358424
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LAMA1,Laminin subunit alpha-1,39706,0.00336232233904263,0.005603544675071,-0.00762062522409652,0.0143452699021818,0.548495914244447
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCN5,CCN family member 5,42120,0.00240637676894901,0.00401107826691893,-0.00545533663421209,0.0102680901721101,0.548561645729696
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HNF1A,Hepatocyte nuclear factor 1-alpha,39768,0.00447699053993248,0.00748603814347199,-0.0101956442212726,0.0191496253011376,0.549822460920906
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EDDM3B,Epididymal secretory protein E3-beta,40020,0.00326493002303188,0.00545944389060073,-0.00743558000254556,0.0139654400486093,0.549830128921217
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FABP3,"Fatty acid-binding protein, heart",40080,-0.00324126357855557,0.00544078528877883,-0.0139052027445621,0.00742267558745094,0.551364982660145
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL3,Interleukin-3,39665,-0.00383619396793208,0.00644431111353322,-0.0164670437504572,0.00879465581459303,0.55166665154627
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RETN,Resistin,42112,0.00267240541869991,0.00449366506776475,-0.006135178114119,0.0114799889515188,0.552051045123902
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AGBL2,Cytosolic carboxypeptidase 2,39719,-0.00557378916729556,0.00942379916173915,-0.0240444355243043,0.0128968571897132,0.554225739193239
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STK4,Serine/threonine-protein kinase 4,42144,-0.00526665692725927,0.00890662179049253,-0.0227236356366246,0.0121903217821061,0.554316854135597
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SMPDL3B,Acid sphingomyelinase-like phosphodiesterase 3b,40020,0.00468968588257976,0.00795111371099668,-0.0108944969909737,0.0202738687561333,0.555327015556069
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CENPJ,Centromere protein J,39881,-0.00434476851061553,0.0073817801150916,-0.0188130575361951,0.010123520514964,0.556155458748915
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENOPH1,Enolase-phosphatase E1,40020,-0.00336817773737336,0.00572863988552932,-0.0145963119130108,0.00785995643826411,0.556575315675158
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CASQ2,Calsequestrin-2,39706,0.00299218757605264,0.00510990258803243,-0.00702322149649093,0.0130075966485962,0.558179462389389
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADGRV1,Adhesion G-protein coupled receptor V1,39719,0.00432606697556565,0.00739096218323842,-0.0101602189035817,0.018812352854713,0.558346119337989
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BST2,Bone marrow stromal antigen 2,42213,0.00308508074255118,0.00530812179921997,-0.00731883798391996,0.0134889994690223,0.561115684330538
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DENND2B,DENN domain-containing protein 2B,39706,0.00301359157847075,0.00518817452242204,-0.00715523048547646,0.013182413642418,0.561348756109344
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDKL5,Cyclin-dependent kinase-like 5,39719,0.00326490327619756,0.00563991314072386,-0.00778932647962121,0.0143191330320163,0.562674116009817
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRELP,Prolargin,42126,-0.00146297322776233,0.00253996469657075,-0.006441304033041,0.00351535757751634,0.564637562430368
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LMOD2,Leiomodin-2,39719,-0.00372254343621173,0.00647475077572433,-0.0164130549566314,0.00896796808420796,0.565349364744267
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SOX2,Transcription factor SOX-2,40035,-0.00143064993413542,0.00249365853180086,-0.00631822065646511,0.00345692078819426,0.566172406730892
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD3E,T-cell surface glycoprotein CD3 epsilon chain,39881,-0.00219863178571055,0.00384023614885521,-0.00972549463746675,0.00532823106604566,0.56697829461695
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CACNA1C,Voltage-dependent L-type calcium channel subunit alpha-1C,39719,-0.0019789348557594,0.00345993370834349,-0.00876040492411264,0.00480253521259384,0.567363017570451
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HDAC9,Histone deacetylase 9,39719,-0.00391439418093677,0.00685605493912071,-0.0173522618616134,0.00952347349973982,0.5680526854594
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD27,CD27 antigen,42186,-0.00262932188988942,0.00460883540239977,-0.011662639278593,0.00640399549881412,0.568351240433209
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD300E,CMRF35-like molecule 2,42182,0.00255571903885076,0.00449524141441136,-0.00625495413339552,0.011366392211097,0.569679015369422
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MORF4L1,Mortality factor 4-like protein 1,39881,-0.00233034408979216,0.00410346641686997,-0.0103731382668573,0.00571245008727298,0.570117199903058
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RGL2,Ral guanine nucleotide dissociation stimulator-like 2,39881,-0.00379861380671394,0.00672979213487075,-0.0169890063910606,0.00939177877763272,0.57246152051171
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EVI2B,Protein EVI2B,39665,0.00238665144004518,0.00423284093782263,-0.00590971679808718,0.0106830196781775,0.572874071877994
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CPLX2,Complexin-2,39665,-0.00180859270035487,0.00325683584498572,-0.00819199095652689,0.00457480555581714,0.57868627461735
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CPA4,Carboxypeptidase A4,39653,-0.0025432170227006,0.0045856398170173,-0.0115310710640545,0.00644463701865331,0.579176988021837
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LAMTOR5,Ragulator complex protein LAMTOR5,40020,-0.00227242000082832,0.00412207952574247,-0.0103516958712836,0.00580685586962692,0.581453123643371
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GRIK2,"Glutamate receptor ionotropic, kainate 2",40054,-0.00255907649816468,0.00465334062007232,-0.0116796241135064,0.00656147111717707,0.582369131145173
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HCG22,Protein PBMUCL2,39706,0.00321346978039824,0.00586747134429476,-0.00828677405441948,0.014713713615216,0.583926426782818
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEACAM18,Carcinoembryonic antigen-related cell adhesion molecule 18,39881,-0.00395814093983657,0.00722762926387683,-0.0181242942970351,0.010208012417362,0.58395036001105
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UHRF2,E3 ubiquitin-protein ligase UHRF2,39706,-0.00205768237381911,0.00378310744556638,-0.00947257296712921,0.00535720821949099,0.586512686259415
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MMP8,Neutrophil collagenase,42186,0.00411139393437835,0.00756043995990694,-0.0107070683870392,0.018929856255796,0.586586011003851
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DLGAP5,Disks large-associated protein 5,40054,0.0028397254786276,0.00525698719464626,-0.00746396942287906,0.0131434203801343,0.589083175940708
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APOB,Apolipoprotein B-100,40102,-0.00124903589384135,0.00232288594736246,-0.00580189235067176,0.00330382056298906,0.590789168042302
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AFAP1,Actin filament-associated protein 1,39863,-0.00465066813571238,0.00866867558142686,-0.021641272275309,0.0123399360038843,0.591630304352115
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAGEA3,Melanoma-associated antigen 3,39881,0.00477577020064499,0.00891893221122886,-0.0127053369333636,0.0222568773346536,0.592339948135001
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,42184,-0.00236004808624659,0.00441688477938825,-0.0110171422538476,0.00629704608135438,0.593126449436841
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANXA5,Annexin A5,41783,0.00169862824522218,0.00319214546587978,-0.00455797686790219,0.00795523335834655,0.594647113268409
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRFN2,Leucine-rich repeat and fibronectin type-III domain-containing protein 2,39768,0.00254839289586476,0.00479311878575968,-0.00684611992422421,0.0119429057159537,0.59496062186087
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPP3R1,Calcineurin subunit B type 1,42004,-0.00220469629801214,0.00415758732479365,-0.0103535674546077,0.00594417485858341,0.595925186782054
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BRD2,Bromodomain-containing protein 2,39719,-0.00197872806274029,0.00373795219384493,-0.00930511436267634,0.00534765823719577,0.596565849563691
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RELB,Transcription factor RelB,39784,-0.00273667006697412,0.00517177073406768,-0.0128733407057468,0.00740000057179854,0.596708790114711
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRDX5,"Peroxiredoxin-5, mitochondrial",42256,-0.00360577391946958,0.00682678067395301,-0.0169862640404175,0.00977471620147833,0.597382883813193
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LHB,Lutropin subunit beta,41861,0.00460254093443215,0.00875792405918956,-0.0125629902215794,0.0217680720904437,0.599224867553828
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TARM1,"T-cell-interacting, activating receptor on myeloid cells protein 1",39768,-0.00432647302269329,0.00823803486087803,-0.0204730213500142,0.0118200753046276,0.599467232512971
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OFD1,Oral-facial-digital syndrome 1 protein,39881,-0.00361055366106178,0.00687588257601491,-0.017087283510051,0.00986617618792744,0.599521766691823
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPINK1,Serine protease inhibitor Kazal-type 1,42120,-0.00249022468416828,0.00475665953362607,-0.0118132773700754,0.00683282800173882,0.600618737326418
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL2RG,Cytokine receptor common subunit gamma,40020,-0.00199202508910806,0.00380910589294745,-0.00945787263928506,0.00547382246106895,0.601010038388863
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LAIR2,Leukocyte-associated immunoglobulin-like receptor 2,42004,-0.00584053892874503,0.0111694303423971,-0.0277326223998433,0.0160515445423532,0.601050159140935
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CNGB3,Cyclic nucleotide-gated cation channel beta-3,39719,0.00290205361449296,0.00556858252930623,-0.00801236814294725,0.0138164753719332,0.602274894006679
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CYP24A1,"1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial",39706,-0.0047680908979891,0.00915154148170197,-0.022705112202125,0.0131689304061468,0.602367257766209
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GPHA2,Glycoprotein hormone alpha-2,40021,0.00250535940427507,0.00483298690375185,-0.00696729492707856,0.0119780137356287,0.604198613443185
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SIGLEC15,Sialic acid-binding Ig-like lectin 15,41829,-0.00414661464990139,0.00803199637552085,-0.0198893275459223,0.0115960982461195,0.605680455422899
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TET2,Methylcytosine dioxygenase TET2,39865,-0.00548162704450298,0.010621480329469,-0.0262997284902623,0.0153364744012563,0.605803082772091
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DYNC1H1,Cytoplasmic dynein 1 heavy chain 1,40020,-0.00251336095007201,0.00487135316934661,-0.0120612131619914,0.00703449126184735,0.605901834828869
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,THY1,Thy-1 membrane glycoprotein,42213,0.00161190213332622,0.00314296586200791,-0.00454831095620927,0.00777211522286172,0.608057809823429
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGF9,Fibroblast growth factor 9,39651,-0.00219738797161979,0.00428517216089808,-0.01059632540698,0.00620154946374045,0.608109948713673
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FAM171B,Protein FAM171B,40020,-0.0014037116065064,0.00273937462754008,-0.00677288587648495,0.00396546266347215,0.608367228504729
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COL15A1,Collagen alpha-1(XV) chain,40097,-0.00149097350664746,0.00291029246953271,-0.00719514674693157,0.00421319973363665,0.608444067145454
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TPSD1,Tryptase delta,40054,0.00203752589403095,0.00399662364204656,-0.0057958564443803,0.0098709082324422,0.610193677655212
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ICAM2,Intercellular adhesion molecule 2,42296,-0.00171284525771797,0.00336576664325544,-0.00830974787849864,0.00488405736306269,0.610829512182852
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PGR,Progesterone receptor,39784,-0.00516876860428035,0.010195314973644,-0.0251515859526227,0.014814048744062,0.612182998818005
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RAP1A,Ras-related protein Rap-1A,39784,0.00373883427147388,0.00738156621318547,-0.0107290355063696,0.0182067040493174,0.612509485323879
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CXCL9,C-X-C motif chemokine 9,42184,0.00356693292114606,0.00705064259243365,-0.0102523265600239,0.017386192402316,0.612934159128077
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,42126,-0.00209562378353014,0.00416542507873332,-0.0102598569378474,0.00606860937078716,0.614902800516068
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRAME,Melanoma antigen preferentially expressed in tumors,39665,0.00129042983649146,0.00259431219124031,-0.00379442205833955,0.00637528173132248,0.618912299329047
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MFAP4,Microfibril-associated glycoprotein 4,39863,-0.00167430437958689,0.00337510618301545,-0.00828951249829718,0.0049409037391234,0.619852012694349
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TEX101,Testis-expressed protein 101,39768,-0.00273876501274292,0.00552718580329694,-0.0135720491872049,0.00809451916171909,0.620251844310831
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,WFDC12,WAP four-disulfide core domain protein 12,42200,0.00336025920750368,0.00680623403832196,-0.00997995950760737,0.0167004779226147,0.621524174672328
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGDCC3,Immunoglobulin superfamily DCC subclass member 3,39719,0.00259251008056637,0.00525308578566618,-0.00770353805933935,0.0128885582204721,0.62165454335049
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPP2R5A,Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit alpha isoform,40021,-0.0059719110206145,0.0121370640775586,-0.0297605566126293,0.0178167345714003,0.622701624238728
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TXK,Tyrosine-protein kinase TXK,39881,-0.00383763185257456,0.0078479153467726,-0.0192195459322489,0.0115442822270997,0.624851619245469
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GHRL,Appetite-regulating hormone,42144,-0.00432119561125014,0.00886573066244392,-0.0216980277096402,0.0130556364871399,0.62598006824591
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RASA1,Ras GTPase-activating protein 1,41829,-0.00163975868486678,0.00336487076735321,-0.00823490538887907,0.0049553880191455,0.626042165659764
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLEC6A,C-type lectin domain family 6 member A,41861,-0.00240196654649246,0.00493946671620427,-0.0120833213102528,0.00727938821726791,0.626776686391104
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCN3B,Sodium channel subunit beta-3,39719,0.0024525724791935,0.00504371842375006,-0.00743311563135663,0.0123382605897436,0.626790997814697
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KIR2DL3,Killer cell immunoglobulin-like receptor 2DL3,41861,-0.00405750742772184,0.00837538186476366,-0.0204732558826586,0.0123582410272149,0.628070369356319
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,S100A16,Protein S100-A16,41813,0.00305070851407171,0.00629732691378646,-0.00929205223694974,0.0153934692650932,0.6280784991615
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,REST,RE1-silencing transcription factor,39665,0.00172787726569488,0.00356735123508378,-0.00526413115506933,0.00871988568645909,0.628141521922359
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IFNGR1,Interferon gamma receptor 1,42184,0.00110161316594804,0.00227932265777257,-0.0033658592432862,0.00556908557518229,0.62888573876271
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HEPACAM2,HEPACAM family member 2,40054,-0.00211791661268373,0.00439014711817321,-0.0107226049643032,0.00648677173893575,0.62951380617773
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADAMTS8,A disintegrin and metalloproteinase with thrombospondin motifs 8,42186,-0.00224225539192022,0.00466002243009856,-0.0113758993549134,0.00689138857107296,0.630404943148259
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DRAXIN,Draxin,42004,0.00219015428812359,0.00456062385202756,-0.00674866846185044,0.0111289770380976,0.6310711381372
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VAMP5,Vesicle-associated membrane protein 5,41876,0.00275659595882119,0.00577497461494616,-0.00856235428647328,0.0140755462041157,0.633132008488312
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SDHB,Succinate dehydrogenase,40021,-0.00326884284971445,0.00687125129765301,-0.0167364953931144,0.0101988096936855,0.634278161095397
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HIP1,Huntingtin-interacting protein 1,39706,-0.00163380725877272,0.00344934056363445,-0.00839451476349624,0.00512690024595079,0.635753746889073
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SEPTIN7,Septin-7,39881,0.00270346990333748,0.00570795157536235,-0.00848411518437272,0.0138910549910477,0.635771854106262
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TMPRSS11D,Transmembrane protease serine 11D,40041,-0.00198401206991571,0.00427143273422019,-0.0103560202289873,0.00638799608915587,0.642310358086355
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FABP9,Fatty acid-binding protein 9,42103,-0.00273865865566792,0.00590048148502884,-0.0143036023663245,0.00882628505498861,0.642554157412425
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DAND5,DAN domain family member 5,39784,0.00268064952767221,0.00578138303119541,-0.0086508612134708,0.0140121602688152,0.642894261800043
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,INSL4,Early placenta insulin-like peptide,40020,-0.00232726319852049,0.00504965134311124,-0.0122245798310185,0.00757005343397754,0.644896817177139
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CORO6,Coronin-6,39719,0.00178345315838062,0.00387300419513738,-0.00580763506408864,0.00937454138084988,0.645178979312649
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ZPR1,Zinc finger protein ZPR1,39719,-0.00466263565951765,0.0101338597887843,-0.0245250008455349,0.0151997295264996,0.645450636063443
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HRG,Histidine-rich glycoprotein,40055,0.00146243377866954,0.00319446281443571,-0.00479871333762445,0.00772358089496353,0.647103336643584
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SAT1,Diamine acetyltransferase 1,39706,0.0024400877084345,0.00535542369767268,-0.00805654273900395,0.012936718155873,0.648666013590498
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,METAP1,Methionine aminopeptidase 1,41829,0.00137852131676502,0.00304707726894253,-0.00459375013036234,0.00735079276389238,0.65098304477589
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VWA5A,von Willebrand factor A domain-containing protein 5A,39665,-0.00367750724968683,0.00813213353174083,-0.0196164889718989,0.0122614744725252,0.651120416294164
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BABAM1,BRISC and BRCA1-A complex member 1,39784,-0.00135951620882601,0.00301316412909837,-0.00726531790185881,0.0045462854842068,0.651860255956992
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD59,CD59 glycoprotein,41664,0.00116743069474784,0.00260991121701542,-0.00394799529060238,0.00628285668009806,0.654661421168532
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHAD,Chondroadherin,39863,0.00241040904913174,0.00539273406648233,-0.00815934972117362,0.0129801678194371,0.654903289615738
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IMPA1,Inositol monophosphatase 1,42004,-0.00280151968344197,0.0062858168354257,-0.0151217206808764,0.00951868131399241,0.655829413193423
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TPPP2,Tubulin polymerization-promoting protein family member 2,39881,-0.00373108552746858,0.00841192528830617,-0.0202184590925487,0.0127562880376115,0.657378998745831
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CSF2RA,Granulocyte-macrophage colony-stimulating factor receptor subunit alpha,42004,-0.00283407497962066,0.00642522679918114,-0.0154275195060157,0.00975936954677437,0.659158476312394
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTEN,"Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN",41829,-0.0013684583934715,0.00313171634188008,-0.00750662242355645,0.00476970563661346,0.662142354721441
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRTAM,Cytotoxic and regulatory T-cell molecule,42004,-0.00236135098415005,0.00541034093450246,-0.0129656192157749,0.00824291724747477,0.662516594241749
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LAMA4,Laminin subunit alpha-4,42184,-0.00150051219372173,0.00344167203610468,-0.00824618938448691,0.00524516499704344,0.662855951571143
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KIR3DL2,Killer cell immunoglobulin-like receptor 3DL2,39665,0.00376993891370355,0.00867244141688348,-0.0132280462633881,0.0207679240907952,0.663786759942214
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OTOA,Otoancorin,39719,0.00246036268836676,0.00567521593245795,-0.00866306053925083,0.0135837859159843,0.664640411395789
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TMCO5A,Transmembrane and coiled-coil domain-containing protein 5A,39768,-0.00248076351435292,0.00573973658693306,-0.0137306472247417,0.00876912019603588,0.66559862285676
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GH2,Growth hormone variant,41861,-0.00748375219782363,0.0173273419365396,-0.0414453423934412,0.0264778379977939,0.665818374915768
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MTIF3,"Translation initiation factor IF-3, mitochondrial",40021,-0.00392491934560465,0.00910300240038128,-0.021766804050352,0.0139169653591426,0.666355122762546
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FAM171A2,Protein FAM171A2,40054,-0.00712728520498084,0.0165789971912811,-0.0396221196998919,0.0253675492899302,0.667278042197004
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TPT1,Translationally-controlled tumor protein,41887,0.00289370604664708,0.00676893040224654,-0.0103733975417561,0.0161608096350503,0.66902369581426
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EPHA10,Ephrin type-A receptor 10,41829,0.00297103096963309,0.00695276011843255,-0.0106563788624947,0.0165984408017609,0.669155904346962
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SDC1,Syndecan-1,42144,-0.00180913158096439,0.00423998989527262,-0.0101195117756987,0.00650124861376994,0.669617331863079
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TDGF1,Teratocarcinoma-derived growth factor 1,41829,-0.00662767395680959,0.0155332109717132,-0.0370727674613674,0.0238174195477482,0.669621401017219
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VSTM1,V-set and transmembrane domain-containing protein 1,41829,0.00222655479408899,0.00525854766812438,-0.0080801986354348,0.0125333082236128,0.671998761824129
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TRAF3IP2,E3 ubiquitin ligase TRAF3IP2,39706,0.00212436407152342,0.00501931709449354,-0.00771349743368391,0.0119622255767308,0.672130523695134
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGF20,Fibroblast growth factor 20,39784,0.00198611820798309,0.0047020204805709,-0.00722984193393588,0.0112020783499021,0.672744019140144
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TGFA,Protransforming growth factor alpha,42103,0.00208417657711019,0.00493421512055609,-0.00758688505917974,0.0117552382134001,0.67274542098372
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CAPN3,Calpain-3,40020,0.00167406945716097,0.00396849883810482,-0.00610418826552448,0.00945232717984642,0.673150568040492
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RTN4IP1,"Reticulon-4-interacting protein 1, mitochondrial",40054,-0.00398562376093221,0.0094993469787201,-0.0226043438392236,0.0146330963173592,0.674809234147932
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AGER,Advanced glycosylation end product-specific receptor,42095,-0.00182343051324533,0.00437250081222803,-0.0103935321052123,0.00674667107872161,0.676669007297913
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYOC,Myocilin,42120,-0.00192592945442806,0.00464852184045403,-0.011037032261718,0.00718517335286183,0.678653907655932
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NRN1,Neuritin,40054,-0.00156790283790358,0.00380245816965737,-0.00902072085043204,0.00588491517462487,0.680098905808496
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINB5,Serpin B5,41876,0.00208496940189906,0.00506721935504144,-0.00784678053398216,0.0120167193377803,0.68074058043816
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NLGN1,Neuroligin-1,39768,-0.00296419481550666,0.00726218177648197,-0.0171980710974113,0.011269681466398,0.683158138783888
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCN2B,Sodium channel subunit beta-2,39768,0.00123464326945606,0.00303925615565051,-0.00472229879561893,0.00719158533453106,0.684580325131094
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CSF3,Granulocyte colony-stimulating factor,41887,0.00204894167745101,0.00506954261336392,-0.00788736184474227,0.0119852451996443,0.686096750200583
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATP5F1D,"ATP synthase subunit delta, mitochondrial",39706,-0.00217978531876261,0.00540591731192296,-0.0127753832501316,0.0084158126126064,0.686793045533209
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CKMT1A_CKMT1B,"Creatine kinase U-type, mitochondrial",42091,0.00283195900824493,0.00704489922753465,-0.010976043477723,0.0166399614942128,0.687700139843874
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CBX2,Chromobox protein homolog 2,39706,0.00168933660988096,0.00420534265858957,-0.00655313500095459,0.00993180822071651,0.687904158575442
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BAMBI,BMP and activin membrane-bound inhibitor homolog,41861,-0.00125684705724439,0.00312912239206281,-0.00738992694568749,0.00487623283119871,0.68794015868397
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLC51B,Organic solute transporter subunit beta,39706,-0.00320191063481045,0.00799103620270854,-0.0188643415921192,0.0124605203224983,0.688658144771275
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VTA1,Vacuolar protein sorting-associated protein VTA1 homolog,42213,0.00295670131482052,0.00742764812593722,-0.0116014890120164,0.0175148916416575,0.690587354937561
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLIN3,Perilipin-3,42144,0.00174341925821672,0.00438656093203423,-0.00685424016857036,0.0103410786850038,0.691045459274109
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACOT13,Acyl-coenzyme A thioesterase 13,40021,-0.00464797307846018,0.0117271090685529,-0.0276331068528238,0.0183371606959034,0.69185884613492
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CGN,Cingulin,39768,-0.00169939971519753,0.0042977299315995,-0.0101229503811325,0.0067241509507375,0.692542414047802
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HK2,Hexokinase-2,41876,0.00113695277851258,0.00287965488786723,-0.00450717080170721,0.00678107635873236,0.692980467718289
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ZNF174,Zinc finger protein 174,39784,0.00153301455897467,0.0038877759507166,-0.00608702630442986,0.0091530554223792,0.693355255857353
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CA8,Carbonic anhydrase-related protein,39784,-0.00114830268328302,0.00291442816020129,-0.00686058187727755,0.00456397651071152,0.693584415507958
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTRC,Chymotrypsin-C,42135,0.00270146436277225,0.006863599075836,-0.0107511898258663,0.0161541185514108,0.693888054715303
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,WFDC2,WAP four-disulfide core domain protein 2,41476,-0.00179274392936649,0.00457499032321907,-0.0107597249628759,0.0071742371041429,0.695170360605234
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COLEC12,Collectin-12,42126,-0.00114351385819924,0.00291965025794081,-0.00686602836376322,0.00457900064736474,0.695314981412238
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MEGF11,Multiple epidermal growth factor-like domains protein 11,39706,0.00136318933157568,0.00349168212998057,-0.00548050764318624,0.0082068863063376,0.696240942995981
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GUK1,Guanylate kinase,39706,0.00155778886186819,0.00399142719165883,-0.00626540843378311,0.0093809861575195,0.69633470356836
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IZUMO1,Izumo sperm-egg fusion protein 1,39665,0.00193334987227447,0.00497340748697255,-0.00781452880219172,0.0116812285467407,0.697478260910987
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTPRK,Receptor-type tyrosine-protein phosphatase kappa,40021,-0.000863584096840983,0.00224084832683798,-0.00525564681744342,0.00352847862376145,0.699961495900514
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAPT,Microtubule-associated protein tau,41829,0.00211946095020274,0.0055420540805804,-0.00874296504773483,0.0129818869481403,0.702147106616603
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GZMB,Granzyme B,42103,-0.00262958212814849,0.00690855909428823,-0.0161703579529534,0.0109111936966564,0.703486520865453
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF9,Tumor necrosis factor receptor superfamily member 9,42004,-0.00179849662873915,0.00472774066951221,-0.0110648683409831,0.00746787508350477,0.703644762677823
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDC25A,M-phase inducer phosphatase 1,39665,-0.00153636044758704,0.00404635652680299,-0.00946721924012089,0.00639449834494682,0.704183365719319
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SH3BGRL2,SH3 domain-binding glutamic acid-rich-like protein 2,39719,-0.00242984840364896,0.00644094077530734,-0.0150540923232514,0.0101943955159534,0.705995028695288
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TP73,Tumor protein p73,39768,-0.00135473077523938,0.00359816405355536,-0.00840713232020789,0.00569767076972913,0.70654822333839
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PROK1,Prokineticin-1,42103,-0.0021594960330802,0.00574972011938147,-0.0134289474670679,0.00910995540090747,0.707233244247727
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GABARAP,Gamma-aminobutyric acid receptor-associated protein,40020,-0.00195405555171143,0.00521253493546405,-0.012170624025221,0.00826251292179811,0.707759845830703
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATF4,Cyclic AMP-dependent transcription factor ATF-4,39665,-0.00134689420452718,0.00360899179105127,-0.00842051811498766,0.00572672970593331,0.709003342617793
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SAP18,Histone deacetylase complex subunit SAP18,39881,-0.00284983418244555,0.00765644049682377,-0.0178564575562201,0.012156789191329,0.709740919243244
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MECR,"Enoyl-[acyl-carrier-protein] reductase, mitochondrial",39804,-0.00351929337606064,0.00946677868546228,-0.0220741795995667,0.0150355928474454,0.710084970470297
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD84,SLAM family member 5,42103,-0.00119299111891036,0.00324792758843895,-0.0075589291922507,0.00517294695442998,0.713395002620814
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATRAID,All-trans retinoic acid-induced differentiation factor,40021,-0.00113509254272645,0.00309447820378345,-0.00720026982214202,0.00493008473668912,0.713766230484808
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GAD1,Glutamate decarboxylase 1,39665,0.00099078814091358,0.002719097263291,-0.00433864249513678,0.00632021877696394,0.715580670432255
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GAMT,Guanidinoacetate N-methyltransferase,39706,-0.00142947729128454,0.00394346304709608,-0.00915866486359285,0.00629971028102377,0.71699102791696
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OSTN,Osteocrin,39768,0.00156115303117997,0.00432913221003134,-0.00692394610048145,0.0100462521628414,0.71839395640014
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,41861,-0.00135871624219371,0.00379022149250703,-0.00878755036750749,0.00607011788312007,0.719990572000782
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNN,Tenascin-N,40097,-0.00162917360026931,0.00454812426745166,-0.0105434971644746,0.00728514996393593,0.720194743189679
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NUDT2,Bis(5'-nucleosyl)-tetraphosphatase [asymmetrical],42094,-0.00207374992311068,0.00581620051576262,-0.0134735029340054,0.00932600308778406,0.721436653301822
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYL1,"Myosin light chain 1/3, skeletal muscle isoform",39706,0.00150922145369581,0.00424098401594093,-0.00680310721754841,0.00982155012494002,0.721948159870463
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ID4,DNA-binding protein inhibitor ID-4,39881,0.00159636678970928,0.00451501369740406,-0.00725306005720268,0.0104457936366212,0.723669230955029
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MORC3,MORC family CW-type zinc finger protein 3,40054,-0.00103645165311897,0.00293659157251756,-0.00679217113525339,0.00471926782901544,0.724137458054108
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MMP9,Matrix metalloproteinase-9,42103,0.00220224690939879,0.00624637476957114,-0.0100406476389606,0.0144451414577582,0.724421082064927
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TSHB,Thyrotropin subunit beta,42144,0.00290808941115149,0.00827555266377855,-0.0133119938098545,0.0191281726321575,0.725288542310955
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GBP4,Guanylate-binding protein 4,41829,-0.00180480503951878,0.00514656121249365,-0.0118920650160063,0.00828245493696876,0.725832972519913
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LILRA4,Leukocyte immunoglobulin-like receptor subfamily A member 4,39706,0.00185116300065498,0.00529878947090768,-0.00853446436232407,0.012236790363634,0.726829186144239
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NUP50,Nuclear pore complex protein Nup50,39706,-0.00125970039448008,0.00364197868953437,-0.00839797862596746,0.00587857783700729,0.729437179004077
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLK15,Kallikrein-15,39999,0.00191866099821181,0.00555410231798538,-0.00896737954503953,0.0128047015414631,0.729763311865781
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAP1LC3A,Microtubule-associated proteins 1A/1B light chain 3A,39719,-0.00112666379056829,0.00330181297047749,-0.00759821721270416,0.00534488963156759,0.732940409347678
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GSTM4,Glutathione S-transferase Mu 4,39706,0.00262340899842958,0.00771064131716345,-0.0124894479832108,0.0177362659800699,0.733688416533457
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CBLN1,Cerebellin-1,39719,-0.00334324051032964,0.00992407501556354,-0.0227944275408342,0.0161079465201749,0.73621270322319
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BRD3,Bromodomain-containing protein 3,39706,0.00174562653389522,0.00518388828518678,-0.00841479450507088,0.0119060475728613,0.736319048458961
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ESPL1,Separin,39665,0.00200555517084506,0.00599479314631973,-0.0097442393959416,0.0137553497376317,0.737971630233599
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,REN,Renin,42144,-0.00296858139955099,0.0089253328678991,-0.0204622338206332,0.0145250710215312,0.739440300059242
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KIRREL1,Kin of IRRE-like protein 1,39719,0.00197325360032568,0.00596250611785335,-0.00971325839066689,0.0136597655913182,0.740693630193687
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DCLRE1C,Protein artemis,39665,-0.00107433031228143,0.00324678176138986,-0.00743802256460556,0.00528936194004271,0.740733569609899
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLURP1,Secreted Ly-6/uPAR-related protein 1,40031,-0.00128870690227673,0.00392142216550174,-0.00897469434666015,0.00639728054210669,0.742439804148206
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITPRIP,"Inositol 1,4,5-trisphosphate receptor-interacting protein",39719,-0.00151997598005491,0.0046338761303636,-0.0106023731955676,0.00756242123545775,0.742907645212549
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FHIP2A,FHF complex subunit HOOK interacting protein 2A,39706,0.00161450849889777,0.004947010692238,-0.0080816324578887,0.0113106494556842,0.74415817501258
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GLI2,Zinc finger protein GLI2,39784,0.00106972607380546,0.00331368433103332,-0.00542509521501985,0.00756454736263076,0.746837367801055
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CFHR2,Complement factor H-related protein 2,40028,0.00192845838555329,0.00599522277198966,-0.00982217824754644,0.013679095018653,0.747712062723224
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD58,Lymphocyte function-associated antigen 3,42109,-0.000588177806567891,0.00184165921908858,-0.00419782987598152,0.00302147426284573,0.749448198829138
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GAD2,Glutamate decarboxylase 2,39784,0.00153494489136824,0.00484336504603679,-0.00795805059886387,0.0110279403816003,0.751312802612254
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRSS53,Serine protease 53,40054,0.00122783886807333,0.00387884791964718,-0.00637470305443513,0.00883038079058179,0.751593207042204
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF21,Tumor necrosis factor receptor superfamily member 21,42213,-0.000935981616810349,0.00296525364027132,-0.00674787875174214,0.00487591551812144,0.752273419349409
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LILRB1,Leukocyte immunoglobulin-like receptor subfamily B member 1,42296,-0.000895435597743811,0.00285018443439114,-0.00648179708915045,0.00469092589366283,0.753398752715384
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TREML1,Trem-like transcript 1 protein,40102,-0.0017082273260043,0.00543938867959699,-0.0123694291380144,0.00895297448600579,0.75349084120036
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRP2BP,LRP2-binding protein,39768,-0.00282044744302281,0.00900973036233724,-0.0204795189532038,0.0148386240671582,0.75425295134572
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FABP6,Gastrotropin,41854,0.00191116408137749,0.00611714435362275,-0.0100784388517231,0.0139007670144781,0.75472080380211
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGLON5,IgLON family member 5,39665,0.00306627834985024,0.0098466569970626,-0.0162331693643925,0.0223657260640929,0.755500486723714
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CALCB,Calcitonin gene-related peptide 2,40054,-0.00131764082713577,0.00424582740177256,-0.00963946253460999,0.00700418088033846,0.756310027634981
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHGA,Chromogranin-A,40097,0.00315020172584747,0.0101791960567412,-0.0168010225453654,0.0231014259970603,0.756966512086015
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAN1A2,"Mannosyl-oligosaccharide 1,2-alpha-mannosidase IB",39804,-0.000818042389889277,0.00264600569635118,-0.00600421355473759,0.00436812877495904,0.75720495067214
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PCARE,Photoreceptor cilium actin regulator,39719,-0.00270067387139675,0.00878848616141035,-0.019926106747761,0.0145247590049675,0.758623533952885
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ALMS1,Alstrom syndrome protein 1,39881,-0.00142229532472913,0.0046393556076622,-0.010515432315747,0.00767084166628877,0.759175338543125
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF17,Tumor necrosis factor receptor superfamily member 17,39863,0.00137753278541542,0.00449632656103701,-0.00743526727421712,0.010190332845048,0.759330074132657
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TYRO3,Tyrosine-protein kinase receptor TYRO3,42144,0.000902485659942319,0.00294787438187606,-0.00487534812853475,0.00668031944841939,0.759496932160498
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GLT8D2,Glycosyltransferase 8 domain-containing protein 2,41829,-0.00144686508623284,0.00474192335975744,-0.0107410348713574,0.00784730469889174,0.760278270539319
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MTPN,Myotrophin,41876,-0.00105872670739268,0.00347327143897978,-0.00786633872779305,0.00574888531300769,0.760507349464948
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COQ7,"5-demethoxyubiquinone hydroxylase, mitochondrial",39804,-0.00137747479843212,0.00452499649007846,-0.0102464679189859,0.00749151832212167,0.760818049657031
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLEC4G,C-type lectin domain family 4 member G,42103,0.00103392522848542,0.00343583636923693,-0.00570031405521896,0.0077681645121898,0.763477382851305
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AMDHD2,N-acetylglucosamine-6-phosphate deacetylase,40097,-0.000787894173569304,0.0026280362687673,-0.0059388452603532,0.0043630569132146,0.764332847072934
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGF3,Fibroblast growth factor 3,39784,0.000906277174982237,0.00302364001945088,-0.00502005726314149,0.00683261161310597,0.76438860435885
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UPK3BL1,Uroplakin-3b-like protein 1,39862,0.00169612015975059,0.00566168572139949,-0.00940078385419241,0.0127930241736936,0.764504408495716
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARG2,"Arginase-2, mitochondrial",40020,0.00131249921772264,0.00438297726508983,-0.00727813622185342,0.0099031346572987,0.764599562817559
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LCP1,Plastin-2,40097,-0.00148538451262148,0.00497444992594772,-0.011235306367479,0.00826453734223604,0.76524884444134
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NPHS2,Podocin,39784,-0.00324255133701321,0.0108848741080491,-0.0245769045887894,0.0180918019147629,0.765789024313138
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PCNA,Proliferating cell nuclear antigen,39665,-0.00193645934246272,0.00651484772862358,-0.0147055608905649,0.0108326422056395,0.766290821820537
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RICTOR,Rapamycin-insensitive companion of mTOR,39784,0.00151034550160825,0.00509997735724195,-0.00848561011858597,0.0115063011218025,0.767123253677352
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGF7,Fibroblast growth factor 7,39665,0.00242910758855314,0.00824075442602529,-0.0137227710864564,0.0185809862635627,0.76817724529492
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLK3,Prostate-specific antigen,40097,-0.00298023380841202,0.0101724808419584,-0.0229182962586506,0.0169578286418265,0.769550500506713
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CACNA1H,Voltage-dependent T-type calcium channel subunit alpha-1H,39706,-0.00180923177392161,0.00619089976433638,-0.0139433953120209,0.0103249317641777,0.770108499095772
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL31,Interleukin-31,39784,0.00171888754838631,0.00589772997783268,-0.00984066320816574,0.0132784383049384,0.770713646172769
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KRT6C,"Keratin, type II cytoskeletal 6C",39706,0.00118122116584852,0.0040883558957874,-0.00683195638989479,0.00919439872159183,0.772645790974855
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GP2,Pancreatic secretory granule membrane major glycoprotein GP2,41702,0.00256762336464754,0.00893611564701666,-0.0149471633035051,0.0200824100328002,0.773863620841903
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGFL4,Insulin growth factor-like family member 4,39784,0.00219571112595278,0.00767413174759478,-0.012845587099333,0.0172370093512385,0.774792953056696
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TGFBR1,TGF-beta receptor type-1,39784,-0.000641095982750252,0.00225236934136982,-0.0050557398918351,0.0037735479263346,0.775931796552178
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DSG4,Desmoglein-4,42051,0.00147840515611663,0.00520536280176065,-0.00872410593533425,0.0116809162475675,0.77640286422745
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FLT1,Vascular endothelial growth factor receptor 1,42067,0.00063444461012513,0.00223676928285867,-0.00374962318427786,0.00501851240452812,0.776688315788658
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MRPL24,"39S ribosomal protein L24, mitochondrial",39706,-0.00114393229586133,0.00404488656783805,-0.0090719099688239,0.00678404537710124,0.777328449822298
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PYDC1,Pyrin domain-containing protein 1,39804,0.00124878520483496,0.00441674349405975,-0.00740803204352215,0.00990560245319208,0.77738250867256
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLAMF8,SLAM family member 8,41861,0.00162661564725746,0.00575358543464865,-0.0096504118046539,0.0129036430991688,0.777401169917773
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NDST1,Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 1,40020,0.00185745830798007,0.00663570322476787,-0.011148520012565,0.0148634366285251,0.779545125275046
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VCPKMT,Protein-lysine methyltransferase METTL21D,39665,-0.00252452558372806,0.00902516259701665,-0.0202138442738807,0.0151647931064246,0.779697254116015
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINC1,Antithrombin-III,40092,0.000424776603190046,0.00152598757833211,-0.00256615905034088,0.00341571225672098,0.780739944450269
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C1QBP,"Complement component 1 Q subcomponent-binding protein, mitochondrial",40054,0.00207725936766175,0.00752392293103845,-0.0126696295771736,0.0168241483124971,0.78248628867626
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD55,Complement decay-accelerating factor,41732,-0.000774363018610628,0.00284329655512929,-0.00634722426666405,0.00479849822944279,0.78535977799287
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HSP90B1,Endoplasmin,41770,0.00188284774918343,0.00694121461263329,-0.0117219328915778,0.0154876283899447,0.786198415712295
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRRC25,Leucine-rich repeat-containing protein 25,42094,-0.00110200034383309,0.00407847722825699,-0.0090958157112168,0.00689181502355062,0.78701150785227
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TIGIT,T-cell immunoreceptor with Ig and ITIM domains,39881,-0.00103720400976449,0.00387976468563285,-0.00864154279360487,0.00656713477407589,0.789214987281784
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLEC4C,C-type lectin domain family 4 member C,42103,0.00132892894867889,0.00499599608610577,-0.00846322338008843,0.0111210812774462,0.790244383560615
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ZP3,Zona pellucida sperm-binding protein 3,39804,-0.00741789463858914,0.028129679547335,-0.0625520665513657,0.0477162772741874,0.79201352810976
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCN2A,Sodium channel protein type 2 subunit alpha,39719,-0.00134247583586224,0.00517864715688547,-0.0114926242633578,0.00880767259163328,0.795460600663317
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD300LF,CMRF35-like molecule 1,42223,0.00162924125286715,0.00634155767822671,-0.0108002117964572,0.0140586943021915,0.797248452229595
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C2,Complement C2,42172,0.000607591890368797,0.00237708320813178,-0.0040514911975695,0.00526667497830709,0.798260708097468
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RBM25,RNA-binding protein 25,39665,-0.00125375521566766,0.00493926094800821,-0.0109347066737637,0.00842719624242843,0.799628342985865
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLAUR,Urokinase plasminogen activator surface receptor,42056,0.000742685677463912,0.00292716628742125,-0.00499456024588175,0.00647993160080957,0.799714605104804
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLSPN,Claspin,41810,-0.000917984508742668,0.00362798501245857,-0.00802883513316146,0.00619286611567613,0.800250120089305
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANKRA2,Ankyrin repeat family A protein 2,39665,-0.00151342231490921,0.00599436111102956,-0.0132623700925271,0.0102355254627087,0.800679407635254
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HEBP1,Heme-binding protein 1,41876,0.00137148972758514,0.00549860700444906,-0.00940578000113501,0.0121487594563053,0.803036134072285
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GKN1,Gastrokine-1,41542,-0.000716624065679709,0.00291980152343671,-0.00643943505161566,0.00500618692025624,0.806123026586696
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KIR2DS4,Killer cell immunoglobulin-like receptor 2DS4,40021,-0.00443724092137354,0.0182262266556232,-0.040160645166395,0.031286163323648,0.807658619854071
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEP152,Centrosomal protein of 152 kDa,39665,-0.00103819653798463,0.00432226778389174,-0.00950984139441243,0.00743344831844317,0.81018210086303
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NXPE4,NXPE family member 4,39706,0.000830038764218644,0.00351216942505666,-0.0060538133088924,0.00771389083732969,0.813179498845759
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GNLY,Granulysin,42120,0.00131539684227199,0.00556875680589282,-0.00959936649727793,0.0122301601818219,0.813273351709288
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AMY1A_AMY1B_AMY1C,Alpha-amylase 1A_Alpha-amylase 1B_Alpha-amylase 1C,39439,-0.00126928468129321,0.00537989944196505,-0.0118138875875447,0.00927531822495828,0.813490982718752
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BHMT2,S-methylmethionine--homocysteine S-methyltransferase BHMT2,39706,0.000630792261347849,0.00269328712107205,-0.00464805049595338,0.00590963501864908,0.814827238162915
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BHLHE40,Class E basic helix-loop-helix protein 40,39719,0.00170559593123555,0.00733174257927199,-0.0126646195241375,0.0160758113866087,0.816051912600762
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRTN3,Myeloblastin,41797,-0.00117701329998674,0.00506618717712323,-0.0111067401671483,0.00875271356717478,0.816287626643646
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SEPTIN3,Neuronal-specific septin-3,40054,-0.00179964015352355,0.00778450095316812,-0.0170572620217331,0.013457981714686,0.817177403711809
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCARB1,Scavenger receptor class B member 1,41829,-0.00139201674076447,0.00605321021619279,-0.0132563087645023,0.0104722752829734,0.81812394069951
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRP2,Low-density lipoprotein receptor-related protein 2,39768,-0.000884420662232872,0.00385009593051186,-0.00843060868603612,0.00666176736157037,0.818318513960918
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDCD1LG2,Programmed cell death 1 ligand 2,42094,0.000758576705122195,0.00331970710546769,-0.00574804922159448,0.00726520263183887,0.819255644727336
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACOX1,Peroxisomal acyl-coenzyme A oxidase 1,42144,-0.00115160440170618,0.00511906711129738,-0.011184975939849,0.00888176713643668,0.82201104436521
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDH6,Cadherin-6,42144,0.000899392125519339,0.00402971554931712,-0.00699885035114222,0.0087976346021809,0.823391171756713
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,42120,-0.000748424874688114,0.0033689444025978,-0.0073515559037798,0.00585470615440358,0.824197419332394
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,39706,-0.000857295243811154,0.00390079398480871,-0.00850285145403622,0.00678826096641391,0.826051008389739
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,F11,Coagulation factor XI,39959,0.000684732786180845,0.00313579223545851,-0.00546141999531783,0.00683088556767952,0.827152471479778
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AIF1L,Allograft inflammatory factor 1-like,39804,-0.00125077410064876,0.00577902468896342,-0.0125776624910171,0.0100761142897195,0.828654076026745
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DCN,Decorin,41876,-0.000537599832396971,0.00249448506970187,-0.00542679056901263,0.00435159090421869,0.829369008440692
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TOP1MT,"DNA topoisomerase I, mitochondrial",39665,-0.00108529196594575,0.00508947420162305,-0.0110606614011269,0.00889007746923543,0.83114200799088
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CSH1,Chorionic somatomammotropin hormone 1,40102,-0.00063131138455785,0.00296283510887258,-0.0064384681979481,0.0051758454288324,0.831271052303997
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TMED1,Transmembrane emp24 domain-containing protein 1,39881,0.00120179280072017,0.00564888658603119,-0.00987002490790096,0.0122736105093413,0.831527102662353
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MN1,Transcriptional activator MN1,39768,0.00130158722728123,0.00619597587601709,-0.0108425254897123,0.0134456999442747,0.833617266422214
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RSPO1,R-spondin-1,42004,0.000740849505035862,0.00352799827277288,-0.00617402710959898,0.00765572611967071,0.833677678659069
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGLC2,Immunoglobulin lambda constant 2,40093,0.000553682262742976,0.00264376354012075,-0.00462809427589369,0.00573545880137965,0.834116824841105
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LMNB2,Lamin-B2,40054,-0.000619804348778339,0.00298642756199723,-0.0064732023702929,0.00523359367273622,0.835591741985704
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCGB1A1,Uteroglobin,42154,-0.00117668176608471,0.00576172957062871,-0.012469671724517,0.0101163081923476,0.838181893744357
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DCUN1D2,DCN1-like protein 2,39665,-0.00169794908730616,0.00831598525427482,-0.0179972801856848,0.0146013820110725,0.838217633134015
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PFDN2,Prefoldin subunit 2,41829,-0.00116995543927118,0.00573138286035505,-0.0124034658455671,0.0100635549670247,0.838254073327232
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD164L2,CD164 sialomucin-like 2 protein,39768,0.000768990200156381,0.00376974447827226,-0.00661970897725725,0.00815768937757001,0.83836523414873
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SEMA3G,Semaphorin-3G,39863,-0.000951282724609897,0.00466340717428056,-0.0100915607861998,0.00818899533698,0.838366160126937
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL2,Interleukin-2,41887,0.000678928695499005,0.0033346473451381,-0.00585698010097167,0.00721483749196968,0.838670646871042
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NINJ1,Ninjurin-1,41861,-0.00114514110005415,0.00562859234574509,-0.0121771820977145,0.00988689989760622,0.838786036938782
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADAMTSL5,ADAMTS-like protein 5,40080,-0.000819377519695994,0.00407939621600475,-0.0088149941030653,0.00717623906367331,0.840813715672236
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ZNF830,Zinc finger protein 830,40020,-0.00159440661362284,0.00806191261950017,-0.0173957553478432,0.0142069421205975,0.843228523042585
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EPHB6,Ephrin type-B receptor 6,41985,-0.000690930403451399,0.00349588608538462,-0.00754286713080525,0.00616100632390245,0.843329098799853
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL1RL1,Interleukin-1 receptor-like 1,42262,0.000941155472714883,0.00477093687969215,-0.00840988081148174,0.0102921917569115,0.843620510939611
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RUVBL1,RuvB-like 1,41861,0.00215658240073348,0.0109914772859522,-0.0193867130797329,0.0236998778811999,0.844452890621449
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SNX18,Sorting nexin-18,40021,0.000888487635801786,0.00454830166630394,-0.00802618363015394,0.00980315890175752,0.845126597078237
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDAN1,Codanin-1,40054,0.000458927727509476,0.00235605314706748,-0.00415893644074279,0.00507679189576175,0.845563608302243
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TPSAB1,Tryptase alpha/beta-1,42243,-0.00105227071328138,0.00545454603832217,-0.0117431809483928,0.00963863952183007,0.847027539756701
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHRDL1,Chordin-like protein 1,42162,-0.000648003296946522,0.00336268590930938,-0.00723886767919291,0.00594286108529987,0.847193745019695
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RHOC,Rho-related GTP-binding protein RhoC,41953,0.00228006450894026,0.0119321323301006,-0.021106914858057,0.0256670438759375,0.848461186057238
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CASP4,Caspase-4,39881,0.00337130116084109,0.0179576488227513,-0.0318256905317515,0.0385682928534337,0.851086997552235
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NOTCH1,Neurogenic locus notch homolog protein 1,42296,-0.000307605609943918,0.00165631052005405,-0.00355397422924986,0.00293876300936202,0.852669292180302
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RPGR,X-linked retinitis pigmentosa GTPase regulator,39768,0.00083038610981644,0.00447796612949457,-0.00794642750399291,0.00960719972362579,0.852888882461672
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LELP1,Late cornified envelope-like proline-rich protein 1,39719,-0.0014124532608682,0.00761886987985662,-0.0163454382253872,0.0135205317036508,0.852927652778643
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSMD5,26S proteasome non-ATPase regulatory subunit 5,39768,-0.00106805380032411,0.00579969789095141,-0.0124354616665889,0.0102993540659407,0.853893980350681
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MUCL3,Mucin-like protein 3,39665,0.000804876905484631,0.004417608991676,-0.00785363671820034,0.0094633905291696,0.855431334465838
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IDS,Iduronate 2-sulfatase,42256,-0.000162386137449681,0.000913016422817351,-0.00195189832617169,0.00162712605127233,0.858838232441471
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EFHD1,EF-hand domain-containing protein D1,40054,-0.000668556635102489,0.00376301145917914,-0.0080440590950936,0.00670694582488862,0.858989136032553
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C1QTNF9,Complement C1q and tumor necrosis factor-related protein 9A,39835,0.000891548822638425,0.00502734449646192,-0.00896204639042693,0.0107451440357038,0.859244778938784
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CST6,Cystatin-M,41853,0.000926963522967531,0.00528161679241036,-0.00942500539015678,0.0112789324360918,0.860683660843447
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NPTX1,Neuronal pentraxin-1,42120,-0.000726656764022225,0.00417304881716198,-0.0089058324456597,0.00745251891761525,0.861765313066878
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BTN1A1,Butyrophilin subfamily 1 member A1,39999,0.000710913252006984,0.00409240694483676,-0.00731020435987307,0.00873203086388704,0.862092552970972
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TCN1,Transcobalamin-1,39916,0.000615953940695719,0.00355082444265763,-0.00634366196691323,0.00757556984830467,0.862286958312153
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MIA,Melanoma-derived growth regulatory protein,42186,-0.000677008279555503,0.00392025086704284,-0.00836069997895946,0.00700668341984845,0.862893752752207
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NEB,Nebulin,39706,-0.000679363242077341,0.00395638289900967,-0.00843387372413629,0.00707514723998161,0.863666298439186
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL17C,Interleukin-17C,41887,0.00131755026240142,0.00776382170971674,-0.0138995402886434,0.0165346408134462,0.865245768057985
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,REG4,Regenerating islet-derived protein 4,42146,-0.000915476281449429,0.00549206323498209,-0.0116799202220143,0.00984896765911547,0.86761596589882
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UPK3A,Uroplakin-3a,39719,-0.000874240756029062,0.00530492823161981,-0.0112719000900039,0.00952341857794577,0.869106262766123
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IFNL1,Interferon lambda-1,41829,-0.00078061417267681,0.00476582145566697,-0.0101216242257841,0.00856039588043046,0.869895734614153
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GUCY2C,Heat-stable enterotoxin receptor,39881,0.00137766913415698,0.00842245229530871,-0.0151303373646481,0.0178856756329621,0.870071951103241
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRKAG3,5'-AMP-activated protein kinase subunit gamma-3,39768,0.000537167583215618,0.00331332400857263,-0.00595694747358674,0.00703128264001797,0.871211722561605
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LGALS3,Galectin-3,42175,0.000498028932695831,0.00310749015847024,-0.00559265177790584,0.0065887096432975,0.872673042054249
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BRME1,Break repair meiotic recombinase recruitment factor 1,39719,-0.000690800043146921,0.00432924553719532,-0.00917612129604974,0.0077945212097559,0.873226089393286
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ESR1,Estrogen receptor,39784,-0.000911731050398446,0.00575044635553191,-0.012182605907241,0.0103591438064441,0.874026751860725
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TMED10,Transmembrane emp24 domain-containing protein 10,39706,0.000795228492530889,0.00505266735058663,-0.00910799951461891,0.0106984564996807,0.874942204744428
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,41696,0.00109118819840695,0.0069469611257683,-0.0125248556080989,0.0147072320049128,0.87518892551531
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNPO1,Transportin-1,39881,0.000580073734663244,0.00369470894848567,-0.00666155580436867,0.00782170327369516,0.875246869019987
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANXA4,Annexin A4,42094,-0.00115851495606667,0.00741478232462736,-0.0156914883123363,0.013374458400203,0.875843171715762
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VNN2,Vascular non-inflammatory molecule 2,42094,0.000730549487150633,0.00472543694766507,-0.0085313069302729,0.00999240590457417,0.877139599950648
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAP1LC3B2,Microtubule-associated proteins 1A/1B light chain 3 beta 2,39706,0.00107401859561682,0.00704604512399149,-0.0127362298474065,0.0148842670386401,0.878851848680089
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,INSL3,Insulin-like 3,40054,-0.00122923744029345,0.00812796867452983,-0.0171600560423719,0.014701581161785,0.879792753129317
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ART5,Ecto-ADP-ribosyltransferase 5,39719,0.00100219393651607,0.00671794286967546,-0.0121649740880478,0.01416936196108,0.881413141541098
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ERC2,ERC protein 2,39768,-0.00115579043347904,0.00792887750465162,-0.0166963903425962,0.0143848094756381,0.884105941140049
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TRPV3,Transient receptor potential cation channel subfamily V member 3,39706,-0.000730260021741822,0.0050469810432814,-0.0106223428665734,0.00916182282308972,0.884956479106851
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HMMR,Hyaluronan mediated motility receptor,39646,-0.00073226689563197,0.00520037276798089,-0.0109249975208745,0.00946046372961057,0.888022390901436
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LCN15,Lipocalin-15,40054,0.000887012449427649,0.00650047340738274,-0.0118539154290425,0.0136279403278978,0.891465299228723
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GFRAL,GDNF family receptor alpha-like,39686,0.000887923383570744,0.00653758503451113,-0.0119257432840711,0.0137015900512126,0.891967565916755
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MDK,Midkine,42146,-0.000716034771216617,0.00529799474680294,-0.0111001044749504,0.00966803493251714,0.892493769783569
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLPS,Colipase,42099,-0.00101797047607349,0.00757632337567139,-0.0158675642923894,0.0138316233402424,0.89311837029905
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RNASE10,Inactive ribonuclease-like protein 10,39804,-0.000688015498535077,0.00515069041200263,-0.0107833687060602,0.00940733770899008,0.893739340983326
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL11,Interleukin-11,41887,0.000864856463274297,0.0065382849003271,-0.0119501819413668,0.0136798948679154,0.894768293309303
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MMP12,Macrophage metalloelastase,42098,-0.000748855195574701,0.00582501631355665,-0.0121658871701457,0.0106681767789963,0.897709031700392
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TEX33,Testis-expressed protein 33,39881,0.000509911169698795,0.00400127227280182,-0.00733258248499276,0.00835240482439035,0.898596726107735
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MANSC4,MANSC domain-containing protein 4,39706,0.000934955168377729,0.00744133933615418,-0.0136500699304845,0.0155199802672399,0.900016610321517
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACADM,"Medium-chain specific acyl-CoA dehydrogenase, mitochondrial",39881,-0.000901924742108867,0.00733156643460847,-0.0152717949539415,0.0134679454697237,0.902094066430562
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LILRB5,Leukocyte immunoglobulin-like receptor subfamily B member 5,42296,-0.000880791137128568,0.0073014977952526,-0.0151917268158237,0.0134301445415665,0.903984712515231
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EXOSC10,Exosome component 10,39706,0.000758569551204959,0.00632604359185246,-0.0116404758888259,0.0131576149912358,0.904555023272316
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATP6V1D,V-type proton ATPase subunit D,42094,0.00032179895038834,0.00271978623365996,-0.00500898206758518,0.00565257996836186,0.905817746760047
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCN3A,Sodium channel protein type 3 subunit alpha,39768,0.00045508681037563,0.00388048814971835,-0.00715066996307235,0.00806084358382361,0.906643839470684
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CINP,Cyclin-dependent kinase 2-interacting protein,39881,-0.000534848115313108,0.00456304905552721,-0.00947842426414645,0.00840872803352023,0.906693564174035
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KCNC4,Potassium voltage-gated channel subfamily C member 4,39719,-0.000683953481708602,0.00584758776552603,-0.0121452255021396,0.0107773185387224,0.906891324541384
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COMMD9,COMM domain-containing protein 9,40020,-0.000460220063811931,0.00414338328620122,-0.00858125130476632,0.00766081117714245,0.91156012541553
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,B4GALT1,"Beta-1,4-galactosyltransferase 1",42184,0.000323473829102246,0.00293901232415255,-0.00543699032623675,0.00608393798444124,0.91236183611258
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINI1,Neuroserpin,39847,-0.000345493031338422,0.00314658366280644,-0.00651279701043905,0.00582181094776221,0.912570526739288
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VTCN1,V-set domain-containing T-cell activation inhibitor 1,41861,0.000361343500625453,0.00332580007303704,-0.00615722464252715,0.00687991164377806,0.913482937631157
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COPE,Coatomer subunit epsilon,41829,0.000524456093796073,0.00491714186951687,-0.009113141970457,0.0101620541580491,0.915061419920008
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENTPD6,Ectonucleoside triphosphate diphosphohydrolase 6,41876,-0.000296079429407758,0.00288081782134208,-0.00594248235923824,0.00535032350042272,0.918142241663714
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD46,Membrane cofactor protein,42091,0.000309743592945688,0.00301398282887338,-0.00559766275164613,0.00621714993753751,0.918148014704224
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TMSB10,Thymosin beta-10,42120,0.000773065399896724,0.00767676350443306,-0.0142733910687921,0.0158195218685855,0.919788589475814
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CAPG,Macrophage-capping protein,41971,-0.000584756162256486,0.00607012575488355,-0.0124822026418282,0.0113126903173153,0.923257255375765
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLCB1,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1",39784,-0.000412126695299522,0.00444042748665649,-0.00911536456914623,0.00829111117854719,0.9260543619928
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MRPL52,"39S ribosomal protein L52, mitochondrial",39646,-0.000253118657714643,0.00276227002896363,-0.00566716791448336,0.00516093059905408,0.92699036125481
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLAMF7,SLAM family member 7,42103,-0.000562260964603418,0.00620146905085382,-0.0127171403042769,0.0115926183750701,0.927759577099717
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACTN4,Alpha-actinin-4,41887,-0.000300813499329499,0.0034024466124922,-0.00696960885981421,0.00636798186115521,0.929551462180734
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLG,Plasminogen,39864,-0.000195683714765776,0.00223749099860901,-0.00458116607203943,0.00418979864250788,0.930310094838611
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL5,Interleukin-5,41887,0.00122965635776844,0.014505028385739,-0.0272001992782799,0.0296595119938168,0.932442012959316
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TIMP2,Metalloproteinase inhibitor 2,40080,0.000222641481339116,0.00286978962523619,-0.00540214618412381,0.00584742914680204,0.938162690289951
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TSPAN15,Tetraspanin-15,39706,0.000409935048174318,0.0054325649401545,-0.0102378922345285,0.0110577623308771,0.939851081029946
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ERCC1,DNA excision repair protein ERCC-1,39665,0.000262377351400151,0.00356962244598933,-0.00673408264273894,0.00725883734553924,0.941407396215365
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IFNL2,Interferon lambda-2,39719,-0.000454264221534473,0.00639271405388149,-0.0129839837671422,0.0120754553240733,0.943351607001576
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EPB41L5,Band 4.1-like protein 5,39768,0.000453030239016391,0.00639576877474163,-0.0120826765594772,0.01298873703751,0.943532162735361
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DUSP29,Dual specificity phosphatase 29,39768,-0.000481662850953932,0.00705143067896557,-0.0143024669817264,0.0133391412798186,0.945542455945907
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGDCC4,Immunoglobulin superfamily DCC subclass member 4,40097,0.000191753965045634,0.00281185192490433,-0.00531947580776685,0.00570298373785812,0.945631736047276
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NDUFS6,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 6, mitochondrial",41861,0.000534144531024249,0.00808031956574977,-0.0153032818178453,0.0163715708798938,0.94729576539872
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,JMJD1C,Probable JmjC domain-containing histone demethylation protein 2C,39665,0.000399560755194515,0.00608213631307495,-0.0115214264184324,0.0123205479288214,0.947622586747024
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLK12,Kallikrein-12,41861,0.000953137974983923,0.0145199824711489,-0.027506027668468,0.0294123036184358,0.947662938136641
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SDC4,Syndecan-4,42144,0.000314346762047711,0.00488246292696185,-0.00925528057479752,0.00988397409889294,0.94866639810089
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RANGAP1,Ran GTPase-activating protein 1,41861,0.000322515288418877,0.00504922479051839,-0.00957396530099717,0.0102189958778349,0.949071388745634
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYBPC1,"Myosin-binding protein C, slow-type",40080,0.000465325007698734,0.00743948335758003,-0.0141160623731581,0.0150467123885556,0.950127564906647
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MORN4,MORN repeat-containing protein 4,39665,-0.000484356448579814,0.00796939345068197,-0.0161043676119165,0.0151356547147568,0.951537905465034
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TYRP1,"5,6-dihydroxyindole-2-carboxylic acid oxidase",39784,0.000379172148836638,0.00669778532016759,-0.0127484870786918,0.0135068313763651,0.954855685062628
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DOCK9,Dedicator of cytokinesis protein 9,39719,-0.000699219116899658,0.0125353288471129,-0.0252684636572409,0.0238700254234416,0.955518223589759
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SHPK,Sedoheptulokinase,39881,-0.000236418391420979,0.00423966619702296,-0.00854616413758598,0.00807332735474402,0.955531298949866
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SIRPA,Tyrosine-protein phosphatase non-receptor type substrate 1,42181,-0.00033157338112166,0.00597644451039726,-0.0120454046215003,0.011382257859257,0.955756884578413
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TBR1,T-box brain protein 1,39768,0.000280512740710476,0.00508714725923851,-0.009690295887397,0.010251321368818,0.956026805708852
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EIF5A,Eukaryotic translation initiation factor 5A-1,41887,0.000151459074809146,0.0030988107109296,-0.00592220991861287,0.00622512806823117,0.961018472107369
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BST1,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2,42213,-0.000234606874245139,0.00491427833986172,-0.00986659242037412,0.00939737867188384,0.961924312788381
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RBM19,Probable RNA-binding protein 19,39706,-0.000235374886530944,0.00503592998284286,-0.0101057976529029,0.00963504787984106,0.962722046801605
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TSLP,Thymic stromal lymphopoietin,41876,0.000271049998359608,0.00633157252085849,-0.012138832142523,0.0126809321392422,0.965854248217433
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MLLT1,Protein ENL,39665,-0.000288446638430152,0.00693114034219519,-0.0138734817091327,0.0132965884322724,0.966805576863121
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL9,Interleukin-9,39881,-0.000237625190880317,0.00583808365636287,-0.0116802691573515,0.0112050187755909,0.967533748179284
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RIPK4,Receptor-interacting serine/threonine-protein kinase 4,39706,-0.000294453503654231,0.00745218409946992,-0.0149007343386153,0.0143118273313068,0.968482636573166
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DPT,Dermatopontin,42296,-0.00010339018481895,0.00261786255644532,-0.00523440079545177,0.00502762042581387,0.968497041068902
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TPRKB,EKC/KEOPS complex subunit TPRKB,39665,0.000268215265534365,0.00687843364764023,-0.0132135146838405,0.0137499452149092,0.968896191078553
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AXL,Tyrosine-protein kinase receptor UFO,42197,-0.000111123872251629,0.00288556793782223,-0.00576683703038321,0.00554458928587995,0.969281469881909
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BNIP2,BCL2/adenovirus E1B 19 kDa protein-interacting protein 2,40080,0.000132603730788063,0.00345817914759348,-0.00664542739849516,0.00691063486007129,0.969413349731446
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CA13,Carbonic anhydrase 13,41998,-0.000409032746316593,0.0106701734021212,-0.0213225726144741,0.0205045071218409,0.9694218069644
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GJA8,Gap junction alpha-8 protein,39665,-0.000248757746649317,0.00681080720837457,-0.0135979398750635,0.0131004243817648,0.970865259057885
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DEFA1_DEFA1B,Neutrophil defensin 1,41869,0.000207675778510552,0.00572930641248429,-0.0110217647899587,0.0114371163469798,0.971085200213923
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KCNH2,Potassium voltage-gated channel subfamily H member 2,39768,-0.000284717238618523,0.00816601131639347,-0.0162900994187497,0.0157206649415127,0.972187144058816
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GP5,Platelet glycoprotein V,39863,-0.000129056776399808,0.00372350687917435,-0.00742713025958154,0.00716901670678193,0.972351499531301
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDE4D,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",39706,-0.000190948107061226,0.0062155867592706,-0.0123734981552316,0.0119916019411091,0.975492746510845
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TPSG1,Tryptase gamma,39784,-8.34128832679289e-05,0.00275407838268364,-0.00548140651332786,0.005314580746792,0.975838702822839
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CPOX,"Oxygen-dependent coproporphyrinogen-III oxidase, mitochondrial",39784,8.90841072449671e-05,0.00296071344044364,-0.00571391423602456,0.00589208245051449,0.975996855834535
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RLN1,Prorelaxin H1,40054,0.000148035988687101,0.00502610882902757,-0.00970313731620694,0.00999920929358115,0.976503526236405
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KIRREL2,Kin of IRRE-like protein 2,41829,-0.000121781926867341,0.00420656153898422,-0.00836664254327642,0.00812307868954174,0.97690455174871
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SHC1,SHC-transforming protein 1,39665,-0.000353341685858986,0.0122568042924313,-0.0243766780990244,0.0236699947273064,0.977002154041169
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PREB,Prolactin regulatory element-binding protein,41887,6.45321621377286e-05,0.00305170251560751,-0.00591680476845299,0.00604586909272845,0.983129297783295
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACRBP,Acrosin-binding protein,40020,7.7569678915203e-05,0.00408048211749169,-0.00792017527136851,0.00807531462919892,0.984833534266917
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTN,Pleiotrophin,41876,-9.50243959761827e-05,0.00513625605694398,-0.0101620862675864,0.00997203747563402,0.985239700311956
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LGALS1,Galectin-1,42144,6.40707751532907e-05,0.00365981287821683,-0.00710916246615169,0.00723730401645827,0.986032760194542
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEACAM1,Carcinoembryonic antigen-related cell adhesion molecule 1,42157,-3.71004828008471e-05,0.00222096406557423,-0.00439019005132635,0.00431598908572465,0.986672474688355
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHEK2,Serine/threonine-protein kinase Chk2,41876,5.60864040015509e-05,0.00345714377951844,-0.00671991540385459,0.00683208821185769,0.987056473941052
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD3G,T-cell surface glycoprotein CD3 gamma chain,39784,-0.000144030779583392,0.00942436105232114,-0.0186157784421328,0.018327716882966,0.987806839310055
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PFDN6,Prefoldin subunit 6,39768,7.92650112161716e-05,0.00673563768893063,-0.0131225848590879,0.0132811148815202,0.990610930025381
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNLZ,DNL-type zinc finger protein,39719,-0.000107616490440045,0.00940805294467264,-0.0185474002619984,0.0183321672811183,0.990873603224395
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ALCAM,CD166 antigen,42296,2.25224054807864e-05,0.00203877997679286,-0.00397348634903322,0.00401853115999479,0.991186115518742
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NOS1,"Nitric oxide synthase, brain",41829,3.75365155032462e-05,0.00563745477507329,-0.0110118748436404,0.0110869478746469,0.994687497553803
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYO6,Unconventional myosin-VI,40054,-2.24981409577953e-05,0.00377201738744527,-0.00741565222035053,0.00737065593843494,0.995241167311241
